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SUMMARY
Analysis of the ci s-actinq motifs and trans-acting 
factors responsible for regulating the expression of the 
varicella-zoster virus (VZV) major immediate early (IE) gene 
was undertaken. The control of VZV IE gene expression has 
relevance to the fields of eukaryotic gene regulation and 
herpesvirus biology.
In order to analyse the control sequences of the VZV 
major IE gene, knowledge of the location of the 5' end of 
its mRNA was required. Primer extension and SI nuclease 
analyses concurred in defining it as being 74 base pairs 
(bp) upstream of the proposed trans/ ion initiation site. 
Analysis of DNA sequences upstream of the start site 
revealed a candidate for a 'TATA' motif present at -25 to 
-30 bp, a finding common to many genes transcribed by 
eukaryotic RNA polymerase II.
Analysis of the activity of the control region of the 
VZV major IE gene was undertaken using plasmids in which
sequences to -1150 were inserted upstream of the "reporter"
£flood i'nq>.
genes/p-galactosidase or chloramphenicol acetyl transferase. 
The activities of the complete control region and of a 
series of deletions were then determined in a range of cell 
types, using short term transfection assays. A significant 
finding to emerge from these experiments was that the 
control sequences responsible for the transcription of the 
VZV major IE gene do not direct a high level of expression 
of reporter genes in any of the cell types tested. The 
baseline level of transcriptional activity was dependent on 
sequences located between nucleotides -131 and -25. 
Co-transfection of a plasmid which expresses the herpes 
simplex virus type 1 (HSV-1) protein Vmw65 resulted in a 
20-50 fold stimulation of expression from the VZV IE 
promoter. This effect depended on the presence of regulatory 
sequences between -409 bp and -130 bp. A second set of 
co-transfection experiments investigated the effect on the 
VZV control sequences of a plasmid encoding the 
transactivating product of the adenovirus 5 ElA gene. The 
presence of this polypeptide resulted in stimulation of 
expression by 10 fold. In contrast with the effect of
Vmw65, the activity of the ElA gene product depended on 
sequences present within the first 131 bp of the mRNA start 
site.
Gel retardation and DNAase I protection assays were 
used to locate sites at which proteins bind to the control 
sequences. Results from these experiments reinforced and 
expanded the conclusions made from the functional assays.
DNA fragments from the promoter region, -35 to -130, were 
shown to bind two proteins. Sequence analysis and 
competition experiments identified these proteins as 
belonging to two families of transcription factors known as 
'CCAAT box binding' proteins and the 'ATF/CRE' family.
A second protein binding region was present between 
-409 and -246 and was shown to consist of two binding sites 
for the cellular transcription factor Oct-1, which binds to 
the consensus ATGCAAAT. The proximal binding site could be 
expanded to incorporate a TAATGARAT motif known to allow 
Vmw65 to participate in the formation of a complex including 
Oct-1 and other cellular proteins, thus allowing Vmw65 
mediated transactivation. Both sites were shown to bind 
Oct-1 and the proximal site was also shown to bind Vmw65 
with high affinity, probably explaining the effect of this 
protein on VZV IE gene expression.
In view of these results the analysis of VZV open 
reading frame (orf) 10 was undertaken. Sequence comparison 
of orflO and Vmw65 had shown considerable homologies between 
the amino-terminal portions of the proteins but the absence 
from orflO of a carboxy-terminal region of 78 amino acids 
known to be essential for transcriptional activation by 
Vmw65. Both the functional activity of orflO and its 
ability to participate in complex formation at TAATGARAT 
motifs were tested. A plasmid, constructed to express the 
product of VZV orflO, failed to stimulate expression from 
plasmids containing HSV-1 or VZV IE control sequences. The 
product of VZV orflO was also produced in vitro and failed 
to participate in the formation of DNA binding complexes 
when incubated with cellular proteins and the TAATGARAT 
motif.
Two other VZV orfs were studied. The first was number 
66, which encodes a protein which shows many similarities to 
known protein kinases. The system chosen to express this
orf utilised the HSV-1 temperature sensitive mutant tsK and 
HSV-1 IE control sequences. At nonpermissive temperatures 
tsK overproduces IE polypeptides, generating quantities 
sufficient for biochemical characterisation of heterologous 
orfs expressed in this way. In order to simplify the 
selection of recombinant viruses containing VZV orfs the E. 
coli B-galactosidase enzyme, with HSV-1 IE control 
sequences, was inserted into the thymidine kinase gene of 
tsK. This done, orf66 was recombined into the virus and 
progeny selected by their inability to metabolise the 
chromogenic substance X-gal. Virus stocks containing the 
VZV orf were purified and its presence confirmed by Southern 
blot hybridisation analysis. No product of the inserted orf 
was detected when viral proteins, synthesised at 38*5°C, 
were analysed by SDS-polyacrylamide gel electrophoresis.
The second orf investigated was number 36, which is 
predicted to encode the VZV pyrimidine deoxynucleoside 
kinase enzyme. Attempts were made to overexpress and 
analyse this enzyme using the plasmid pKK233-2, which allows 
inducible expression of unfused proteins in prokaryotic 
cells. High levels of expression were achieved but no novel 
kinase activity could be detected. The possible reasons for 
this finding are discussed.
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1. INTRODUCTION
1.1. The Human Herpesvi ruses.
1.1.1. Herpesviruses - Description and Classification.
Herpesviridae are a group of large, DNA containing, 
viruses which possess a similar overall structure consisting 
of envelope, tegument, capsid and core (DNA-protein 
complex)(Wildy et al., 1960, Epstein 1962).
The envelope is a large, loosely fitting, structure 
derived from the nuclear membrane of the infected cell. It 
is typically triple layered in section and has projections 
8nm in length (Morgan et a l ., 1959, Epstein, 1962, Wildy and 
Watson 1963, Asher et a l ., 1969, Spear and Roizman, 1972). 
The structure found between the envelope and the capsid is 
known as the tegument. Its structure on electron microscopy 
is ill defined, though a fibrous appearance is often 
observed on negatively stained material (Wildy et a l ., 1960, 
Epstein, 1962, Roizman and Furlong, 1974). The nucleocapsid 
lies within the tegument and has been studied in most detail 
in HSV-1. It is an icosahedral structure, 100-110nm in 
diameter, consisting of an outer layer of 150 hexameric and 
12 pentameric capsomeres (Wildy et aJ.., 1960) and an inner 
layer of proteinaceous material in a T=4 icosahedral lattice 
(Schrag et al., 1989). The herpes virus core is located 
within the capsid and contains the DNA and protein arranged 
in a toroidal structure (Epstein, 1962, Nazerian, 1974, 
Furlong et a^L., 1972). The most widely accepted model for 
the structure of this component is that of Furlong et a l ., 
(1972) who described a centrally located cylinder, likely to 
be proteinaceous in nature, around which is wound DNA 
probably, in the form of a nucleoprotein filament.
The classification of herpes viruses was made on the 
basis of their biological properties including host range, 
length of reproductive cycle, cytopathology and 
characteristics of latent infection, by the Herpes study 
group appointed by the International committee on taxonomy 
of viruses (Roizman et a_l., 1981). Table 1. shows a summary 
of the characteristics of herpesvirus subfamilies together 
with the human herpes viruses which belong to them.
Table 1.1.
CHARACTERISTICS OF HERPESVIRUS SUBFAMILIES AND 
DESIGNATION OF HUMAN HERPESVIRUSES
Alphaherpesvirinae
Short reproductive cycle
Wide or narrow host range in tissue culture 
Cytolytic infections
Latency frequently established, primarily in 
ganglia 
Herpes simplex virus 1 
Herpes simplex virus 2 
Varicella-zoster Virus
Betaherpesvirinae
Relatively short reproductive cycle; slowly 
progressing infection in tissue culture 
Narrow host range in tissue culture; frequently 
restricted to natural host
Cytomegalic; infected cells undergo enlargement 
Human cytomegalovirus 
Human herpes virus 6
Gammaherpesvirinae
Host range limited to family or order of natural 
host
In tissue culture replication in lymphoblastoi.d 
cells; some cause lytic infections in epithelioid 
and fibroblastic cells
Latent infections, often in lymphoid tissues 
£jp&-frzJs\ — 13a rr n^ s
1.1.2. Human Herpesviruses and Disease.
The six human herpes viruses thus far recognised cause 
a variety of conditions ranging from the mild to the fatal. 
HSV-1 and HSV-2 normally cause a subclinical primary 
infection of mucocutaneous membranes or traumatised skin. A 
latent infection is then established in the sensory ganglia 
serving the area of primary infection, with recurrent 
infections also occurring in this distribution (Baringer and 
Swoveland, 1973, Fraser et al., 1981). HSV-1 normally
affects the oropharynx or the eyes, while HSV-2 infections 
are mainly localised to the mucous membranes and skin of the 
genitals (Whitley, 1985).
Varicella-zoster virus (VZV) is the cause of the 
childhood condition of chickenpox, a widespread vesicular 
rash present mainly on the head and trunk.though mucous 
membranes can also be affected. It is spread either by 
direct contact or as an airbo;.rne infection (Johnson ^t al.,
1982). Again, latency in sensory ganglia follows the 
primary infection and reactivation can lead to the painful 
disease of shingles (Hope-Simpson, 1965). This can occur at 
any time following primary infection though it does so more 
commonly with advancing age, a finding that may be related 
to decreased immune defence (Schimpff et a l ., 1972). Both 
herpes simplex viruses and VZV can spread to the central 
nervous system (CNS) and cause meningitis and encephalitis, 
potentially life threatening conditions (Kennedy, 1987).
Human cytomegalovirus (HCMV) infection is normally a 
benign, self limiting or asymptomatic infection. However, 
transplacental transfer of HCMV, which can occur as a result 
of both primary infections and reactivation of latent virus, 
is, medically, the most important congenital viral infection 
with intrauterine death, prematurity, malformations and 
somatic and mental retardation being potential sequelae 
(Alford and Britt, 1984). Reactivation of latent virus can 
occur as a result of immunostimulation or immunosuppression 
and, like primary infections, results in a range of 
conditions including simple pyrexia, infectious 
mononucleosis and hepatitis (Ho, 1982).
Figure 1.1. STRUCTURES OF THE GENOMES OF THE HUMAN
HERPESVIRUSES
The genomes are represented as linear molecules. 
The bold lines represent unique sequences and the boxes 
represent repeat sequences with arrows indicating the 
relative sequence orientations. The genomes are described 
in Section 1.1.3..
ABREVIATIONS: 
Sequences; °L - unique, long
us - unique, short
i/t r l  - internal/terminal repeat long
I/TRs " internal/terminal repeat short
1
IQ
direct repeat, left
d r  - direct repeat, right
ori
This figure was adapted from McGeoch (1989), with 
permission.
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3Human herpes virus 6 has been isolated from patients 
with lymphoproliferative disorders and can cause the 
condition exanthem subitum, presumably as a manifestation of 
primary infection (Yamanishi £t al., 1988).
Epstein-Barr virus (EBV) usually causes subclinical 
primary infections, though increasing age is generally
associated with increasing severity of symptoms resulting in 
infectious mononucleosis amongst adolescents. This virus 
has also been found to be associated with the development of 
two tumours, Burkitts lymphoma and nasopharyngeal carcinoma,
though the precise role played by the virus in these
conditions is not clear (Neideman et a l ., 1976; Miller, 
1985) .
1.1.3. Genome Structures of the Human Herpes Viruses
The genomes of all herpes viruses are linear DNA 
molecules which differ amongst themselves with respect to 
size, base composition, and the pattern of large scale
repeated sequences (Honess, 1984). No unique value for
genome size can be given as all herpes viruses so far 
sequenced have several sources of natural variability. The 
overall genome arrangements for the human herpes viruses, 
for which details are available, are given in figure 1.1.
The completed sequence of HSV-1 (strain 17) was
published by McGeoch et al., (1988). It consists of 152,260
nucleotides in each strand, with one overhanging residue at
each end (Mocarski and Roizman, 1982) and has an overall G+C
content of 68.3%. The genome can be considered to be
subdivided into covalently joined long and short
segments which are themselves composed of a central unique
sequences (U and Uc ) flanked by oppositely oriented repeats J_j b
(TR and IRT , TR„ and IRC ). Directly repeated a sequences J-l Li b b
of 400bp exist at the genomic termini and at least one copy 
of the a sequence is also found at the junction of the and 
g segments (Davison and Wilkie, 1981, Roizman, 1979). The 
genome exists in four equimolar sequence orientations formed 
by the relative inversion of the long and the short 
sequences; one of these has been designated the prototypic 
orientation. The genome structure and composition of HSV-2
4is very similar to that of HSV-1 albeit with a slightly
higher G+C content.
Analysis of the VZV genome was commenced by Ludwig et
al., (1972) who used isopycnic sedimentation to determine
its G+C content to be 46%. Further analysis of the genome,
(Dumas et aJL. , 1980), using DNA isolated from infected
cultures, suggested a molecular weight of 80xl06
(approximately 120kbp). The gross structure of the VZV
genome was then investigated by restriction mapping (Dumas
et a l ., 1981) and examination of annealed single stranded
virion DNA molecules by electron microscopy (Ecker and
Hyman, 1982; Straus et a l ., 1982; Gilden et al., 1982).
These initial studies suggested that the VZV genome
consisted of two segments, and c . The segment was shownL
to be a unique sequence of lOOkbp while the segmentO
consisted of a central unique portion of 5.4kbp flanked by 
inverted repeated sequences of 6.8kbp. Further analysis of 
restriction endonuclease digestion patterns showed half 
molar fragments of TRg and IRg suggesting the existence of 
two genome isomers formed by the inversion of the segmentO
relative to the segment (Dumas et al., 1981; Straus etL
al., 1981,1982; Ecker and Hyman, 1982). More detailed
analysis of the genomic termini and comparison with the Lb
joint by sequencing revealed that, in contrast with most 
herpes viruses, the VZV genome possessed no terminal 
redundancy (Davison, 1984), and that 88.5 bp inverted 
repeats were present flanking the T segment (Davison, 1984). 
Like HSV-1, each 3' end of the genome was shown to have a 
single unpaired residue, C at the segment terminus and G 
at the segment terminus. Finally this study demonstratedO
the presence of two minor genomic arrangements constituting 
5% of the total and resulting from the inversion of the 
segment from its prototypic orientation (Davison, 1984). 
Thus, the overall structures of VZV and HSV genomes are 
similar but VZV remains unique amongst herpes viruses thus 
far analysed in having unequal proportions of its sequence 
orientations.
A total of 14 restriction endonuclease maps of the VZV 
genome were published during the early 1980's (Dumas et al., 
1981; Ecker and Hyman, 1982; Straus et a l ., 1982, 1983; 
Davison and Scott, 1983; Gilden et a J ., 1982; Mish ra et
5a l ., 1984). These, along with epidemiological studies of
virus isolates and studies of genome variability Ln vivo and 
in vitro, led to the demonstration of variability in the 
size of fragments derived from specific locations within the 
virus genome. Comparison of these with the sequence of the 
Dumas strain (Davison and Scott, 1986) showed that the 
variability mapped to three locations at which tandem direct 
reiterations of short G+C rich sequences were found. A
fourth variable locus was found in the U sequence close to
L
the k_c; joint (Hondo et. al_. , 1987); this contains 88bp 
direct repeats with three mismatches which are not G+C rich 
and are separated from each other by 24bp spacers. The 
role, if any, of these variable regions, which also occur in 
other herpes viruses in both coding and non-coding regions 
of the genome (Davison and Wilkie, 1981; Watson et a l ., 
1981), is not clear.
The sequence of HCMV, though nearing completion, is as 
yet unpublished. It is larger than those of HSV-1, VZV and 
EBV, being approximately 230kbp with a G+C content of 56%. 
Its overall arrangement is similar to that of HSV, having 
long and short segments with inverted terminal repeats 
(Westyfr&te et al. , 1983), an equivalent to the a sequence, 
and 4 equimolar sequence orientations (Spaete and Mokarski, 
1985) .
EBV was the first herpes virus whose complete sequence 
was determined. The sequence, 172282 residues of base 
composition 59.9% G+C, was derived from the B95-8 strain 
(Baer et al., 1984). The arrangement of the genome shows 
considerable differences from that of HSV, having long and 
short unique sequences bounded by variable numbers of 540bp 
direct repeats at the termini and 3072bp direct repeats 
internally.
A much less complete picture is available for the gross 
structure of the HHV6 genome although preliminary results 
suggest that it contains approximately 160kbp with a base 
composition of 42% G+C it consists of a single unique region 
flanked by direct repeats and appears to be most closely 
related to HCMV (Lawrence et al.. , 1990).
1.2. Biology and Pathology of VZV Infections
61.2.1. VZV Infections I_n Vivo.
As noted above, VZV causes two main clinical 
conditions, chickenpox, a childhood exanthem, and shingles 
which follows reactivation.
Since chickenpox is a benign condition and lacks a good 
animal model (Provost et al., 1987), knowledge of its 
pathogenesis comes largely from analogy with other viral 
exanthems (Gelb, 1985). Infection appears to occur through 
the mucosa of the upper respiratory tract or the 
conjunctivae with both air spread and direct transmission 
being possible as routes of infection (LeClair et al., 1980; 
Gustafson et al., 1982; Weller, 1983).
An incubation period of about 14 days occurs between 
primary infection and the appearance of vesicles. During 
this period the virus replicates at the initial site of 
infection and then spreads as a primary viraemia in the 
blood and lymph. The virus is taken up by the cells of the 
reticuloendothelial system and undergoes multiple cycles of 
replication which result in a secondary viraemia (Feldman 
and Epp 1979). This is associated with prodromal symptoms 
which are rapidly followed by the typical vesicles occurring 
in the skin, the mucous membranes and the parenchyma of 
almost every organ (Cheatam et al., 1956, Johnson, 1940, 
Taylor-Robertson and Caunt, 1972). Vesicle formation is 
initiated by infection of the endothelial cells of 
capillaries allowing virus spread to the surrounding 
tissues. In the case of the skin this results in the 
infection of basal layers of the epidermis causing 
extracellular oedema, separation of the basal layer s from 
the unaffected stratum corneum and thus formation of the 
typical vesicle (Gelb, 1985). New vesicles occur in crops 
over a period of three days (Gold, 1966) after which, under 
normal circumstances, the immune response to the virus 
results in its clearance (Gershon and Steinberg, 1979, 
Feldman et al., 1975, Rand et al., 1977).
Complications of chickenpox fall into two categories. 
First, uncontrolled infection can lead to varicella 
pneumonia with widespread damage to the linings of small 
blood vessels in the lungs resulting in thrombosis and 
haemorrhage (Cheatham et a_l. , 1956). Second, aberrant
immune responses to the virus may result in 
meningoencephalitis, Guillian-Barre syndrome and Reyes 
syndrome, which can occur up to three weeks after the onset 
of the rash (Johnson, 1982, Johnson et al., 1985, Kennedy, 
1987) .
During the course of its primary infection VZV 
establishes a latent infection in the sensory ganglia of 
spinal nerves and the trigeminal nerve, as proposed 
initially by Hope-Simpson (1965). That this occurs at the 
vesicular stage of the infection is suggested by the finding 
that frequency of reactivation in a given dermatome 
correlates with the density of vesicles during the primary 
infection (Gelb, 1985, Kennedy, 1987). Evidence that the 
dorsal root ganglia are indeed the site of latency is argued 
for by the unilateral, segmental pattern of recurrence. 
However, direct evidence is lacking as, unlike HSV, VZV 
cannot be recovered from ganglia obtained randomly at 
autopsy (Price, 1986; Kennedy, 1987), though viral DNA has 
been detected in lysates of ganglia in the absence of 
clinical disease by Southern hybridisation (Gilden et al.,
1983). Attempts to localise the site of VZV latency within 
the ganglia are more controvertial, with both neuronal 
(Hyman et al., 1983) and non-neuronal (Croen et al., 1988) 
sites being proposed. Both of these studies detected RNA by 
in situ hybridisation from many but not all areas of the 
genome, raising the possibility that at least partial 
reactivation had occurred as a result of the death or 
illness of the donor. These findings are in contrast to the 
single family of latency associated transcripts (LATs) 
mapped to the long terminal repeats of HSV-1 (Stevens et 
al. , 1987, Wechsler et aJ.., 1988). The significance of 
these differences between the HSV and VZV systems is not, as 
yet, clear.
While too little is known of the processes of the 
initiation and maintenance of latency to make meaningful 
comparisons between HSV and VZV, differences in reactivation 
are obvious at both clinical and histological levels. HSV 
reactivates to form a small lesion affecting a small part of 
a dermatome while VZV reactivation classically results in 
the appearance of vesicles throughout the dermatome. The 
histological picture of VZV reactivation is of acute
8inflammatory changes throughout the ganglion affected, with 
neuronal death and resulting sensory loss (Zacks et al., 
1964, Ghatak and Zimmerman, 1973), while there is reason to 
doubt whether neuronal death results from the reactivation 
of HSV (Price, 1986). These findings suggest reactivation 
of VZV results in a full lytic infection within the ganglion 
as well as at the epithelium, in contrast, no £uch evidence 
of infection throughout the ganglion exists for HSV 
reactivation.
The stimuli that result in clinically detectable 
reactivation also differ between the two viruses. HSV can 
be induced to reactivate by a variety of stimuli including 
exposure to UV light, fever, stress and hormonal changes 
(Wildy et al., 1982, Hill, 1985). By contrast reactivation 
of VZV is strongly associated with reduced immunity 
(Hope-Simpson, 1965, Schimpff et al., 1972). Indeed, there 
is evidence to support a model of frequent, subclinical, 
reactivations of latent VZV, in which clinical presentation 
is prevented by an effective immune response but the antigen 
released is sufficient to boost antibody levels and so mark 
the event (Luby et ad.., 1977). These alterations in humoral 
immunity could also be explained by reexposure to exogenous 
VZV which also occurs (Brundell ed: ad.., 1975 , Gershon et 
al., 1984).
Investigation of the mechanism of latency and 
reactivation would obviously be facilitated by the 
availability of a animal model system which replicates the 
pathogenesis of VZV infection. Neither of the published 
systems, guinea pig (Myres et al., 1980, 1985, Walz-Cicconi 
et a l ., 1986) or common marmoset (Provost et al., 1987),
show external signs of disease or evidence that they could 
be used for the investigation of latency.
1.2.2. Growth of VZV in Tissue Culture
Problems in developing systems for the investigation of 
VZV biology continue when the growth of the virus in tissue 
culture is considered. In common with its restricted host 
range _in vivo, human and primate cells have been found to be 
most permissive for virus replication in tissue culture
9(Grose and Brunell, 1978, Schmidt and Lennette, 1976, Caunt 
and Taylor-Robinson, 1964). However, even when permissive 
cells are infected, only low titres of cell free virus can 
be obtained (Taylor-Robinson and Caunt, 1972, Shiraki and 
Hyman, 1987). In contrast, virus infected cells can be used 
to propagate infections at high efficiency (Rapp, 1964). 
The dearth of infectious cell free virus is hard to explain 
as large numbers of apparently mature virions are found 
associated with the surface of cells late in infection. 
Indeed, studies comparing pfu with the numbers of particles 
of normal morphology in sonicated samples of infected cells 
have determined a ratio of approximately 10 :1 (Shiraki and 
Takahashi, 1982, Gelb, 1985). Coat lability (Cook and
Stevens, 1968), lysosomal enzymes, (Gershon et al., 1973) 
and faulty maturation in tissue culture (Becker et al., 
1965) have been proposed to explain this phenomenon. Even 
when infectious cell free virus is obtained, either from 
tissue culture or directly from vesicles, the rate at which 
infection proceeds is less than that seen with infected 
cells (Caunt and Taylor-Robinson, 1964, Schmidt and 
Lennette, 1972) suggesting that factors related to the 
infected cells as well as the virus itself, may be relevant 
to the,, iji vitro, phenotype of the virus.
Attempts have also been made to investigate the 
interaction of VZV with neurones using cell culture systems 
(Wigdahl et a l . , 1986, Vafai et aJL., 1988, Merville-Louis et 
al., 1989). These workers came to different conclusions 
regarding both the ability of VZV to undergo lytic infection 
and the transcripts and proteins produced during the
infective process. The discrepancies were presumably
related to differences in the sources of the cells and the
culture systems used. Thus the relevance of any or all of
these systems to viral infections of humans awaits further 
evaluation.
1.3. Molecular Biology of VZV
1.3.1. The VZV Genome.
The derivation of the sequence of the VZV genome
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(Davison and Scott, 1986) marked a turning point in the 
study of the virus. Prior to this study the information 
available regarding products induced by virus infection was 
restricted to two main groups, first, activities of
pyrimidine deoxynucleoside kinase (Doberson et a l ., 1976),
DNA polymerase (Miller and Rapp, 1977) and endonuclease
(Cheng et al., 1979) enzymes had been detected. Second
three major families of glycoproteins had also been defined 
using monoclonal antibodies (Davison et al., 1986; section
I.5.3.4.). In addition, several attempts had been made to 
enumerate virus specified proteins using SDS-PAGE (Wolff, 
1978; Asano and Takahashi, 1979, 1980; Shemer et. a l ., 1980; 
Shiraki et al., 1982).
Analysis of the complete sequence of VZV (Davison and 
Scott, 1986) resulted in the identification of 71 orfs in 
the VZV genome. Of these, 65 are unique and three are 
present in each of the repeated sequences flanking the short 
unique region (figure 1.2.; table 2.). Due to the similar 
genome arrangements in VZV and HSV, these data have provided 
information about the functions of over one third of the 
predicted VZV orfs (Table 2). Additional information came 
from comparison of VZV sequence data with that in the NBRF 
database. This revealed similarities between VZV orfl3 and 
known thymidylate synthetase enzymes and between orf66 and 
known protein kinases. Only the latter of these is also 
present in the HSV-1 sequence (McGeoch and Davison, 1986). 
Since the publication of the VZV sequence, new data have 
come to light which have allowed allocation of functions to 
five VZV orfs probably involved in DNA replication. These 
are homologues of the HSV proteins which, along with the DNA 
polymerase and the major DNA binding protein, have been 
shown to be necessary and sufficient for origin dependent 
DNA replication (Challberg, 1986). In addition orf61 has 
been shown to have a small but significant degree of 
homology with the HSV IE gene 1 (Perry et al., 1986), orf59 
has been shown to bear strong similarities to the recently 
recognised uracil DNA glycosylase (Worrad and Carradona, 
1988; Mullaney et al., 1989) and orf47 to other protein 
kinaseu(Smith and Smith, 1989).
Three studies have reported attempts to map RNA 
transcripts to individual orfs (Maguire and Hyman, 1986;
Figure 1.2. SUMMARY OF VZV GENE LAYOUT
The genome is represented in four sections, heavy
horizontal lines indicating the unique regions (U and U0 ),L S
the two large open rectangles depicting the inverted repeats 
flanking Ug (TRg anc* IRS^f anc  ^ tw° ^eav^' short,
vertical lines denoting the inverted repeats flanking U
L
(TR^ and 1RL ) • ORFs 1 to 71 are illustrated as arrows 
against the appropriated strand, and correspond to the 
protein coding regions shown in Table 1. Light vertical 
lines indicate potential polyadj^lation sites in the 
appropriate strand. The locations of the four reiterations 
(R1 to R4) are denoted by filled rectangles; R l , R 2 , and R3 
are in the coding regions of ORFs 11, 14, and 22, 
respectively.
Taken directly from Davison and Scott, (1986) with 
permission.
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Table 1.2.
i n
QRF Codons Mol. wt. Function^
1 108 12103
2 238 25983
3 179 19149
4 452 51540
5 340 38575
6 1038 122541
7 259 28245
8 396 44816
9 302 32845
10 410 46375
11 819 91825
12 661 74269
13 301 34531
14 560 61350
15 406 44522
16 408 46087
17 455 51365
18 306 35395
19 775 86823.
20 483 53969
21 1038 115774
22 2736 306325
23 235 24416
24 269 30451
25 156 17460
26 585 65692
27 333 38234
28 1194 134041
29 1204 132133
30 770 86968
31 868 98062
32 143 15980
33 605 66043
34 579 65182
35 258 28973
36 341 37815
37 841 93646
38 541 60395
39 249 27078
40 1396 154917
41 316 34387
42 395 82752
45 352
43 676 73905
44 363 40243
46 199 22544
47 510 54347
48 551 61268
49 81 8907
50 435 48669
51 835 94370
52 771 86343
53 331 37417
54 769 86776
55 881 98844
56 244 27166
57 71 8079
homologue of HSV-1 IE6 3 
DNA replication 
dUTPase
homologue of HSV-1 Vmw6 5
thymidylate synthetase 
glycoprotein (gpV)
DNA replication
ribonucleotide reductase
DNA polymerase 
major DNA-binding 
protein
glycoprotein (gpII)^gB
deoxynucleoside kinase 
glycoprotein (gpIII)
major capsid protein
protein kinase 
exonuclease
DNA replication 
DNA replication
DNA replication
58 221 25903
59 305 34375
60 159 17616
61 467 50913
62/71 1310 139989
63/70 278 30494
64/69 180 19868
65 102 11436
66 393 43677
67 354 39362
68 623 69953
uracil DNA glycosylase
homologue of HSV-I IE110 
homologue of HSV-1 IE175 
homologue of HSV-1 IE68
protein kinase 
glycoprotein (gpIV) 
glycoprotein (gpl)
*
Data largely taken from Davison and Scott, 
(1986)
+ All predicted mol. wt. values, except those of 
the primary translation products of genes 14, 31 
and 68, were calculated from the amino acid 
sequence commencing at the first in-frame ATG in 
the ORF
0 References to appropriate DNA sequence data from 
HSV or other organisms which confirm the assignment 
of VZV gene functions are largely given in Davison 
and Scott, (1986). Functions characterised since 
then are referenced in the text.
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Ostrove et al. , 1985; Reinhold et al., 1988). In the most 
recent of these, a total of 78 transcripts were identified 
and their direction mapped by northern blotting. Sizes 
ranged from 0.8kbp to over 8.0kbp and the probes used 
represented over 99.7% of the genome. In a few cases it was 
possible to map transcripts to individual orfs, however in 
most cases lack of resolution in the mapping made the 
allocation of transcripts to specific orfs impossible. In 
yet other cases transcripts mapped appeared not to correlate 
with any orf predicted from the sequence. More detailed 
mapping and eventually nuclease SI analysis will be required 
to define the locations of transcripts. This has been 
achf&ved for only two VZV orfs, number 61, the major IE 
gene, (this thesis) and number 36, the dPyK, (Davison and 
Scott, 1986 ) .
Along with descriptions of the functions of VZV
proteins, studies into the control of their synthesis has
suffered greatly from the lack of high titre cell free virus
with which to carry out infections. However, it has been
assumed that gene regulation in VZV occurs in a manner
similar to that described in HSV and other herpes virus
infections, that is, in the form of a cascade of three broad
i/f'/zz/
groups of proteins, immediate early (IE), prior to/protein 
synthesis, early (E), followmg^protein synthesis but prior 
to DNA synthesis, and late (L) following genome replication. 
This classification of genes is not absolute. For example, 
in HSV the large subunit of ribonucleotide reductase is 
regulated as an early protein. However, inhibition of 
protein synthesis, and thus early gene expression, does not 
prevent its transcription (Honess and Roizman, 1974; DeLuca 
et a l ., 1984). A similar situation occurs with regard to 
the separation of E and L gene expression by DNA 
replication.
General functions can be ascribed to each temporal 
class of HSV proteins, IE genes fulfil regulatory roles, E 
genes provide the machinery for viral DNA synthesis and L 
genes encoding the fabric of the virus. Evidence that this 
general plan of genome expression and functions holds for 
VZV comes, first, from sequence analysis, which reveals many 
similarities between the genes encoded by the two viruses. 
In addition, two attempts to analyse VZV IE proteins using
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cycloheximide block and release in the presence of
actinomycin D have been made (Lopetegui et al., 1985;
Shiraki and Hyman, 1987). The results concurred in
detecting a subset of VZV proteins synthesised under the 
"IE" conditions, suggesting similarities to the HSV system, 
and in the molecular weights of some of the proteins 
produced. However, there were discrepancies as to the size 
and number of the minor species present.
1.3.2. Immediate Early Genes of VZV
1.3.2.1. VZV orf62.
VZV orf62 encodes a protein of predicted molecular 
weight 140,000 (140K) that bears strong sequence similarity 
to HSV-1 IE gene 3, which encodes the protein Vmwl75 
(McGeoch et al., 1986; Davison and Scott, 1985) and the 
equine herpes virus 1 (EHV-1) major IE gene, which encodes a 
protein of predicted molecular weight 155,000 (Grundy et 
al., 1989). These homologies are localised to two regions 
within the coding sequences, region 2 and region 4, amino 
acids 468-641 and 736-1148 of the VZV sequence, respectively 
(McGeoch et al., 1986; Grundy et al., 1989).
The functions of the HSV protein, Vmwl75, have been 
studied in detail due to its central role in the 
transcriptional programme. Conditional HSV-1 mutants with 
lesions in IE gene 3, notably tsK, fail to synthesise E and 
L proteins at non-permissive temperature (Marsden et a l ., 
1976; Preston, 1979a; Dixon and Schaffer, 1980; Watson and 
Clements, 1978, 1980) and over synthesise IE proteins and 
Vmwl36 (Marsden et al., 1976; Preston, 1979a). Upshift of 
the virus at later stages of infection returns the virus to 
this phenotype (Preston, 1979b; Watson and Clements. 1980) 
suggesting that the requirement for Vmwl75 continues 
throughout the lytic cycle. These and other experiments 
suggest that major functions of this polypeptide are both 
the control and maintenance of the transition from IE to E 
and L phases of transcription, and the regulation of its own 
transcription. In this context it is interesting to note 
that Vmwl75 binds to the hexanucleotide ATCGTC which is
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found at its own transcriptional start site (Faber and
Wilcox, 1986).
Functional correlations between 140K and Vmwl75 have 
also been noted. Analysis of the transactivation of both 
the HSV glycoprotein D and the rabbit beta globin promoters 
in short term transfection assays suggested that 140K was a 
more efficient transcriptional activator than Vmwl75 
(Everett and Dunlop, 1984; Everett, 1984). Furthermore, 
Vero cells that contain integrated copies of orf62 (F114 
cells) complement the growth of HSV-1 t_s mutants whose
mutations are in the coding sequences for Vmwl75.
Interestingly, the transcription of 140K from F114 cells 
could be stimulated by superinfection with HSV-1, an effect 
that occurred even in the presence of cycloheximide
suggesting that, like HSV IE genes, (see section 1.4.), the 
transcription of orf62 could be stimulated by a component of 
the HSV virion, (Felsner et al., 1988).
1.3. 2. 2. VZV orf4.
This orf is predicted to encode a protein of molecular 
weight 51,540 (Davison and Scott, 1986). Its sequence shows 
similarities to that of the HSV IE protein Vmw63 which is 
encoded by HSV IE gene 2 (McGeoch et al., 1988). Analysis 
of the role of this HSV protein using both ts mutants (Sacks 
et al., 1985) and deletions (McCarthy et al., 1989) revealed 
it to be essential for viral replication in tissue culture 
and that its absence resul ted in a severe restriction of 
the production of 'true' L proteins (Sacks et al., 1985; 
McCarthy et a l ., 1989). Analysis of the function of Vmw63 
in transient expression assays has yielded somewhat 
contradictory results but it seems that the protein acts in 
concert with Vmwl75 and VmwllO to regulate, both positively 
and negatively, the expression of subsets of viral genes 
(Everett, 1986; Rice and Knipe, 1988; Sekulovich et a l ., 
1988) in apparent agreement with the phenotypes of virus 
mutants (Sacks et al., 1985; McCarthy et al., 1989).
Homologues of orf4 have also been detected in two gamma 
herpes viruses, EBV (Davison and Taylor, 1987) and herpes 
virus saimiri (Nicholas et al., 1988). The products of 
these orfs act both independently and in concert with the
14
product of the EBV gene BZLF1 to stimulate expression from a 
range of both viral and cellular promoters (Nicholas et al., 
1988; Chevallier-Greco et al., 1986). Finally, recent 
evidence suggests that the product of orf4 can act in short 
term transfection assays to stimulate expression from the 
VZV dPyK promoter and from other viral and cellular 
promoters (Inchauspe and Ostrove, 1989).
1.3.2.3. Orf63
This orf is predicted to encode a protein of molecular 
weight 30,494 and shows sequence similarities to the HSV IE 
protein Vmw68. The functions of neither of these proteins 
is known. A mutant of HSV-1 has been constructed which 
lacks the carboxyterminal third of Vmw68 (Post and Roizman, 
1981). It exhibits poor growth in tissue.culture, reduced 
expression of at least one L gene in some cell lines and was 
not neurovirulent in mice (Sears et a l ., 1985).
1.3.2.4. Orf61.
This orf encodes a homologue to HSV-1 IE gene 1 which 
encodes the protein VmwllO. Sequence similarities between 
the proteins are confined to a region in the amino terminus 
of the protein which has the potential to encode a zinc 
finger domain (Perry et al., 1986; Berg, 1986). The HSV 
protein is not strictly essential for viral replication in 
tissue culture. Virus mutants that lack both the entire 
protein, dll403 (Stow and Stow, 1986) and the zinc finger 
domain alone, FXE (Everett, 1989), exhibit a similar 
phenotype growing efficiently at high multiplicity of 
infection (moi) and in a very restricted fashion at low moi 
especially on slow growing cell types (Stow and Stow, 1986; 
Everett, 1989). This suggests that VmwllO has a role early 
in infection in committing the viral genome to the lytic 
cycle especially in situations where low copy numbers of the 
genome are present. In transient expression assays in cell 
culture VmwllO acts as a transactivator of early gene 
expression both independently and in synergy with Vmwl75 
(Everett, 1984b; O'Hare and Hayward, 1985a and b; Quinlan 
and Knipe, 1985; Mavromara-Nazos et al., 1986). Mutational
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analysis of the protein showed that these two roles were 
separable and that the zinc finger domain was essential for 
independent transactivation (Everett, 1987, 1988a).
Interestingly, in view of the specific region found to be 
conserved between the HSV and VZV proteins, VZV coinfection 
rescues the HSV mutant dll403 (Stow and Stow, 1989). No 
evidence exists that this phenomenon is related to orf61,
indeed coinfection with HCMV, which lacks a VmwllO
homologue, also rescues the mutant.
It should be emphasised that no definitive evidence 
exists that any of the VZV orfs mentioned above is regulated 
as an IE gene, though combining the expression evidence of 
Shiraki and Hyman, (1987) with sequence comparisons and 
functional studies suggest that orf62, orf4 and orf63 
represent good candidates for IE genes with the situation
regarding orf61 being rather less clear.
1.3.3. Regulation of Early Gene Expression.
As yet, due to the inability to induce co-ordinate 
infections with VZV, there is no direct evidence as to the 
presence of a distinct class of E genes, that is, those 
produced following protein synthesis but not dependent on 
DNA replication.
Indirect evidence suggests that this class of proteins 
does exist. Sequence analysis reveals clear homologues of 
many of the E genes encoded by the HSV genome. What is 
known about the function of VZV IE genes (Everett, 1984; 
Everett and Dunlop, 1984; Felsner et al.., 1987;Inchauspe and 
Ostrove,1 9 8 9 ) suggests that orf62 and orf4 function as 
transactivators, and one would predict that their targets 
would be E and L genes. This supposition is reinforced by 
very preliminary studies on the VZV dPyK control region 
which show that this promoter has a TATA box which alone is 
sufficient to allow transactivation by the VZV IE gene 
homologues (Inchauspe and Ostrove,1989).
The control of E gene expression in HSV has been 
studied using both transient expression assays and viruses 
containing mutations in the regulatory sequences of the E 
genes (Everett, 1983, 1984b; Coen et ad.., 1986). These
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studies defined several functional elements including the 
cap site, TATA box, GA rich sequences, Spl binding sites and 
CCAAT box motifs to be important for E gene transcription. 
None of these was shown to be solely responsible for the 
stimulation of expression by IE gene products, though 
experiments with mutants returned to virus suggested that 
the TATA box of the dPyK gene was of primary importance 
(Coen et al., 1986).
While the model of HSV gene expression predicts that E 
genes require IE gene products to stimulate their expression 
other findings question this simplistic viewpoint. The 
demonstration that the rabbit beta-globin gene was regulated 
as an early gene in transient expression assays and when 
integrated into the virus genome but not when its natural 
chromosomal environment in rabbit kidney cells (Everett, 
1983, 1984b; Smiley et a l ., 1982), and the ability of the
HSV TK promoter to function autonomously in transient 
expression assays but apparently not in the viral genome, 
raises the possibility that mechanisms other than cis-actinq 
sequences are important in the control of E gene expression 
in the context of the viral genome.
1.3.4. Control of Late Gene Expression.
No direct evidence is available that defines a separate 
class of VZV L genes, dependent for their full expression on 
the replication of viral DNA.
HSV-1 again provides the model for L gene control. The 
available evidence suggests that the expression of 'true' L 
genes, those whose expression cannot be detected prior to 
DNA replication, such as US11, depends only on the presence 
of a TATA box and a linked, functional, origin of 
replication (Johnson and Everett, 1986b; Johnson et al.,
1986). This finding was confirmed by the conversion of an E 
gene, gD, to L gene regulation, as assayed in short term 
expression assays, by the deletion of sequences upstream of 
its TATA box and linkage to an HSV origin of replication. 
The other category of L genes, known as 'leaky1 L genes, 
produce proteins that are detectable prior to DNA 
replication but require this event for their full
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expression. The major capsid protein Vmwl55, is an example 
of this category. Analysis of virus mutants with mutations 
in the IE genes encoding Vmw63 or Vmw68 suggest that these 
IE proteins are involved in the control of L gene expression 
(Sears et. cCL. , 1985; Sacks et al. , 1985) and analyses using 
transient expression assays suggest that other IE genes can 
also exert an effect (Dennis and Smiley, 1984; DeLuca et
a l ., 1985; Mavromara-Nazos et al., 1986; Everett, 1986).
The mechanism by which DNA replication induces L gene 
expression is unknown.
1.3.5. VZV Encoded Enzymes.
1.3.5.1. Pyrimidine Deoxynucleoside Kinase.
The presence of novel thymidine kinase, deoxycytidine 
kinase and bromodeoxycytidine kinase activities in cells
infected with VZV was first detected by Doberson et al., 
(1976). They also determined that the activities 
co-purified with a column fraction of approximate molecular 
weight 70,000. These findings were confirmed and extended 
by the demonstration that the activities were due to a 
single protein species (Hackstadt and Mallavia, 1978). 
Analysis of the protein under denaturing conditions revealed 
a single species with a molecular weight of 35,000, 
suggesting that the functional form of the enzyme was a 
dimer (Lopetegui et al., 1983; Shiraki et al., 1985). In 
common with other herpes virus TKs, and in contrast to 
cellular TKs, the VZV enzyme functions as a deoxycytidine 
kinase (Jamieson and Subak-Sharpe, 1974; Cheng et ad.., 1979 ) 
and as a thymidylate kinase (Chen ed: al., 1979; Chen and 
Prusoff, 1978). However, the properties of the VZV enzyme 
were found to differ from those of HSV-1 in its heat 
stability and its ability to phosphorylate deoxycytidine in 
preference to thymidine (Cheng et al., 1979).
The location of the gene encoding the dPyK activity was 
mapped between 0.50 and 0.52 map units by Sawyer et al ., 
(1986) who investigated the transformation of LTK cells to 
a TK+ phenotype with restriction endonuclease fragments. 
They also found that for a given TK activity a much higher
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copy number of VZV genes was present in transformed cells 
compared with cells transformed with HSV-1 TK. A possible 
explanation for this finding was provided when the gene and 
its upstream sequences were sequenced and the 5' end of the 
mRNA mapped. This revealed the presence of two initiation 
codons closely followed by termination codons in the 5 1 
untranslated region of the mRNA. These small orfs were in 
different reading frames from that of the dPyK and may 
represent a mechanism to reduce translational efficiency. 
This finding might explain the finding of Sawyer et a l ., 
(1986) who found that many more copies of the VZV dPyK gene 
were required to produce the same level of TK activity in 
LTK cells transformed with a fragment containing VZV orf36 
compared with those transformed with an equivalent HSV 
fragment.
Herpesvirus TKs differ structurally from their 
cellular counterparts in that their functional form is a 
dimer (Shiraki et al., 1985) while vaccinia virus TK, which 
is similar to cellular TKs, functions as a tetramer (Kit et 
a l ., 1985). The enzymes' sequences reflect these functional 
differences. Those herpes virus TKs for which sequence data 
are available (McKnight, 1980; Wagner et al., 1981; Swan and 
Galloway, 1983; Otsuka and Kit, 1984; Baer et al., 1984; 
Davison and Scott, 1986) have no recognisable similarities 
to the TKs from several vertebrates and pox viruses (Boyle 
et al., 1987) beyond a region common to all enzymes which 
use ATP (Otsuka and Kit, 1984; Walker et a l ., 1982; Gentry, 
1985; Fry et a l ., 1986). Comparison of the herpes virus TK 
sequence with that of yeast thymidylate kinase (Jong et al., 
1984), the only sequence data available for that enzyme, 
demonstrated a greater degree of similarity than between 
herpes virus and cellular TKs (Robertson and Whalley, 1988). 
This led the authors to suggest that herpes virus TKs may 
have evolved from cellular enzymes other than TKs, possibly 
thymidylate synthetase or deoxycytidine kinase.
1.3. 5. 2. Thymidylate Synthetase.
Another enzyme involved in thymidine metabolism is 
thymidylate synthetase (TS), which converts deoxyuridine 
monophosphate to thymidine monophosphate. It was detected
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in the VZV sequence by its considerable homology with other
TS enzymes from bacteriophage to man, and is not present in
the HSV-1 sequence (Davison and Scott, 1986). Confirmation
of the sequence data came with the expression of the orf in
an E. coli strain whose own TS had been deleted (Thompson et
al ., 1987). Cells expressing the putative VZV TS were able
to grow in the absence of thymidine and released tritiated
water from 2-deoxy[5- H]uridylate. The enzyme could also be
specifically labelled with
325-fluoro-2-deoxyuridine[ pJmonophosphate and was found to 
have a molecular weight of 32,500 on SDS-PAGE.
Thus VZV can produce thymidylate de novo using the TS 
and by thymidine salvage using the dPyK. The reasons for 
the presence of both enzymes in the genome, especially in 
view of the absence of a TS from HSV, are not clear. 
Nevertheless, the presence of this enzyme in VZV infected 
cells might provide a target for antiviral chemotherapy.
1.3.5.3. Protein Kinases.
As mentioned in section 1.3.1., comparison of the 
sequence of orf66 with those of non-herpes proteins led to 
the identification of both it and the HSV-1 gene US3 as 
possible protein kinases (McGeoch and Davison, 1986). Many 
of the conserved regions within these proteins align with 
the regions of greatest similarity in several eukaryotic 
protein kinases, particularly those of the serine-threonine 
kinase family. These results were of particular interest in 
view of the reports from various laboratories of protein 
kinase activity associated both with HSV virions (Rubenstein 
et a^. , 1972; Lemaster and Roizman, 1980) and with cells
infected by HSV-1 and the closely related pseudorabies virus 
(Blue and Stubbs, 1981; Purves et al., 1986). The evidence 
available regarding the characteristics of the kinases 
detected were somewhat contradictory. Purves et al.,
(1986), described a kinase present in infected cells, but 
not virions, that is expressed as an early protein and 
phosphorylated viral and other polypeptides on serine and 
threonine residues. Roizman's group (Lemaster and Roizman, 
1980), in contrast, described a kinase, present in the 
capsid/tegument structure of virions which phophorylated
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only virion proteins. The resolution of which of these 
activities corresponds to the kinase encoded by US3 has come 
from work by Frame et al., (1987), who demonstrated 
antigenic identity between the kinase isolated by Purves et 
a l ., and the product of US3 using an anti-peptide monoclonal 
antibody to the C-terminus of US3, and Purves et al.,
(1987), who demonstrated that an HSV-1 mutant, from which 
the majority of gene US3 had been deleted, failed to induce 
a novel protein kinase. This virus was, however, able to 
grow normally in tissue culture (Longnecker and Roizman,
1987), suggesting that the activity of this kinase is 
non-essential in this situation.
Although no direct evidence exists that VZV orf66 
encodes a protein kinase the degree of homology between this 
gene and US3 is strongly suggestive. In this connection 
Montalvo and Grose (1987), have reported a virus-induced 
polypeptide resolving to 50,000 daltons on SDS-PAGE which 
phosphorylates Gpl, the major VZV glycoprotein, on serine 
and threonine residues but has no effect on other VZV 
glycoproteins. This size is consistant with the protein 
being the product of orf66, which has a predicted molecular 
weight of 43,677, but further studies will be required to 
characterise the protein and other possible substrates 
further.
Finally, another gene, conserved amongst HSV, VZV and 
EBV, has been predicted to be a protein kinase. No 
information is yet available as to the functions of the 
products of these genes, UL13 in HSV, orf47 in VZV and BGLF4 
in EBV, but their amino acid sequences make it likely that 
they are serine/threonine rather than tyrosine kinases 
(Smith and Smith, 1989).
1.3.5. 4. Glycoproteins
Sequence analysis of the VZV genome revealed five open 
reading frames with sequence characteri sties of 
glycoproteins (Davison and Scott, 1986), that is, a 
hydrophobic signal sequence close to the amino terminus and 
a carboxy terminal region comprising a more extensive 
hydrophobic membrane spanning portion followed by a basic, 
cytoplasmic, portion. These have now all been shown to
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specify glycoproteins, the nomqblature of which was 
standardised at the 1985 Herpes Virus workshop (Davison et 
al., 1986). The gpl family consists of 2-4 proteins ranging 
in molecular weight from 45,000-100,000 encoded by orf68 
(Ellis et al., 1985). They are the most abundcnt and
immunogenic of the VZV envelope glycoproteins and stimulate 
the production of complement dependent neutralising 
antibodies (Edson et al., 1985a). Analysis of gpll on
SDS-PAGE revealed a major species of molecular weight
140,000 on non-reducing SDS-PAGE but 65,000 on reducing gels 
suggesting that this protein consists of a disulphide linked 
heterodimer (Vafai et al., 1983; Grose et al., 1984). It is 
encoded by orf31 (Keller et al., 1986a) and shows homology 
to HSV-1 gB both on sequence analysis and using monoclonal 
antibodies (Edson et al., 1985b; Kitamura et al., 1986).
The third most abundent VZV glycoprotein, gpIII, migrates 
with a molecular weight of 105,000 to 130,000 on SDS-PAGE. 
Using a partial amino acid sequence of the purified protein, 
Keller et ad.., (1986b) showed that it is encoded by orf 37.
Antipeptide antibodies were used to characterise the product 
of orf67 as gpIV, a group of minor glycoproteins of 
molecular weight 45,000 to 55,000 (Davison et al., 1985). 
Again molecular analysis has been used to identify the 
product of orf14 as gpV by its expression in vaccinia virus. 
This construction resulted in the production of specific 
glycoprotein products of molecular weight 85,000 to 95,000 
(Kinchington et al., 1986)
1.3.6. DNA Replication.
Little or no direct evidence is available relating to 
the overall scheme of VZV DNA replication. However, the 
following scheme has been proposed using HSV-1 as a model 
(Davison, 1984). On entering the cell nucleus, the genome 
circularises, forming two -g joints, one pre-existing and 
one new. A phase of limited replication ensues during which 
recombination between the repeated sequences flanking the 
and c sequences can occur. This is followed by a major 
phase of replication to form long molecules consisting of 
head to tail concatemers of the genome, probably by a 
rolling circle mechanism. Unit length genomes are then
22
produced by site specific cleavage which usually results in 
the major genomic configuration but occasionally the minor 
form is produced. This unequal distribution of isomers 
suggests that part of the signal for genomic cleavage is 
situated in the U region close to the normal site of
cleavage and part is located in one or both of the repeated
sequences that bound the L and S segments. Recognition of 
the signals present in repeated sequences alone would 
produce the minor genome configuration while recognition of
the full sequence would generate major configuration.
Evidence for this scheme of replication comes again 
from comparisons with the HSV-1 system. HSV-1 encodes three 
origins of replication, one situated in both IR and TR
O  O
and one in UL (Frenkel et al., 1976; Jean et al., 1977; 
Rixon and Ben-Porat, 1979; Vlazny and Frenkel, 1981; Spaete 
and Frenkel, 1982). Any one of these origins can be deleted 
without affecting viral replication (Longnecker and Roizman, 
1986; Polvino-Bodinar et al., 1987). OriS consists of a 90 
bp fragment containing a 45 bp palindrome with 18 centrally 
located A or T residues flanked by G+C rich tracts, and is 
located between the 5' ends of IE genes 3 and 4/5 (Stow, 
1982; Stow and McMonagle, 1983). OriL is located between 
the genes encoding the DNA polymerase and the major DNA 
binding protein and is similar in structure to OriS although 
it has a rather larger, 72 bp, palindrome (Gray and Kaerner, 
1984; Quinn and McGeoch, 1985; Weller et al., 1985).
The VZV origins of replication are found in an 
equivalent position in the TRg and IRg to HSV oriS. They 
consist of a 45 bp palindrome with 33 centrally located A 
and T residues. On the 5 1 side of the IR palindrome the
O
sequence CGTTCGCACTT, also found in HSV-1 origins, is 
present, and two further copies of this motif are found 
further 5 1 to th e VZV origin. Interestingly, plasmids 
encoding the VZV origin of replication can be stimulated to 
replicate by superinfection with both VZV and HSV-1 (Stow 
and Davison, 1986), though HSV induced replication was about 
5% of the level of similar constructs encoding HSV-1 OriS.
Not surprisingly, given these sequence and functional 
similarities, VZV encodes homologues of all seven of the 
HSV-1 proteins shown by Challberg et al., (1986) to be
necessary and sufficient for origin-dependent replication.
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Two of these genes encode the viral DNA polymerase and the 
major DNA binding protein, orf28 and orf29 in the VZV 
genome. The UL42 gene product, VZV orf16, has been 
identified as a previously detected DNA binding factor found 
in extracts of HSV-1 infected cells (Parris et al., 1988). 
Recently presented evidence suggests that the UL9 gene 
product, VZV orf51, is a sequence specific origin binding 
protein (Oliv o et al., 1988; Weir et al., 1989) and that 
the product of UL5, VZV orf55, is a component of the DNA 
helicase activity found in virus infected cells (Weir et 
a l . , 1989). In addition, many of the other proteins
involved in DNA replication in HSV such as dUTPase (Wohl and 
Frenkel, 1980; Preston and Fisher, 1984), thymidine kinase 
(Kit and Dubbs, 1963; Jamieson et al., 1974), ribonucleotide 
reductase (Coen, 1972; Dutia, 1983), alkaline exonuclease 
(Keir and Gold, 1963; Preston and Cordingley, 1982), and 
uracil DNA glycosylase (Mullaney et al ., 1989) also have 
homologues in VZV.
1.4.
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Regulation of Herpesvirus IE Genes.
1.4.1 Cis-acting Sequences
The initial evidence that the IE genes of HSV-1, in 
common with those of other viruses, were controlled by 
potent regulatory sequences came from experiments in which 
the synthesis of viral proteins was prevented by the use of 
metabolic inhibitors or viral ts mutants (Kozak and Roizman, 
1974; Clements et al., 1977; Preston, 1979; Watson et 
al.,1979; Anderson et al., 1980; Dixon and Schaffer, 1980; 
Watson and Clements, 1980). This treatment resulted in the 
rapid accumulation of large amounts of IE mRNAs, which were 
translated into high levels of IE protein upon removal of 
metabolic inhibitors.
The nature of the IE regulatory signals was initially 
investigated by Post et al., (1981). They used the coding 
sequences of HSV-1 TK as a reporter gene under the control 
both of its own upstream sequences, which result in its 
regulation as an E gene, and those of IE gene 3. These 
constructs were used to convert TK HSV-1 mutants to TK+ . 
Growth of the viruses under IE conditions, using 
cycloheximide block and actinomycin release, resulted in 
detectable TK activity only when the reporter gene was 
regulated by IE upstream sequences. This showed that 5' 
flanking sequences were sufficient to determine the 
regulatory characteristics of IE gene expression. A further 
series of experiments were presented in which the IE 3-TK 
construct was used to produce a biochemically transformed 
cell line containing the chimeric gene. Superinfection of 
this cell line with HSV-1 resulted in stimulation of TK gene 
transcription even when viral protein synthesis was 
inhibited. This result distinguished HSV-1 from other 
viruses studied in implicating a component of the virion in 
stimulating expression from the IE regulatory sequences. 
This virion component was later identified as Vmw65, also 
termed VP16, the product of gene UL48, and is a major 
component of the virus tegument (Campbell et al., 1984; 
Section 1.4.2.).
These data were extended by the demonstration that the 
regulatory sequences of IE gene 3 could be divided into two
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functional parts (Mackem and Roizman, 1982b). One of these 
was a promoter region which, like the wild type TK 
regulatory signals, was sufficient to transform TK- cells 
and viruses to a TK phenotype. The other was a distal 
regulatory element which, when added to either promoter 
domain, converted the expression of TK genes to an IE 
phenotype in both cells and viruses.
Further studies confirmed and expanded these initial 
observations by showing that the findings held both for all 
other IE genes in both HSV-1 and HSV-2 (Mackem and Roizman, 
1982a,b,c; Cordingley et al., 1983; Preston et al., 1984; 
Mosca et al., 1985; Gaffney et al., 1985) and when other 
assay systems such as microinjection of Xenopus oocytes and 
short term transfection assays were used (Cordingley et al., 
1983; Lang et a l ., 1984; Preston et al., 1984; Preston and 
Tannahill, 1984; Kristie and Roizman, 1984).
Sequence comparisons, together with more detailed 
deletion analysis, revealed the presence of conserved 
cis-acting sequences in the regulatory regions of all of the 
IE genes of HSV-1 and HSV-2. Of these, an AT rich motif, 
TAATGARAT (R=purine), was present in at least one copy in 
all IE control regions and appeared to be essential for the 
response to the virion factor (Mackem and Roizman, 
1982a,b,c; Cordingley et al., 1983; Preston et al., 1984; 
Lang et al.,1984; Bzik and Preston, 1986; O'Hare and 
Hayward, 1985b). A 20-mer oligonucleotide containing this 
sequence was sufficient to confer responsiveness to the 
virion component when inserted, into a plasmid, in either 
orientation, upstream of a HSV IE promoter-CAT gene 
construct (Gaffney et al., 1985). Stimulation of 
transcription was increased by the presence of multiple 
copies of the oligonucleotide.
Sequences flanking the TAATGARAT motif have been shown 
to modify the response to Vmw65. In particular, G+A rich 
sequences can supplement the activity of TAATGARAT motifs, 
and were also found to convert an otherwise nonfunctional 
but related sequence, TAACGAGGAAC, to virion responsiveness 
(Bzik and Preston, 1986). However, these G+A sequences were 
not found to mediate significant independent activity. 
Similar results were reported by Triezenberg et al ., 
(1988b), however they placed more emphasis on the importance
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of the G+A rich sequences which, they suggested, would
mediate stimulation by the virion factor in the absence of a 
TAATGARAT motif. Further studies will be required to 
resolve these differences.
In addition to the promoter and virion factor 
responsive elements present upstream of all IE genes, a 
distinct enhancer-like element was found in the intergenic 
region between IE genes 3 and 4/5 (Lang et al., 1984; 
Preston and Tannahill, 1984). This was found to be active
in the absence of Vmw65 and to stimulate activity from
linked promoters in an orientation independent fashion and 
from a considerable distance (at least lOOObp) upstream.
However, unlike other enhancer sequences, the HSV fragment
appeared not to function from a position downstream of the
reporter gene (Preston and Tannahill, 1984) . The crucial 
components of the enhancer-like element appear to be two 
GC-rich Spl binding site consensus sequences and the G+A 
rich motif described above (Bzik and Preston, 1986).
1.4.2. Virion Trans-Inducing Factor
As detailed above, initial experiments to characterise
the regulatory sequences of HSV IE genes suggested that a 
component of the virus particle was involved in the 
stimulation of IE gene expression (Post et al., 1981). The 
location of the transinducing factor within the virion was 
investigated using the HSV-1 mutant, tsB7, which fails to 
uncoat at non-permissive temperature. This mutant retained 
its ability to stimulate the expression of HSV IE constructs 
at non-permissive temperature, suggesting that the 
stimulatory component was located external to the virus 
nucleocapsid (Knipe ^t al., 1981; Batterson and Roizman, 
1983). The protein responsible for this effect was 
identified by Campbell et al. (1984), who co-transfected 
cloned restriction fragments of HSV-1 DNA with an IE-TK 
reporter plasmid and assayed for stimulation of TK 
expression. Having isolated a fragment capable of 
stimulating expression they located the gene responsible by 
subcloning and immunoprecipitation studies and identified it 
as that encoding Vmw65. This protein was known to be a
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major tegument phosphoprotein, estimated to be present at 
approximately 1000 molecules per virion (Heine et al., 1974; 
Marsden et a_l., 1978 ). Protein Vmw65 is essential for
virion assembly since the mutation in ts2203 has been mapped
to this gene (Ace et al., 1988). This mutant fails to 
assemble virus particles at the non permissive temperature 
(V. G. Preston, pers. comm.).
Sequencing of the fragment encoding Vmw65 (Pellett et 
a l ., 1985; Dalrymple et al., 1985) revealed an orf with the 
potential to encode a polypeptide of predicted molecular 
weight 50,342, which was homologous to a VZV gene product 
represented by orf10. The most notable feature of the
primary struct are of the HSV orf is the presence of an 78
amino acid carboxy-terminal region distinguished by a high 
frequency of acidic residues giving it an overall charge of 
-19 at physiological pH. This carboxy-terminal "acidic 
tail" is absent from VZV orf10. Recent studies have 
revealed the importance of acidic domains in the function of 
a group of eukaryotic and prokaryotic transcriptional 
activators including Vmw65 (Hope and Struhl, 1986; Gill and 
Ptashne, 1987; Sadowski et al., 1988; Triezenberg et al., 
1988a; Greaves and O'Hare, 1989). These results suggest 
that Vmw65 consists of 2 functional regions. The 
carboxy-terminal 78 amino acids function as an activating 
region (Sadowski et al., 1988; Triezenberg et al., 1988; 
Greaves and O'Hare, 1989) while the amino terminal 413 amino 
acids are responsible for the ability of the protein to form 
complexes with the TAATGARAT motif in a sequence specific 
fashion (Triezenberg et al., 1988; Ace et al., 1988; Greaves 
and O'Hare, 1989; this thesis). No direct evidence bears on 
the question of whether the acidic domain is involved in the 
activity of Vmw65 as a component of the virion structure, 
however the absence of this region from VZV orflO suggests 
that it is not.
An intriguing aspect of Vmw65, given its role as a 
sequence specific transactivator, is that it fails to show 
any substantial affinity for double stranded DNA (Marsden et 
al., 1987). This apparent contradiction was resolved by the 
demonstration that both cellular proteins and the TAATGARAT 
motif are required to allow Vmw65 to interact specifically 
with DNA (McKnight et al., 1987; Preston et al., 1988;
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O'Hare and Goding, 1988). The identity of one of the 
cellular components involved in the complex was suggested by 
the ability of the octamer sequence (ATGCAAAT) to compete 
for proteins binding to the TAATGARAT motif (O'Hare and 
Goding, 1988) . These data were confirmed by the 
demonstration that a purified preparation of a HeLa cell 
factor, named octamer transcription factor (OTF) 1, was 
required for the formation of a Vmw65-containing tertiary 
complex at the TAATGARAT motif (Gerster and Roeder, 1988). 
These workers also suggested that a second cellular factor 
was involved in complex formation as reactions containing 
only purified OTF-1 and Vmw65 synthesised _in vitro failed to 
bind efficiently to oligonucleotides containing the 
TAATGARAT motif. Binding activity could be restored with 
OTF-1 depleted HeLa cell extract.
The requirement for OTF-1 in Vmw65 activity led to the 
reassessment of TAATGARAT sequences upstream of HSV IE genes 
and the demonstration that many of them represent a combined 
octamer/TAATGARAT binding site (O'Hare and Goding, 1988, 
ApRhys et al., 1989), though the TAATGARAT motif alone is 
sufficient to bind cellular factors, form tertiary complexes 
and mediate Vmw65-induced transactivation (Bzik and Preston, 
1986). Conversely, the octamer sequence alone, while 
binding cellular factors efficiently, is not capable of 
supporting tertiary complex formation or Vmw65 mediated 
transactivation (Post et al., 1981; Gerster and Roeder, 
1988; O'Hare et al., 1988; this thesis). The only data 
incompatible with this model is that presented by O'Hare and 
Goding, (1988) who report Vmw65 stimulation of CAT 
expression from a plasmid encoding the CAT gene under the 
control of the HSV TK promoter and a single octamer 
sequence, however no evidence was provided that this 
sequence could mediate tertiary complex formation, and thus 
its significance remains unclear.
Mutational analyses of Vmw65 have confirmed the model 
of two functional domains. Triezenberg et al., (1988a) 
produced a series of carboxy-terminal deletions and showed 
that the 78 amino acid residues at the carboxy-terminus were 
crucial for the activity of the protein in stimulating 
transcription. Truncated proteins derived from Vmw65 but 
encoding only part of the acidic region showed intermediate
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activities when assayed in short term transfection assays. 
This suggested that the number of negatively charged 
residues and not necessarily the integrity of the acidic 
region, was important in the ability of the protein to 
stimulate transcription, a finding in accordance with 
results from other systems (Hope et al., 1988). In addition 
Triezenberg et al., (1988) presented indirect evidence as to 
the role of the amino terminal portion of the protein. In 
the absence of the acidic tail the amino terminal segment 
acted dominantly and specifically to interfere with the 
trans-inducing activity of wt Vmw65 polypeptides, suggesting 
competition for binding to the cellular proteins involved in 
the tertiary complex. Ace et al., (1988) presented more 
detailed data as to the location of functionally important 
regions within the polypeptide. They constructed a series 
of in frame, four amino acid, insertion mutants throughout 
the orf and assayed these for their ability to stimulate 
transcription, form tertiary complexes in an in vitro 
binding assay and fulfil the protein's structural role by 
rescuing the HSV-2 mutant ts2203. Of the ten mutants 
described five failed to rescue ts2203, and four had at 
least a partial defect in both transactivation and tertiary 
complex formation. One insertion, mutant _inl4, was found to 
produce a protein which was able to rescue ts2203 but not to 
transactivate IE gene expression or to form tertiary 
complexes. These results had three important implications, 
first, transcriptional activity correlated closely with 
tertiary complex formation, second, amino acids required for 
the formation of tertiary complexes are widely distributed 
within the amino terminal domain of the protein and third, 
the protein's structural and transactivating roles are 
separable.
A major step towards understanding the biological 
relevance of the stimulation of IE genes by Vmw65 was made 
with the construction of an HSV-1 mutant, in!814 (Ace et 
a l ., 1989). This virus contains the lesion present in the
mutant Vmw65 protein in!4 described above (Ace et al., 1988) 
and thus produces a Vmw65 molecule which fails to stimulate 
IE gene expression but fulfils its role in virion structure. 
This deficit resulted in a surprisingly small reduction in 
the accumulation of IE mRNAs when inl814 was grown in tissue
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culture under cycloheximide block. Levels of IE RNA 1 and 2 
were reduced five fold, while those of IE RNA 4 were reduced 
only two fold and IE 3 accumulation remained unchanged. 
Mutant _inl814 had a high particle to pfu ratio which was 
even more pronounced on slow growing cell types such as HFL. 
Interestingly this aspect of its phenotype is similar to 
that of mutants dll403 and FXE which lack functional VmwllO 
protein (Stow and Stow, 1986; Everett et al., 1989; section
1.3.2.4.) suggesting the possibility of similar roles at 
different stages of the virus life cycle for these gene 
products.
Infection of mice with in!814 revealed that the mutant 
is essentially avirulent (Ace et al., 1989), not surprising 
given the growth restricted nature of the virus in tissue 
culture. Analysis of the mutant in the mouse eye model of 
latency revealed that the virus goes through the full cycle 
of induction, maintenance and reactivation without the usual 
steps of replication at the site of inoculation and in the 
ganglion (Steiner et al., submitted).
These data are consistent with a view of Vmw65 as one 
of several factors, possibly including VmwllO, which act to 
commit the viral genome to a lytic form of expression. 
Transactivation by Vmw65 is not essential in tissue culture 
where its role can be duplicated by large amounts of input 
virus, or by cellular transcription factors, presumably 
present at higher concentrations in faster growing cells. 
However, in the more stringent environment of an infected 
animal or in a situation where the numbers of genomes are 
restricted in tissue culture, the deficit in transactivation 
results in fewer genomes being committed to the lytic cycle 
and thus defects in replication and virulence .in vivo and a 
proportionately higher particle to pfu ratio .in vitro.
The in vitro phenotype of i_nl814 was partially 
reproduced in another set of studies using a cell line 
constitutively expressing a mutant Vmw65 protein lacking the 
78 amino acid carboxy-terminal acidic region (Friedman et 
al., 1989). This cell line showed reduced permissiveness 
for viral replication, especially when the virus was 
inoculated at low multiplicities, which correlated with 
decreased expression of its IE genes. The authors suggested 
that these findings could be explained by a model where the
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amino terminal portion of the protein competed with wild 
type Vmw6 5 in the formation of complexes on TAATGARAT 
sequences, thus reducing transactivation.
1.4.3. Octamer Binding Proteins.
The octamer motif (ATGCAAAT) was initially 
characterised as a cis-actinq sequence which conferred 
B-cell specific transcription on the immunoglobulin light 
and heavy chain genes. It is present in both the promoter 
and enhancer elements of these genes (Falkner and Zachau, 
1984; Parslow et al. , 1984; Mason et al., 1985).
This motif is also found upstream of genes not 
specific to lymphoid cells, notably the histone H2B gene 
(LaBella et al., 1988; Sturm et al.,1988), the U2 snRNA gene 
(Ares et al., 1985; Mattaj et al., 1985; Mangin et al .,
1986), the control regions of SV40 E genes (Zenke et al., 
1988), the HSV thymidine kinase and HSV IE genes (McKnight 
and Kingsbury, 1982; ApRhys et al., 1989), and also in the 
adenovirus origin of DNA replication (Pruijn et ad.., 1986; 
Rosales et al., 1987). However, the detection of the 
octamer sequence, and in many cases the demonstration of its 
ability to interact with proteins, has not always correlated 
with evidence of the functional significance of this 
sequence in the stimulation of transcription in non-lymphoid 
cells (Preston et al., 1984; Davidson et a l ., 1986; Tanaka 
et al.,1988) . A
To date three proteins (Oct-1, 0ct-2a and 0ct-2b) 
which interact with the octamer motif have been purified and 
for two of these (Oct-1 and 0ct-2a) sequence data are 
available (Sturm et al., 1988; Clerc et a_l., 1988; 
Scheidereit et ad.., 1988; Schreiber et al. , 1988). Oct-1 is 
a protein of 100 kda, also referred to as OTF-1 (Fletcher et 
al., 1987), OBP100 (Sturm et al., 1987), NFIII (O'Neill et
al ., 1988) and NF-Al (Staudt et al., 1986) and found in a
wide range of cell types, while Oct-2a and Oct-2b, proteins 
of 60 kda and 75 kda respectively, are confined to lymphoid 
cells (Landolfi et a_l. , 1986; Singh ^t al_., 1986; Schreiber 
et a l ., 1988). Analysis of the amino acid sequence of these 
proteins revealed the presence of a homeo domain, a
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conserved amino acid sequence found in a class of proteins 
important in the control of developmental processes (see 
section I.5.3.I.). Close to this domain a second conserved 
sequence was found which defined a subset of homeobox 
proteins now known as POU proteins (Herr et al., 1988). 
Members of the POU protein family initially comprised Oct-1, 
Oct-2, Pit-1 which is synthesised in pituitary cells and 
implicated in the activation of growth hormone and prolactin 
genes (Bodner et al., 1988; Ingraham et al., 1988) and 
Unc86, which has a genetically defined role in the 
differentiation of specific nematode neural cells (Finney et 
al., 1988), thus POU from Pit-1, Oct and Unc86. More recent 
data have added to this list (He et al., 1989; Scholer et 
al., 1989), though functional analyses of these new protein 
species is still awaited. The Oct-1 and Oct-2 proteins show 
considerable homology within their POU and homeo domains 
(98% and 88% respectively) which have been shown to be 
responsible for their interaction with DNA (Sturm et al., 
1988; Clerc et al., 1988; Scheidereit et al. , 1988). 
However outside these regions the proteins have little 
similarity in sequence, suggesting considerable differences 
in their mechanism of action (Herr et al., 1988).
An interesting aspect of the function of both Oct-1 
and Oct-2, that has emerged through the study of purified 
preparations of these proteins, is the wide range of DNA 
sequences with which they can interact. Analysis of 
interactions with variants of octamer sequences (Baumruker 
et al . 1988; Kelmer et a l . 1989) revealed that the protein 
will recognise degenerate sequences as diverse as TAATGARAT 
and CTCATGA, though with less affinity than the prototypic 
octamer motif. Sequences flanking the 8 bp core become 
increasingly important in facilitating interactions with 
sequences less closely matched to the octamer motif 
(Baumruker et ad.., 1988).
A great deal of evidence has accumulated regarding 
the DNA-protein interactions of the octamer sequence in both 
lymphoid and non-lymphoid cells, however the functional 
significance of this motif has been the subject of some 
debate. In lymphoid cells a direct correlation has been 
established between the presence of octamer elements in 
promoters and enhancers and the stimulation of transcription
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(Davidson et al., 1986; Gerster et al., 1987; Lenardo et 
al., 1987; Wirth et al., 1987). However repetition of these 
experiments in non-lymphoid cells has, in general, resulted 
in unaltered levels of transcription (Davidson et al., 1986; 
Zenke et al., 1986; Ondek et al., 1987; Tanaka et al., 
1988). Thus the same motif, or set of motifs, appears to 
stimulate transcription in lymphoid cells but not in other 
cell types tested, despite interacting with proteins in both 
systems.
Three exceptions to this deficiency of octamer 
mediated transcription in non-lymphoid cells have been 
described. First, expression of the U2 snRNA gene is 
dependent on the presence of a functional octamer binding 
motif in its 5' control region (Mattaj et al., 1985; Manjin 
et a l ., 1986). Second, the stimulation of expression of the 
human histone H2b gene, during the S phase of the cell cycle 
results from the presence of an octamer motif (LaBella et 
al., 1988), and third the stimulation of HSV IE gene 
expression, by the virion protein Vmw65 (Gerster et al.,
1988), is dependent on the binding of Oct-1 to the
degenerate octamer sequence TAATGARAT. However, in both of 
the latter two cases baseline gene expression (that is non-S 
phase and without Vmw65) is unaffected by the presence or 
absence of octamer motifs or their derivatives (LaBella et 
al., 1988; Preston et al., 1984; Bzik and Preston, 1986).
Recent data from Herr's laboratory (Stern et al., 1989) 
have identified the homeo domain of Oct-1 as the site 
necessary for the interaction with Vmw65. They achieved 
this by showing that a fragment containing only the POU and 
homeo box sequences was able to form a complex with
TAATGARAT and Vmw6 5. A series of domain exchanges between 
Oct-1, Oct-2 and Pit-1 then localised the site of
interaction to the homeo box. Seven amino acid changes in 
this 60 amino acid domain distinguish Oct-1 from Oct-2, 
conversion of three of these from the Oct-1 sequence to the 
Oct-2 sequence, abrogated the interaction of Vmw65 with 
Oct-1. These changes affect residues on the solvent exposed 
face of a predicted <?f-helix. Reciprocal changes did not 
confer the ability to form a complex on Oct-2.
Interestingly, the important region of the homeo box shows 
potential structural similarity to the DNA binding domain of
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the repressor. Equivalent mutations in this protein have 
been shown to affect the regulatory interactions of this 
protein without interfering with its DNA binding activity. 
In conclusion Stern et al., (1989) suggest that the 
conservation of the homeo box through evolution results at 
least in part from its ability to form protein-protein as 
well as protein-DNA interactions.
The demonstration that the DNA binding domain of Oct-1 
is intimately involved in its interaction with Vmw65 also 
relates to the alteration in binding specificity from 
ATGCAAAT to TAATGARAT that occurs as a result of the 
interaction (Preston et al., 1988; this thesis). It is 
possible that the lower affinity interaction between Oct-1 
and TAATGARAT is necessary to allow interaction with Vmw65.
1.4.4. IE Gene Regulation in Other Alpha-Herpesviruses
In comparison to the large body of knowledge concerning 
the regulation of the IE genes of HSV, information regarding 
the regulation of other ^ -herpesvirus IE genes, is minimal. 
One study has reported the sequence and characterisation of 
the regulatory region of the pseudorabies virus (PRV) major 
IE gene (Campbell and Preston, 1987). These data revealed 
the presence of potent regu/ktory sequences, including 
repeated motifs which showed some similarity to those 
present in the enhancers of HCMV and murine cytomegalovirus 
(MCMV) major IE genes. The PRV IE gene regulatory sequences 
were responsive to Vmw65 though no TAATGARAT motif was 
detected and PRV does not appear to encode a homologue of 
Vmw65 (Hampl et a l ., 1984). Several copies of the octamer 
motif are present in the regulatory region though it would 
contrast with the HSV system if these were the sequences 
responsible for the Vmw65 responsiveness. This study also 
demonstrated that a Vmw65 homologue is not necessary for the 
expression of ^-herpesvirus IE genes, a finding confirmed by 
Ace et al., (1989), and suggest that either a cis-acting 
sequence bound by a cellular factor or a simple promoter 
strength model are sufficient to distinguish IE genes from 
the other temporal classes.
Only one allusion to the sequences regulating a VZV IE 
gene has been made. This involved the stimulation of
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expression in cell lines stably transformed with VZV orf62 
with its own regulatory sequences by infection with HSV-1 
under IE conditions suggesting that this promoter is also 
responsive to Vmw65 (Felsner et al., 1988). The lack of a 
published mRNA start site for the transcript precluded 
further analysis of the regulatory sequences.
1.5.
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Eukaryotic Transcriptional Regulation
1.5.1. Cis-Actinq Sequences
Control of transcription by RNA polymerase II in
eukaryotic cells is mediated, at the most basic level,
through the specific interaction of proteins and DNA 
sequences. Initial experiments attempted to define these 
sequences by deletion and mutagenesis of control regions and 
analysis of the effects of these manipulations on the level 
of transcription in cells or cell free systems. Data from 
these studies have revealed basic patterns in the 
arrangement and function of control sequences (Maniatis et 
al., 1987).
Taking the 5' end of the mRNA as +1, a short A+T rich
sequence, known as the TATA box, is found at or around -28.
Mutations in this motif have been shown to affect the 
accuracy of mRNA initiation to a larger extent than the rate 
of transcription (Grosscheld and Birnsteil, 1980; Benoist 
and Chambon, 1981; Ghosh et al., 1981). The TATA box is the 
most highly conserved cis-acting motif in genes transcribed 
by RNA polymerase II and is thought to be involved in the 
formation and positioning of a multisubunit complex 
incorporating the enzyme itself. However TATA boxes are 
absent from a significant subset of genes transcribed by 
this enzyme (Melton et a l ., 1984; Reynolds et al., 1984; 
Valerio et al., 1985). Some of these have been shown to 
fulfill cellular "housekeeping" functions and to have their 
5' ends in so called CpG rich islands, though the connection 
between these observations is not clear (Bird, 1986).
The region upstream of the TATA box contains upstream 
activating sequences (UASs). These are short (8-12bp) 
motifs which act to stimulate transcription either 
constitutively, as in the case of CCAAT box elements (Myres 
et al., 1986) and Spl binding sites (Jones and Tjian, 1985), 
or in response to specific stimuli such as serum stimulation 
(Treisman, 1985), heat shock (Bienz and Pelham, 1986), viral 
infection (Goodbourn et. a_l., 1985, 1986), exposure to heavy 
metals (Serfling et al., 1985) and steroids (Renkawitz et 
al., 1984). These cis-acting sites have all been shown to
mediate their effects through interactions with proteins.
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The motifs can be present in either orientation and show a 
decrease in activity with increasing distance from the TATA 
box (McKnight et al., 1982). More subtle changes in 
positioning can also affect transcription, the insertion of 
oligonucleotides that alter spacing by a half turn of the 
DNA helix results in a more profound reduction in 
transcriptional activity than those that result in a full 
turn (Takahashi et al. , 1986).
A second group of sequences that act to stimulate 
transcription are known as enhancers. These have been 
defined by their ability to act over considerable distances 
both upstream and downstream of the mRNA start site and by 
their independence of orientation in relation to the gene. 
They are longer than UASs, sometimes comprising hundreds of 
bases (Edlund et al., 1985), and contain binding sites for 
many different proteins (Serfling et al., 1985).
The enhancer sequence studied in most detail forms part 
of the SV40 E gene regulatory sequences. These consist of a 
TATA box and two upstream control elements. The proximal of 
these comprise three 21 bp repeats each of which in turn 
contains two binding sites for the transcription factor Spl. 
These act as UASs (Myres et ad.., 1981). The distal control 
region consists of two 72 bp repeats (Banerji et al., 1981; 
Gross et al., 1981; Moreau et al., 1981). Each of the 72 bp 
repeats can be divided into three 15-20 bp elements called 
A, B and C that cooperate to form the enhancer (Zenke et 
al., 1986; Herr and Clarke, 1986; Herr and Gluzman, 1985;
Clarke and Herr 1987). These enhancer elements function 
autonomously when present in two or more copies and display 
unique patterns of cell specific enhancer activity (Ondek et 
al., 1987; Schirm et al., 1987). Enhancer function is
maintained even when elements are separated by up to 100 bp 
(Ondek et al., 1988). Enhancer elements are in turn 
composed of sequence motifs which are individual protein 
binding sites. Enhancer motifs differ from elements in that 
there appear to be strict constraints on the spacing between 
the individual motifs within elements. The activity of 
multimers of enhancer elements is completely lost if 
individual motifs are separated by as few as five bases 
(Ondek et al., 1988).
A further question, as yet unresolved, is whether
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enhancers and UASs are qualitatively different in terms of 
their mechanism of action, or whether the unique features of 
enhancers relate simply to the presence of a large number of 
protein binding sites. Several lines of evidence argue 
against a qualitative difference between UASs and enhancers. 
First, the same sequence motifs such as activating protein 1 
(API) binding sites (Lee et al., 1987) and the octamer motif 
(Bohmann et al., 1987b; Parslow et al., 1987) act in both 
UASs and enhancers. Second, the SV40 enhancer can replace 
UASs deleted from the B-globin promoter (Treisman and 
Maniatis, 1985). Third, while a single heat shock upstream 
promoter element fails to act at a distance, duplication of 
this motif gives rise to an element with all the properties 
of an enhancer (Bienz and Pelham, 1986). This last 
phenomenon could not be reproduced when CCAAT box motifs 
were duplicated (Bienz and Pelham, 1986).
In favour of qualitative differences between promoter 
and enhancer sequences is the finding that, while similar 
sequence motifs exist in promoters and enhancers, they may 
interact with different proteins (Muller et al., 1988). In 
addition, a body of evidence suggests that transcription 
stimulated by enhancers can be suppressed by proteins such 
as the adenovirus E1A product (Velcich and Ziff, 1985; Hen 
et al., 1985; Stein and Ziff, 1987) and a cellular
equivalent present in undifferentiated but not 
differentiated F9 cells (Germain et al., 1985). These 
proteins reduce enhancer driven transcription while leaving 
promoter driven transcription unaffected,, but their 
mechanism of action is not clear.
Thus, the source of functional differences between UASs 
and enhancers is not known, however, the close juxtaposition 
of numerous protein binding sites in an enhancer does appear 
to result in activity that is qualitatively different from 
the sum of its parts.
1.5.2. Proteins Involved in Transcriptional Regulation
Cis-acting elements mediate control over the level and 
tissue distribution of transcription largely through specific 
interactions with proteins. Detailed knowledge of the
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proteins and their interactions with DNA will be necessary 
to understand the mechanisms involved in the regulation of 
transcription.
Given the diversity of cis-acting motifs and evidence 
that they act by forming specific interactions with protein 
factors, a one-to-one relationship between factor and motif 
seemed likely. This model proved too simplistic. Recent 
studies have provided examples of different motifs which 
interact with the same protein (Baumruker et al.. , 1988), 
different proteins that bind to the same motif (Chodosh et 
al., 1988) and protein-DNA interactions that involve single 
proteins, homodimers (Struhl, 1987) or an array of different 
proteins (Preston et al., 1988; Gerster and Roeder, 1988). 
Given this complexity, no attempt will be made to describe 
every factor that has been reported, detailed descriptions 
of only those three families of factors directly involved in 
this project will be given. These, the octamer binding 
proteins (section 1.4.3.), the activating transcription 
factor (ATF)/cyclic AMP response element (CRE) binding 
protein and API family and the CCAAT box binding proteins, 
do, however, provide good examples of some of the problems 
and surprises in this field.
1.5. 2.1. ATF/CREB Protein Family
The transcriptional regulatory proteins which bind to 
ATF/CRE motifs are proving to be an important model for the 
mechanisms which control gene regulation. The binding site 
core was derived from two separate sources. Analysis of a 
series of cellular genes whose transcription was known to be 
responsive to cAMP led to the identification of the core 
sequence TGACGTCA that bound a factor involved in cAMP 
dependent gene regulation (Short et al., 1986; Montminy et 
a l ., 1986; Comb et al., 1986; Silver et al., 1987; Tsakada
et a l ., 1987). Concurrently, work on the regulation of
adenovirus early gene regulation led to the identification 
of the same sequence as binding a cellular factor (named 
ATF) involved in the stimulation of transcription. This 
cis-acting sequence was found in the promoter regulatory 
regions of the adenovirus E1A, E2, E3 and E4 genes (Hurst 
and Jones, 1987; Lee and Green, 1987). Further analysis
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demonstrated that the ATF binding motif conferred cAMP 
responsiveness to these genes both in short term 
transfection assays and during viral infections. In 
addition, responsiveness to the adenovirus transactivating 
protein E1A, could also be mapped to this motif (Lee and 
Green, 1987).
Several lines of evidence suggest that the rigid 
conservation of the consensus TGACGTCA is neither necessary 
nor sufficient for cAMP responsiveness. In some situations 
non-consensus motifs have been shown to stimulate 
transcription more effectively than the consensus sequence 
and in others sequences flanking the core motif are 
essential for cAMP responsiveness (Montminy et al., 1987; 
Bokar et al., 1988; Deutch et al., 1988). Furthermore, it 
is likely that a family of proteins bind to the ATF 
consensus (see below), and flanking sequences may play a 
vital role in selecting the members of the family that bind 
and thus the functional characteristics of the binding site.
Running concurrently with the identification of cAMP 
responsive genes and the analysis of their cis-acting motifs 
has been the analysis of the proteins which interact with 
them. The first report of purification of a CRE binding 
protein was by Montminy and Bilezikjian (1987) who 
identified a nuclear phosphoprotein of molecular weight
43,000 which they purified from both the phaeochromocytoma 
cell line (PC12) and rat brain, using affinity to the CRE of 
the rat somatostatin gene. This protein was found to 
stimulate transcription of the cAMP responsive gene iri vitro 
and bound to the CRE as a dimer (Montminy and Bilezikjian,
1987)
More recently, cloning and sequencing of the genes 
encoding ATF/CRE binding proteins has been achieved. Two 
groups have published very similar sequences of CRE binding 
proteins from a human placental \gtll library (Hoeffler et 
al., 1988) and from rat brain (Gonzalez et al., 1989).
These proteins had apparent molecular weights of 38kd and 
43kd on SDS-PAGE, however their predicted molecular weights 
from sequence data were 35kd and 38kd respectively (Hoeffler 
et al., 1988; Gonzalez et al., 1989). A third group has 
published the sequence of a 54.5kd CRE binding protein from 
a human brain cDNA library (Maekawa et al., 1989). While
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the amino acid sequence of this protein is largely unrelated 
to the others published, all three proteins share important 
features related to their function and control. A 
carboxy-terminal "leucine zipper" and DNA binding domain 
(section 1.5.3.3.) is present in all of the proteins 
suggesting a relationship to the large family of DNA binding 
proteins that contain this motif. In addition the proteins 
encode sites for phosphorylation by protein kinase C and 
protein kinase A, and the 35/38kd proteins contain a 
potential phosphorylation site for caesin kinase II 
(Gonzales eit a_l. , 1989). Further sequence analysis revealed 
that the amino-terminal 268 amino acids of the 38kd protein 
has an acid to base ratio of 2.3 to 1, suggesting that an 
acidic activating domain might be present (Hoeffler et al., 
1987; section 1.5.4.). In addition, residues 10-100 and 
160-240 of this protein contain approximately 20% glutamine 
residues raising the possibility that this protein may act 
to stimulate transcription by two different mechanisms 
(section 1.5.4.). The 54.5kd protein does not possess a 
notably acidic region (Maekawa et al., 1989), however 18 
proline residues are present/a region between residues 200 
and 272 suggesting that, like a similar sequence in CTF/NFl 
(section 1.5.4.), this too may represent an activating 
region.
The mechanism by which increased levels of cAMP alter 
these transcription factors to induce increased gene 
expression is currently the subject of intense study. The 
CRE /ATF family are known to be phosphoproteins which bind 
to their cognate sites as dimers and it has been shown that 
transcriptional activity both in cells and cell free 
extracts can be stimulated by the catalytic subunit of the 
cAMP dependent protein kinase and inhibited by its 
regulatory subunit (Grove et al., 1987; Day _et a].., 1989). 
As mentioned above, CRE binding proteins thus far analysed 
contain phosophorylation sites for several protein kinases. 
The functional relevance of these sites was demonstrated by 
Yamamoto et al., (1988) who found that phosphorylation by 
protein kinase C resulted in increased dimer formation, 
while phosphorylation by protein kinase A resulted in a 20 
fold increase in transcription in the _in vitro assay used. 
This study also showed that the removal of phosphate
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residues causes a reduction in dimer formation, binding and 
transcriptional activation.
In vivo, the adenovirus E1A protein acts to stimulate 
adenovirus E gene expression (see sect. 1.5.2.4.). ATF 
binding sites have been directly implicated in this activity 
though the mechanism remains controversial. Several 
attempts have been made to determine whether E1A and 
cAMP-mediated transcriptional stimulation are related. 
Evidence available to date has not clarified the situation 
since single, synergistic and separate pathways have been 
reported (Engel et al., 1988; Sassone-Corsi, 1988; Leza and 
Hearing, 1989). These contrasting findings may be due to 
differences in cell types and species of origin, to the 
assays employed (virus infection compared with DNA 
transfection) or to the different promoter regions analysed. 
Further work will be required to differentiate between the 
possibilities.
1.5. 2. 2. Activating Protein 1
The API binding site (TGAGTCA) bears a striking 
resemblance to the CRE core (TGACGTCA), and indeed these two 
sites show 10%-15% cross-competition in protein binding 
studies (Hurst and Jones, 1987). Despite this similarity, 
the functions mediated by API binding proteins differ 
markedly from those bound by CREs.
The API binding consensus was derived from analysis of 
genes whose transcription was found to be induced by the 
tumour promoter TPA (Lee et al., 1987; Angel et al ., 1987; 
Piette and Yaniv, 1987). This core sequence, like the CRE, 
was shown to interact specifically with a series of protein 
species and to confer TPA responsiveness on heterologous 
promoters from a position either 3 1 or 5 1 to the reporter 
gene sequences (Angel et al., 1987). Progress towards 
identifying the proteins involved in API activity was made 
with the discovery that the API binding site is very similar 
to that of the yeast transactivator GCN4 (consensus 
ATGA(C/G)TCAT) which is involved in the regulation of 
aspects of amino acid metabolism (Hope and Struhl, 1986). 
The similarity of these two sites suggested that there might 
also be a connection between the proteins binding to them
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(Struhl, 1987).
Independently Vogt et al. , (1987) demonstrated sequence 
similarity between GCN4 and an oncogene, jun, which is 
responsible for the induction of fibrosarcomas in chickens 
by avian sarcoma virus 17 (Maki et a l ., 1987). The 
similarity between API and GCN4 binding sites and between 
the proteins jun and GCN4 led to the demonstration that jun 
was responsible for part of the DNA binding activity defined 
as API (Bohman et al. , 1987; Angel et al., 1988; Bohman et 
al ., 1988). More recent data have revealed that jun is one 
of a family of related proteins. Two others, jun B and jun 
D, have also been sequenced (Ryder et al., 1988, 1989). 
Comparisons of DNA sequences of the family of jun proteins 
revealed that regions thought to be important in 
dimerisation, interactions with DNA and stimulation of 
transcription show over 70% similarity amongst the three 
proteins. The remainder of the predicted amino acid
sequences show a much lower level of similarity, recalling 
the situation with the ATF protein family (Section
1.5.2.1.) .
Studies on another oncogene product, fos, which is 
responsible for the induction of osteogenic sarcomas by the 
FBJ murine sarcoma virus (Curran and Teich, 1982) showed 
that it toc> contributes to API binding activity. The 
cellular homologue of v-fos was known to be a nuclear 
phosphoprotein found in complexes with a second, 39kd, 
protein (Curran et al., 1984) and several pieces of evidence 
suggested that it was involved in gene regulation (Cohen and 
Curran, 1988; Sambucetti and Curran, 1988; Distel et al.,
1987). A series of studies then led to the revelation that 
the 39kd protein that bound with fos in the DNA binding 
complex was jun (Rauscher et al., 1988; Chiu et al., 1988; 
Sassone-Corsi et al_., 1988; Lamph et a_l., 1988) . Sequence 
comparisons between fos and related proteins, and peptides 
derived from API, demonstrated that these proteins also 
contributed to API binding activity. Additional studies 
revealed that antibodies against fos could inhibit binding 
of proteins to the API motif (Rauscher et a l ., 1988). In 
addition, comparisons of the sequences of fos and related 
proteins with those of the jun protein family and other DNA 
binding proteins showed that the fos and jun protein
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families contained leucine zipper motifs and associated DNA 
binding domains (Landschultz et al., 1988b; section
1.5.3.3.) .
Thus API binding activity appears to be dependent on 
co-operative interactions between the fos and jun protein 
families. It is likely that the two constituents of the 
complex contribute equally to DNA binding activity (section
1.5.3.3.) but their relative contributions to 
transcriptional activation are not known. It is also known 
that members of the fos and jun protein families can form 
heterodimers with at least some of the members of the 
complementary family in vitro (Turner and Tjian, 1989). 
This obviously provides scope for great flexibility of 
interactions _in vivo. The extent and functional 
significance of these interactions await further analysis.
To generalise further, the fos/jun and ATF/CREB protein 
families appear to represent important elements in the 
control of cellular transcription. There are striking 
similarities between these protein families. All bind, as 
dimers, to similar DNA sequences, they share significant 
homology in sequences that control protein dimerisation and 
protein-DNA interactions and their transcriptional 
activities are altered by post-translational mechansims. 
The extent and significance of interactions amongst the fos, 
jun and ATF/CREB families _in vivo is not clear but is 
obviously of great interest. It should also be noted that 
while most of the similarities between proteins in all three 
families centres on their DNA binding domains, the remainder 
of the proteins must contribute sequences of relevance to 
the proteins' individual roles. The analysis of these 
sequences will be of great importance.
1.5.2.3. CCAAT Box Binding Factors
CCAAT box motifs are present in the UASs of many genes 
transcribed by RNA polymerase II (Mellon et al., 1981; Jones 
et al., 1985; Myres et al ., 1986; Graves et al., 1986; 
Morgan et al. , 1988), and are important in the stimulation 
of transcription (Graves et al., 1986; Myres et al., 1986).
A related site was also found to be responsible for 
stimulating the replication of adenovirus DNA (Nagota et
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al., 1982; Rawlins et al., 1984; Hay, 1985).
Purification of proteins that interact with both 
transcription and replication sites yielded surprising 
results. Proteins purified by affinity chromatography using 
CCAAT motifs from the human £-globin and human ras genes 
yielded several species with molecular weights between 52 
and 66kd which were named CCAAT transcription factor (CTF) 1 
(Jones et al., 1987). These were shown to be structurally 
and functionally identical to protein species, named nuclear 
factor (NF) 1, purified using a consensus derived from the 
adenovirus origin of replication (Rosenfeld and Kelly,
1986). Concurrently, a second CCAAT box binding protein was 
purified using the HSV TK promoter and murine sarcoma virus 
long terminal repeat and called CCAAT binding protein (CBP) 
(Graves et al., 1986). CBP could be distinguished from 
CTF/NF1 by heat stability and binding affinities for mutant 
CCAAT box motifs (Graves et al., 1986). This protein was 
also found to be identical to a second species purified by
Johnson et ad.., (1987) using a completely unrelated sequence
A A ATGTGG /T /T /TAG, an "enhancer core homology" common to many 
animal virus enhancers (Weiher et aJL., 1983). It was 
initially named enhancer binding protein (EBP) but when it 
was shown to be identical to CBP the names and acronyms were 
combined resulting in C/EBP (Johnson et al., 1987). Studies 
using proteolysed fragments of the protein showed that both 
CCAAT and enhancer core binding activities co-localised to a 
14kd domain. Sequence data are available for C/EBP and 
CTF/NF1 (Landschultz ejt al., 1988a; Santoro et a l ., 1988). 
Comparison of these confirmed that the proteins are encoded 
by different genes and, surprisingly, that no similarity 
exists between the DNA binding domains of the proteins. 
C/EBP contains a leucine zipper motif and associated DNA 
binding domain (Landschultz et al., 1988; section I.5.3.3.), 
while the CTF/NF1 sequences responsible for binding DNA do 
not resemble any of the currently recognised motifs (Santoro 
et a l ., 1988). Sequencing of CTF/NFl cDNAs also revealed 
that transcripts of this gene could be spliced in at least 
three ways to form a family of factors (Santoro et: a l .,
1988). This at least partially explains the heterogeneity 
in molecular weights seen in purified preparations of the 
protein (Jones et. al. , 1987). Thus the same cis-acting
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motif can interact with at least two entirely distinct 
proteins whose DNA binding domains have no detectable 
sequence similarity.
The heterogeneity and complexity of the CCAAT box 
binding proteins does not stop here. In addition to C/EBP 
and CTF/NF1, numerous apparently different CCAAT box binding 
activities have been purified both from different cell types 
and also from the same cells (Hatamotchi et al. , 1986; Cohen 
et a l ., 1986; Barberis et al., 1987; Dorn et al., 1987;
Chodosh et al., 1988; Raymondjean et al., 1988; Gallinari et 
al., 1989) .
The proteins purified by Chodosh et al., (1988) are of 
particular interest. They consist of two novel species 
purified from HeLa cells, CCAAT box binding proteins (CP) 1 
and 2, which were distinguishable by their different 
affinities for individual CCAAT box motifs. Both proteins 
bound DNA most efficiently in the form of heterodimers. A 
fascinating insight into the complexity of gene regulatory 
mechanisms and their conservation across species boundaries 
came from the demonstration that the two components of CP-1 
(CP-1A and CP-lB) could form functional heterodimers with 
the yeast proteins HAP-2 and HAP-3 which control catabolite 
derepression of cycl gene expression in Saccharomyces 
cerevisiae (Guarente et al., 1984; Pinkman and Guarente, 
1985). Complexes formed between CP-lA and HAP-2 and CP-lB 
and HAP-3 (Chodosh et al., 1988b). A further component of 
the HAP2/HAP3 complex has recently been identified (Forsburg 
and Guarente, 1989). This protein, termed HAP4, is 
necessary for DNA binding by the HAP2/HAP3 complex _in vitro 
and contains a highly acidic region, necessary for the 
activity of the complex. Mutant strains from which this 
region was absent had lost the ability to regulate cycl 
expression (Forsburg and Guarente, 1989). These mutants 
could be rescued by replacing the acidic activating region 
of HAP4 with that of GAL4 (Forsburg and Guarente, 1989).
Thus CCAAT box binding proteins represent a 
structurally and functionally diverse group of proteins, 
whose only connection appears to be their affinity for the 
pentanucleotide CCAAT. Their importance is emphasised by 
the widespread use of this motif in promoter sequences and, 
in at least one case, the functional conservation of
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protein-protein interactions between yeast and man.
1.5.2. 4. Adenovirus ElA Protein
A second overall group of transcriptional regulatory 
proteins exists, which may function in a fundamentally 
different fashion from those described above. It includes 
viral immediate early proteins such as the adenovirus early 
region 1A (E1A ) gene products, the pseudorabies virus major 
IE gene product and the HSV IE gene product VmwllO. These 
do not appear to rely on sequence specific DNA interactions 
to mediate their effects and are able to transactivate a 
variety of promoters by mechanisms that are not yet fully 
understood (Berk, 1986; Everett, 1989) . Their functional 
similarity has been demonstrated by experiments in which 
co-infection with pseudorabies virus was shown to allow an 
adenovirus mutant (dl312), which lacks a functional E1A 
gene, to grow in tissue culture (Feldman et al., 1982; 
Imperiale et a l ., 1983). In addition, cotransfection of E1A 
stimulates expression of HSV E gene expression in short term 
transfection assays (Everett and Dunlop, 1984). However, no 
direct evidence exists to prove that the mechanisms of 
action of these different proteins are similar.
The products of the adenovirus ElA gene are 
multifunctional, nuclear phosphoproteins which transactivate 
other adenovirus E genes, immortalise primary rodent cells, 
repress the activity of transcriptional enhancers and 
influence cellular differentiation (Berk, 1986; Moran and 
Matthews, 1987).
The ElA gene of group C adenoviruses produces two major 
spliced products early in infection, the 12S and 13S mRNAs, 
which encode proteins of 243 and 289 amino acids, 
respectively. These proteins are distinguished only by 46 
amino acids at positions 140-185 in the 13S product, which 
are highly conserved amongst several adenovirus serotypes 
(Kimelman et al., 1985) and are essential for stimulation of 
E gene expression. Other areas of conservation between 
adenovirus serotypes exist between residues 40 and 80 
(Domain 1) and 121 and 140 (Domain 2). These have been 
shown to be essential for the other roles of ElA (Moran and
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Matthews, 1987 ) .
The presence of ElA alone is insufficient to induce 
cells to a fully transformed phenotype, though both the 12S 
and the 13S products are equally efficient in immortalising 
cells (Haley et al., 1984; Roberts et al., 1985; Zerler et 
al., 1986). Complete transformation requires expression of 
the ElB region (Houweling et al., 1980; van den Elson, 1983) 
though this function can be replaced by an activated H-ras 
oncogene or the polyoma virus middle T antigen (Ruley, 
1983). These immortalisation functions of ElA are
unaffected by deletions of sequences beyond residue 139 and 
thus are unlikely to depend on transactivation (Zerler ^t 
al., 1987).
Adenovirus infection is also known to stimulate DNA 
replication in serum starved, G arrested, primary or 
secondary cells (Shimojo and Yamashita, 1968). This 
function has also been mapped to ElA and is presumably 
related to the proteins' ability to induce the 
immortalisation of cells (Braithwaite et al., 1983).
Initial data suggested that the repression of enhancer 
driven transcription was linked to the function of 
immortalisation and induction of DNA synthesis, however, 
more recent studies have isolated mutants in domain 2 that 
affect transcriptional repression alone (Velcich and Ziff, 
1988; Subramanian et al., 1988).
The mechanism of transcriptional stimulation by ElA has 
been the subject of considerable interest. Adenovirus 
mutants with lesions in ElA produce decreased levels of 
early region transcripts (Nevins, 1981) and replicate very 
poorly in HeLa cells (Harrison et al., 1977; Jones and 
Shenk, 1979). However, like the HSV-1 mutants _inl814 (Ace 
et al., 1989), dll403 (Stow and Stow, 1986) and FXE
(Everett, 1989), this defect is much less severe at high 
multiplicities of infection (Shenk et a_l., 1979). ElA also 
stimulates the expression of numerous cellular genes, 
transcribed by either RNA polymerase II or III, in short 
term transfection assays (Green et. a_l., 1983; Svensson and 
Akarjarvi, 1984; Allan et al., 1984 Gaynor et a l ., 1984, 
1985; Stein and Ziff, 1984; Hoeffler and Roeder, 1985), 
though it fails to stimulate the transcription of their 
endogenous counterparts (Green et al., 1983; Babich et al.,
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1983; Gaynor et aJL., 1985) with the exception of the gene 
encoding heat shock protein 70 (Kao and Nevins, 1983) and a 
B-tubulin gene (Stein and Ziff, 1984).
Evidence that ElA uses a different mechanism of 
activation from other transcriptional activators has come 
from several studies. Firstly, ElA fails to make sequence 
specific interactions with DNA (Chatterjee et al., 1988). 
Secondly, target sequences responsible for ElA mediated 
transactivation are also responsible for transcriptional 
activity in the absence of ElA. These motifs have been 
shown to bind cellular proteins involved in the regulation 
of transcription such as TATA box binding factors (Wu et 
al., 1987; Wu and Berk, 1988; Simon et al., 1987; Williams 
et al., 1989), E2F (Thalmeier et al., 1989; Heibert et al., 
1989), E4F1 and ATF (Lee and Green, 1987; Lee et al., 1987; 
Lin and Green, 1988; Pei and Berk, 1989) and CCAAT box 
binding factors (Williams et al., 1989).
Given these data, two basic mechanisms for ElA 
stimulation have been proposed. ElA could act directly by 
binding to a variety of transcription factors and deploy a 
potent activating region to stimulate transcription, a 
proposition supported by the domain exchange experiments of 
Lillie and Green, (1989). Alternatively, ElA could act to 
increase the quantities of active cellular transcription 
factors. Again evidence exists to support this proposition 
as increased levels of functional TFIIID (Hoeffler and 
Roeder, 1985; Yoshinaga et al., 1986), TFIID (Leong et al.,
1988) and E2F (Raychaudhuri et al., 1987; Reidel et al., 
1988; Babiss et al., 1989) have been detected following 
adenovirus infection. Of course, it is possible that ElA 
could act in either way on different promoters, though this 
proposition seems rather unlikely given that a 49 residue 
synthetic peptide corresponding to ElA domain 3 appears to 
be able to function autonomously to transactivate viral 
genes in vitro and i_n vivo (Pusztai et al., 1989) . Thus the 
detailed mechanism of ElA action remains controversial.
1.5.3. DNA Binding Domains
The ability of proteins to bind DNA in a sequence
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specific fashion is an essential pre-requisite for the
regulation of transcription in both eukaryotic and 
prokaryotic systems (Maniatis et al., 1987). In principle, 
sequence information can be directly "read" from DNA by
hydrogen bond formation in the major groove of B form DNA, 
without disruption of the double stranded structure (Seeman 
et. ad.. , 1976). Information can also be expressed, and
presumably identifed, by means of structural inhomogeneities 
along the backbone of the DNA helix resulting from the 
specific sequence in question (Schleif, 1988).
Analysis of information derived from the published
sequences of DNA binding proteins has allowed the 
identification of conserved structural motifs by which many 
proteins recognise DNA (Anderson et al., 1981; Fairall et 
al., 1986; Landschultz et al., 1988b; Johnson and McKnight,
1989) .
1.5.3.1. Helix-Turn-Helix
The helix-turn-helix (HTH) structure was initially 
characterised through extensive analysis of the DNA binding 
domains of three prokaryotic regulatory proteins, the CRO 
and Cl proteins of bacteriophage lambda and the catabolite 
activator protein (CAP) of E .coli. These proteins bind as 
dimers to sites which have dyad symmetry (Anderson et al., 
1981; McKay and Steitz, 1981; Pabo and Lewis, 1982; Steitz 
et al., 1982). The essential structural components of their 
binding regions, which have been analysed in detail both by 
mutagenesis and crystallographic studies, are two short 
^-helices separated by a j£- turn (Anderson et al., 1981; Jordan 
and Pabo, 1988; Otawinowski et al., 1988; Aggarwal et al.,
1988). The carboxy-terminal helix, helix-3, interacts with 
the major groove, and is locked in place by hydrophobic 
interactions with helix-2 which is positioned over it 
relative to the DNA. Amino acid similarities between 
prokaryotic HTH proteins are less striking than their 
structural constancy (Pabo and Sauer, 1984), however, 
sufficient conserved residues are present to allow 
identification of new HTH motifs by sequence comparison. 
These have allowed the identification of HTH motifs in 
eukaryotic DNA binding proteins such as MATal and MATa2, the
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products of the mating type locus in the yeast Saccharomyces 
cerevisiae (Scott and Weiner, 1984). In addition Langhorn 
and Scott, (1984) and Shephard et al., (1984) noted that the 
sequence similarities could be further extended to the 
products of Drosophila homeotic genes which were already 
known, through genetic analysis, to be intimately involved 
in the regulation of developmental processes (Wright et al., 
1989 ) .
The realisation that homeobox sequences share
similarity with bacterial HTH proteins led to the prediction 
that these proteins would fulfill their regulatory function 
by forming sequence specific interactions with DNA.
Although difficulties have attended attempts to link
specific homeotic gene products to their appropriate sites
on DNA, it is clear that homeobox-containing proteins
localise in the nuclear compartment (DiNardo et a l ., 1985;
Carrol and Scott, 1985), are capable of avid interaction 
with specific DNA sequences (Desplan et al., 1985; Beachy et 
al., 1988) and depend on the homeodomain for
sequence-specific recognition of DNA (Desplan et al., 1988). 
That homeobox proteins can function as transactivators was 
recently confirmed by the identification of the POU proteins 
(Herr et al., 1988; Section 1.4.3.). Analysis of these 
proteins also revealed that the function of proteins that
contain homeodomains is not confined to regulating
developmental processes, as Oct-1 is found in almost every 
cell type (Fletcher et al., 1987), and no developmental role 
for it has yet been defined.
1.5.3.2. Zinc Finger Motifs
The zinc finger motif was originally proposed from
studies on the RNA polymerase II transcription factor 
TFIIIA. Purification, cloning and sequencing of this 
factor, which binds to the internal control region of the 5S 
rRNA gene (Miller et al., 1985), revealed a sequential and 
ordered occurrence of cysteine (Cys) and histidine (His) 
residues (Cys-^-Cys-N^-His-N3-His ) repeated nine times.
These observations, coupled with earlier experiments that 
had shown that TFIIIA binds zinc (Hannas et al., 1983) 
prompted Fairall et a_l. , (1986) to propose that each repeat
52
sequestered a single zinc ion via tetrahedral co-ordination 
with the spatially conserved Cys and His residues. The 12 
amino acid loop between the invariant Cys and His pairs 
contains scattered basic and several conserved hydrophobic 
residues and is thought to be involved in specific 
interactions with DNA (Fairall et al. , 1986). This type of 
zinc finger is also present in transcriptional regulatory 
proteins from yeast (Hartshorne et al., 1986; Stillman et 
al., 1988) and humans (Page et al., 1987; Kadonaga et al. ,
1987). These include the transcription factor Spl, which 
contains three zinc fingers that are known to be necessary 
and sufficient for DNA binding and require zinc to do so 
(Kadonaga et al., 1987).
A second type of zinc finger, related to, yet distinct 
from the Cys2His2 arrangement described above, has been
observed in a wide range of DNA binding proteins (Weinberger
et al., 1985; Miesfeld et al., 1986; Jeltsch et al., 1986; 
Green et al., 1986; Greene et al., 1986; Wray et al., 1987; 
Baum ^t al., 1987). This arrangement relies on clusters of 
4 to 6 cysteine residues to coordinate the zinc ion. Like 
the Cys2His2 fingers these occur in 25 to 30 residue 
clusters that tend to be repeated. The best characterised 
members of this family of proteins are the mammalian hormone 
receptors. The rat glucocorticoid receptor requires zinc 
for DNA binding activity and substitution mutations that 
alter key cysteine residues result in loss of function 
(Freedman et al., 1988; Severne et al., 1988).
The mechanism by which zinc fingers establish sequence 
specific contacts with DNA has not yet been fully resolved. 
The model proposed by Fairall et al., (1986) suggested that 
the Cys and His residues form a stable scaffold through
their interaction with zinc, allowing the residues between 
to loop out and form sequence specific contacts with the
DNA. No evidence has come to light that contradicts this 
basic view though the small differences in DNA binding 
specificity between progesterone and oestrogen receptors 
have been shown to depend on differences in several 
non—conserved amino acids at the base of the finger regions 
(Mader et al., 1989).
1.5.3.3. The Leucine Zipper
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A third conserved DNA binding motif has recently been 
identified and given the descriptive, if somewhat 
misleading, title "leucine zipper" (Landschultz et al., 
1988b). In common with the zinc finger motif previously
described, this DNA binding domain comprises two distinct 
parts, a structural region also involved in dimerisation, 
the zipper motif itself, and an adjacent DNA binding domain 
rich in basic amino acids. (Landschulz et al., 1988b). 
Both of these elements are required to allow specific 
protein-DNA interactions.
The leucine zipper was first proposed by McKnight's 
group (Landschulz et. al. , 1988b) as a result of studies on 
the protein C/EBP (section 1.5.2.3.). They noticed a heptad 
repeat of 4 leucine residues within a sequence that could 
form a stable ©L-helix with the leucine residues all present 
on one face. The next 30 residues contained a high 
proportion of basic amino acids. This whole structure was 
shown to lie within a fragment that contained the DNA 
binding activity of the entire protein (Landschulz et al., 
1988a). A computer search revealed a similar leucine
repeats in the amino acid sequence of the proto-oncogenes 
fos, jun and myc and the yeast regulatory protein GCN4, all 
of which were known to bind DNA as dimers (Hope and Struhl, 
1987; Rauscher et al., 1988; Chiu et al., 1988;
Sassone-Corsi et al ., 1988; Lamph et al., 1988). Thus it 
was proposed (Landschulz et ad.., 1988b) that the leucine 
zippers form the interaction domain between monomers and the 
region containing the basic residues allows interaction of 
the dimer with DNA.
Details of the interaction between individual leucine 
zipper regions are still obscure, however they are known to 
be essential for the proteins' DNA binding activity 
(Landschulz et al., 1988a; Gentz et al., 1989; Turner and 
Tijan, 1989; Schuerman et al., 1989). The initial model for 
the interaction (Landschulz e_t a_l. , 1988b) was that monomers 
bound in an antiparallel configuration with interdigitation 
of leucine residues on the helices stablising the 
interaction (thus the zipper metaphor). More recent studies 
have challenged this concept by demonstrating that the 
helices probably interact in a parallel configuration
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(O'Shea et al., 1989; Landschulz et al., 1989; Gentz et al.,
1989). These studies suggested that leucine zippers may 
adopt the coiled coil configuration found in fibrous 
proteins such as keratins, lamins, and myosin (Cohen and 
Parry, 1986), which classically depend for their structure, 
on the presence of a 4-3 repeat of hydrophobic amino acids. 
This arrangement is found in GCN4, jun and C/EBP but not in 
fos and m y c , and a simple requirement for hydrophobic 
residues fails to explain the strict conservation of leucine 
residues.
The details of the interactions between leucine zipper 
motifs are essential to an understanding of the processes 
that control dimerisation, which in turn, is essential for 
an understanding of the DNA binding activities of this 
important family of regulatory proteins (see sections 
1.5.2.1., 1.5.2.2. and 1.5.2.3.). GCN4 and C/EBP form only 
homodimers, while fos and jun can form both homodimers and 
heterodimers. Interestingly, the affinity with which the 
latter two proteins form dimers mirrors the affinity with 
which the completed dimer interacts with DNA. Thus fos/jun 
heterodimers form easily and bind DNA avidly, jun homodimers 
form less easily and bind DNA with less affinity, fos-fos 
homodimers are difficult to detect, and fos has low affinity 
for DNA (Nakabeppu et al., 1988; Turner and Tjian, 1989). 
These data suggested that the ability to dimerise and not 
the affinity of individual DNA binding domains regulates the 
affinity of protein-DNA interactions. This was confirmed by 
recent domain exchange experiments (Kouzarides and Ziff, 
1989; Sellers and Struhl, 1989) which showed that linking 
the fos DNA binding region with the GCN4 zipper motif 
resulted in a dimer that bound the API site with high 
affinity. Further corroboration of this model came from 
Neuberg et al., (1989), who exchanged the fos zipper motif 
with that of jun to create a protein which formed a 
homodimer and bound to the API site with moderate affinity.
Potential leucine zipper motifs have been detected in 
many other proteins. These include transcriptional 
regulatory proteins such as Drosophila zeste protein and 
Oct-2 in which they are not required for binding to any 
known DNA recognition sequences (Johnson and McKnight, 1989) 
and proteins with functions unrelated to transcriptional
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regulation such as voltage gated potassium channels 
(McCormack et al., 1989), glucose transporter proteins 
(White et a_l., 1989) and the F glycoproteins of
paramyxoviruses (Buckland et a l ., 1989). In these examples 
the zipper motif is not flanked by a basic region. These 
data suggest that this motif has a much wider role in 
protein-protein interactions than the one involved in the 
transcriptional regulators thus far described.
The three categories of DNA binding motifs described 
above define three categories of eukaryotic DNA binding 
proteins which include approximately 80% of those proteins 
for which sequence data on? available (Johnson and McKnight,
1989). Proteins that do not fall into these categories 
include heat shock transcription factor (Wiederrecht et al.,
1988), CTF/NF1 (Santoro et al., 1988), HAP2 (Pinkham et al .,
1987) and HAP3 (Hahn et al_. , 1988) .
1.5.4. Activating Domains
Experiments in several systems have demons trated that 
at the simplest level, proteins or complexes that function 
as transcriptional activators have two functional surfaces. 
One of these is responsible for the appropriate positioning 
of the factor either through direct binding to DNA, or 
through protein-protein interactions. The other is required 
for the stimulation of transcription. This model was 
initially developed from work in prokaryotic systems in 
which mutants with activator proteins that bound DNA but 
failed to activate transcription were isolated (Guarente et 
al., 1982; Hochschild et al., 1983). The activating 
surfaces of these proteins were shown to consist of an 
amphipathic c<.-helix bearing solvent exposed, predominantly 
negatively charged, residues (Bushman and Ptashne, 1988). 
Further experiments showed that the organisation into 
independent DNA binding and transcriptional activation 
functions also held for eukaryotic activators. Brent and 
Ptashne, (1985) replaced the DNA binding domain of the yeast 
transcriptional activator GAL4 with that of the bacterial 
repressor Lex A, to produce a protein that, when expressed
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in yeast, activated transcription of a gene bearing a Lex A 
operator upstream of its TATA box. These findings- were 
confirmed using another yeast activator, GCN4 (Hope and 
Struhl, 1985, 1986)
Three experiments provided evidence that, like 
prokaryotic systems, one class of eukaryotic activators 
depended on the presence of local concentrations of acidic 
residues. Deletion analysis of GAL4 (Ma and Ptashne, 1987a) 
and GCN4 (Hope and Struhl, 1986) showed that the removal of 
acidic domains resulted in loss or reduction of 
transcriptional activity. Point mutations in GAL4 that 
increased transcriptional activity involved the 
incorporation of negatively charged residues (Gill and 
Ptashne, 1987). Finally, sequences that functioned as 
activating regions when attached to appropriate DNA binding 
domains were readily detected by random cloning of fragments 
of the E.coli genome (Ma and Ptashne, 1987b), and analysis 
of the active fragments showed that they often had the 
potential to form amphipathic PC-helices (Ma and Ptashne, 
1987b).
The implied requirement for secondary structure in 
activating regions was confirmed by the construction of two 
oligonucleotides, each encoding a 15 amino acid peptide 
which were attached to DNA encoding the binding domain of 
GAL4. One peptide was designed to form an <x-helix with 
charged residues on one surface, in the other the same amino 
acids were arranged in scrambled order. Only the construct 
encoding the activating region in the form of the p£-helix 
activated transcription in yeast (Hope et al. , 1988).
The conservation of these acidic regions as activating 
domains was demonstrated in a series of experiments in 
which, given appropriate binding motifs, the well defined 
yeast transcriptional activator, GAL4, was shown to 
stimulate transcription in Drosophila larvae (Fischer et 
al., 1988), tobacco cells .(Ma et al. , 1988) and mammalian
cells (Kakidani and Ptashne, 1988; Webster et al ., 1988a)
A possible corollary to the basic premise that 
activating regions interact with other components of the 
transcriptional machinery to stimulate transcription is that 
in the absence of interactions with DNA, transcription 
factors would retain their capacity to interact with
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components of the transcriptional machinery, sequestering 
them from transcriptional complexes and causing a general 
reduction in transcription. This model has proved accurate 
in both yeast and mammalian systems (Gill and Ptashne, 1988; 
Triezenberg et al., 1988; Sadowski et al., 1988). In
addition, as noted previously, the HSV-1 protein Vmw65 
contains an acidic, carboxy-terminal domain essential for 
its role as a transactivator (section 1.4.2.). This domain 
has been used in exchange experiments and shown to function 
as a potent transcriptional activating region (Sadowski et 
al., 1988) .
While acidic activating regions were the first to be 
discovered and remain the best characterised, the sequences 
of several known transcriptional activators have been shown 
to lack regions containing significant net negative charge. 
Spl is a sequence specific transcriptional activator that 
binds, through three zinc finger motifs (see section
1.5.3.2.), to the motif GGGCGG found upstream of many 
eukaryotic genes. Deletion analysis of this factor has 
revealed four separate regions that contribute to 
transcriptional activation (Courey and Tjian, 1988). The 
two regions which are most potent as activators contain a 
high portion of glutamine residues (25% overall) they also 
have a low charge density. These regions appear to be 
functionally redundant, the presence of either conferring 
almost wild type activity on the protein (Courey and Tjian,
1988). The third activating region is only one tenth as 
active as the Gin rich regions, has a high charge density 
and a net charge of -6, but differs from other acidic 
activating regions in that increasing its net negative 
charge does not increase its ability to activate (Courey and 
Tjian, 1988). The fourth activating region is found at the 
C-terminus, it fails to function when present alone but 
appears to be necessary for full activity of the other 
regions (Courey and Tjian, 1988). Further evidence that 
glutamine rich sequences constitute bona fide 
transcriptional activating regions comes from experiments in 
which DNA encoding a 145 amino acid, glutamine rich region, 
from the Drosophila antennapedia protein was shown to 
substitute for the activation domains of Spl when linked to 
the Spl zinc fingers (Mitchell and Tjian, 1989). Inspection
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of sequence data from other established or suspected
transcription factors reveals glutamine rich regions in 
Drosophila ultrabithorax and zeste proteins (Mitchell and 
Tjian, 1989); in yeast HAPl, HAP2 and GAL4 (Pfeifer et al ., 
1989; Pinkham et al., 1987; Suzuki et al., 1988); and in 
mammalian factors Oct-1 (Sturm et al., 1988), Oct-2
(Scheidereit et al., 1988), jun (Bohmann et a l ., 1987), AP-2 
(Imagawa et ad.., 1987) and serum response factor (SRF)
(Norman et al., 1988), although the activation functions of 
these proteins have not yet been systematically defined.
A third type of activating region has recently been 
identified in CTF/NF1 (Mermod et a l ., 1989). Deletion 
analysis characterised it as a 100 residue region which 
contains 25% proline residues. It displays none of the 
features of the glutamine rich or acidic activating regions 
but will replace the activating regions of Spl when linked 
to the Spl DNA binding domain (Mermod et a l ., 1989). Again, 
proline rich regions have also been noted in other mammalian 
transcription factors (Imagawa et al., 1987; Struhl et al., 
1988; Clerc et ad.., 1988; Norman et al. , 1988), though 
analysis of their activity as functional activating regions 
is awaited.
1.5.5. Mechanism of Action of Transcriptional Activators
The endpoint of all processes mediated by 
transcriptional activators is the enhancement of RNA 
polymerase II mediated transcript initiation or elongation. 
Transcription is carried out by a multienzyme complex which, 
in addition to RNA polymerase II, contains a minimum of five 
basic factors; TFIIA, TFIIB, TFIID, TFIIE and TFIIF 
(Reinberg et al., 1987). These six factors are essential to 
form a pre-initiation complex that is resistant to the 
action of heparin, an inhibitor of transcriptional 
initiation (Reinberg et ad., 1987). Kinetic studies have 
suggested the order in which factors associate with DNA to 
form the initiation complex (Samuels and Sharp, 1986). 
Initial binding requires factors TFIIA and TFIID which, 
along with RNA polymerase II, form a complex which is 
resistant to the presence of 0.02% sarkosyl, another
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inhibitor of initiation (Davison et al., 1983). The 
situation regarding TFIIA is not as certain as for other 
factors since a requirement for this fraction has not been 
consistently demonstrated and there is significant 
disagreement relating to its molecular weight and properties 
(Reinberg et al., 1987; Samuels and Sharp, 1986; Egly et 
a_l. , 1984). In contrast, TFIID has been well characterised 
as the TATA box binding factor. Its importance to 
transcription initiation has been demonstrated by its 
functional conservation between mammals (Sawadogo and 
Roeder, 1985) and yeast (Buratowski et al., 1988), though in 
terms of molecular weight the factors from these species 
vary between 120-140 kd in mammals (Samuels and Sharp, 1986) 
and 27 kd in yeast (Buratowski et al., 1988). Once TFIIA, 
TFIID and RNA pol II have bound DNA, rapid binding of the 
other factors required to form the heparin resistant complex 
occurs (Fire et al., 1984). This complex is competent for 
chain initiation and elongation (Bunick et al., 1982).
To function as transcriptional activators, proteins 
must act to enhance one or more of the steps described 
above. Evidence exists for at least two basic mechanisms by 
which this might be achieved. Activators could function 
indirectly, to alter the form of the DNA template and thus 
facilitate the formation of an initiation complex. The 
presence of CpG rich islands covering the regulatory regions 
of constitutively transcribed genes and the developement of 
nuclease hypersensitive sites around genes whose 
transcription has been induced (Gross and Garrard, 1988) is 
evidence for this mechanism, though questions of cause and 
effect in both situations have not been fully resolved.
A second mechanism by which transcriptional activators 
could function is by acting directly on the components of 
the initiation and elongation complexes. Evidence that this 
occurs is implicit in the multitude of demonstrations that 
transcriptional activators function in short term 
transfection assays and in cell free extracts. Insights 
into the mechanism by which transcriptional activators 
mediate their effects have begun to accumulate more recently 
with the availability of purified preparations and the 
sequences of the relevant factors.
TFIID has been identified as a target of several
transcriptional activators. The PRV IE protein appears to 
act by facilitating the interaction of TFIID with the 
promoter, a role that can be reproduced by pre-incubation of 
the DNA template with a purified preparation of the factor 
(Abmayer et al. , 1988 ). ATF and GAL4 have also been shown 
to alter TFIID binding, Horikoshi et al., (1988a,b) showed 
that binding of either transactivator to sites upstream of 
the adenovirus E4 TATA box resulted in a qualitative 
alteration of the footprinting pattern of partially purified 
mammalian TFIID. These studies were complemented by
functional analyses (Hai et al ., 1988) which showed that 
transcription could be inhibited by an oligonucleotide 
containing the ATF binding motif added prior to TFIID, TFIIB 
and RNA polymerase II. Addition of the oligonucleotide 
after these factors left transcription unaffected, 
suggesting a transient requirement for the activator in the 
formation of a preinitiation complex.
Given the diversity of transcriptional activators thus 
far discovered, it would be surprising to find a single 
mechanism of action used by all. It is no surprise that 
other transactivators have been analysed and found not to 
act through TFIID. Earlier data from Roeder1s group, who 
described the effect of ATF on TFIID using the adenovirus E4 
TATA box, showed that no alteration in the TFIID footprint 
resulted from the binding of a gene specific transcription 
factor, USF, to the adenovirus major late promoter (Sawadogo 
and Roeder, 1985). Indeed, using this system, binding of 
TFIID alone protected a region from -40 to +35, the same 
nucleotides as were protected around the E4 TATA box,
presumably by TFIID, in the presence of ATF (Horikoshi et 
al., 1988b). In a second model, using yeast TFIID (Schmit 
et al., 1989), the transcription factor Spl was shown not to 
affect the in vitro binding of this factor. This result is 
not directly comparable with those described above as while 
the yeast factor functionally replaces mammalian TFIID, the 
discrepancy in their molecular weights means that simple
comparisons may not be directly informative.
Other data implicate RNA polymerase II as a target for
activators. This enzyme comprises a large multiprotein 
complex consisting of 8-10 subunits ranging in molecular 
weight from 240,000 to 10,000 kd. The largest subunit is
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highly conserved from yeast to man and has a 
carboxy-terminal domain consisting of the sequence 
Tyr-Ser-Pro-Thr-Ser-Pro-Ser repeated 52 times in mice and 26 
times in yeast. This carboxy-terminal domain has been
proposed as a site for the action of transcriptional 
activators as its removal eliminates transcription and 
partial deletions cause graded reductions in activity 
(Allison et al., 1988, Bartolmei et al., 1988).
An elegant study by Allison and Ingles, (1989), 
provided insights into the role of the carboxy-terminal 
repeats of RNA polymerase II and their functional 
relationship with acidic activating regions. These workers 
made mutant yeast strains containing alterations in two 
proteins. Deletions or extensions were made to the RNA 
polymerase II carboxy-terminal repeats and deletions were 
made to the acidic regions encoded by the transcriptional 
activator GAL4. Analysis of yeast strains combining
mutations in both proteins revealed that wild type GAL4 
could complement partial deletions of repeats from RNA 
polymerase II without loss of function. Mutants with 
deletions of acidic residues and the RNA polymerase II 
carboxy-terminal repeats had considerably reduced activity. 
Conversely, activity in mutants with large deletions in the 
activating region of GAL4 such that its stimulating activity 
on wild type RNA polymerase II was reduced, could be rescued 
by mutations which resulted in an increase in the number of 
repeats at the C-terminus of RNA polymerase II. Thus a 
functional connection can be drawn between the acidic 
regions of activators and the carboxy-terminal repeats of 
RNA polymerase II, though no information as to the mechanism 
by which they are connected can be implied.
Even from the evidence available to date, it is clear 
that the regulation of eukaryotic gene expression is a 
complex and flexible system. Current knowledge provides a 
reasonable picture of the first level of complexity in gene 
regulation, that of protein-DNA interactions. In a few 
systems this rather narrow focus has been expanded to show 
the importance of protein-protein interactions which will 
provide a second level of complexity. These interactions 
can be either direct, with components of the transcriptional
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machinery as apparently occurs in the case of ATF and TFIID 
(Horikoshi et al., 1988a), or indirect, with the formation 
of multi-protein complexes as in the case of the Vmw65-Oct-l 
interaction (Preston et al ., 1988; Gerster and Roeder, 1988) 
and the HAP2/3/4 interaction in yeast (Forsburg and 
Guarente, 1989).
Surprising complexity exists even at the level of 
protein-DNA interactions with multiple proteins interacting 
with the same DNA motif and multiple DNA motifs interacting 
with the same protein. Both of these phenomena can be 
viewed as increasing the flexibility of the transcriptional 
regulatory machinery. Further advances in the understanding 
of gene expression will no doubt produce more surprises, but 
hopefully also a greater understanding of the mechanisms 
that control this vital process.
1.6. Aims of the Project.
The initial aim of this project was the analysis of VZV 
orfs by expression in heterologous systems. The first orf 
chosen for study was number 66 which encodes a putative 
protein kinase. The system chosen for its expression was 
the HSV-1 mutant tsK under the control of HSV-1 IE sequences 
(see Appendix 2). This course of study proved fruitless in 
that no product of orf66 could be detected on SDS-PAGE. 
After the first year, preliminary analysis was undertaken on 
two other VZV orfs. One was the VZV dPyK gene which was 
expressed using the plasmid pKK233-2 (see Appendix 1), the 
other involved investigation of the regulation of VZV IE 
gene expression with a view to analysing the function of orf 
10 the proposed homologue of the HSV protein Vmw65. For 
reasons that are now apparent (Appendix 1) successful 
expression of the VZV dPyK gene did not result in detectable 
TK activity however investigation of the regulatory 
sequences of the VZV major IE gene yielded interesting data. 
First the site of mRNA initiation was mapped. Second, 
functional analyses were performed to determine the 
sequences that are important in the stimulation of 
transcription. Third, protein binding assays were 
undertaken in an attempt to identify the protein species 
responsible for transcriptional stimulation. These data
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revealed that, like HSV-1, HSV-2 and PRV, the expression of 
the major IE gene of VZV is responsive to stimulation by the 
HSV-1 protein Vmw65. Analysis of VZV orf10, the homologue 
of Vmw65 was then undertaken to determine whether it 
possessed transcriptional stimulating activity. The results 
of these analyses are presented.
2 . MATERIALS
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2.1. Viruses
HSV-1 viruses used in this study were all derived from 
strain 17(syn+ ) (Brown et al., 1973) including the mutant 
tsK (Marsden et aJL. , 1976).
The VZV strain used was that described by Dumas et al., 
(1981) which was propagated from stocks held by Dr. D.
Dargan.
2.2. Tissue Culture Media
ETC^q - Glasgow Modified Eagles Medium (GMEM)
(Busby et a l ., 1964, supplied by Gibco) 
supplemented with 10 0 units/ml 
penicillin, lOOug/ml streptomycin, 10% 
tryptose phosphate and 10% calf serum.
DCc - Dulbecco's Modified Eagles Medium (DMEM)
D
(supplied by Gibco) supplemented with 100 
units/ml penicillin, lOOug/ml 
streptomycin, 2.5% foetal calf serum 
(FCS) and 2.5% calf serum.
EF1q - GMEM supplemented with 100 units/ml
penicillin, lOOug/ml streptomycin, and 
10% FCS.
For viral titrations infected cells were overlaid with 
GMEM supplemented as above and with 0.6% Noble 
Agar.
2.3. Tissue Culture Cells
BHK-21 clone 13 cells (Mcpherson and Stoker, 1962) were 
used for growth and titration of HSV-1 and in 
transient transfection assays.
WS HeLa cells (originally obtained from Dr. W.
Schaffner, Zurich) were used for transient 
transfection assays.
Flow HeLa Cells (Flow Laboratories) were used in the 
production of nuclear extracts.
Vero Cells (Flow Laboratories) were used for transient 
transfection assays.
Human Foetal Lung (HFL) cells were originally supplied 
by Dr. B. Carritt and used for the propagation of 
VZV.
Bacterial Strains
Escherichia coli K12 DHl (recAl, nalA, r„-, itu-,
— _ R R
endol , B , relA l ) (Hanahan, 1983) was used for 
routine plasmid construction and amplification. 
Escherichia coli W3110 Laclq , (Brent and Ptashne,y
1981) was used for the induced expression of VZV 
orf36.
Bacterial Culture Media
Bacteria were routinely grown in L. Broth [1% (w/v) 
NaCl, 1% (w/v) bactopeptone, 0.5% (w/v) yeast 
extract] and L. Broth agar [L. Broth plus 1.5% 
(w/v) agar].
Plasmids.
pVZVSstf Terminal SstI fragment of the short repeat of 
VZV in the vector pATl53 (Davison and 
Scott, 1983) .
pVZVKpnj Kpnl fragment of the short unique region of 
VZV containing the putative protein kinase 
gene. (Davison and Scott, 1983) 
pFJ3 pCHllO (BIOLABS) with polylinker of pUCl8
added at residue 4080 (Dr. F. Rixon, pers. 
comm.)
pBLW2 CAT gene with HSV-2 IE 5 terminator sequences
in pUC8 (Gaffney et al., 1985). 
pl40cat VZV ORF62 upstream region from -1146 to +55 
inserted into pCAT (McKee et al., in press) 
pFS8 HSV-1 TK gene under the control of SV40 E
gene regulatory sequences (Campbell et al.,
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pIE3CAT
pRR5 5
pl2 S
pl3 S
pMCl
pTZORFlO
pMCORFlO
pGEMTIF
A494*23
1984)
HSV-1 IE gene 3 regulatory sequences (-331 to 
+26) fused to the CAT gene in a vector 
derived from pBLW2 (Stow et al., 1986).
IE promoter and enhancer sequences of HCMV 
strain AD169 (Fickenscher et al., 1989). 
Kindly provided by Dr. R. Ruger 
Adenovirus 5 E1A gene and control sequences 
12S cDNA replacing coding 
Kindly provided by Dr. N.
5 ElA gene and control sequences 
13S cDNA replacing coding 
Kindly provided by Dr. N.
with the 
sequences 
Jones.
Adenovi rus 
with the 
sequences 
Jones.
Coding and regulatory sequences of Vmw6 5 
inserted as a 2.7kb fragment into pUC9. 
(Campbell et al., 1984) .
1290bp fragment containing VZV orflO cloned 
into pTZl8 (Pharmacia). (McKee et al., in 
press).
Coding region of VZV orflO cloned into 
pMCl.inl7 (Ace ^t al., 1988; McKee et al., 
in press).
HSV-1 gene encoding Vmw6 5 doned under the 
control of the T7 promoter in pGEM2.
A 360bp fragment containing the HSV-1 IE-3 
regulatory sequences inserted into the 
HSV-1 BamHI p fragment within the coding 
sequences of the TK gene. Provided by Dr. 
C.M. Preston.
2.7. Oligonucleotides
Oligonucleotides were synthesised using a Biosearch 
8600 DNA synthesiser by Dr. J. McLaughlin or 
provided by Dr. N. Jones. Sequences of the 
oligonucleotides used are given in Appendix 3.
2.8. Chemicals
2.10
2.11
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Chemicals used were of the highest purity available and 
were obtained from Sigma Chemical Co., BDH 
Chemicals or an alternative supplier. Other 
suppliers included Kochlight Ltd. (boric acid, 
acrylamide, caesium chloride, sodium hydroxide, 
trichloracetic acid [TCA]) and Pharmacia Fine 
Chemicals (Sephadex G50).
Radiochemicals
Amersham and NEN Dupont supplied all radiochemicals 
used.
Commonly Used Buffers
(electroelution buffer)
40mM Tris, 5mM sodium acetate, ImM EDTA.
90mM Tris, 90mM Boric acid, ImM EDTA, pH8.3 
TBE loading buffer
50% (v/v) lxTBE, 50% (v/v) glycerol, 0.1%
(w/v) bromophenol blue.
150mM NaCl, 15mM trisodium citrate.
Enzymes
DNAase, RNAase and Lysozyme were supplied by Sigma; 
Proteinase K, T4 polynucleotide kinase and T4 
ligase were from Boeringer Mannheim, most 
restriction endonucleases were from Bethesda 
Research Ltd. or New England Biolabs though Afllll 
came from Northumberland Biologicals. Reverse 
Transcriptase, isolated from avian myloblastosis 
virus came from Life Sciences Inc.
EEB
TBE
TBELB
SSC
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3. METHODS
3.1. Tissue Culture
Baby hamster kidney BHK-21 (C13) cell monolayers were 
grown in ETC^q medium at 37°C, on 175cm2 (Nunclon) flasks, 
in an atmosphere of 5% C02 , 95% air. Cultures were passaged 
every 2 to 3 days. This was achieved by removal of growth 
medium, addition of 10 ml of trypsin/versene (1:1 v/v) and 
incubation until cells detached from the flask. ETC10 
(10ml) was added and the cells resuspended by pipetting. 
This suspension was used to seed further monolayers.
Monolayer cultures of human foetal lung (HFL) cells 
were grown in EF^q medium at 37°C on 175cm2 (Nunclon) flasks 
in an atmosphere of 5% CC>2 , 95% air. The cultures were 
passaged every 3 to 4 days as described above.
HeLa cells (obtained from Dr. R. D. Everett) were
grown in Dulbecco's Modified Eagles Medium (DMEM) (supplied
by Gibco) supplemented with 100 units/ml penicillin,
lOOug/ml streptomycin, 2.5% foetal calf serum (FCS) and 2.5%
2
newborn calf serum. They were routinely passaged in 175cm 
(Nunclon) flasks and harvested as described above.
Vero cells (obtained from Dr. R. D. Everett) were grown 
in EF10 medium at 37°C on 175cm2 flasks in an atmosphere of 
5% CC>2 , 95% air. The cultures were passaged every 2 to 3
days as described above.
3.2. VZV Stocks and Propagation
The VZV strain used for these studies was that 
described by Dumas et a l . (1981), which was kindly provided
by Dr. D. Dargan. Stocks were produced by infecting 
subconfluent HFL monolayers with VZV-infected HFL cells. 
These were incubated at 37°C until a cytopathic effect (cpe) 
of 60%-80% had developed. This normally occured after 4-5 
days but infected cultures could be subcultured as described 
in section 3.1. and the infection allowed to continue until 
an adequate level of cpe developed. Cells were harvested 
using trypsin and versene as described above, (section 3.1.) 
and 1/6 of the product of one 750 ml flask used to continue 
the infection in another flask of subconfluent cells. The
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rest of the cells were pelleted (1500 rpm for 2min), 
resuspended in EF^q , with 10% dimethylsulphoxide (DMSO) and 
a further 10% FCS added. Cells were then stored at -140°C.
3.3. Mapping of mRNA 5 1 terminus
3.3.1. Extraction of Cytoplasmic RNA
For RNA preparation cells were grown on 90mm plates 
until 80% confluent. HFL cells, infected with VZV, were 
harvested as described (section 3.2.) and approximately
5
5x10 cells were added to each plate. The plates were 
incubated at 37°C for 24 hr. Medium was then decanted, the 
cells washed in ice cold PBS and monolayers scraped into ice 
cold PBS. This suspension was centrifuged at lOOOg for 5 
min at 4°C. Cell pellets were resuspended in 5ml of lysis 
buffer (0. 2M Tris HC1 pH 8.5, 0.14M NaCl, 2mM M g C ^ r  lOug/ml 
cycloheximide, 0.5% NP40), pipetted 4 times through a 10ml 
pipette and centrifuged at lOOOg for 3 min at 4°C. The 
supernatant was transferred to a flask, at room temperature, 
containing 15ml 3mM Tris HCl (pH 8.5), 2mM EDTA, 0.2% SDS 
and 15ml phenol/chloroform. The contents were mixed by 
swirling then left for 10 min before centrifugation at lOOOg 
for 10 min at 20°C. This procedure was repeated two further 
times after which the supernatant was added to 15ml of 
chloroform mixed and centrifuged for 5 min at lOOOg. NaCl 
(0.1M) was added to the supernatant from this final 
extraction and RNA precipitated overnight at -20°C after 
addition of 2 volumes of ethanol. The RNA was then pelleted 
by centrifugation at lOOOg for lOmin at 4°C, washed in 
ethanol, dried and dissolved in 150ul of distilled water.
3.3.2. Oligonucleotide Purification
Oligonucleotides were produced by Dr. J. McLaughlan 
using a Biosearch 8600 DNA Synthesiser. On receipt they 
could be stored at -20°C. Before purification protecting 
groups were removed by incubating the sample at 55 C for 5 
hr. The samples were then frozen, dried under vacuum and 
redissolved in sample loading buffer (90% v/v deionized
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formamide and lxTBE). Oligonucleotides were then loaded 
onto a denaturing acrylamide gel (15% with 4% crosslinker) 
(section 3.2.7.) and run at 35 W. Separate dye tracks were 
employed to monitor progress and the run stopped after the 
xylene cyanol band had progressed past 7cm. The 
oligonucleotide bands were visualised by the shadow casting 
technique, in which the gel was removed from the plates and 
placed on a fluorescent thin layer chromatography plate. An 
ultraviolet lamp was used to observe fluorescent quenching 
and the desired oligonucleotide, always the slowest moving 
dark band, was excised. The gel fragment was then diced and 
incubated overnight at 45°C in gel elution buffer (GEB) 
(0.5M sodium acetate, 0.1% w/v SDS, 2mM EDTA, 20mM Tris HCl 
(pH7.5)) with. Samples were then filtered through a Whatman 
GF/C filter, precipitated in 2.5 volumes of ethanol at -20°C 
for 2 hrs, centrifuged at 36,900g for 20 min, washed in 
ethanol dried and resuspended in 50ul of water.
3.3.3. Generation of Double-Stranded Oligonucleotides.
If double stranded oligonucleotides were required they 
were annealed by mixing 25ul of each preparation in a 
solution containing 0.3M sodium acetate, 2mM EDTA and 40mM 
Tris HCl pH7.5. These were incubated at 50°C for 1 hr, 37°C 
for lhr and at room temperature for 1 hour. After this the 
annealed oligonucleotides were precipitated in 2.5 volumes 
of ethanol for 2hr at -20°C, centrifuged Qt 36900g for 20 
min, washed in ethanol and dried.
The concentration of oligonucleotides was established 
by comparison of samples with previously quan. tified 
oligonucleotides. Double stranded and single stranded 
oligonucleotides were separated on a 14% non-denaturing 
polyacrylamaide gel (section 5. 3. 2.) and samples were 
compared by fluorescent quenching.
3.3.4. 5' [32P] Labelling of Probes
Oligonucleotide probe (50ng) was dissolved in kinase 
buffer (70mM Tris HCl pH7.6, lOmM MgCl^, 5mM DTT), 50uCi of 
[ p ]- ATP plus 2 units of T4 polynucleotide kinase were 
added and the mixture incubated at 37°C for lhr. The
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radiolabelled sample was loaded onto a 5% non-denaturing
acrylamide gel and run at 250V for 2hr as described in
section 3.3.2. The appropriate band was cut out, chopped 
into small pieces and incubated overnight in 600ul of GEB at 
45°C. After this incubation the supernatant was decanted 
and purified by passage through a Sephadex G50 column and 
collected in 250ul samples. The five samples showing the 
highest levels of radioactivity were selected, to these was 
added lug of poly(dl).poly(d C ) prior to precipitation in 
ethanol for 30min at -70°C. Following centrifugation at 
ll,600g for 10 min, washing in ethanol and drying, the 
pellets were dissolved in lOul to lOOul of water and 
subjected to Cerenkov counting.
3.3.5. Primer Extension Analysis.
Assays were carried out as described by Inoue and Cech
(1986). lOug of RNA was annealed to a 5' end labelled
oligonucleotide primer. The primer, a 29-mer, (51- 
GGGGTGTAGAGCGCTGCATCGGCGGCGAT ’3) was designed to be 
complementary to the N-terminus of the VZV orf62. 
Hybridisation was initiated at 90°C in hybridisation buffer 
containing 50 mM Tris pH 8.3 and 40 mM KCl. Thereafter the 
temperature was allowed to decrease to 45°C over one hour. 
M g C ^  was added to 5 mM and each deoxynucleoside 
triphosphate to 500 uM. This mixture was incubated with 10 
units of reverse transcriptase for 30min and compared with 
size markers using denaturing polyacrylamide gel 
electrophoresis.
3.3.6. Nuclease SI Analysis.
Approximately 5ng of oligonucleotide 5' end labelled 
with [32P]- ATP was precipitated with lOug of cytoplasmic 
RNA. The resulting pellet was resuspended in 20ul of 90% 
v/v deionised formamide, 0.4M NaCl, 40mM PIPES (pH6.8), ImM 
EDTA and heated at 90°C for 5min. Samples were transferred 
rapidly to a water bath at 58°C and incubated for 16hr.
They were then placed on ice. 4000 units of Si nuclease in 
the appropriate buffer ^ added to each sample to give 
final concentrations 25mM NaCl, 30mM sodium acetate (pH4.5),
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O.lmM ZnSC>4 in a volume of 200ul.
The samples were incubated at 37°C for 90min. EDTA (pH
7.5) and sodium acetate (pH 7.0) were then added to final 
concentrations of 20mM and 0.3M respectively. The samples 
were phenol/chloroform extracted, ethanol precipitated and 
electrophoresed on a denaturing polyacrylamide gel alongside 
G and G + A sequence tracks.
3.3.7. G and G + A Sequencing
G and G + A sequences were derived to provide marker 
tracks for both nuclease SI analyses and DNAase I 
footprinting assays. The method followed was that of Maxam 
and Gilbert (1977). DNA analysed was uniquely end labelled 
using either T4 kinase or T4 polymerase, sections 3.2.3. and
3.6.4. respectively.
Radiolabelled DNA was resuspended in 0.1 mM NH^OH, 3ug 
of sonicated calf thymus DNA was added and the total volume 
adjusted to lOul with deionized water. Samples were then 
heated to 90°C for 1 min and chilled on ice.
To cleave at G residues 200ul of G buffer (50mM sodium 
cacodylate pH8.0 and ImM EDTA) and lul of DMS were added 
and the mixture incubated at 20°C for 10 min. The reaction 
was stopped by the addition of G stop (1.5M ammonium acetate 
pH7.0, 1M 2-mercaptoethanol, 40ul carrier DNA). DNA was 
precipitated at -70°C in ethanol and pelleted by 
centrifugation for 10 min at ll,600g. The supernatant was 
then decanted and 25 0ul of 2M ammonium acetate/0.1M EDTA and 
750ul ethanol added. It was precipitated at -70°C and 
centrifuged as above. The resulting precipitate was washed 
with ethanol and dried.
Cleavage at G + A residues was achieved by adding lOul 
of water and 2ul of PIP-Formate pH4 (9.5 ml H^0, 0.45ml 88% 
formic acid, 15ul piperidine) and incubating at 37°C for 
25min. The reaction was then frozen, lyophylised, dissolved 
in 20ul of water and again frozen and lyophylised.
Ammonium hydroxide (5M) was then added to both samples, 
they were lyophylised, and lOOul of 1M piperidine added 
prior to incubation at 90°C for 30min. The samples were 
transferred to 1.5 ml reaction tubes containing lOOul of 2M 
ammonium acetate/0.ImM EDTA, ethanol precipitated, washed
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and dried. Samples could be stored in this condition ready 
for use.
3.3.8. Denaturing Polyacrylamide Gels.
A 50ml volume of acrylamide solution was prepared, 
containing 8% or 10% acrylamide (diluted from a stock of 29% 
acrjlamide, 1% N,N1 methylenebisacrylamide, 7M urea), 21ml of 
10M urea, 0.55xTBE, 300ul of 10% ammonium persulphate (APS) 
and 50ul TEMED. This solution was poured into a mould 
(230mm/450mm/0.35mm). After polymerisation the gel was 
pre-run at 40W for lhr prior to loading. The samples were 
dissolved in 80% deionized formamide, 0.55xTBE, ImM EDTA, 
0 .1% w/v xylene cyanol and 0.1% bromophenol blue, and 
denatured by heating to 100°C for 3min before loading. 
Electrophoresis was performed in 0.55xTBE at 40W for 
approximately 2hr.
3.4. Construction, Preparation and Characterisation of
Plasmid DNAs.
3.4.1. Restriction Enzyme Digests.
DNA was digested in a final volume of between lOul and 
50ul in the reaction conditions specified by the 
manufacturer of the enzyme used. The number of units of
enzyme added was dependent on the activity of the enzyme and
the amount of DNA present. Reaction mixtures were generally 
incubated at 37°C for 3hr.
Partial cleavage to produce linear molecules was
achieved by incubating 2ug of DNA with 2 units of enzyme in
the presence of lOug/ml to 500ug/ml ethidium bromide to 
identify conditions that produced a maximum of singly cut 
molecules.
3.4.2. Separation of Fragments by Non-denaturing Gel 
Electrophoresis.
Agarose gels: 200ml horizontal slab gels
(26 0mm/16 0mmx7.5/mm) containing 0.5 to 1.5% (w/v) agarose 
were electrophoresed in 0.5xTBE plus 0.5ug/ml ethidium
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bromide, for approximately 16hr at 50V. Samples were loaded 
in 10% glycerol, 0.5xTBE and 20ug/ml bromophenol blue.
: 50ml (10 0mm/7 0mm/7mm) gels were also
used. These gels were electrophoresed in TBE at 40V for lhr. 
Samples were loaded as for the horizontal slab gels and 
bands visualised by the addition of lug/ml ethidium bromide 
and subsequent UV transillumination.
Polyacrylamide gels: Vertical non-denaturing
polyacrylamide gels were used for resolving DNA fragments 
smaller than 0.5kbp and analysis of DNA-protein interactions 
in gel retardation assays. A solution of 50ml containing 5 
to 10% acrylamide (diluted from a stock of 29% acrylamide 
and 1% methylenebisacrylamide) and 0.5xTBE was prepared and 
0.7ml of 10% APS and 50ul TEMED added immediately prior to 
pouring into a prepared gel sandwich (26 0mm/16 0mm/lmm). 
Acrylamide was allowed to polymerise and then samples were 
applied in 5% glycerol, 0.5xTBE and 0.1% bromophenol blue. 
Electrophoresis was carried out in 0.5xTBE at 160-250V for 
2-4hr. Bands were visualised either by soaking the gel in 
lug/ml ethidium bromide prior to UV illumination, or when 
DNA bands were radiolabelled, by autoradiography of the wet 
or dried gel.
3.4.3. Purification of Fragments from Gels.
Agarose gels: a slice of agarose containing the
required DNA fragment was removed from the gel. The DNA was 
isolated from the agarose by electroelution in lxEEB at 
20mA/sample for l-2hr using an apparatus designed for this 
purpose. The DNA was removed in 200ul EEB and purified by 
phenol/chloroform extraction and precipitation with an equal 
volume of isopropanol at room temperature in the presence of 
5ug, of carrier, E.coli ribosomal RNA (rRNA). Carrier was 
not added if the DNA was for use in phosphatase or kinase 
reactions.
Polyacrylamide gels: gel slices containing DNA
fragments were cut into small pieces and incubated overnight 
in 600ul of GEB at 45°C. The sample was then centrifuged 
for 2min at ll,600g and the supernatant retained. The 
acrylamide pellet was washed with a further 400ul of GEB and
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centrifuged as before. The supernatants were pooled and 
filtered through Whatman GF/C paper in a 2ml syringe. The 
DNA was then precipitated at -20°C for 1-3 hr by the 
addition of 2 volumes of ethanol.
3.4.4. Ligation of DNA Fragments into Plasmid Vectors.
Ligations were performed using 50ng of linearised
vector, 200-500ng of purified fragment and 1 unit of T4 
ligase in 20mM Tris HCl (pH 7.6), lOmM MgCl2 , lOmM DTT and
0.6mM ATP in a 4ul reaction at 15°C for 16hr.
If the cleaved ends of the vector DNA were compatible 
with each other, reannealing of the linearised vector was 
prevented by pretreatment with calf intestinal phosphatase
either in 50mM Tris HCl (pH 8.5) or in the same conditions
as the restriction enzyme digest. Purification of fragments 
was either by gel electrophoresis (section 3.4.3.), or 
phenol/chloroforn extraction and precipitation.
Staggered cut termini of DNA fragments were converted 
to blunt ends by treatment with T4 DNA polymerase.
Reactions contained 0.5-1.0ug DNA, 33mM Tris HCl (pH 7.8), 
66mM potassium acetate, lOmM magnesium acetate, lOOug/ml 
BSA, 200uM dCTP, dGTP, dTTP and dATP plus 4 units of T4 DNA 
polymerase, and were incubated for lhr at 37°C.
Phosphorylated restriction enzyme site linkers were 
inserted into vectors by the same procedure as DNA 
fragments, each ligation using 0.15ug of linker.
3.4.5. Transformation of E .coli.
10ml of L.Broth was inoculated with lOul of a glycerol 
stock of DH-1 cells and incubated at 37°C overnight. 1ml of 
this culture was added to 90ml of L.Broth and the mixture 
shaken at 37°C until the OD6Q0 was 0.2 (normally for 2.5 
hours). After cooling on ice for lOmin the culture was 
centrifuged at lOOOg for lOmin at 4°C. Bacterial pellets 
were resuspended in a total of 50ml of ice cold lOOmM CaCl2 
and incubated on ice for lhr. This mixture was centrifuged 
as before and E.coli resuspended in 1ml of ice cold lOOmM 
CaCl2 . 2ul of ligation mix was added to lOOul of CaCl2 
shocked cells and incubated on ice for lhr. The mixture was 
heated at 42°C for 1 min and added to 2ml of L.Broth. These
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cultures were agitated at 37°C for 90 min a.nd 150ul samples 
were spread on L.Broth agar plates containing the 
appropriate antibiotic. Plates were incubated at 37°C 
overnight.
3.4.6. Analysis of Transformed E.coli Colonies.
Colonies were picked from agar plates into 2ml of 
L.Broth plus antibiotic and shaken at 37°C for 7hr. 
Chloramphenicol was added to a final concentration of 
25ug/ml and incubation continued overnight at 37°C. The 
following day the E.coli cells were pelleted at 2,900g for 
5min and resuspended in lOOul of STET (8% w/v sucrose, 5% 
v/v Triton X100, 50mM EDTA, 50mM Tris HCl pH 8.0) containing 
lmg/ml lysozyme. Following incubation at 100°C for lmin the 
mixture was centrifuged at ll,600g for lOmin. The 
supernatant was precipitated by addition of lOOul of 
isopropanol at -20°C for 1 hr. Following centrifugation at 
ll,600g for lOmin the pellets were dried and resuspended in 
33ul of water.
These DNA samples were generally assayed for large 
insertions or deletions by screening for increased or 
decreased size compared to vector DNA. Further analysis was 
carried out by restriction digestion of samples.
3.4.7. Large Scale Plasmid DNA Preparations.
Two methods were used for the large scale preparation 
of plasmid DNA. For routine preparations the "hard lysis" 
procedure, an adaptation of the method of Guerry et al.
(1973) was used, however, if the plasmid was required for 
short term transfection assays in HeLa cells further 
purification by CsCl banding was required and the 
"maxi-boiling" technique of Holmes and Quigly (1981) was 
used.
Hard Lysis: A single colony or lOul of glycerol
stock of bacteria containing the appropriate plasmid was 
added to 10ml of L.Broth plus antibiotic and incubated at 
37°C overnight. From this stock 0.5 ml was taken and used 
to inoculate 350ml of L.Broth containing antibiotic and the
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culture was shaken at 37°C for 8hr. Chloramphenicol was 
then added to a final concentration of 25ug/ml and 
incubation continued overnight. The culture was then 
centrifuged at 4,000g for lOmin. After decanting the 
supernatant, the pellet was suspended in 5ml of 25% w/v 
sucrose, 50mM Tris HCl (pH 8.0), and 2.5ml of lysozyme, 
freshly prepared at lOmg/ml, was added. The samples were 
mixed and left on ice for 30 min. 2ml of 250mM EDTA (pH
7.5) was added and, after a further 5min on ice, 1.5 ml of 
5M NaCl and 1.5 ml of 20% w/v SDS were mixed with the 
extract. After incubation on ice for a further 2hr, the 
preparations were centrifuged at 36,900g for lhr at 4°C. 
The supernatant was then subjected to two extractions with 
phenol/chloroform, one with chloroform alone and 
precipitated with two volumes of ethanol at -20°C. The 
precipitate was pelleted by centrifugation at 1500g for 
15min and dissolved in 10ml of 20mM Tris HCl, pH 7.5, lOOmM 
NaCl, ImM EDTA plus lOug/ml RNAase. After incubation at 
37°C for 4hr, approximately 2mg of proteinase K was added 
and samples maintained at 37°C overnight. The proteinase K 
was removed by two phenol/chloroform extractions plus one 
chloroform extraction. Sodium acetate was added to a final 
concentration of 0.3M and DNA was precipitated by addition 
of 0.5 volumes of isopropanol for 2hr at room temperature. 
After centrifugation at 1500g for 15 min pellets were washed 
with ethanol, dried and dissolved in 500ul of water.
"Maxi-Boiling" Technique. Bacterial cultures 
were prepared as above. Cells were pelleted and resuspended 
in 17ml of STET per 350ml culture. 2ml of lOmg/ml lysozyme 
in STET was added for lmin incubation prior to boiling the 
suspension for 45sec. The lysate was cleared by 
centrifugation at 36,900g for 40min at 4 C and DNA 
precipitated from the supernatant by addition of 0.9 volumes 
of isopropanol. After pelleting by centrifugation at 1500g 
for lOmin at room temperature the drained pellets were 
resuspended in TE (lOmM Tris HCl pH 7.5, ImM EDTA pH 7.5), 
CsCl was added to give a final density of 1.6g/ml and 
ethidium bromide added to a final concentration of 0.5mg/ml. 
The solution was incubated on ice for 15min and cleared by 
centrifugation at l,500g for lOmin at 4°C. The DNA was
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banded by centrifugation at 128,500g for 16hr at 15°C in a 
TV865 rotor. DNA was visualized by daylight or longwave UV 
illumination and the lower, supercoiled, band recovered with 
a large bore needle and a syringe, after removal of the 
upper linearised, chromosomal DNA band. The DNA was then 
extracted twice with butan-l-ol (TE saturated), dialyzed 
against TE at room temperature for 3hr, then treated with 
RNAase and proteinase K, purified and dissolved as described 
above.
3.4.8. Estimation of DNA Concentration.
A series of dilutions of plasmid DNA, linearised with 
an appropriate restriction enzyme was prepared. The samples 
were electrophoresed beside DNA of known concentration and 
photographed on polaroid 655 film under UV illumination. 
Concentration of DNA was estimated from densitometric traces 
on a negative film.
3.5. Functional Assays of Plasmid Constructs
3.5.1. Transfection of Plasmid DNA into BHK Cells.
Plasmid DNA was transfected into BHK cells using the 
calcium phosphate precipitation technique, a modification of 
the method of Shen et al ., (1982).
Mixtures were prepared containing plasmid DNAs to a 
total of 9ug, and deionized water added to a total volume of 
173ul, 200ul of 2xHeBS (260mM NaCl, 9.8mM KC1, 1.6mM 
Na2HP04 , llmM D-glucose, 42mM HEPES, pH7.05) was then added 
and the solution vortexed. Finally 27ul of 2M CaCl2 was 
added and samples again mixed by vortexing. The tubes were 
allowed to stand at RT for lOmin while the medium was 
removed from 80% confluent cell monolayers grown in 50mm 
diameter petri dishes. The precipitates were added dropwise 
to the cell monolayers and incubated at 37°C for 45min with
intermittent shaking.
5ml of ETC-, n medium was added to each monolayer and the
o
incubation continued for a further 3-4hr at 37 C. The 
medium was then removed from the cells and 25% v/v DMSO in 
lx HeBS was applied at room temperature for 4 min (Stow and
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Wilkie, 1976). The DMSO was then removed and cells were 
washed twice with ETC1Q, a further 5ml of ETC10 was added 
and monolayers were incubated at 37°C for 16hr.
3.5.2. Transfection of Plasmid DNA into HeLa cells.
Freshly split cells were seeded at 106 cells per 50mm 
Petri dish and the following day the rapidly dividing 
subconfluent monolayers were transfected by the calcium 
phosphate precipitation method (Corsalo and Pearson, 1981). 
Transfections used 12ug of pl40CAT or its derivatives, 2ug 
of pFJ3 and 4ug of pMCl; pUCl8 was used to equalise amounts 
of DNA within experiments. Deionised water was added to the 
plasmids to a final volume of 140ul, 160ul of HBS (280mM 
NaCl, 50mM Hepes, 1.5mM Na2HPO^ pH7.12) and 20ul of 2M C a C ^  
were then added, each step being followed by brief vortexing 
of the samples. After standing for 30 min the precipitate 
was added dropwise to the cell monolayers which were then 
incubated at 38.5°C. The cells were washed after 18hr, 
fresh medium added and, after a further 24hr at 38.5°C, 
extracts were prepared.
3.5.3. Preparation of Cell Extracts.
Medium was removed and monolayers were washed with ice 
cold PBS. 2ml of ice cold TEN (lOOmM NaCl, 50mM Tris HCl (pH
7.5), lOmM EDTA) was then added, the monolayers were scraped 
off the plates and transferred to 15ml Falcon tubes. The 
cells were centrifuged at 1500g for 1 min, resuspended in 
75ul 0.2M Tris HCl (pH 7.5), lysed by sonication, 
transferred to 1.5ml vials and centrifuged at ll,600g for 2 
min to remove debris. The cell extract supernatants were 
stored at -70°C.
3.5.4. Chloramphenicol Acetyl-tran^ferase Assays of 
Transfected Cells.
CAT assays were performed using the method of Gorman 
(1982). Assay mixtures containing cell extract (section
3 .5.3.), adjusted on the basis of beta-galactosidase
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activity and diluted to 25ul with 0.2M Tris HCl (pH7.5), lul
50mM acetyl co-enzyme A, 14ul water and 0.5ul
14
[ C ]-chloramphenicol (45uCi/mmol), were incubated at 37°c 
for lhr. The reaction was stopped by extracting the 
chloramphenicol and its acetylated products in 200ul of 
ethyl acetate. The ethyl acetate was removed under vacuum, 
and the pellets dissolved in 20ul of ethyl acetate before 
spotting onto thin layer chromatography plates. After 
running in 95% v/v chloroform/methanol, plates were air 
dried and autoradiographed. The amount of radioactivity in 
the chloroamphenicol and its 3-monoacetylated product was 
determined by scintillation counting, enabling the 
percentage conversion of substrate to product to be 
calculated. The amount of radioadfivity as 1-acetylated 
chloramphenicol was not significant.
3.5.5. Preparation of Cell Extract for TK Assay
Medium was removed from cell monolayers which were then
washed with ice cold PBS. Cells were scraped into 1ml of
fresh PBS, the cell suspension transferred into 1.5ml 
reaction tubes and centrifuged at 2700g for 1 min. The 
supernatant was carefully removed and the cells were 
resuspended in lOOul of ice cold TK lysis buffer (20mM Tris 
HCl, pH 7.5, 2mM MgCl2 , lOmM NaCl, 6.5mM 2-mercaptoethanol, 
0.5% v/v NP40) by vortexing and the tubes then placed on ice 
for 5 min. Samples were centrifuged at ll,600g for 2 min, 
and the supernatant was transferred to fresh tubes and 
maintained on ice or stored at -70°C.
3.5.6. Thymidine Kinase Assays of Transfected Cells
Samples of cell extracts were assayed for TK activity
in a reaction mixture containing lOmM Na2HPO^/NaH2PO^ pH6.0,
lOmM MgCl9 , 5mM ATP, 0.ImMTTP and lOOuCi/ml [3H ]-thymidine 
« _
in 50ul at 30 C. In most experiments a 5ul sample of cell 
extract and a 30min incubation period were used. The 
reaction was terminated by the addition of thymidine to 3 3uM 
and heating at 90^C for 4 min. The tubes were then cooled 
on ice for 5 min, centrifuged at ll,600g for 2 min and 50ul 
of the supernatant spotted onto a DE81 filter paper disc.
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The discs were washed three times in a solution of 4mM 
ammonium formate (pH4.0) and lOmM thymidine at 37°c and 
twice in absolute alcohol. Following drying under a heat 
lamp the discs were placed in vials and 5ml of scintillation 
fluid added. Incorporation of [ H]-thymidine was determined 
by scintillation counting and used as a measure of TK 
activity.
3.5.7. Beta-galactosidase (B-gal) Assays of Transfected
Cells.
Extracts prepared for use in CAT assays and TK assays 
were also used to assay B-gal activity. 25ul of extract was 
added to 175ul of Z buffer (60mM Na2HPC>4 , 4mM NaH2P04 , lOmM 
KC1, ImM MgSO^, 20mM 2-mercaptoethanol, adjusted to pH 7.0) 
along with 40ul of O-nitrophenyl-B-D-galactopyranoside 
(4mg/ml) and incubated at 30°C for 30min to 4hr. Reactions 
were stopped by the addition of lOOul of 1M Na2HCC>2 , and the 
absorbance of the solution measured at 420nm.
3.6. Expression of VZV Proteins in E.coli.
3.6.1. Preparation of Extracts for TK Assays.
A 2ml volume of L.Broth was inoculated with a single 
bacterial colony from an agar plate or lOOul of the 
appropriate glyoerol stock. After growth in a shaking 
incubator at 37 C for 2hr isopropyI-B.D-galactoside (IPTG) 
was added to a final concentration of ImM and the incubation 
continued for a further 2-3hr. Bacteria were pelleted by 
centrifugation at 2,900g for lmin, and, after the 
supernatant had been discarded, resuspended in lOOul of TK 
lysis buffer with lysozyme added to a final concentration of 
500ul/ml. This solution was incubated on ice for 10 min 
prior to freezing and thawing (-70°C to 37 C) three times. 
Centrifugation at ll,600g for 10 min resulted in a clarified 
supernatant which could be stored at -70 C.
3.6.2. Assays for TK Activity in E.coli extracts.
Two buffers were used in attempts to detect TK activity 
in lysates of bacterial cells. The first was that
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previously optimised for the estimation of HSV TK activity 
(see section 3.5.6.). The second was one described for the 
analysis of VZV TK activity (50mM Tris HC1 (pH7.5 or pH 
8.0), 5mM [ 3 -thymidine, 2mM ATP, 2 m M M g C l 2 , 5mM 
2-mercaptoethanol, with or without 5mM TTP) UDoberson et 
al., 1976; Shiraki et al. , 1985). To both of these buffers 
was added lOul of cell extract to make a total reaction 
volume of 50ul which was incubated at 30°C for lhr. The 
rest of the assay was carried out exactly as described in 
section 3.5.6.
3.6.3. SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE).
A 50ml volume of gel mix was prepared containing the 
required amount of 30% acrylamide / 3% DATD to give a final 
concentration of between 8% and 12% acrylamide in lxGB 
(315mM Tris HCl, pH8.9, 0.1% SDS). Polymerisation was 
initiated by the addition of 0.5ml 10% w/v APS and 40ul 
TEMED, and the mixture was poured into a vertical gel mould 
(170mm/130mm/l.5mm). While still liquid the acrylamide was 
overlaid with 2ml GB and allowed to polymerise for 30min.
24ml stacking gel solution was prepared, containing 5% 
acrylamide, 0.5% DATD, lxSGB (125mM Tris HCl, pH 6.7, 0.1% 
SDS), 0.5ml of 10% APS and 35ul of TEMED. The GB was 
removed from the surface of the running gel and, after 
washing, the mould was filled with the stacking gel solution 
and a suitable teflon comb inserted.
Samples were prepared by boiling for 5min in a 
denaturing buffer of final concentration 50mM Tris HCl (pH 
6.7), 0.4% SDS, 10% glycerol, 5% 2-mercaptoethanol. Gels 
were electrophoresed for 3-4hr in a buffer containing 50mM 
Tris, 65mM glycine and 0.1% SDS and either fixed by soaking 
overnight in 25% methanol, 6% acetic acid prior to drying 
and autoradiography or stained in Coommassie Brilliant Blue 
for lhr and destained in 25% methanol/6% acetic acid for 2-3 
days.
3.7. DNA Binding Assays
3.7.1. Nuclear Extracts.
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HeLa cell nuclear extracts were prepared as described
by Preston et al. (1988), a method slightly adapted from
that of Dingnam et al. (1981). Cells were scraped from 90mm
diameter Petri dishes and centrifuged at 1500g for 5min at
4°C. Cell lysis was performed by resuspending the cells in
2 packed volumes of Buffer A (lOmM HEPES pH 7.9, 1. 5mM
M g C ^ r  lOmM KC1, 0 . 5mM DTT and 0 . 5mM phenylmethylsulphonyl
fluoride [PMSF]) containing 0.5% NP40, with intermittent
mixing at 4°C for lOmin. Nuclei were pelleted by
centrifugation at 13,200g for 15min at 2°C. The supernatant
was carefully discarded and the nuclei lysed by resuspending
the pellet in 3ml of Buffer C (20mM HEPES ph7.9, 25% v/v
glycerol, 0.42M NaCl, 1.5mM MgCl9 , 0.2mM EDTA, 0.5mM PMSF
9and 0.5mM DTT) per 10 cells, with intermittent mixing at 
4°C for 30min. The suspension was centrifuged at 13,200g 
for 15min at 2°C and the supernatant (nuclear extract) 
collected and stored in small samples at -70°C.
3.7.2. Extraction of Virus Proteins for Gel Retardation 
Assays.
Cell released virus particles, (1x10^), prepared as 
described in section 3.8.3. were concentrated by 
centrifugation at 25,000g for 2hr, resuspended in PBS/0.5% 
calf serum, and centrifuged through a cushion of 10% w/v 
sucrose in 10mm PBS at 25,000g for 2hr. The pellet was 
resuspended in lOmM Tris HCl, 50mM NaCl, ImM EDTA (pH 7.5), 
NP40 added to a final concentration of 0.03%, and the 
samples kept on ice for lhr. The extract was centrifuged at 
50,000g for lhr and the supernatant stored at -70°C.
Before the samples were analysed in gel retardation 
assays protein level comparisons were made by SDS-PAGE and 
Coommassie Brilliant Blue staining.
3.7.3. In Vitro Transcription of pGEMTIF and pGEMVZV and 
Translation of RNA Products.
The plasmids pGEMTIF and pGEMVZV A and B were cleaved 
with EcoRI before carrying out the transcription reaction.
In vitro transcription was performed using the Riboprobe
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system (Promega Biotech) following the manufacturers
protocol and incubating 1 ug of plasmid DNA, 0.5 mM
G (51)ppp(51)G (Pharmacia) and 0.4 mM of each nucleoside
triphosphate in a total volume of 25ul at 37°C for lhr.
In vitro translation was carried out by addition of
2 .5ul of transcription mixture to 20ul of rabbit
reticulocyte lysate (Amersham). Duplicate samples were
incubated for 90 min at 30°C either in the presence or in
35the absence of 30uCi [ S]methionine (sp. act.>800Ci/mmol) 
in a 25ul reaction mixture. Non-radioactive samples were 
stored at -70°C for use in gel retardation assays. The 
radiolabelled translational mixture was processed for 
SDS-PAGE as described in section 3.6.3.
3.7.4. 3'-end Labelling of Probes.
lOug of plasmid DNA was digested with appropriate
restriction enzymes and purified by phenol/chloroform
extraction and ethanol precipitation. The DNA fragments
were then labelled in T4 polymerase buffer (33mM Tris
acetate pH7.9, 66mM sodium acetate, lOmM magnesium acetate)
32
containing lOmM DTT, 0.1% BSA, 0 . 5mCi/ml oc.- [ P]-dATP,
0.5mCi/ml oc-[32p]-dTTP, lOOuM dGTP, lOOuM dCTP and 1 unit of 
T4 polymerase in a total volume of 20ul for l^rat 37°C.
3.7.5. Gel Retardation Reactions.
Formation and analysis of protein-DNA complexes was 
performed as described by Preston et a l . (1988). DNA
fragments were end-labelled as described in section 3.7.4. 
and extracted from a polyacrylamide gel as described in 
section 3.4.3. Reaction mixtures contained the following 
components: lOmM HEPES pH 7*9, 0.6mM dithiothreitol, 2 *3mM 
MgCl2 , 85mM NaCl, 0*lmg/ml bovine serum albumin, 4ug 
poly(dl).poly(dC), 0*2ng [32P]-end labelled fragment 
(containing approximately 10,000 dpm), 5ug of mock-infected 
HeLa cell nuclear extract and, where appropriate,
0.3ug-1.0ug of virion extract, Vmw65 or orflO synthesised in 
vitro. Incubation was at 25°C for 30min, and reaction 
mixtures were loaded directly onto a 3*5% polyacrylamide 
gel. After electrophoresis for 3*5hr at 160V, the gel was
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dried and exposed for autoradiography. If assays involved 
the use of competitor oligonucleotides, a 100-fold molar 
excess was incubated with the rest of the components of the 
reaction for 15 min prior to the addition of the 
radiolabelled fragment.
3.7.6. DNAasel Protection Assays
Gel retardation reaction mixtures of 60ul were 
assembled, containing approximately 10 cpm of DNA fragment 
labelled uniquely at one 3' end. After incubation at 25°C 
for 30min, 7ul of 150ug/ml DNAasel was added, and incubation 
continued at 25°C for 3min. EDTA was added to a final 
concentration of lOmM, and samples were loaded onto a 3.5% 
polyacrylamide gel. After electrophoresis, the gel was 
sliced, and the peaks representing IEC and free DNA were 
identified by Cerenkov counting of the slices. Complexed 
and free DNA were recovered by electroelution, extracted 
once with phenol/chloroform, once with chloroform, and 
precipitated with ethanol. DNA fragments were analysed by 
electrophoresis on a 10% polyacrylamide gel containing 
0.5xTBE and 7M urea. Markers were obtained by using G and 
G+A sequencing reactions as described in section 3.3.6.
3.8. Constuction and Purification of HSV mutants.
3.8.1. Co-transfection of Virus DNA and Plasmid DNA into 
Cells.
Plasmid DNA was linearised (within the vector 
sequences) and 0.5ug transfected with 0.5ug of virus DNA 
into cells as described in section 3.5.1., except that 2.0ug 
of calf thymus DNA was used as carrier and precipitates were 
gently mixed on addition of CaCl2 and not vortexed. 
Transfected monolayers were incubated in ETC^q at 31 C for 3 
days. The virus progeny were isolated by scraping into the 
growth medium which was transferred into a 5ml glass vial. 
Cells were then disrupted by sonication and the sonicate 
stored at -70°C.
3.8.2. Isolation of Virus Plaques.
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A series of 10-fold dilutions in ETC^q were made from 
virus stocks prepared as describe in section 3.8.1. The 
medium was removed from confluent cell monolayers and 200ul 
of diluted virus added to each dish. Following virus
absorption at 37°C for lhr medium was carefully removed and 
the cells overlaid with 4ml of agar growth medium (Eagles 
medium containing 10% NBC, 10% TP and 0.5% Dif co Bacto 
Noble agar). Plates were incubated at 31°C for three days 
until virus plaques were visible and then overlaid with 2ml 
of agar growth medium containing 1.8ug of
5-Bromo-4-chloro-3-indolyl-B.D-galactoside (X-gal). Plates 
were then incubated for a further 16hr and inspected for
plaques surrounded by the blue colour of metabolised X-gal.
If the colour produced was not intense the plates were 
incubated overnight at 38.5°C. Single plaques were scraped 
up in approximately 50ul of agar using a micropipette, 
transferred to 200ul of ETC^q , sonicated and stored at 
-70°C.
3.8.3. Large Scale Preparation of Virus Stocks
2
Confluent BHK monolayers in 850cm roller bottles were 
infected with 0.03 pfu of virus per cell in 50ml ETC^q . 
After incubation at 31°C for 3-4days, when extensive cpe had 
developed, cells were shaken into their medium and 
centrifuged at l,000g for 15min at 4°C to produce a pellet 
containing infected cells and a supernatant containing cell 
released virus (CRV). The cell pellet was sonicated in 1ml 
of ETC1q to release the virus and the cell debris pelleted 
by centrifugation at l,000g for 15min at 4°C. The 
supernatant designated cell associated virus (CAV) was 
stored in aliquots at -70°C. CRV was purified by 
centrifugation at 13,200g for 2hr at 4°C, the virus pellet 
was sonicated, resuspended in 10ml ETC^q and stored at -70 C 
in small aliquots.
3.8.4. Large Scale Preparation of Viral DNA
CRV was prepared as described (section 3.8.3.), however 
after centrifugation at 13,200g for 2hr at 4°C the virus
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pellet was resuspended in 20mM Tris HCl (pH 7.5), lOOmM 
NaCl, 2mM EDTA and 0.2% SDS containing 0.25mg/ml proteinase 
K, and incubated at 37°C overnight with gentle agitation. 
DNA was extracted three times with phenol/chloroform and 
once with chloroform, precipitated in two volumes of 
ethanol, dried and dissolved in 0.4ml of water.
3.8.5. Small Scale Preparation of Virus-Infected Cell
DNA.
Confluent cell monolayers on 50mm diameter petri dishes 
were infected at 1 pfu/cell. Following virus absorption at 
37°C 5ml of ETC^q was added and the plates incubated at 31°C 
for 18hr. The medium was decanted, and the cells were 
washed with 5ml PBS, scraped into 1ml PBS and pipetted into 
a 1.5ml vial. Vials were centrifuged at 2700g for 3min, the 
supernatant discarded and 0.4ml of TK lysis buffer added. 
Samples were then incubated on ice for 5min and centrifuged 
at ll,600g for 2min. The supernatants were collected and 
EDTA, SDS and NaCl added to final concentrations of 5mM, 
0.2% and 0.1M, respectively. DNA was purified by two 
phenol/chloroform extractions, one chloroform extraction and 
precipitation in 2 volumes of ethanol. Vials were 
centrifuged at ll,600g for lOmin and the pellets washed in 
ethanol, dried under vacuum and dissolved in 40ul of water.
3.9. Southern Blot Analysis of Virus DNA.
3.9.1. Internal Labelling of Probes by Nick Translation.
32DNA was labelled with P as described by Rigby et al.,
(1977). l.Oug of plasmid DNA was incubated in a reaction
mix containing 40mM dATP, 40mM dTTP, 2.5ul of lOxNTB (5M
Tris HCl, pH7.5, 1M MgCl2 , ImM DTT and 5mg/ml BSA) and
2xl0-4ug DNAasel at RT for 3min. The mix was placed on ice
and diluted to 25ul by the addition of 30uCi of both
c*-[ 32P]-dCTP and cX- [ 32P ] -dGTP, 3 units of E.coli DNA
3 2polymerase I plus distilled water. P labelled DNA was 
then separated from unincorporated triphosphates by 
centrifugation (1500g for 4min) through a 1ml Sephadex 
(fine) G50 column that had been tightly packed by
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centrifugation (1500g, 4min) in a plastic syringe.
3.9.2. Transfer of DNA to Nitrocellulose.
The method used was essentially that of Southern 
(1975). The agarose gel to be blotted was shaken gently for 
45min in Gel Soak I (200mM NaOH, 600mM NaCl), then for a 
further 45min in Gel Soak II (1M Tris HCl, pH8.0, 0.6M NaCl)
at room temperature. The gel was then transferred to two
sheets of Whatman 3MM filter paper, supported by a glass 
plate. The edges of the filter paper were placed in a tray
containing 6xSSC. A sheet of nitrocellulose, the same
dimensions as the gel, was placed on top of the gel and 
covered by two sheets of 3MM paper and a stack of paper 
towels, also cut to size. The towels were weighted and the 
blot left overnight in order for the DNA to transfer to the 
nitrocellulose. The following day the nitrocellose was 
removed, allowed to dry in air and baked at 80°C for 2hr.
3.9.3. DNA/DNA Hybridisation.
Hybridisations were carried out by the method of 
Southern (1975). The nitrocellulose containing separate DNA 
fragments was prehybridised in 100ml 6xSSC, 5xDenhardts 
(0.5% w/v Ficoll, 0.5% w/v polyvinylpyrollidone, 0.1% SDS, 
0.5% w/v BSA) and 20ug/ml denatured calf thymus DNA at 65°C 
for 2hr in a sealed polythene bag. Meanwhile the probe was 
denatured by incubation in 0.2M NaOH for 10 min at RT, and 
then neutralised by the addition of 0.2M HCl.
The prehybridisation mixture was removed and replaced 
with the denatured probe in a mix of the same final 
composition as the prehybridisation solution. The 
nitrocellulose filter was shaken overnight at 65°C then 
washed in 10xDenhardts/4xSSC for 30min at RT, followed by 
three washes in 0.3xSSC, 0.1% SDS at 65°C. It was air dried 
and autoradiographed.
3.10. Analysis of Viral Proteins
3.10.1. Radiolabelling of Viral IE Polypeptides.
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An incubation of 38.5°C was used throughout. Cell
monolayers in 30 mm diameter Petri dishes were infected with
a moi of 1 pfu/cell and the virus incubated for lhr to allow
absorution. The cells were then overlayed with 2ml an ETC^q
pre heated to 38.5°C and incubated for a further 4hr. The
medium was then removed from the dishes and the cells washed
with PBS. 0.3ml of PBS containing lOOuCi/ml 
35 .[ S ]-methionine was added and the monolayers
incubated for a further lhr before being harvested.
3.10.2. Preparation of Protein Samples for SDS-PAGE.
The medium was removed from each dish and the 
monolayers washed with ice cold PBS. The cells were then 
rapidly washed with ice cold TE (lOmM Tris HCl, pH7.5, ImM 
EDTA), 0.3ml TE was added and the monolayers incubated at 
4°C for lOmin. The cells were transferred to a 1.5ml vial 
and denatured by boiling for 20min in "boiling mix". 
Samples of 25ul were analysed by SDS-PAGE (Section 3.6.3.)
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4. RESULTS
4.1. Mapping the 5 1 terminus of the VZV major IE RNA.
To analyse the transcriptional regulation of VZV orf62,
it was first necessary to determine the location of the mRNA
5'-terminus. Two techniques were used for this analysis.
First, the length of the 5' untranslated region was
determined by primer extension analysis using a 5'
32
[ P ]-labelled synthetic oligonucleotide complementary to 
29bp of the N-terminal coding sequence of orf62 (Figure
4.1.). This particular sequence was chosen to ensure 
hybridisation within the mRNA and also to minimise the 
amount of coding sequences transcribed by the reverse 
transcriptase. Figure 4.1. shows that an extension product 
of approximately 105 bases was produced from three separate 
VZV-infected cell RNA preparations but not from 
mock-infected cell RNA. This indicates that the mRNA 5 1 
terminus is about 105 bases from the 5 1 end of the primer 
and thus that the length of the 5' noncoding region is 71 
bases as the 5' end of the oligonucleotide hybridises 34 
bases 3 1 to the proposed initiator ATG. No other higher 
molecular weight products were present on the 
autoradiograph, suggesting that the 105 base band represents 
the true 5' terminus rather than a "strong stop" for reverse 
transcriptase. To confirm this resultwith increased 
precision, and to exclude the existence of an intron within 
the 5' noncoding region, nuclease SI analysis was carried 
out using a radiolabelled probe that spanned the 5'terminus 
predicted by primer extension. As shown in Figure 4.2., a 
cluster of protected DNA bands of 44, 45 and 46 bases were 
observed when VZV-infected cell RNA, (lane 6 ), but not 
mock-infected cell RNA, (lane 5) was used. These data place 
the start site of the mRNA at 73, 74, and 75 bases upstream 
of the proposed ATG and as such basically confirm the 
results gained from the primer extension assay. The 
resolution of the gel and the precision of the marker tracks 
allow a more accurate definition of the mRNA start site by 
nuclease SI analysis, and as such the mRNA start site was 
assigned to the C residue shown in figure 4.1., 74 bases 
upstream of the proposed ATG. These assays together exclude
Figure 4.1. DNA sequences in the upstream regulatory
region of VZV orf 62.
Restriction endonuclease cleavage sites relevant to the 
results are named and underlined. The mRNA start site is by 
convention designated +1, a 'TATA' box homology TTTTAA, is 
present at position -25 to -30. A 13bp sequence centered at 
-255 contains both octamer and TAATGARAT motifs and a simple 
octamer motif in inverse orientation is present at 
nucleotides -346 to -339. In addition, the CCAAT box 
ATF/CRE, and PEA-2 motifs centred at -117, -73 and -50, 
respectively, are underlined and labelled. Sequences from 
which oligonucleotides for use in primer extension and SI 
nuclease analysis were constructed are underlined. The A 
residue at position +57 was changed to a G residue during 
the construction of pl40CAT. The origin of DNA replication 
(residues -882 to -1140) is marked and labelled, as are the 
repeated sequences Reiteration R4 (residues -550 to -699).
A loose copy of this figure is provided at the back of 
the thesis.
Cla I----------------------------
CCCGTGTGTTTTTTTTTATCACGTCAAAT££ATTTTAAAAAGCCTGCCGCTCCATTTGGA -1112
atatatatattctgtgaaaagcccgcccacaccccataaaaccgcgacatcgcgggaaca
-------------------------------  Origin of DNA Replication
CG C GC GAAC AAGAAAC TCTCTCTCTTTCTC TAT AT AT AT AT ATAT AT AT AT AT AT AT ATA
TAGAAAG AAAGT G C GAAC GGTGGTTG G AC AC AT GC C AAAAC ATGAAAAC C C AT AC AGT GA
AAAAACGGGAAGTGCGAATGCAGATCAAAAGAGTGTATCCGATTGGCGTACACCACAGAC
ATGCGGACGCCCAATTTAACCCCCCCCCTTTTTCACCCCCCCACCCCACCCCATTCCACC
Dde I
CCAGGAAGTGCGAACGGGTTTACATGCCTCAGATATGAAGTTCTTCGACTTGTTTTTOAA
TAAATTTTTTTGTGATTTTCTACAACGGTTTAGAGAATTATGGTTATAAACATCGGCGGfi
Kpnl..........................................................
GTACCGCGCCCCCTCCCCATCGGCGGGGTACCGCGCCCCCTCCCCATCGGCGGGGTACCG
Reiteration R4 ..............................   Kpnl.......
CGCCCCCTCCCCATCGGCGGGGTACCGCGCCCCCTCCCCATCGGCGGGGTACCGCGCCCC
CTCCCCATCGGCGGGGGGTTACGTGAACACCACAACCCCGTGTGTATTTTATGGGTTATC
AccI
gcgggcttcgtgccgcctgacataatcgttgggaggggtggtggtgtatacgcttgttga
Sail
ttgcgcgaacgtaatcacgacgcagaqggacccaaacacaccgtcgacgtgcatttgatt
Octamer
AACTAGATGCCGGATGGGTGGAAACAACCCGTGTTATATAAGATGTTTT££ATGTGAGAC
AccI
AACCCCAATTGTCTTTATGTATATTATATATCGTCTGTAGACACACGATGATTGGTTGTT
Octamer/TG A f U I I
ATTTAAACATArGTAAATGAAATTCACATGTCTGGTATCCCTTGTTATGATGTTGTAAGG
TATGCGGAAATAGACACCGGGCGTACATCGCCAACCAGCGGTCTCTCCTTAAACGCATAC
Xh ol C CAAT
tatggtccatgaacttcccgcctcgagtctcgtccaatcactacatcgtcttatcattaa
Sspl ATF/CRE PEA-2 Afllll
GAATATTTACACCCTGACGACACGGGGAGGAAATATGCGGTCGAGGGGGGGGCACAACAC
' TATA' Seal mRNA| *GTTTTAAGTACTGTTGGAACTCCCTCACCAACCGCAATCGCAATCCTTTGAAGGCTGCGA
—  si Nuclease Oligo.
EcoRI Met
GAGCCTTTGGAAAAr’/rrncnTACGTCTAAATTCACCCCAGTGCGATGGATACGCCGCCGA
------------------ (G)
TGCAGCGCTCTACACCCCAACGCGCGGGGTCGCCTGATACTTTGGAGTTAATGGACCTGT
P.E. Oligo.
-1052 
-992 
-932 
-872 
-812 
-752 
-692 
-632 
-572 
-512 
-452 
-392 
-332 
-272 
-212 
-152 
-92 
-32 
+2 9 
+89 
+ 149
Figure 4.2. Mapping the 5' end of the mRNA.
Primer extension analysis was performed on three RNA 
samples prepared from different batches of VZV infected HFL 
cells (lanes 1, 2 and 3) and from mock infected HFL cells 
(lane 4). Markers of the indicated sizes (bases) were run 
in parallel. Extended product is labelled (f) .
Nuclease SI analysis was performed on RNA prepared from 
VZV infected HFL cells (lane 6) or mock infected cells (lane 
5).  G and G+A tracks of the oligonucleotide used in the 
assay were included as size markers and appropriate 
exposures are shown (lanes 7 and 8). Undigested 
oligonucleotide (Q) and digested product (0) are labelled.
PRIMER EXTENSION
VZV INFn Ml 
LANE 1 2  3 4
S1 NUCLEASE MAPPING
Ml INFG+A &G 
TRACKS 
5 6 7 8
St
■ *
The formal possibility remains that these findings 
could be explained by the presence of two introns. One of 
these would represent some or all of the residues between 
+80 and +46 in figure 4.1. The downstream end of the other 
intron would have to be precisely at the residue designated 
+-1 in figure 4.1., this intron could be of any size and thus 
could terminate upstream of the SI nuclease oligonucleotide. 
This possibility could be excluded by nuclease SI analysis 
using a probe spanning residues +-80 to +46.
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the possibility that splicing occurs within the the 5'
untranslated region. The presence of an intron in the 5'
untranslated region would have resulted in a discrepancy
between results of the primer extension and the SI nuclease
analyses, whereby the 5' terminus predicted by primer
mapped
extension would have downstream of that predicted by SI
nuclease analysis by the length of the intron.(see. ouzr)
The presence of more undigested probe in figure 4.2. 
lane £  ( .infected cell RNA) than lane S (M.I. cell RNA) was 
noted. This finding suggested the possibility of protection 
of the probe by longer transcripts. This was not a 
consistent finding since in other experiments at least as 
much undigested probe was present in mock infected tracks. 
Variations in the amount of undigested probe within an 
experiment could result from differences in the amount of 
viral DNA present in the RNA preparations. The presence of 
viral DNA is a particular problem with VZV infections as 
coordinate infections are impractical because of 
difficul ties in iso/ating cell free virus at high titres 
(Section 1.2.2.). Thus at 24 hours, when RNA was extracted, 
considerable amounts of viral DNA would have been present, 
given that virus DNA replication has been detected only 6 
hours after infection of cell monolayers (Gelb, 1985). It 
is impossible to be certain as to the amount of viral DNA 
that was present in the RNA preparations used. The 
possibility of nonspecific hybridisation to other viral 
transcripts also cannot be excluded. The formal possibility 
also exists that protection of the entire probe from SI 
nuclease digestion was by a bona fide viral transcript. If 
so it was not detected by primer extension analysis and thus 
must either have terminated in the 32 bases between the 5' 
ends of the oligonucleotides employed for SI nuclease and 
primer extension analysis or continued so far upstream of 
the primer extension oligonucleotide that its 5' end was not 
detected by primer extension analysis.
Inspection of the sequence (Figure 4.1.) reveals the 
element TTTTAA centred at 28 bases upstream of the mRNA 
start site. This probably represents the TATA box, a 
ci^s-acting element known to be an important signal for the 
correct initiation of transcription by RNA polymerase II 
(Section 1.5.1. ) .
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4.2. Functional Studies
4.2.1. Plasmid Construction
Having defined the location of the mRNA start site, 
attempts were made to characterise functional aspects of the 
regulatory sequences. In order to achieve this plasmids 
were constructed using CAT and B-galactosidase as reporter 
genes driven by sequences present 5 ’ to orf62. These can be 
considered in two groups, both derived from the VZV genomic 
clone pVZVSstf, (kindly provided by Dr. A. Davison). 
Plasmid pVZVSstf contains the terminal SstI fragment from 
the short repeat region of VZV cloned into the PstI site of 
pAT153 by GC tailing, creating a PstI site at the genome 
terminus.
The first group of plasmids (Figure 4.3.) was produced 
using a 1265bp Ddel-Hindlll fragment of pVZVSstf which was 
inserted into pUC18 between the PstI site, blunt ended using 
T4 DNA polymerase, and the Hindlll site, creating pVZVDH. A 
BamHI-Scal fragment (residues -78^. to -22) was excised from 
this plasmid and inserted into the pUC9 polylinker using the 
BamHI and HincII sites, creating pVZVBH. Finally a 
Xbal-Hindlll fragment was excised and inserted between the 
Xbal and Hindlll sites of pFJ3 which contains the E.coli 
B-galactosidase gene with SV40 early gene termination 
signals (kindly provided by Dr. F. Rixon) to form the 
plasmid pTM14gal. An equivalent CAT construct (pTMl4cat) 
was produced by replacing the Hindlll-BamHI fragment of 
pTM14gal, which contains the B-galactosidase gene, with the 
Hindlll-Bglll fragment of pBLW2, which contains the CAT 
gene.
The plasmid p^]fL4cat was then modified by the 
insertion of a 52bp double stranded oligonucleotide encoding 
VZV sequences between -33 and +20 (Appendix 3; figure 4.2). 
This oligonucleotide was designed to have 5' overhanging 
ends complementary to those produced by the restriction 
enzymes Afllll and BamHI. A partial digest of pTMl4cat was 
carried out using Afllll and the product cleaved to 
completion with BamHI. The appropriate fragment was
Figure 4.3. Production of Plasmids pTMl4gal, pTMl4cat and 
pTM15cat.
VZV sequences are represented by an open box and 
labelled. The messenger RNA start site is marked along 
with the reporter gene used. Relevant restriction 
endonuclease cleavage sites are labelled. pUCl8 was 
digested with PstI and Hindlll, the PstI site was 
blunt-ended and the VZV fragment inserted to form pVZVDH. 
Digestion with BamHI and HincII allowed the introduction of 
the fragment containing the putative orf62 regulatory 
sequences into pUC9. The Hindlll and Xbal sites in pFJ3 
allowed the replacement of SV40 control sequences with those 
of orf62 to form pTM14gal. The CAT gene that replaced the 
B-gal gene to form pTMl4cat, were contained within a 
Hindlll-Bglll fragment. The sequence of the double stranded 
oligonucleotide (oligonucleotide 3) is provided in Appendix 
3, and is identical to the sequence between -30 and +22.
BamHI Sail 
Xbal Pstl/Ddel 
-784
Seal
-22
Hindlll
+480
PUC18
J?rf62 contro l se r |
BamHI Sail 
-784 Xbal
PstI Hindlll 
-22
+ pUC9
pVZVDH
pUC9
orf62  con tro l s e q
pVZVBH pUC9
\
+ pFJ3
Xbal Sail 
-7 8 4
PstI Hindlll 
-22
orf62 contro l s e q .
T r
PstI PstI BamHI 
Hindlll Sail 
Afllll -22
Xbal Sail 
-784
PTM14GAL
orf 6 2  co n tro l s a g
C A T g e n e
R eplaces
B -gal
PTM14CAT
Xbal Seal Afllll BamHI 
-33 +22
orf62 contro l se q+  5 2 b p  Afllll/ 
BamHI < '
w 
. . .» .‘I oligo
pTM15CAT
pUC 18
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purified and the oligonucleotide inserted. This resulted in 
a plasmid in which the polylinker sequences, present in 
pTMl4cat, were replaced by VZV sequences, including the mRNA 
start site. The plasmid was named pTM15cat.
A completely separate construction, pl40cat, encoding 
the regulatory sequences and the CAT gene was, constructed 
by G. Disney, again using pVZVSstf (McKee et al., in press). 
This plasmid was constructed from pl40 which contains VZV 
sequences from the Clal site at -1146 to the genomic
terminus PstI site of pVZVSstf excised and inserted between 
the AccI and PstI sites of a pUC9 plasmid from which the 
EcoRI site had been removed by cutting and filling in. 
Plasmid pl40ET is a derivative of pl40 in which an EcoRI 
site was created by oligonucleotide mutagenesis of 
nucleotide +55 relative to the VZV orf 62 mRNA start site, 
changing the sequence AAATTC to GAATTC (figure 4.1.). The 
new EcoRI site in pl40ET was converted to a Bglll site
(pl40BT) by cleaving with EcoRI, filling in and inserting an
oligonucleotide linker (GAGATCTC). Using this novel Bglll 
site and a Smal site in vector sequences immediately 5' of 
the VZV insert, the orf62 region from -1146 to +55 of pl40BT 
was cloned between the Smal and BamHI sites of pCAT to give 
pl40cat (Figures 4.4. and 4.5.).
Sequential 5 1 deletions of pl40cat, pTMl4cat and
pTM14gal were made using the Sail site at -410 and the Xhol 
site at -131 forming pl4oA410cat, pTMl4Zkl0cat and pTMl4ii 
410gal and pl40 Al31cat, pTMl4Z\l31cat and pTMl4/l-31gal 
respectively (Figure 4.5.). In pTMl4cat and pTMl4gal the 
Sail and Xhol sites were digested and ligated to a Sail site 
present immediately 5' to the VZV sequences. In pl40cat 
they were filled in using T4 polymerase and ligated to a 
Smal site again found immediately 5' to the VZV sequences.
The reasons for the construction of these different 
vectors encoding different reporter genes under the control 
of orf62 regulatory signals are related to the twin problems 
encountered throughout this part of the project, namely, the 
low level of transcriptional activity induced by the control 
sequences of orf62 and the inconsistent nature of short term 
transfection assays (Everett et al., 1989).
4.2.2. Analysis of Control Region Deletions
Figure 4.4. Parental Plasmids used in Transfection 
Assays.
Schematic representations of plasmids are presented. 
VZV sequences are represented by heavy lines. The open box 
marked R4 represents Reiteration R4 and the shaded box 
marked Ori represents an origin of DNA replication. The 
octamer motif is marked o, the combined octamer/TAATGARAT 
motif is marked o+ and the promoter fragment, ****. the 
position of both ends of the VZV sequences incorporated in 
the plasmid are given and the approximate position of the 
mRNA start site is marked r t  The positions of the various 
cis-acting sequences are approximate.
pTM14gal
pTM14cat
pTM15cat
p140cat
-1146 Ori
p140A781cat
pTM15+cat
Figure 4.5. Deletions of VZV coding sequences derived
from pl40cat
VZV coding sequences are marked by a heavy line, 
plasmid sequences by a faint line. Boxes marked Ori and R4 
represent an orig fn of DNA replication and R4 Reiterations 
respectively. Relevant restriction endonuclease cleavage • 
sites are marked, and the mRNA start site is marked thus r Cis-actinq motifs present are annotated as follows.
Oct octamer TTTTGCAT
Oct/TG octamer/TAATGARAT ATGTAAATGAAAT
C CCAAT box CCAAT
A ATF/CRE site TGACGACA
TATA - 'TATA 1 TTTTAA
Equivalent deletions were produced from pTMl4gal and 
pTM14cat.
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Short term transfection assays described in the
following sections were all performed with an internal
control. In the case of the B-galactosidase assays the
internal control was, either pFSR, a plasmid that expresses
U/\CjJ2J~ 'TIj l  c o r \ h x>I
the HSV-1 TK gene/SV40 E gene regulatory sequences, or 
pSV2CAT, which contains the CAT gene under the control of 
the same regulatory sequences. VZV derived plasmids 
encoding the CAT gene were co-transfected with pFJ3, which 
expresses the B-galactosidase 
gene under the control of SV40 regulatory sequences. The 
rationale behind these procedures was that assays of the 
control plasmid expression could be used to normalise the 
test plasmid assays, thus reducing the effect of variability 
between transfections. In the case of CAT assays this was 
achieved by altering the amount of extract present in the 
assays while for B-gal assays a numeric conversion was used.
Results of an early experiment in which pTMl4gal, 
pTMl4^410gal and pTMl44l31gal were transfected into BHK 
cells with or without pMCl, which encodes HSV-1 Vmw65, are 
shown in figure In the absence of pMCl no
B-galactosidase activity was detected; however, 
co-transfection of this plasmid resulted in detectable 
activity from cells transfected with pTMl4gal or pTMl4t! 
410gal but not pTMJ-.131gal. The results summarise the basic 
findings derived from analysis of the regulatory sequences 
of orf62 which were later confirmed using other constructs. 
They are as follows; first, a low level of baseline 
expression, which could not be detected above background in 
this experiment, was generated by cis-acting sequences of 
orf62 and cellular factors; second, this level of activity 
was not increased significantly, if at all, by the presence
of sequences 5 1 to the Xhol site at -131, at least not
enough to become detectable above background in this 
experiment; third, sequences 5 1 to -131 confer 
responsiveness to stimulation by Vmw65 resulting in a large 
relative increase in expression. The results gained from 
this experiment, however, were not reproduced in other 
experiments using pTMl4gal because transfection efficiency, 
as measured by the expression of the internal control
plasmid, was not sufficiently high to detect production of
Figure 4.6. An Early Transfection Experiment Using Plasmid 
pTM14gal and deletions.
Transfections were normalised using the plasmid pFS8 
which encodes the HSV TK genes with SV40 control sequences. 
Results represent the average of two independent 
experiments. The result of the B-galactosidase assays were 
divided by the result of a TK assay of the same extract to 
give the normalised units presented on the ordinate. The 
reporter plasmids shown were co-transfected in the presence 
(+) or absence (-) of the plasmid pMCl. Total amounts of 
plasmid were kept constant with pUCl8.
16
14
12
10
Beta-Gal.
TK. 8
6
pMC1
pTM14gal pTM, 410gal pTM Jl31gal Mock
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B-galactosidase even in the presence of pMCl.
Obviously this situation, especially the inability to 
detect baseline expression, was unsatisfactory. It was 
known that eukaryotic cells produce endogenous 
B-galactosidase activity and it seemed possible that this 
background activity obscured the signal from transfected 
plasmids in the absence of pMCl. To address this question a 
construct, pTM14cat, was produced as described (section
4.1.2.) and transfected into BHK cells. No CAT activity 
could be detected in this experiment in the presence or 
absence of pMCl, respite detectable levels of control 
plasmid activity.
BHK cells, the standard cell type used for short term 
transfection assays, are not permissive for VZV infections. 
It was considered possible that the blockage to productive 
infection was at the level of IE transcription, thus 
explaining the low expression of pTMl^gal and pTMl^cat. 
Therefore both pTMl4cat and pTMl4gal were assayed in Vero 
cells, which are permissive for VZV infection. Again 
however, while low levels of activity, five fold above 
background, were detected in assays in which pTMl4gal and 
pMCl were present, unstimulated activity from pTMl4gal could 
not be detected above background, and no CAT activity could 
be detected in cells transfected with pTMl4cat in the 
presence or absence of pMCl.
In considering further the possible reasons for the 
low levels of expression from these plasmids, it was noted 
that neither pTMl4gal nor pTMl4cat contained the VZV orf62 
mRNA initiation site. The plasmids had 81bp and 50bp 
respectively between the TATA box and the ATG of their 
reporter genes, sufficient for the normal initiation of 
transcription. However, it remained possible that other 
signals were present around the mRNA initiation site which 
normally contributed to increased gene expression. The 
plasmid pTMl5cat (figure 4.4.) was constructed as described 
to investigate this possibility. Reporter gene expression 
from this plasmid was assayed in BHK cells but found to be 
not significantly higher than pTMl4gal.
When the plasmid pl40cat became available (section
4.2.1.), an experiment was conducted in BHK cells to compare
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the activity of this plasmid with pTM14cat and pTMl5cat. 
The result (Figure 4.7.), shows a high level of expression 
from pl4Ocat compared with the activity obtained from cells 
transfected with pTMl4cat and pTMl5cat. Similar results 
were obtained in parallel experiments by G. Disney
(unpublished observations). In view of these results, 5'
end point deletions were made as described above (Figure 
4.5.) and plasmids pl4()4410cat and pl404l31cat compared with 
pl40cat by transfection in both BHK and HeLa cells (Figure 
4.8.). The data from a series of such experiments are given 
in table 4.1. They confirmed the results gained with 
pTMl4gal in that deletion to -410 or -131 did not
significantly reduce the expression of CAT in either cell 
type in the absence of pMCl. When pMCl was included in 
transfection mixtures, expression of pl404.410cat was 
stimulated on average 22-fold in BHK cells and 15-fold in 
HeLa cells and pl40cat was stimulated 38 fold and 24 fold in 
the same cell types. The expression of pl40^[l31cat was 
stimulated by 1.2 fold in BHK cells and by 2.25 fold in HeLa 
cells. In view of the much higher stimulations of other 
plasmids in both cell types it was considered that these 
stimulations were not significant. Therefore sequences that 
respond to Vmw65 are largely located between -410 and -131, 
but sequences that determine basal expression are located 
within the 131bp upstream of the mRNA 5 1 terminus.
To summarise this section, despite problems with 
transfection efficiency and an unexpectedly low activity of 
the orf62 promoter, positive results were obtained using 
B-galactosidase as a reporter in BHK cells (figure 4.5.) and 
Vero cells and CAT as reporter in both BHK cells and HeLa 
cells (figure 4.8., table 4 . 2 . ) .  The orf 62 promoter 
responds to stimulation by Vmw65, and sequences 
indispensible for this effect lie upstream of -130. Basal 
promoter activity is conferred by DNA sequences within the 
region -130 to +55.
4.2.3. Comparison of pl40cat with other Herpesvirus IE 
Control Sequences
An experiment was undertaken to make a direct
Figure 4.7. Initial comparison of pl40cat, pTMl5cat and 
pTMl4cat.
As in all CAT assays, results were initially normalised 
using co-transfection with pFJ3, a plasmid that expresses 
B-galactosidase under the control of SV40 early control 
sequences. B-galactosidase results were used to adjust the 
amount of extract used in CAT assays. This experiment shows 
a comparison of pl40cat (lanes 1 and 2), pTMl5cat (lanes 3 
and 4) and pTMl4cat (lanes 5 and 6) in the presence (+) and 
absence (-) of pMCl.
Reporter Plasmid
pMCl
Lane
pTMl5cat pTM14cat
Figure 4.8. Activity of pl40C&T and Deletion Mutants in 
BHK and HeLa Cells.
To demonstrate the responsiveness of pl40cat and the 
deletion mutants derived from it to Vmw65, tracks marked + 
were cotransfected with pMCl and those marked - with pUCl8. 
Samples 10-16 were excised from the same autoradiograph and 
represent equal exposures.
/
Lanes 1-9 are the result of BHK cell transfections.
Lanes 10-16 are the result of HeLa cell transfections.
P140CAT pA410CAT p a 131CAT pCAT 
pMCi + - + - + -
LANE 1 2 3 4 5 6 7
P140CAT pA410CAT pAl31CAT MT 
pMC1 - + - + - + -
LANE 10 11 12 13 14 15 16
■
CO 
+
Table 4.1.A. BHK Cells
_Normalised Percent. Acetlyation*
Plasmids pMCl Experiments Ave
1 2 3 4 5 6 7
28.5 2 26 19.5 23.5 8.5 5
+ 1320 33 660 1510 1540 64.5 56
Stimn 46.3 16.5 24.5 77.4 65.5 7.6 11.2 35
p!40cat
15 24 9.5
pl40A410cat
+ 600 460 50.5
Stim11 40 19.2 5.3 22
32 34 14
pl40Al31cat
+ 36 36 20
Stimn 1.1 1 1.4
* BHK cells were transfected as described. The plasmid pFJ3, 
which expresses the B-galactosidase gene, was transfected in all 
experiments as an internal control. The volumes of extracts used 
in CAT assays were then adjusted on the basis of the 
B-galactosidase results in order to reduce the effect of 
variability between individual transfections.
Table 4.1.B . Hela Cells
Plasmids pMCl 
pl40cat
4
Stim~
pl40A410cat
St im~
pl40Al31cat
+
Stim~
Normalised Percent 
Experiments
2 2 1
46 62 19.5
23 31 19.5
1 1
18 12
18 12
2 2
4 5
2 2.5
Acetylation*
Ave.
1
23
23 24.1
15.
2^ 3.
* HeLa cells were transfected as described, again the plasmid 
pFJ3 was used as an internal control and volumes of extract of 
the test plasmids were adjusted on the basis of the 
B-galactosidase activity measured.
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comparison between the regulatory regions of orf 62, those 
of its HSV homologue, IE gene 3, and those of its functional 
homologue in HCMV, the major IE gene. It was not intended 
to extrapolate any biological significance from this result, 
especially given the fact that autoregulation restricts the 
expression of all these genes during the lytic cycle. 
However, given the problems encountered detecting baseline 
expression from the VZV promoter, it was felt that a more 
formal comparison amongst these regulatory sequences would 
be informative. Thus, a series of short term transfection 
assays were undertaken to compare pl40cat with pIE3CAT and 
pRR55 in which the HSV IE3 and the HCMV IE control 
sequences, respectively, direct the expression of CAT. The 
results of this experiment (figure 4.9.) show that the VZV 
sequences were much less active in directing CAT expression; 
it was necessary to dilute extracts of cells transfected 
with pIE3CAT and pRR55 250-fold to obtain comparable enzyme 
levels. Thus in this direct comparison, expression of CAT 
from the VZV major IE gene was more than two orders of 
magnitude lower than its HSV and HCMV counterparts even in 
the presence of Vmw65, and in its absence the figure 
increased to over three orders of magnitude.
4.2.4. The Effect of Leader Sequences on Transcription.
The next stage in the analysis of the VZV orf62 
regulatory region was to determine the sequences responsible 
for the apparent difference in the activities of pl40cat and 
pTM15cat. As shown (figure 4.4.) pl40cat contains 
additional VZV sequences both 3',+55 to +20, and 5 1, -783 to 
-1143, to those present in pTMl5cat. Evidence gained from 
the deletions of pl40cat strongly argued that the 5 1 
sequences were not responsible for the differences in 
expression, as detectable levels of CAT activity were 
produced by both pl4oA410cat and pl4oAl31cat, (Figure 4.8.). 
Therefore residues from +55 to +20 region were implicated. 
To clarify this situation two further plasmids were 
constructed in which fragments encoding the proximal 
regulatory sequences of pl40cat were transferred to 
pTMl5cat, and vice versa. This was achieved using an Afllll 
site at -35 and the EcoRI site 200bp within the CAT gene of
Figure 4.9. Comparison of IE Control Sequences of HSV-1, 
HCMV and VZV
Comparison of the activities of IE control sequences of 
VZV (lanes 1 and 2), HCMV (lanes 4 and 5) and HSV-1 (lanes 6 
and ?) linked to the CAT gene. Lane 3 is a mock transfected 
track. In lanes marked + (2, 5 and 7), reporter plasmids 
were co-transfected with pMCl while in lanes marked - (1, 4 
and 6) pUC18 was added in order to equalise plasmid 
quantities.
p140CAT CON pRR55 pIE3CAT 
pMC1 + + “ +
DILnx 1 1 1 2 5 0  2 5 0  250  2 5 0
LANE 1 2 3 4 5 6 7
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each plasmid. The new plasmids produced by this exchange 
were named pl4()A781cat and pTMl5+cat, (Figure 4.4.). 
Experiments comparing all four plasmids in BHK cells are 
shown in table 4.2.and figure 4.10. These results show that 
plasmids pTMl5cat and pl40i781cat behaved in an equivalent 
manner, as did pl40cat and pTMl5+cat, suggesting that 
sequences 3' to +20 had no effect on basal activity. 
Stimulation of transcription by pMCl resulted in greater 
discrepancies within each set of comparable plasmids but no 
significant trends emerged. One notable feature of these 
experiments was that transfections with plasmids pl40A781cat 
and pTM15cat yielded considerably less activity in the 
absence of pMCl than those which encoded the sequences 
between -781 and -1146. This finding did not correlate with 
results of experiments comparing plasmids pl40A410cat and 
pl40zi! 131cat with pl40cat in which CAT activity with and 
without pMCl was similar. The reasons for this apparent 
discrepancy are not clear.
The plasmids pTMl5+cat and pl40A781cat were constructed 
to test the proposition that the differences between the 
activities of pl40cat and pTMl5 cat resulted from the 
presence of sequences between +55 and +20. This was shown 
not to be the case. The absolute activities of the plasmids 
pl4oA781cat and pTMl5cat, which lack sequences between -781 
and -1143, were considerably less than those of pl40cat and 
pTM15+cat which contain these sequences. The reasons for 
this differences are not clear as pl4oA410cat, which lacks a 
further 374 bases, produced values closer to those of 
pl40cat (compare tables 4.1. and 4.2. experiments 1 and 2).
4.2.5. The Effect of Adenovirus E1A products on the orf62 
Promoter.
A final set of transfections was performed to assess 
the effect of the adenovirus ElA transactivator protein on 
the control sequences of orf62. The reason for carrying out 
this experiment was the presence of the sequence motif 
ACAGCAGT at -71 to -79. This sequence is a 7 out of 8 match 
for the CRE or ATF binding site, ACTGCAGT (section
I.5.2.I.). Binding by members of this protein family has 
been shown to mediate responsiveness to the ElA gene
Figure 4.10. Effect of 5'Untranslated Sequences on 
Transcriptional Efficiency.
Plasmids pl4oZl781cat (lanes 1 and 2), pl40cat (lanes 3
and 4), pTM15cat (lanes 5 and 6) and pTMl5+cat (lanes 7 and
8) were transfected into BHK cells in the pres ence (lanes
2, 4, 6 and 8) or absence (lanes/,3, 5, l) of pMCl.
Total quantities of plasmids were kept constant using pUCl8. 
B-galactosidase assays were used to normalise CAT assays for 
transfection efficiency. Quantitations of CAT activity from 
this and other equivalent experiments are shown in Table
4.2.
Reporter Plasmid : 
pMCl :
Lane :
pl404"7 81cat pl40cat pTMl5cat pl5+cat 
- + -  +  - +  - +
1 2 3 4 5 6 7 8
Table 4.2.
Plasmids
pl40cat
Normalised Percent. Acetylation* 
pMCl Experiments
1 2  3 4
28.5 - 8.5 5
+ 1320 - 64.5 56
Stimn 46.3
Ave.
7.8 11.2 21.8
pi40A7 SI cat
Stimn
4
270 
67 .5
3
200
66.7
1
26
26
0.8
17.5
21.9 A3^ 3.
pTM15+cat
Stim
38 61 4 3
660 880 51.5 47
17.4 14.4 12.9 15.7 15.1
pTM15cat
Stimn
2
19
9.5
2
34
17
1
27
27 17 .8
* Reporter plasmids shown were transfected into BHK cells 
with equal quantities of the control plasmid pFJ3 which 
encodes the B-galactosidase gene. The quantity of extract 
used for d e t e r m i n a t i o n  of CAT activity was adjusted to 
equalise these values thus controlling for transfection 
efficiency. The values are expressed as counts per minute x 
10~3
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product. Thus, the responsiveness of the orf62 promoter to 
ElA gene products was intended to provide functional 
corroboration for the sequence and protein binding data 
(figure 4.14) that suggested that members of the ATF/CRE 
protein family were involved in the control of the 
expression of orf62. The transactivation function of E1A 
has been mapped to a 46 amino acid region between residues 
243 and 289 (section 1.5.2.4.). Of the two main mRNAs 
encoded by the ElA gene, only the 13S component contains 
this transactivation domain, whereas the smaller 12S 
component does not. Plasmids that express the "12S" or 
"13S" gene products were obtained from Dr. N. Jones. These 
plasmids were cotransfected with pl40cat and deleted
derivatives. The results of this experiment (figure ^.11.) 
show that co-transfection of a plasmid expressing the 13S 
component with pl40CAT results in a 10-fold increase in CAT 
activity. This effect also occured when pl40A410CAT and p 
14oAl3lCAT were tested, both plasmids being stimulated to a 
similar extent. Thus sequences between +55 and -131 mediate 
responsiveness of the orf62 control sequences to the "13S" 
ElA gene product, but the exact target for stimulation 
(thought to be the ACAGCAGT or the TATA element) has not 
been identified.
4.3. Protein Binding Studies
4.3.1. General Analysis
To complement and extend the functional assays, 
attempts were made to locate and characterise protein
binding sequences in the orf62 regulatory region. Gel 
retardation assays were used for initial investigations. 
Fragments derived from restriction enzyme digests designed 
to cover the entire regulatory region were radiolabelled and 
incubated with nuclear extracts from HeLa cells. The 
results of a series of such assays are shown in figure 4.12. 
Two main regions of protein binding activity were detected. 
The first, lane 6, is located between the Sail and the Xhol 
sites at -409 and -130 respectively, and was named Region B. 
It corresponds to the region shown by the functional
Figure 4.11. Effects of the Products of the ElA Gene on 
orf62 Control Sequences.
Plasmids pl40cat, pl40 410cat, pl40 131cat and pBLW2 
were co-transfected with plasmids expressing the 289 amino 
acid product of the adenovirus 5 ElA gene (lanes 2, 5, 8 and 
11), 243 amino acids product of the same gene (lanes 1, 4, 7 
and 10) and pUC18 lanes (lanes 3, 6, 9 and 12). On this 
occasion no reporter plasmid was used to normalise 
transfection efficiency but the amount of protein added to 
individual reactions was controlled by Bradford assay. The 
relative CAT activity is given below the assays.
Reporter Plasmid 
Cotransfected with 
Lane
pl40CAT pl40 410CAT pl40 131CAT pBLW2 MT
12S 13S pUC 12S 13S pUC 12S 13S pUC 12S 13S pUC 
1 2 3 4 5 6 7 8 9 10 11 12 13
CAT Activity 
Normalised
200 23.5 15 190 13.5 37 340 49 0.3 0.9 0.5 0.1
A ’ f d  e>€
0 3
Figure 4.12. Gel Retardation Assays Using DNA Fragments
f Within the Putative Control Regions of orf62
The fragments assayed were derived from plasmid pVZVDH 
which was digested with the restriction endonucleases shown. 
The positions of the relevant cleavage srires are shown 
diagrammatically above the assays. Complexes that were 
subjected to further analysis were detected in lanes 6 and 7 
marked ® a n d  fl respectively. The Xbal/Kpnl fragment (lanes 
1 and 4) consistently generated a retarded complex 
marked X  ,
Xba I 
-781
KpnI 
-692
Kprft
-584
Acc\ Sail 
-466 -409
Afliii 
-246
Xho\ Seal
-130 -25
_J L_
Xhol
+197
R4 ’TA TA ’ mRNA ■V
Fragment :- XbaM Xball KpnM 
KpnI A eel SalI
Lane 1 2 3
Xfcal/ KprAI Sam Xholl Scall 
KprA Sail Xhol Seal Xhol
4 5 6 7 8
A f l l t l l
Xhol
M  K
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analysis to respond to stimulation by Vmw65. A further 
fragment cleaved with Afllll and Xhol from this region, lane 
9 representing sequences -246 to -130, failed to direct 
complex formation, suggesting that the binding site(s) 
responsible for the retarded bands lies between -246 and 
-409, a result confirmed by subsequent experiments, (section 
4.3.3.). The second fragment that results in prominent 
complex formation consists of sequences between -130 and -25 
produced by Xhol and Seal. This corresponds to the baseline 
promoter region of the functional studies and was named 
Region A. The complex formed at Region A can be resolved 
into two main parts, the upper being a diffuse area of
radiodensity and the lower, a more discrete band.
Other fragments, notably those containing sequences 
between -584 and -784, appeared to interact with proteins 
resulting in retarded bands (lanes 1 and 4), however, these 
bands were of much lower intensity than those of lanes 6 and 
7, and in view of the results of the functional studies, 
were not investigated further during the course of the work 
presented here. Nevertheless, the results suggest that 
specific protein binding occurs at this interesting region 
of the VZV genome.
4.3.2. Region A - The Proposed Promoter Fragment
In order to define the locations of the binding 
activities of Region A further, subfragments from this 
region were radiolabelled and assayed as shown in figure 
4.13. The fragment assayed in lane 1 was cleaved with 
Afllll and SspI and spans -246 to -90. It binds a complex 
with a similar appearance and mobility, but apparently, in 
this experiment, lower affinity, than the lower complex 
formed by the fragment encoding the whole of region A (lane 
2). Since, sequences between -246 and -130 had already been 
shown not to form retarded complexes (Figure 4.1.2., lane 9), 
this localises a potential binding site to between the Xhol 
site at -131 and the SVpI site at -91. Lane 3 shows 
complexes formed by a SspI to Seal fragment spanning -90 to 
-35 and representing the 3' portion of Region A. A 
complicated, or poorly resolved array of bands are formed on 
this fragment, which do not resemble complexes formed by the
Figi^re 4.13. Analysis of Promoter Fragment: I.
Section A.
The promoter fragment (-131 to, -30) was analysed in two
o ^ l u  sad
parts. Residues -131 to -87^ within a larger fragment (Lane
1), while residues -87 to -35 were assayed in isolation 
(Lane 3). The pattern of binding to the entire fragment is 
reproduced for comparison (Lane 2). Complexes marked 0 were 
common to Lanes 1 and 2, the complex marked #  was unique to 
lane 2 and the complex marked J was unique to lane 3.
Section B.
Double stranded oligonucleotides 4 and 5 (Appendix 3)
were incubated alone (Lanes 2 and 3 respectively) or in
combination (Lane 4), with HeLa cell nuclear extract, prior
32to the addition of [ ]P-labelled fragment (residues -131 to 
-35). In the absence of competitor two complexes could be 
discerned, one, marked 0  , migrated slowly, the other, 
marked 0  , migrated more quickly. Oligonucleotides were
added at approximately 100 fold molar excess.
Afllll
-246
aA-
Xhol SspI Afllll
-130 -90 .35
I CCAAT | ATF/CRE________PEA-2 | t ATA
CGTCCAATCAC TGACGACA TGCGGTC TTTTAA
oligo 4 oligo 5
Section A
Probe :- Afllll/ Xhol/ SspI/ 
SspI Afllll Afllll
Lane > 1 2  3
Section B
Probe :- Xhol/Afllll fragment 
C om petitor:- - oli 4 oli 5 oli4/oli5
Lane :- 1 2  3 4
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complete Region A fragment. Thus, neither part of Region A 
alone could reproduce the binding activity of the entire 
fragment.
Two possible explanations can be proposed to explain 
these findings. The binding activity seen in lane 2 could, 
at least in part, be dependent on the integrity of a site 
situated around -91, and cleavage at or close to this site 
could disrupt this motif and thus prevent binding. 
Alternatively the pattern could result from additive effects 
of proteins binding at two unrelated sites, on the large 
fragment. Thus the lower complex would result from the 
binding of a single protein to the fragment while the upper 
complex would result from the occupation of both sites by 
proteins. Separate fragments would not then reproduce this 
pattern. These possibilities are obviously not mutually 
exclusive.
A search of this Region A for known cis-acting motifs 
revealed three possible protein binding sites centered at 
-53 (PEAII), -78 (ATF/CRE) and -115 (CCAAT). The fact that 
PEAII is an enhancer binding protein that to date has only 
been detected in mouse cell extracts led to the suspicion 
that the latter two factors were more likely to be of 
significance. Oligonucleotides encoding these sites and 
their flanking sequences were designed and synthesised. The 
use of these oligonucleotides as competitors in gel 
retardation assays is shown in figure ^.13 section B. 
Preincubation with oligo 5, which includes the ATF site 
(lane 3), resulted in the disappearance of the upper complex 
leaving the lower one unaffected. Oligo 4, which includes 
the CCAAT box homology competes for the lower band, (lane
2), however, this oligonucleotide also appears to reduce 
overall binding leaving only a small amount of diffuse bands 
(compare lanes 2 and 4). This result is in concordance with 
that shown in figure 4.13. section A in suggesting that the 
lower band in lane 2 is largely the result of protein 
binding to the distal half of region A. Competition with 
both oligonucleotides (section B lane 4) left little binding 
activity. Taken together, the results of figure 4.13. 
sections A and B suggested the presence of two protein 
binding sites in Region A. The most likely candidates for 
these are the CCAAT box motif present at -115 and the
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CRE/ATF binding site at -78. However, a simple model, in 
which two distinct binding sites of equal affinity each 
interact independently with a protein, does not entirely 
explain the findings as competition with oligo 4 left little 
binding activity, apparently less than that present in the 
upper complex alone. This suggests the possibility of an 
interaction between the two proteins whereby binding to the 
region encoded by oligo 4 facilitates binding to the site in 
the proximal part of the fragment.
Attempts were then made to identify the binding 
proteins. Oligonucleotides known to encode binding sites 
for ATF and API, along with an oligonucleotide which 
contained two mutations that inactivate the ATF binding site 
(2/4), were kindly provided by Dr. N. Jones. The result of 
an experiment, in which these oligonucleotides were used 
both as probes and competitors in gel retardation assays is 
shown in figure 4.14. First, use of the ATF oligonucleotide 
as a probe revealed a single, relatively diffuse, complex 
(lane 1). Use of the same oligonucleotide as a competitor 
removed this complex almost completely (lane 2), the API 
oligonucleotide competed partially for the complex (lane 3), 
and oligo 2/4, in which the ATF binding site had been 
mutated, (Appendix 3) failed to compete for the ATF complex 
(lane 4). The use of the API oligonucleotide as a probe 
(lanes 5-8) resulted in a much lower level of protein 
binding. However, the complex which was produced was 
removed completely by an excess of the API oligonucleotide 
(lane 7), the ATF oligonucleotide competed to a small extent 
(lane 6) and oligo 2/4 again failed to compete (lane 8). 
These data are consistent with those already reported using 
the same oligonucleotides (Hurst and Jones, 1987). Finally, 
using Region A as a probe the dual complex was again 
produced in the absence of competitors (lane 9). Addition 
of an excess of the ATF oligonucleotide effectively competed 
for the upper complex (lane 10). The API oligonucleotide 
also competed, though slightly less efficiently (lane 11). 
Again the oligo 2/4 failed to compete to any measurable 
extent (lane 12). These data suggest strongly that ATF, or 
members of that protein family, represents one of the 
binding activities associated with region A, since the upper 
complex formed by the fragment containing this region shows
Figure 4.14. Analysis of Promoter Fragment: II.
Protein binding to the promoter fragment (Xhol/Hindlll 
of pVZVBH, residues -131 to -25) was compared with binding 
to oligonucleotides containing the ATF and AP-1 binding 
sites. These oligonucleotides, along with one (2/4) 
containing mutations known to prevent binding to the ATF 
site, were also used as competitors. The oligonucleotide 
containing the ATF site was used as a probe in Lanes 1 to 4, 
that containing the AP-1 site was used as a probe in lanes 5 
to 8 and the -131 to -25 fragment of pVZVBH was used as a 
probe in lanes 9 to 12. Lanes 1, 5, and 9 contained no 
competitor oligonucleotides, the ATF oligonucleotide was 
added, prior to labelled fragment, in lanes 2, 6 and 10, the 
AP-1 oligonucleotide was added to lanes 3, 7,and 11 and the 
oligonucleotide containing the mutated ATF site, 2/4, was 
added to lanes 4, 8 and 12. All oligonucleotides were added 
at approximately 100 fold molar excess. The slower and 
faster migrating complexes were again marked 0  and 0  
respectively. The complexes present in the ATF and AP-1 
tracks were marked 4  and 0  respectively.
Labelled .
Fragment A 1 h ol|g ° AP1 oligo Xhol/Hindlll fragment of pVZVBH
Competitor
Oligo. '  A TF AP1 2/4 - ATF AP1 2/4 - ATF AP1 2/4
LANE 1 2 3 4 5 6 7  8 9  10 11 12
103
the same response to competition as the radiolabelled ATF 
oligonucleotide. It was also noted that competitors that 
remove the upper complex increased the intensity of the 
lower complex (compare lane 9 with lanes 10 and 11), again 
suggesting that the upper complex results from binding of 
the fragment by two or more proteins. The removal of one 
protein thus results in more fragment bound by a single 
protein and thus increased intensity of the faster migrating 
complex. Also the double complex runs more slowly than the 
ATF complex.
Further evidence towards identifying the binding 
species was produced by another competition experiment 
(figure 4.15). Again Region A was used as the probe. Four 
oligonucleotides, in two pairs, were used as competitors. 
Two of these contained the motifs present in Region A 
represented by the HSV TK CCAAT box and the ATF 
oligonucleotide used previously. The others were the 
mutated ATF oligonucleotide (2/4) used previously and an 
oligonucleotide which encoded the TAATGARAT motif found 
upstream of HSV IE genes. Lane 1 shows complex without 
competitor oligonucleotides. Lane 2, in which the HSV CCAAT 
box alone was the competitor, yielded a pattern similar to 
that seen in figure 4.13., section B lane 2, when oligo 4 
was the competitor, although the TK CCAAT box appeared to be 
less effective in competing for the complex. This failure 
of full competition is not surprising given the number and 
diversity of proteins which are known to bind to this 
cis-acting sequence (see section 1.5.2.3.). Again, 
competition of protein binding from this site left little
evidence of ATF binding, though comparison of lanes 4, 5 and
6 does appear to show a diffuse complex in the lane which 
lacks the ATF competitor (lane 5). This result suggests 
that the absence of the CCAAT box binding activity in some
way reduces the affinity of the ATF binding species for its
site. The converse is not true, as shown in lanes 3 and 6, 
since the presence of the oligonucleotide encoding the ATF 
binding site again results in the removal of the upper 
complex and an increase in the intensity of the lower, CCAAT 
box related, complex. Finally, competition with both 
specific oligonucleotides (lane 6) resulted in the removal
Figure 4.15. Analysis of the Promoter Fragment: III.
The Xhol/Hindlll fragment of pVZVBH (residues -131 to 
-20) again served as the probe and was incubated with HeLa 
cell nuclear extract. A 100-fold molar excess of 
oligonucleotides containing the CCAAT box motif (Lanes 2, 4 
and 5), the ATF/CRE motif (Lanes 3, 4, and 6), the mutated 
ATF/CRE motif (Lanes 5 and 7) and the TAATGARAT motif (Lanes 
6 and 7). As before the faster and slower migrating 
complexes are marked 0  and 0  , respectively. Sequences of 
the competitor oligonucleotides are given in Appendix 3.
Probe Xhol/Hindlll fragment of pVZVBH
Competitor -  c a a t  a t f  c a a t  c a a t  a t f  t g
Oligonucleotides + + + +
ATF 2 /4  TG 2 /4  
Lane 1 2 3 4 5 6 7
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of most of the binding activity, while the non-specific 
oligonucleotides had little effect (lane 7).
4.3.3. Formation of Protein-DNA Complexes Responsible for 
Stimulation by Vmw65
Previous studies have shown that stimulation of 
transcription by Vmw65 depends on the presence of TAATGARAT 
in the control sequences of the gene in question. Vmw65 
does not bind directly to TAATGARAT but interacts with 
proteins that themselves recognise the octamer element 
ATGCAAAT as well as TAATGARAT (section 1.4.2.). Analysis of 
the region upstream of the TATA box reveals two sites which 
match the octamer element closely (figure 4.1). Site I 
(TTTTGCAT) is centered at -345 and matches the octamer 
element at 7 out of 8 positions in the opposite orientation. 
Site II (ATGTAAATGAAAT) is centered at -256, and is a more 
complicated motif representing a combination of the octamer 
sequence (7 out of 8 matches) and the TAATGARAT motif (8 out 
of 9 matches). Both of these sites are within nucleotides 
-409 to -130, defined above as the region that determines 
the response to Vmw65. Binding of cell proteins and Vmw65 
to these sites was investigated by gel retardation assays 
(figure 4.16.). Three radiolabelled fragments from the 
region -410 to -131 in the VZV IE promoter were tested in 
the assay. A 114 bp Sall/AccI fragment, containing 
TTTTGCAT, gave a complex (lane 2) equivalent to that denoted 
HC3 by Preston et al., (1988), and upon addition of herpes 
simplex virion extract, a very diffuse complex that migrated 
slowly into the gel was formed (lane 1). Production of both 
radiolabelled complexes was competed by addition of 
oligonucleotides containing ATGCAAAT (lanes 3 and 4), but 
not by an oligonucleotide containing the HSV-1 TK gene CCAAT 
motif (lanes 5 and 6). A 49 bp Accl/Afllll fragment 
containing ATGTAAATGAAAT readily formed the 'HC3' complex 
(lane 8), and upon addition of virion extract a major band 
representing IEC was formed (lane 7). Oligonucleotides 
containing TAATGAGAT or ATGCAAAT competed efficiently (lanes 
9-12), but oligonucleotides containing CCAAT or adenovirus 
major late promoter (MLP) recognition sites did not (lanes 
13-16). An Afllll/XhoI fragment comprising the remainder of
Figure 4.16. Gel Retardation Analysis of the Region Between
-409 and -130.
Fragments containing the octamer motif (114 bp) and the 
octamer/TAATGARAT motif (49 bp) were incubated with HeLa 
cell nuclear extract. HSV-1 virion extract was present in 
lanes labelled + and absent from lanes labelled -. A 
100-fold molar excess of oligonucleotides containing octamer 
(lanes .3, 4, 9 and 10), TAATGARAT (lanes 11 and 12), CCAAT 
box (lanes 5, 6, 13 and 14) or adenovirus MLP binding site 
(lanes 15 and 16) were added as competitors. Complexes HC3 
and IEC are labelled.
A
G
A
TG
TTTTG
C
A
T 
A
TG
TA
A
A
TG
A
A
A
T
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the -409 to -130 region failed to form any protein-DNA 
complexes ( f i g u r e d  12. lane 9). Thus the two subfragments 
of the -409 to -130 region that bind proteins both interact 
with Vmw65, but IEC forms far more efficiently on the
Accl/Af1III fragment that contains a 8/9 match to TAATGARAT. 
The activity of the very weak IEC formation by the 114bp
fragment that contains the octamer motif alone, in terms of 
the stimulation of transcription, is questionable and thus 
lends weight to previous data which showed that octamer
motifs alone are ineffective in Vmw65 mediated 
transcriptional stimulation (section 1.4.3.).
T h e  gel retardation assays (figure 4*. 16) provide 
strong evidence that the Sall-AccI and the Accl-Afllll 
fragments bind the protein Oct-1, The Accl-Afllll 
also forms a tertiary complex. In order to confirm the 
location of the binding activity detected by the gel
retardation analyses, DNAase I protection analysis of the 
Accl-Xhol fragment was undertaken (^. 17.). Protection from 
DNAase I digestion was present at the ATGTAAATGAAAT motif 
both in the presence and absence of partially purified 
Vmw65. No other differences from the control lane 
containing fragment alone were detected. Comparisons of the 
protection pattern between lanes 2 and 3 (with and without 
partially purified Vmw65) shows a small extension of the 
footprint towards the "GARAT" portion of the motif.
By analogy with the well characterised HSV-1 system, it 
is clear that the two elements with homology to the octamer 
and/or TAATGARAT are responsible for the observed 
stimulation of expression from the VZV major IE promoter by 
Vmw65, and it is likely that the element ATGTAAATGAAAT is of 
major importance for the effect.
4.4. Activity of VZV orf10
It was of interest to determine whether the VZV 
homologue of Vmw65, orf10, could also stimulate 
transcription from the VZV major IE gene. To investigate 
this possibility, the coding sequences of Vmw65 in the 
plasmid pMCl were truncated by removing sequences between 
amino acids 413 and 471 which encode the majority of the
Figure 4.17. DNAasel Footprinting Analysis of a 165bp 
Accl/Xhol (-296 to -131) Fragment.
Tracks 4 and 5 are G and G+A sequencing tracks. Prior 
to DNAasel treatment, fragment in track 1 was incubated with 
HeLa cell extract and virion extract, fragment in track 2 • 
with HeLa cell extract, while track 3 represents free 
fragment alone. Dark bars represent the sequences protected 
and hypersensitive sites are labelled HS.
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acidic region (figure 4.18.) to form the plasmid pMCl 15-17, 
and then replaced by those of orflO to form the plasmid 
pMCORFlO. Figure 4.19. shows a comparison of the ability of 
pMCl and pMCORFlO to stimulate transcription from the 
plasmids pl40cat, pTMl4gal and pTM8, which encodes the 
B-galactosidase gene directed by HSV IE3 control sequences 
(Appendix 2). In both of these examples pMCORFlO failed to 
stimulate expression of the reporter gene products, whereas 
a 10-30 fold increase in activity was observed upon 
co-transfection of pMCl. The results show that pMCORFlO 
fails to stimulate transcription. Comparison of the 
sequences of orflO and Vmw65 had shown considerable 
similarity in their amino-terminal domains (figure 4.18.). 
However, Vmw65 encodes a further region of 78 amino acids at 
its carboxy-terminus whose major characteristic is its 
acidity, having a total charge of -19. Acidic regions had 
been shown to be important for the ability of a group of DNA 
binding proteins to stimulate transcription (section
1.5.4.). Thus the absence of the acidic region from the 
coding sequence of orflO alone would be sufficient to 
explain its lack of transcriptional activity. However, in 
view of the existence of transcriptional activators which 
lack acidic activating (section 1.5.3.) regions and the 
possibility that roles other than transcriptional activation 
might be served by the formation of the IEC, it was still of 
considerable interest to determine whether the protein 
encoded by orflO would form a complex analogous to IEC. The 
coding sequences of orflO were inserted into the polylinker 
of the plasmid pTZl8R, which allows the transcription of 
orfs ini vitro. Two separate clones of this construction, 
pTZORFlOA and pTZORFlOB, were isolated and transcribed, 
together with the plasmid pGEMTIF (Ace et al, 1988) which 
encodes Vmw65, using T7 RNA polymerase. In addition, 
pGEMTIF.ini5 (Ace et al., 1989) cleaved with BamHI was 
transcribed, to provide a transcript lacking the sequences 
encoding the acidic C-terminal tail but retaining the 
N-terminal 410 amino acids of Vmw65 that are homologous to 
orflO. The transcripts were then translated, using rabbit 
reticulocyte lysate, in the presence or absence of 
[ ] -methionine. Samples of reactions in which
[35g]-methionine was incorporated, revealed the presence of
Figure 4.18. Optimal Alignment of the Amino Acid Sequences 
of HSV-1 Vmw65 and the VZV orflO Product.
Amino acid sequences (adapted from Dalrymple et a l ., 
(1985)), are presented using the single letter code. The 
alignment was determined using the optimal alignment program 
of Taylor, (1984). Identical amino acids are denoted by *, 
acidic residues within the carboxy-terminal 78 amino acids 
are presented in bold script and the positions of the Sail 
site and the insertion mutants in!4, in!5 and _inl7 (Ace et 
al ., 1988) relevant to this project are indicated.
HSV-1 1: - M D ..LLVDELFADMNADGASPPPPRPA..GGPKNTPAAPPLYATGRLSQA.QLMPSPPMPVPPA
* * * * * * * * * * * *  *
VZV 1 MECNLGTHEPSTDTWNRSKTEQAWDAFDESLFGDVASDIGFETSLYSHAVKTAPSPPWVASPK
70 ALFNRLLDDLGFSAGPALCTMLDTWNEDLFSALPTNADLYRECKFLSTLPSDV. . . VEWGDAYVPERTQIDIRA * * ** ** ** * * ******** * * *** ** * ** * * * * 
75 ILYQQLIRDLDFSEGPRLLSCLETWNEDLFSCFPINEDLYSDMMVLSPDPDDVISTVSTKD..HVEMFNLTTR.
141 HGDVAFPTLPATRDGLGLYYEALSRFFHAELRAREESYRTVLANFCSALYRYLRASVRQLHRQAHNRGRDRDLG 
* * * * ** * * * * * * * * *  * * * * * *  *
145 . GSVRLPSPPKQPTGLPAYVQEVQDSFTVELRAREEAYTKLLVTYCKSIIRYLQGTAKRTTIGLNIQNPDQKAY
215 EMLRATIADRYYRETARLARVLFLHLYLFLTREILWAAYAEQMMRPDLFDCLCCDLESWRQLAGLFQPFMFVNG 
** * * * * * *  * * * *  * * * * * *  * * *  * ** * ** * * ** * * *
219 TQLRQSILLRYYREVASLARLLYLHLYLTVTREFSWRLYASQSAHPDVFAALKFTWTERRQFRCAFHPVLCNHG
289 ALTVRGVPIEARRLRELNHIREHLNLPLVRSAATEEPGPALTTPPTLHGNQARASGYFMVLIRAKLDSYSSPTT 
* * * *** * * * ***** ** ** * * * * * * *  *
2 93 IVLLEGKPLTASA; REONYRRRELGLPLVRCGLVEENKSPLVQQPSFSVHLPRSVGFLTHHIKRKLDAYAVKHP
ini4 Sail inl5
363 SPSEAVMREHAYSRARTKNNYGSTIEGLLDLPDDDAPEEAGLAAPRLSFLPAGHTRRLSTAPPTDVSLGDELH 
* * * * * * *  * * ** * * * * ** *  *
357 QEPRHVRADHP YAKWENRN YGS SI............ EAMILAPPSPSEILPGDPPR____PPTCGFLTR
inl7
437 LDGEDVAMAHADALDDFDLMLGDGDSPGPGFTPHDSAPYGALDMADFEFEQMFRDALGIDEYGG
Figure 4.19. Transcriptional Activity of pMCORFlO.
pMCORFlO was co-transfected with three reporter 
plasmids and its transcriptional activity was compared with 
that of equal quantities of pUCl8 and pMCl. Section A shows 
the effects of pVZVORFlO (Lane 1), pUC18 (Lane 2) and pMCl 
(Lane 3) on CAT gene expression from the plasmid pl40cat. 
Section B shows the effect of the same three plasmids on 
B-galactosidase expression from the plasmids pTMl4gal and 
pTM8. .
SECTION A
Reporter Plasmid > p140CAT 
Cotransfected with orflO pUC pMC1 
Lane > 1 2  3
SECTION B
16 1
14 -
normalised 12
bet a-gal -jg
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j __ L
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translation products of the expected sizes upon SDS-PAGE 
(Figure 4  20.). Some discrepancy is noted between the 
predicted molecular weights of Vmw65 and the product of 
orflO which are 54,000 and 43,000 respectively, and their 
apparent molecular weights of 63,000 and 54,000 
respectively. This could be the result of
post-translational modifications occuring in the rabbit 
reticulocyte lysate or some characteristic of the primary 
structure of the protein. In any case, it is not directly 
relevant to this experiment, the main purpose of which was 
simply to demonstrate that protein was produced. The 
differences in the intensities of the bands produced by the 
VZV and HSV orfs are largely due to the occurence of 3 times
more methionine residues in HSV-1 Vmw65 than in VZV orflO.
35Samples of reactions lacking [ S 3-methionine, were used for 
gel retardation assays with radiolabelled DNA fragments 
containing the TAATGARAT elements of VZV or HSV-1 (Figure 
4.21). As expected, Vmw6 5 produced in vitro from pGEMTIF 
directed the formation of IEC when tested with the 49 bp 
Accl/Afllll from the VZV IE gene or the 74 bp 
oligonucleotide derived from HSV-1 IE gene 4/5 (lanes 7 and 
12). Truncated Vmw65 also formed IEC with each fragment 
(lanes 6 and 11), showing that the acidic C-terminus does 
not participate in the interaction of Vmw65 with cellular 
proteins to form IEC. VZV orflO, however, did not direct 
the formation of a complex analagous to IEC with either VZV 
or HSV-1 fragments (lanes 3, 4 and 10). Therefore, although 
orflO is a homologue of Vmw65, it does not activate IE 
transcription or form IEC.
Figure 4.20. In vitro Translation of Vmw65 and ORFlO 
Polypeptides.
RNA transcribed from pGEMTIFinl5 after BamHI cleavage
(lane 1), pGEMTIF (lane 2), pGEM2 (lane 3) and pGEMORFlOA
and B (lanes 4 and 5) all cleaved with Hindlllwere
35translated in vitro in the presence of [ S ]-methionine.
Del WT pGem ORF ORF 
15 10 A 10 B
LANE 1
Figure 4.21. Gel Retardation Assay Using In vitro
Synthesized Vmw65 and ORFlO Products.
Radiolabelled probes used in binding reactions were a 
49bp Accl/Af1III fragment from the VZV major IE gene control 
sequences (lanes 1-7) and a 74 bp fragment from HSV-1 IE 
control sequences (lanes 8-12). Fragments were incubated 
with HeLa cell nuclear extract alone (lanes 1 and 8), and 
with addition of virion extract (lanes 2 and 9), or 
translated products of ORFlO (lanes 3, 4, and 10), pGEMTIF 
(lane 5), pGEMTIFinl5 (lanes 6 and 11), or pGEMTIF (lanes 7 
and 12). The positions of complexes IEC and HC3 are 
indicated.
>zm
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5. DISCUSSION
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5.1. Cis-actinq Sequences
For the purpose of discussion the sequence upstream of 
the proposed ATG of VZV orf62 can be divided into four 
sections. These are the 5' untranslated region, the 
promoter region (sequences -1 to -131), the Vmw65 responsive 
region (-131 to -410) and sequences present further 
upstream.
5.1.1. 5 1 Untranslated Region
Primer extension and SI nuclease analyses revealed that 
the 5' untranslated region consists of 74 bases and lacks an 
intron. Further circumstantial evidence confirming this as 
the mRNA start site comes from the presence of a TATA box 
centred at -28 and functional regulatory elements further 
upstream.
Functional significance for sequences around the mRNA 
start site has been demonstrated in the HSV-1 system where a 
motif (ATCGTC), which spans the mRNA initiation site 
interacts with the IE-3 gene product Vmwl75 (Beard et a l ., 
1986; Faber and Wilcox, 1986; Kristie and Roizman, 1986a; 
Muller, 1987; Faber and Wilcox, 1988). This motif appears 
to be involved in the ability of Vmwl75 to autoregulate its 
own expression (Gelman and Silverstein, 1987b; Muller, 1987; 
Roberts, 1988). Sequence similarity between the mRNA 
initiation sites of IE-3 and orf62 is not present and this 
feature correlates with the inability of 140K to 
down-regulate the expression of Vmwl75 (Disney et a l ., 
manuscript in preparation). Recent, unpublished, results 
from G. Disney (manuscript in preparation) suggest that the 
product of orf62 does autoregulate its own expression but 
that sequences within the 5' untranslated region are not 
essential for this effect. Thus, orf62 can complement 
Vmwl75 defective mutants (Section 1.3.2.2.), suggesting that 
the ability to transactivate is conserved both in terms of 
the mechanism of transactivation and the recognition of the 
essential genes whose expression depends on the presence of 
Vmwl75. However the autoregulatory functions of the product
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of orf62 and Vmwl75 appear to be divergent, at least in 
terms of sequence recognition, if not also in their 
mechanism of action.
Mapping of the mRNA start site of orf62 also allows 
direct comparison with HSV-1 IE gene 3. Little conservation 
is apparent between the two sequences, the HSV-1 leader 
sequence being 301 bases compared to the 74 bases of the VZV 
leader. The only other VZV gene whose mRNA initiation site 
has been defined is that of the dPyK which was mapped by 
Davison and Scott (1986). It is located 410 bases upstream 
of the proposed initiation codon compared with a 5' 
untranslated region of 110 bases for the homologous HSV-1 
gene (McKnight, 1980). Together, these data suggest that 
little conservation exists between the structures of the 
mRNA leader sequences of HSV-1 and VZV.
5.1.2. The Promoter
The promoter region, functionally defined by the 
plasmid pl4oAl31cat, extends from the initiation site to 
-131. This fragment contains three recognised cis-acting 
elements, the TATA box (centred at -28), an ATF/CRE binding 
site (centred at -75) and a CCAAT box (centred at -116). In 
addition there is a sequence motif for the murine enhancer 
binding protein PEA-2 (TGCGGTC, centred at -52) though no 
binding activity related to this site was detected and the 
factor currently has not been detected in non-murine cells.
The proposed TATA box TTTTAA is present at -28. 
Comparison with the TATA sequences of the homologous genes 
in other herpes viruses; HSV-1 (ACTATAT), HSV-2 (ACTATAT), 
PRV (CTTATAA) and EHV-1 (GTATAAA - predicted), reveals 
little obvious conservation, amongst these motifs. The 
significance of differences in TATA box sequences is 
controversial. Recent evidence, gained using cloned yeast 
and purified human TFIID (the TATA binding factor, section
1.5.5.) suggests that a single TFIID species exists, that it 
binds to a wide range of TATA like sequences, and that, even 
in the absence of a detectable TATA box, TFIID may still be 
essential for RNA polymerase II mediated transcription. 
Moreover the finding that TFIID protects sequences from -35 
to +40 from DNAase I digestion suggests that additional
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sequences may play a role in TFIID binding. However, as 
other data show functional differences between TATA 
sequences (Simon et al. , 1988), the significance of the 
precise TATA sequence remains controversial.
The ATF/CRE motif at -75 (TGTCGTCA) is not a perfect 
match to the consensus sequence for this element, TGACGTCA. 
Again, the significance of this deviation from the consensus 
is not clear. Non-consensus binding sites have proved to be 
effective in both baseline and cAMP stimulated transcription 
(Bokar et a l ., 1988) and ATF/CRE motifs with an A to T
transversion at this position are present in the adenovirus 
E3 and E4 promoters and also in the heat shock protein 70 
promoter (Lee et ad.., 1987 ). The TGTCGTCA motif was shown 
to bind proteins of the ATF/CRE family in gel retardation 
assay and competition experiments (figures £.13, £.14 and 
1^.15). The presence and binding activity of this site 
raised the possibility that the expression of orf62 might be 
responsive to stimulation by cAMP and the 289 amino acid 
product of the adenovirus E1A gene. Attempts to analyse the 
effect of altered cAMP levels on gene expression failed. It 
is relevant, however, that monomers of the ATF/CRE motif 
appear to mediate only small alterations in the levels of 
gene expression in response to cAMP and thus any effect on 
orf62 expression would be predicted to be relatively small. 
Moreover, it is likely that only certain members of the 
ATF/CRE family mediate this effect (J. Nevins pers. comm.) 
and until all of these proteins have been defined, and their 
individual binding specificities allocated, the precise 
function and relevance of this site should be regarded as 
preliminary. Thus the significance of this, potentially 
important, regulatory mechanism remains unclear.
Binding of proteins to the CCAAT box consensus was also 
demonstrated using both a fragment containing the CCAAT 
motif alone and one containing both CCAAT and ATF/CRE sites. 
As mentioned (section 1.5.2.3.), the family of CCAAT binding 
proteins appears to be even more diverse in terms of 
structure and function than the ATF/CRE family. Again for 
many of these proteins definition of the precise cis-acting 
sequences with which they interact and their potential for 
modification by post-translational mechanisms awaits 
cloning, sequencing and expression of the genes. Thus
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little information can be deduced as to the significance of 
the CCAAT motif at -116, beyond its general and established 
function as a cis-actinq element involved in transcriptional 
activation.
The use of fragment A which encodes both protein 
binding sites, along with competitor oligonucleotides 
allowed direct comparisons of the amounts of protein binding 
to these two sites in the orf62 promoter. This led to two 
observations. First, the CCAAT motif appeared to be 
responsible for a much higher degree of binding- than the 
ATF/CRE binding site. Second, binding to the CCAAT box 
resulted in an apparent increase in binding to the ATF/CRE 
site. It is known that DNA binding proteins can interact to 
enhance the interaction of factors with adjacent binding 
sites. Data exists to show that this occurs in the binding 
of Oct-1 and Oct-2 to two different sites in the 
immunoglobulin heavy chain enhancer (Kelmer et al., 1989), 
binding of oestrogen receptors to two imperfect oestrogen 
responsive DNA elements, and for binding of the progesterone 
receptor to two adjacent progesterone response elements 
(Martinez and Wahli, and Tsai et al., abstracts of papers 
presented at the Cold Spring Harbour Meeting on Cancer 
Cells, Regulation of Eukaryotic mRNA Transcription, Sept. 6 
to Sept 10, 1989, ppl42 and 212). These instances are not 
directly pertinent to the promoter of orf62. They all 
involve interactions between members of one protein species 
and binding sites that are separated by only a few bases. 
Thus, whether the effect seen in figures 4.11 and 4.12 
represents a genuine example of different proteins 
interacting to modify binding, by a direct or indirect 
mechanism, or is merely an artifact of the assay system, is 
not clear. However, the fact that the the centres of both 
motifs are separated by 41 bases, an almost integral number 
of turns of B-form oc-helix lends some, very circumstantial, 
support to the notion that a genuine interaction might take 
place, and suggests a way in which its importance might be 
tested.
The response of the plasmid pl4C)Al31 to the 13S product 
of the adenovirus E1A gene was not unexpected, given the 
range of promoters stimulated by this protein (section 
I.5.2.4.). However, this experiment was not primarily
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designed to demonstrate the responsiveness of orf62 
expression to E1A, but rather to provide functional 
corroboration for the protein binding data which suggested 
that the promoter sequence contained an ATF/CRE motif. In 
this respect it was only partially successful as recent data 
have shown that all three elements of the promoter can 
mediate transcriptional stimulation by the 13S product 
(section I.5.2.4.). The available evidence tends to argue 
against mediation of 13S stimulation by the orf62 TATA box 
(Simon et a l . , 1988). However, discrimation between the 
ATF/CRE motif and the CCAAT box will await the availability 
of the functional and precise protein binding 
characteristics of the members of both families of proteins.
Thus the VZV orf62 promoter appears to consist of 3 
elements, a TATA box, a ATF/CRE binding and a CCAAT motif. 
In overall structure this is very similar to the general 
arrangement found upstream of numerous other genes both 
viral and cellular. For example the beta-globin promoter 
comprises a TATA box (-26 to -30), a CCAAT box (-72 to -77) 
and a beta-globin specific element (-85 to -95) (Myres et 
al ., 1986) and the adenovirus E3 promoter consists of a TATA 
box (-25 to -30), an ATF site (-54 to -61), an AP-1 site 
(-87 to -93) and a CCAAT box (-172 to -176) (Hurst and 
Jones, 1986). Thus the orf62 promoter, like those described 
above, falls into the pattern detailed in section 1.5.1., 
having a TATA box and one or more UASs within approximately 
200 bp of the mRNA start site. It is noteworthy that both 
ATF/CRE and CCAAT motifs are common to many promoters and 
thus the proteins are, presumably, distributed amongst many 
tissues, so no particular tissue tropism for orf62 
expression is suggested by the promoter sequences.
5.1.3. Vmw65 Responsive Region
The feature that distinguishes the regulatory sequences 
of ck-herpes viruses from those of other viruses and from 
most other cellular promoters is the responsiveness of their 
IE genes to the HSV-1 transactivating protein Vmw65. Data 
both from functional analyses and protein binding assays 
presented here demonstrate that this is also true for the
expression of VZV orf62. The data explain the findings of
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Felsner et al., (1988) who characterised a cell line stably 
transformed with orf62. These workers showed that orf62 
transcripts and protein product could only be detected in 
the presence of superinfecting HSV-1. The transcriptional 
stimulation was unaffected by the presence of cycloheximide 
during infection suggesting the involvement of a virion 
component. Felsner et al. failed to locate the 5' end of 
the mRNA and therefore assumed that, like HSV-1, the TATA 
box was situated around -350 relative to the first AUG of 
orf62. Thus their allocations of important cis-actinq
elements involved in the regulation of gene expression were 
not accurate.
The Vmw65 responsive region, -131 to -410, contains two 
motifs relevant to Vmw65 responsiveness, an 
octamer/TAATGARAT motif, centered at -2 56, and an octamer 
motif centered at -343. Only the octamer/TAATGARAT motif 
was able to induce efficient formation of a tertiary complex 
and, in common with the HSV-1 model, it was presumed to 
mediate Vmw65 responsiveness. The function, if any, of the 
octamer motif is not clear.
The demonstration that one of the cellular proteins 
involved in Vmw65 responsiveness is Oct-1 (Gerster and 
Roeder, 1988), led to the reassessment of the TAATGARAT 
motifs present in the upstream regions of the IE genes of 
HSV-1 and HSV-2 (apRhys et al., 1989). Several groups 
showed that TAATGARAT elements could be subdivided into two 
groups by the presence or absence of the residues ATGC 
immediately upstream (O'Hare and Goding, 1988; Gerster and 
Roeder, 1988; apRhys et al., 1989). The presence of these 
residues forms a 7 out of 8 match for the octamer motif 
while leaving the TAATGARAT element unaffected 
(ATGCTAATGARAT). In addition apRhys et al., (1989) 
suggested that all elements were present in the positive 
orientation with respect to the mRNA start site, by 
allocating those in the intergenic region between IE genes 3 
and 4/5 to one or the other gene. The significance of the 
combination of the octamer and TAATGARAT motifs is not 
clear, as single octamer sequences alone do not appear to 
mediate Vmw65 responsiveness. However, evidence exists that 
the combined motif binds Oct-1 with higher affinity than 
TAATGARAT alone in the absence of Vmw65 (Baumruker et al.,
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1988). Thus, the octamer motif might act to localise the 
cellular protein to the viral IE genes making the 
interaction with Vmw65 and the other cellular protein(s) at 
the TAATGARAT motif more efficient. Interestingly the only 
IE genes whose regulatory sequences contain simple TAATGARAT 
motifs and no combined elements are the IE-3 genes of HSV-1 
and HSV-2. These regulatory sequences include an enhancer, 
and their transcription is least affected by the absence of 
Vmw65 (Ace et a l ., 1989). This suggests that they are less 
dependent on stimulation by the virion protein, and thus 
mechanisms that improve the efficiency of Vmw65 mediated 
transactivation might be of less importance.
The Vmw65 responsive motif of orf62 falls precisely 
into the pattern of the HSV IE genes, in that, lacking an 
enhancer, it contains an octamer/TAATGARAT motif and the 
whole motif is oriented in the positive sense with respect 
to the mRNA start site.
5.1.4. Sequences Further Upstream
The fourth region of potential interest in the 
regulation of orf62 transcription lies upstream of -410. 
Only sequences from -410 to -783 were analysed by gel 
retardation while functional analysis was performed on 
sequences from -410 to -1143. Protein binding assays 
consistently revealed a retarded band of low intensity with 
sequences between -668 and -783. Functional assays showed a 
small overall increase in both baseline and Vmw65 stimulated 
activity when plasmids containing this region were compared 
with those containing deleted sequences.
The region between -410 and -1143 contains two 
noteworthy sequence elements. One is the origin of DNA 
replication, and the other a set of 27bp direct repeats 
known as reiteration R4 (Davison and Scott, 1986). The 
reiterations contain 12 potential binding sites for the 
cellular transcription factor Spl, which is not detected 
with the gel retardation protocol used (C. M. Preston, pers. 
comm.). These could be responsible for the increase in 
baseline expression seen in plasmids that incorporate this 
sequence, though in the SV40 system increased distance 
between the TATA box and a series of six Spl sites from 20
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to 50 bp reduced expression by 50-fold (Takahashi et a l ., 
1986). This result brings the importance of an array of Spl 
sites 455 bp upstream of the TATA box into question. 
Origins of DNA replication are known to be essential for the 
full expression of HSV L genes (Johnson et al., 1986) but 
have never been implicated in the control of IE genes. 
However, given the considerable potential for secondary 
structure resulting from their sequence, it is conceivable 
that they could affect transcription iri vivo, under certain 
ci rcumstances.
5.2. Analysis of orf10
The observation that the regulatory sequences of VZV 
orf62 are stimulated by the HSV-1 protein Vmw65 led to 
obvious interest in VZV orf10, whose predicted amino acid 
sequence shows 35% conservation with that of Vmw65 
(Dalrymple et a l ., 1985; figure ^.18). Functional and
protein binding analysis of this orf, presented in this 
thesis, revealed that it could neither stimulate 
transcription from a variety of promoters containing 
TAATGARAT elements, nor could it form complexes in gel 
retardation assays with cellular proteins and DNA fragments 
containing TAATGARAT elements. Thus the function of the 
product of orflO in the VZV lifecycle appears to be confined 
to a structural role, equivalent to that of Vmw65, in the 
virion tegument. The sequences conserved between orflO and 
UL48 may therefore provide an indication of residues 
important in virion structure and, by exclusion, 
protein-protein interactions important in transactivation.
One caveat must be noted with regard to these and other 
experiments in which negative results are derived from the 
analysis, in isolation, of the functions or products of DNA 
sequences. The possibility cannot be excluded that 
mutations accruing during the process of cloning or during 
subsequent manipulations might be responsible for the 
absence of activity. This pertains to the data on orflO 
function, particularly those relating to protein-protein 
interactions. The possibility that mutation(s) in orflO 
affected the results of binding assays was addressed by the
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use of two independent clones of pORFlO in these 
experiments, but not by sequencing of the clones used. The 
expression of the VZV TK gene i_n vitro (Appendix 1) provides 
a salutary lesson in this regard. The absence of a 
recognised activating region from the sequence of orflO 
supports the evidence from functional assays, making it 
unlikely that the inactivity as a transactivator results 
from mutations incorporated during manipulations. However, 
it remains possible that its ability to form a DNA binding 
complex with Oct-1 was affected by mutations accruing during 
its analysis.
The presence of orflO in the VZV genome with its 
apparent homology to the structural but not the 
transactivating roles of Vmw65 raises the question of the 
mechanism(s) by which these proteins diverged and the 
selective pressures that resulted in this divergence. Two 
possible routes of evolution are, acquisition of the ability 
to transactivate by an orf 10-like precursor or loss of this 
ability by a Vmw65-like progenitor. The salient point in 
any progression between the two proteins is that two 
distinct requirements must be fulfilled in order for Vmw65 
to transactivate, these are, complex formation with cellular 
proteins, and stimulation of transcription. As far as is 
known neither of these two aspects of Vmw65's activity has a 
role that is independent from the other. This does not 
present a problem in the transition from a transactivator to 
a non-transactivator, as loss of one function releases 
selective pressure on the other, resulting in its eventual 
loss. A model for evolution in the other direction, ie. to 
a transactivator, could be explained by one of three 
mechanisms. First, both functions could be acquired 
simultaneously. Second, either complex formation with 
cellular proteins or the interaction with transcriptional 
complexes could have or have had a role distinct from the 
other. Third, one of these functions could have been 
acquired or retained in the absence of selective pressures. 
The first and last of these options will be excluded from 
further discussion as no logical mechanism for them can be 
proposed. Thus either orflO developed from a Vmw65-like 
protein whose transactivating function was lost, or a role 
for complex formation with cellular factors or for the
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acidic activating region exists in isolation. The only 
absolute resolution to this problem would come from the 
discovery of an £<-herpesvirus encoding a Vmw65 homologue 
with either the acidic activating region or the ability to 
form complexes with cellular proteins. In the absence of 
such a virus further analysis represents pure speculation. 
Intuitively one would argue against evolution away from a 
sophisticated and apparently advantageous (Ace et al., 1989) 
mechanism for the stimulation of IE gene expression, though 
the differences between HSV and VZV biology make this 
possible. A role for complex formation in the absence of 
transactivation could be related to the role of TAATGARAT 
sequences in the absence of Vmw65 as they may function in 
VZV and PRV. As will be argued below (section 5.3.2.) this 
may relate to the mechanism, by which <X-herpesvirus IE genes 
are defined. A role for the acidic domain in the absence of 
complex formation is suggested by the findings of Sadowski 
et al., (1988) who showed that the presence of a strong
activating region, in the absence of its binding motif can 
act, non-specifically, to reduce transcription. The
transactivati ng domain of Vmw65 might originally have acted 
as an immediate inhibitor of cellular transcription. An 
attempt could be made to distinguish between these two 
possibilities by constructing a virus analagous to in!814 
but abolishing the transactivating function on Vmw65 by 
deleting its activating region rather than by inhibiting 
complex formation.
5.3. Functional Significance of orf62 Regulatory
Sequences
Considerable differences exist between the regulatory 
regions of the major IE genes of VZV, PRV and HSV. PRV is 
the least well defined and perhaps the most complex of these 
elements. It consists of a promoter, which contains a TATA 
box, a Spl site and an inverted CCAAT box, and an
enhancer-like sequence. The enhancer contains six repeated
15bp elements similar to those present in the IE gene
enhancers of HCMV and MCMV which are B-herpes viruses. In 
addition, inspection of the sequence in the light of the
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importance of the octamer motif in Vmw65 responsiveness 
reveals octamer sequences centred at -250, -150 and -384. 
The latter two of these can be extended to give the 
sequences ATGCAAAGCAGAC and ATGCAAATCAGAG respectively which 
might be predicted to function as Vmw65 responsive elements. 
HSV IE gene 3 has a well defined arrangement of a TATA box 
and Spl sites forming the promoter, an enhancer sequence 
between -174 and -332 and TAATGARAT elements centred at -174 
and -332 (Bzik and Preston, 1986). In contrast to the 
complex nature of these sequences orf62 has the simple 
arrangement described above (figure 4.5.).
Thus the expression of the IE genes of HSV-1, HSV-2, 
VZV and PRV are all stimulated by the HSV-1 virion factor, 
Vmw65, but neither VZV nor PRV apparently encode an active 
homologue. This raises the question of why the cis-acting 
elements that mediate the response are retained in the 
regulatory sequences of the VZV and PRV IE genes. The 
conservation of responsiveness to Vmw65 in PRV and VZV could 
be fortuitous and provide no selective advantage to either 
virus. This possibility cannot be excluded by the results 
presented here or elsewhere, however, it remains an 
explanation of last resort. Two overall mechanisms exist 
that would explain the conservation of this function in 
terms of its advantage to the virus. First, it could relate 
to the well defined mechanism of TAATGARAT controlled, Vmw65 
mediated transcriptional stimulation. Second, it might 
imply the existence of a mechanism, separate from Vmw6 5 
mediated transactivation, resulting from the interaction of 
Oct-1 or other octamer binding proteins with TAATGARAT.
5.3.1. A Cellular Homologue of Vmw65?
The first of these alternatives is basically an
argument for another factor acting as a functional homologue 
of Vmw65, be it a cellular protein or another constituent of 
the VZV or PRV virions. The finding that PRV fails to
stimulate the expression of HSV IE genes in the presence of
cycloheximide (Campbell et ad., 1987) and the absence of 
another sequence showing similarity to Vmw65 from the VZV 
genome (Davison and Scott, 1986), argues against the
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presence of an alternative virion component acting in the 
same way as Vmw65. There is evidence to support the concept 
of a cellular factor that acts as a functional homologue of 
Vmw65. Efficient Vmw65 mediated transactivation depends on 
the formation of a multiprotein complex incorporating Vmw65, 
Oct-1 and one or more other cellular factors, all binding 
specifically to TAATGARAT (Section 1.4.2.). The salient 
feature of the formation of this complex is that, in the 
absence of Vmw65, Oct-1 alone binds to TAATGARAT (Gerster et 
a l . , 1988; Stern ^t a_l., 1989) . Only with the addition of
Vmw65 does recruitment of other cellular factor(s) take 
place. The presence of a cellular mechanism that 
facilitates the interaction of Vmw65 with Oct-1 suggests 
that this mechanism developed to allow the efficient 
interaction of Oct-1 with a cellular factor which functions 
as a Vmw65 homologue. This protein, if it exists, must be 
expressed in either a tissue or cell cycle specific fashion 
or have different binding constraints from Vmw65, as 
deletion of TAATGARAT elements from the HSV IE-3 or IE-4/5 
promoters cause no reduction in transcription in the absence 
of Vmw65 (Preston, et a l ., 1984; Bzik and Preston, 1986). 
Stimulation of transcription by the octamer motif in the 
absence of Vmw65 appears to occur in the cell cycle 
dependent regulation of the H2b gene. In this system an 
octamer sequence, which can be extended to an 
octamer/TAATGARAT consensus (LaBella et al ., 1988), is 
responsible for cell cycle co-ordination of the expression 
of the H2b gene. This could signify the existence of a cell 
cycle specific Vmw65 homologue, though a separate, cell 
cycle specific, transactivating, octamer binding protein 
could also explain the findings. An alternative explanation 
for the existence of this "interaction factor" is that it 
acts, more generally, to facilitate protein-protein 
interactions with DNA binding proteins other than Oct-1. In 
this regard it is relevant that the homeodomain of Oct-1 is 
necessary and sufficient to mediate the interaction with 
Vmw65 (Stern et al., 1989). The cellular factor(s) 
recruited by Vmw65 could normally function in interactions 
between homeodomain containing proteins other than Oct-1 and 
transcriptionally active factors equivalent to Vmw65. Thus, 
the activity of the VZV and PRV Vmw65 responsiveness
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elements in recruiting a Vmw65 homologue iji vivo and thus 
stimulating IE gene expression, remains unproven.
5.3.2. An Additional Role for TAATGARAT?
A second possible explanation for the Vmw65 
responsiveness of the VZV and PRV IE genes is that the 
conservation of the Vmw6 5 response element, TAATGARAT, 
results from its role in a mechanism separate from Vmw65 
mediated transcriptional activation. One obvious function 
for this motif would be in providing the minimal signal 
necessary to distinguish «_-herpesvirus IE genes from the 
other temporal classes. This mechanism has not been defined 
in any of the pt-herpesviruses, though two simple models can 
be proposed to explain it. First, promoter strength alone 
could result in the expression of IE genes swamping that of 
other viral genes and preventing their detection prior to 
the active down regulation of IE expression and the 
stimulation of E gene expression by the IE gene products. 
This view gains some credence from the finding that some of 
the most potent regulatory sequences known are found 
upstream of viral IE genes. However, the relative weakness 
of the orf62 regulatory sequences in the absence of Vmw65, 
argues against this possibility. The second model involves 
a specific signal which denotes IE genes. This signal could 
act either to allow viral or cellular factors to stimulate 
the expression of IE genes or, conversely, to prevent their 
suppression. Evidence that TAATGARAT represented this 
minimal essential signal came from data which showed that 
this motif alone converted an IE promoter-CAT, plasmid 
construct, to IE type regulation in short term transfection 
assays (Gaffney et a l ., 1985). However, a role for Vmw65 
transactivation in this effect is ruled out by its absence 
from PRV and VZV (Campbell et al., 1987; this thesis), and 
by the regulation of IE genes in the HSV mutant inl814 (Ace 
et al., 1989). Thus, by elimination, a cellular mechanism 
that either actively stimulates expression, or specifically 
relieves suppression, of IE regulatory sequences seems the 
most likely mechanism for defining o(-herpes virus IE genes. 
Given the conservation of the TAATGARAT motif in 
CXf-herpes virus IE gene regulatory sequences, the interaction
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of Oct-1 with this element represents a good candidate for a
mechanism to define IE genes. However, any mechanism
proposed that suggests a role for Oct-1 in activating IE
genes has to explain the general inability of this factor to
stimulate transcription from TATA box dependent promoters in
the absence of Vmw65 (section 1.4.3.). Some evidence that
such a mechanism exists comes from an observation that
binding of Oct-1 to TAATGARAT induces an alteration in DNA
conformation when compared with binding of purified
preparations of the same protein to octamer sequences. This
alteration was detected as a different moblil/ty of complexes
binding to the two motifs in gel retardation assays (apRhys
et al., 1989), and might suggest that a conformational
f4
change m  DNA structure results/IE regulatory sequences 
being made available to transcriptional complexes. Evidence 
against this concept comes from a series of HSV-2 mutants in 
which all of the TAATGARAT elements were deleted from the 
upstream region of IE-3 (Smith et ad.., 1989). Growth of 
these viruses under cycloheximide block resulted in reduced 
but detectable IE-3 mRNA synthesis. However, the authors 
also constructed a virus which lacked all of the 
conventionally recognised regulatory sequences of IE-3, 
including the TATA box. This mutant also produced 
detectable IE-3 mRNA under cycloheximide block, thus the 
significance of the results is not clear.
5.4. A Connection Between IE Gene Regulation and Virus
Biology?
VZV remains something of an enigma. It is a very 
successful and well adapted human parasite with no obvious 
difficulty in propagation or infectivity in its natural 
host, yet in tissue culture the only efficient technique to 
initiate infections is by the use of infected cells. The 
VZV system also lacks a convenient animal model that mirrors 
viral pathogenesis in humans. Does the regulation of the IE 
genes have any bearing on this? Evidence that it might 
comes from the phenotypes of mutant viruses in which the 
expression of functional IE gene products is curtailed 
either by mutations in their coding sequences (Harrison et 
al., 1977; Jones and Shenk, 1979; Shenk et a l ., 1979; Stow
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and Stow, 1986; Everett, 1989) or by down regulation of 
their expression (Ace et al., 1989). In such viruses the 
absence or reduced expression of IE proteins results in 
defective growth both in vitro and in vivo. The growth 
defect can be overcome by high multiplicities of infection. 
It is obviously impossible to extrapolate directly between 
HSV and adenovirus mutants and wild type VZV but if the use 
of infected cells is viewed as generating localised high 
multiplicities of infection then some resemblance is 
present. Attempts were made to rescue this proposed defect 
in VZV IE gene regulationj^oinf ection of UV irradiated tsK. 
Controls for this experiment showed that the _in vitro 
phenotype of _inl814 could be rescued using this technique 
(Ace et al, 1989) but the failure to produce cell free VZV 
precluded a definitive answer.
5.5. Future Prospects
The overall aims in future work on VZV are to increase 
the understanding of this important but ill understood 
pathogen. This will inevitably continue to be hindered by 
the lack of high titre stocks of cell free virus and of a 
good animal model system. Thus, the best hope for 
significant advances appears to be the analysis of 
individual orfs in isolation. This process will be
facilitated by the presence of homologues of many VZV genes 
in the HSV genome. The drawback of this high degree of 
input from the HSV system is that it results in a tendency 
to view VZV as an inferior version of HSV-1.
The analysis of the IE genes of VZV is held back by the 
lack of basic information. The only data available to date 
regarding the identities of these genes are sequence 
homology with HSV genes and the molecular weights of bands 
determined by SDS-PAGE, from cells infected with VZV under 
cycloheximide block. One method by which these genes might 
be identified would be to map the mRNA initiation sites of 
candidates and analyse their regulatory sequences .in vitro, 
though absolute confirmation of the identities of the VZV IE 
genes will await antisera directed against individual 
polypeptides.
With respect to this project, work could be continued
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to analyse the interaction between the promoter motifs, 
perhaps by introducing five and ten base insertions and 
deletions between them. In addition the site of the E1A 
responsiveness could be located within the promoter by 
further deletion analysis and the replacement of the VZV 
TATA box with that of SV40 which is known to be unresponsive 
to ElA. Finally the availability of cell free VZV would 
allow the effect of altered IE gene regulation on virus 
titre to be tested.
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APPENDIX 1
Expression of the VZV Pyrimidine Deoxynucleoside Kinase
Gene
As detailed previously (section 1.3.5.1.) orf36 encodes 
the VZV dPyK gene. It was decided to express the product of 
this orf using the plasmid pKK233-2 (Amman and Brosius, 
1985) which was designed to allow the expression of unfused 
eukaryotic proteins in E.coli. This system potentially 
allows easy manipulation of the primary sequence enabling 
correlations to be drawn between enzymatic activity and 
specific amino acid sequences. Prokaryotic systems are also 
convenient for the production of large quantities of 
proteins and thus have the potential to allow analysis of 
tertiary structure. pKK233-2 contains the highly expressed 
trc promoter (a trp-lac fusion promoter with the consensus 
17bp spacing between the trp35 region and the lac UV5-10 
region), the lacZ ribosome binding site and ATG initiation 
codon. The ATG start codon is located 8 bases downstream 
from the ribosome binding site within a unique Ncol site 
(Amman and Brosius, 1985). This site can be cleaved to 
generate a 5' overhang compatible with that of the 
restriction endonuclease Afllll which spans the initiation 
codon of VZV orf36.
A 1103bp EcoRI-SnaBI fragment containing orf36 was 
excised from the VZV clone Sst h (kindly provided by Dr. A. 
Davison) and inserted between the HincII and EcoRI sites of 
pUC9 (Figure A l . 1.). A partial digest of this plasmid with 
Afllll was then carried out followed by complete digestion 
with Hindlll. This produced a 1043bp fragment which was 
inserted between the Ncol and Hindlll sites of pKK233-2, to 
form plasmid pTMORF36. Several independent clones of this 
plasmid were isolated, and two were grown up into large 
scale preparations (pTMORF36.1 and pTMORF36.2).
To analyse the proteins produced by this construct, 
E.coli W3110 cells were transformed with pTMORF36.1 and 2 
and grown in the presence or absence of IPTG. Lysates of 
these cells were separated using a 12% SDS-PAGE gel and 
stained with coomassie brilliant blue (figure Al.2). Lanes 
1 and 2 show untransformed W3110 in the presence and absence
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°f IPTG. Lanes 3 to 6 show cells transformed with
pTMORF36.1 and 2 in the absence (lanes 3 and 5) or presence 
(lanes 4 and 6) of IPTG. Two novel bands were observed in 
lanes 4 and 6. These are labelled B a n d  A and their
approximate molecular weights are 15,000 and 40,000 
respectively. A slight increase in intensity of a band, 
labelled X, is also observed in lanes 4 and 6. It is not 
clear whether this represents an induced species or merely 
overloading of these tracks. If it does represent an 
induced species then its source cannot be explained. Lanes 
7 and 8 show the lysate of W3110 cells transformed with the 
plasmid pCI15 (Amman and Brosius, 1985) which contains an 
N-terminal deletion mutant of the cl repressor in the same 
background as pTMORF3 6.1 and pTMORF3 6.2. This plasmid is 
known to express a protein of molecular weight 26,000 
(labelled C). The predicted molecular weight of the VZV TK 
is 37,814 which corresponds approximately to band A. It is 
not clear what band B represents though it is possible that 
it results from proteolytic cleavage of the species present 
in band A.
Experiments were then undertaken to compare dPyK 
activity in extracts of W3110 cells transformed with 
pTMORF36.1, pTMORF36.2, pKK233-2 and the plasmid pTKl which 
contains the HSV TK gene (table Al.l). An initial 
experiment used the assay system optimised for the HSV TK • 
(table Al.l section A). This assay gave background values 
in extracts of cells transformed with pTMORF36.1, pTMORF36.2 
and pKK233-2 but an obvious increase in activity in cells 
transformed with pTKl. Further experiments, used protocols 
previously described for the detection of activity from the 
VZV dPyK (Doberson et al., 1976; Shiraki et al., 1985). 
Again, no difference in activity could be detected when 
extracts from transformed and untransformed cells or from 
cells incubated in the presence or absence of IPTG were 
compared. Thus, despite the production of considerable 
amounts of proteins, no novel activity was detectable in 
cells expressing VZV orf36.
Since this work was completed, both published and 
unpublished reports have provided an explanation for these 
apparent contradictions. Recent comparisons of dPyK 
sequences from wild type VZV strains and those of a series
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of acyclovir resistant VZV mutants revealed one mutation 
(T->C at +853, resulting in a Leu to Ser substitution at 
residue 288) that was unique to the Dumas strain of VZV. 
This mutation distinguished the dPyK gene of the Dumas 
strain both from all other VZV strains sequenced (Sawyer et 
al., 1988) and from published TK sequences of other herpes 
viruses (Mittal and Field, 1989). The mutation falls within 
a region of high conservation amongst herpes virus TK 
sequences although it is not within the defined nucleotide 
or nucleotide/nucleoside binding sites (Olsuka and Kit, 1984; 
Gentry, 1985; Darby et al. , 1986 ) and is absent from the 
sequence of the marmoset herpes virus TK (Ofsuka and Kit, 
1984). Recent unpublished evidence from P. Harrison (pers. 
comm.) have provided direct evidence that the Leu to Ser 
substitution at residue 288 is responsible for the 
inactivity of the enzyme. Site directed mutagenesis was 
carried out on pTMORF36.1 to convert the C residue to a T at 
position +853 thus returning the Ser to a Leu at residue 
288. This manipulation resulted in a plasmid which 
unequivocally expressed TK activity under the conditions 
optimised for both HSV-1 and VZV enzymes (described above). 
Interestingly, as noted above, residue 288 does not fall 
within regions previously recognised as being essential for 
enzyme function suggesting that this residue may serve an 
role in the structural integrity of the protein, its ability 
to dimerise or its enzymatically active site or sites.
Figure Al.l. STRUCTURE AND CONSTRUCTION OF pTMORF36.
pTMORF36 is derived from the vector pKK233-2 (Amman 
and Brosius, 1985), andthe VZV clone Sst h. The shaded 
rectangle represents orf36, Ptrc '*'S a trP"^ac fusion 
promoter and 5S represents the 5S rRNA gene and 
transcriptional and transcriptional terminators. Relevent 
restriction endonuclease sites are marked. The EcoRI-SnaBI 
fragment is 1103bp and the Af 1111-H/wfHT fragment is 1035bp.
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Figure A l .2. EXPRESSION FROM PLASMID PTMORF36
Plasmids were expressed in E.coli W3110 cells. 
Lanes 1 and 2 show polypeptide synthesis from untransformed 
cells. Lanes 3-8 show expression from cells transformed 
with pTMORF36.1 (3 and 4), pTMORF3 6.2 (5 and 6) and pCI 
(7and 8). Cultures were incubated for four hours of 37°C 
and IPTG was added in lanes 2, 4, 6 and 8 after two hours. 
Cells were lysed and separated by SDS-PAGE prior to staining 
with Coomassie Blue. The novel bands are labelled A, B, C 
and X, and are referred to in the text.
LANE
Table A.1.1.
TK assays, on lysates of W3110 cells, transformed with 
the plasmids indicated and grown in the presence (+) or 
absence (-) of IPTG were carried out, as described. In 
section A, results are expressed in counts per minute while
_3
in section B they are expressed in counts per minute x 10 
The assays in section B were performed in the presence and 
absence of dTTP.
Table - Al. 1. TK ASSAYS OF EXTRACTS OF CELLS
TRANSFORMED WITH pTMORF36.
A). HSV TK ASSAY CONDITIONS. 
pTMORF36.1 pTMORF36.2 pKK233-
IPTG
l.mM
+ 3900 3800 3700
3100 3900
B). VZV TK ASSAY CONDITIONS
-3
counts x 10
Plasmids pCI pTMORF36.1 pTMORF36.
IPTG ImM + + +
pH7.5 25 22 8 42 21)
pH8.0 107 90 19 130 96)
pTKl
39500
55900
+TTP
pH7.5 119 177 122 204 174) _TTp
pH8.0 162 33 129 147 138)
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APPENDIX 2
Purification of Recombinant Viruses Using 
B-galactosidase Expression as a Marker.
The aim of the experiments presented here was to 
express the putative protein kinase encoded by VZV orf66 in 
quantities sufficient for structural and functional 
analysis. To achieve this, it was decided to use the HSV-1 
mutant tsK, which at non-permissive temperature, 
over-expresses its immediate early polypeptides (Preston, 
1979; Section I.3.2.I.). The aim was to insert orf66 with 
HSV-1 IE control sequences into the TK gene of tsK and 
select recombinant progeny using the nucleoside analogues 
bromodeoxycitidine (BCdR) or acyclovir. The plasmid 
A494*23, constructed by C. Preston (figure A2.1), is based 
on pAT153 and has the HSV BamHI p fragment, which encodes 
the HSV TK gene, inserted into a unique BamHI site. A 360bp 
fragment encoding the control sequences of the HSV-1 IE3 
gene, with a unique Xhol site downstream, was inserted into 
an SstI site within the coding sequence of the TK gene.
The orf66 coding sequences were excised from the 
genomic clone Kpn j in two parts (figure A 2 .2). A 2140bp 
BamHI subfragment was inserted into pUC9 to form pTM3, and a 
940bp SspI subfragment inserted into pUC9 to form pTM2. A 
465bp AccI/SnaBI fragment was transferred from pTM3 to pTM2 
between a blunt ended PstI site and a SnaBI site. Xhol 
linkers were inserted to flank orf66 forming pTM4. The Xhol 
fragment was inserted into the Xhol site of A494*23 to form 
pTM7.
This plasmid was co-transfected with tsK DNA and both 
BCdR and acyclovir used in attempts to select TK 
recombinants. Ten TK- isolates were prepared but the 
presence o^orf66 could not be detected when these were 
analysed by Southern hybridisation, suggesting that the 
viruses selected resulted from spontaneous muta tions in the 
TK gene rather than insertion of orf66. In order to 
circumvent this problem it was decided to produce a virus
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encoding the B-galactosidase gene under the control of IE 
regulatory sequences and select recombinants by the presence 
or absence of B-galactosidase activity in the plaquing 
overlay. The presence of the enzyme can easily be detected 
by its action on the chromogenic substance, X-gal. The 
B-galactosidase gene and SV40 polyadenylation signals were 
excised from the plasmid pFJ3 as a 3737bp Hindlll fragment. 
The fragment was inserted into the Xhol site of A494*23 
(figure A 2 .2.) to form pTM8. pTM8 was co-transfected into 
BHK cells along with tsK DNA and recombinant viruses 
selected by their ability to metabolise X-gal. One 
recombinant, VT1, isolated in this way, was subjected to 
three rounds of plaque purification and grown in bulk to 
allow the preparation of viral DNA.
VTl DNA was then co-transfected with pTM7 or A494*23, a
negative control and recombinant viruses selected by their
inability to metabolise X-gal. Ten virus stocks were
obtained from transfections with pTM8 and four from
transfections with A494*23. These were each subjected to
four rounds of plaque purification. Proteins produced by
these viruses and VTl were analysed using SDS-PAGE following
35pulse labelling with [ S ]-methionine at non-permissive 
temperature. The protein profiles of viruses VTM7.1-10 were 
identical as were those of VTM23.1-4, thus, for ease of 
presentation a representative sample is shown (figure 
A2 .3 .) . The proteins produced by VTl under IE conditions 
are shown in lane 5 . The prominant band, marked B-gal, 
with a relative mobility of approximately 116,500, was 
assumed to be the product of the B-galactosidase gene. The 
proteins produced by VTM7.1 and VTM7.2 (lanes 3 and 4) lack 
this band and fail to show any novel band corresponding to 
the product of orf66 whose predicted molecular weight is 
43,5 77. Lane 2 shows the prot£/ns produced by VTM23.1.
This lane again lacks the 116,500 product but this is 
replaced by a band running with an approximate relative 
molecular weight of 25,000. This may represent the 
carboxy-terminal portion of the HSV TK expressed under the 
control of the IE 3 promoter as the first ATG codon 
downstream of the IE-3 regulatory sequences occurs in the TK 
reading frame and has a good (6 out of 8) match to the Kozak 
consensus (Kozak, 1984).
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The genotypes of the viruses were analysed by Southern 
hybridisation, using the plasmid pTK as a probe (figure 
A 2 . ,/j.) . Virus stocks VTM7.1-10 (lanes 1-5 and 13-17) have a 
restriction pattern consistent with the insertion of the 
coding sequences of pTM7 into the TK gene (compare with lane 
23). In addition, VTMl and VTM23.1 also produced the 
expected patterns. This confirms that orf66 was inserted, 
apparently correctly, into the TK gene of jtsK. In spite of 
this no protein was produced.
There are numerous possible stages at which a mutation 
could have arisen preventing the expression of orf66. The 
plasmid A494*23 has been used successfully for the 
expression of HSV orfs (J. Calder pers. comm.) and thus a 
fundamental defect in it is unlikely. It also seems 
unlikely that the problem has occurred at the stage of virus 
construction as all ten virus stocks appear to be identical 
both in terms of proteins produced and the fragment 
inserted. Thus the most likely reason for the failure of 
protein expression is the incorporation of mutations during 
the production of pTM7. This possibility was not 
investigated further.
Figure A2 .1 CONSTRUCTION OF PLASMID A494*23
This plasmid was constructed from the vector 
pATl53. The BamHI p fragment, derived from the genomic 
clone is represented by a heavy line and the coding 
sequences of the HSV-1 TK gene by an open box. The 360bp 
fragment containing the HSV-1 IE gene 3 control sequences is 
represented by black shading. Relevant restriction 
endonuclease sites are marked.
+ TKBamHI p
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Figure A 2 .2. CONSTRUCTION OF PLASMIDS pTM8 AND pTMORF66
Both plasmids were derived from the plasmid A494*23 
(figure A2.1.). The HSV-1 BamHI p fragment is represented 
by a heavy line, the coding sequences of the HSV TK gene by 
an open rectangle and the HSV-1 IE sequences by black 
shading. Both the E.coli B-galactosidase gene and VZV orf66 
(shaded rectangles) were inserted into the Xhol site of 
A494*23 forming pTM8 and pTMORF66 respectively. Relevant 
restriction endonuclease sites are marked. The fragment 
marked B-gal is 3737bp in length and is derived from pFJ3. 
The fragment marked orf66 was derived from VZVKpn j. The 
complete orf was constructed from two overlapping fragments, 
pTM2 which contains a 940bp SspI fragment, and pTM3, 2140 
BamHI fragment, both of which were inserted into the pUC9 
vector. The sub-fragments were joined using a SnaBI site 
within the overlap. Constructs were checked using 
restriction enzyme analysis.
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Figure A 2 .3. ANALYSIS OF PROTEINS PRODUCED BY
RECOMBINANT VIRUSES
Cells were mock infected (lane 1) or infected with
VTM23.1, VTM7.1, VTM7,2 or VTMl (lanes 2,3,4, and 5,
respectively) in the presence of cycloheximide. Proteins
35were labelled with [ S] methionine after removal of the 
cycloheximide by washing at 4h post infection. Proteins 
produced were separated by SDS-PAGE on a 12% gel and 
detected by autoradiography.
M.I. VTM VTM7 VTM7 VT1 
23.1 7.1 7.2 
LANE 1 2  3 4 5
Vmw175
Vm w136
B -g a l (M 116,500) 
Vmw110 r
Vmw68
Vmw63
Figure A 2 .4. ANALYSIS OF THE GENOMES OF RECOMBINANT
VIRUSES
DNA was prepared from plaque purified isolates of 
recombinant viruses. The DNA was cleaved with BamHI and 
loaded anto a 1% agarose gel in the following pattern.
Lanes 1-5 and 13-17, VTM7.1-10 respectively.
Lanes 6, 7, 18 and 19, VTM23.1-4 respectively
Lanes 8 and 20, VTMl
Lanes 9 and 21, mock infected
Lanes 10 and 22, tsK
Lanes 11, 12, 23, 24, and 25 were marker tracks
containing plasmid DNA. Lane 23 is BamHI-cleaved pTM7,
generating 1.8kbp and 2.4kbp bands, marked (0 ) that identify 
the presence of orf66.
DNA fragments were separated, transferred to
32nitrocellulose and hybridised with a P labelled probe 
derived from plasmid pTK which contains the sequence of the 
HSV-1 TK gene. The sizes of the fragments are as marked.
Lane 1 2 3 4 5 6 7 8 9 10 11 12 MR kb
Lane
• %.«* • * • « •
•l, • * • • •
3.6
2.4
1.8
13 14 15 16 17 18 19 20 21 22 23 24 25 MD kb
• ! * * » ft
3.6
2.4
1.8
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Appendix .3
Oligonucleotides Used in the Project
Primer Extension Oligonucleotide, single stranded, 
sequence taken from Davison and Scott, (1986), bases 109100 
to 109127.
5'-GGGGTGTAGAGCGCTGCATCGGCGGCGT-3'
SI Nuclease Mapping Oligonucleotide, single stranded, 
sequence taken from Davison and Scott, (1986), bases 109159 
to 109238.
5'-GAGTTTTCCAAACGCTCTCGCAGCCTTCAAAGGATTGCGATTGCGGTGAGGGAGTT
CCAACAGTACTTAAAACG-31
5' Untranslated Region of VZV orf62 as incorporated 
into pTMl5cat, double stranded, sequence taken from Davison 
and Scott, (1986), bases 109159 to 109238.
5'-CACGTTTTAAGTACTGTTGAAACTCCCTCACCAACCGCAATCGCAATCCTTG-3'
Oligonucleotide 4 used in gel retardation assays, 
double stranded, sequence taken from Davison and Scott,
(1986), bases 109344 to 109310.
5'-AGCTTCTTCCCGCCTCGAGTCTCGTCCAATCACTACCATCG-31
Oligonucleotide 5 used in gel retardation assays, 
double stranded, sequence taken from Davison and Scott,
(1986), bases 109,309 to 109264.
5'-TCTTATCATTAAGAATATTTACACGGTGACGACACGGGGAGGAAAG-3'
Oligonucleotide BS2wt, from Hurst and Jones, (1987), 
encodes the ATF motif from the adenovirus 5 E3 promoter. A 
kind gift of Dr. N. Jones.
5'-GGCGGCTTTCGTCACAGGGTGCGG-3 1
Oligonucleotide BS2/4, fron Hurst and Jones, (1987), 
encodes a non-functional ATF concensus the mutation that 
differentiates it from BS2wt is underlined. A kind gift of
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Dr. N. Jones.
5 1-GGCGGCTTTCTTCACAGGGTGCGG-3'
Oligonucleotide BS3wt, from Hurst and Jones, (1987), 
encodes the API motif from the adenovirus type 5 E3 
promoter, Hurst and Jones, (1987). A kind gift of Dr. N. 
Jones.
5 1-GAAGTTCAGATGACTTAACTCAG-3'
Octamer Oligonucleotide. The octamer motif 
(underlined) was derived from sequences upstream of the 
rearranged VUDJU region of the murine gene (Grosscheld andn n
Baltimore, 1985). A gift of Dr. C. M. Preston.
5'-AGCTTGCCTCATGAGTATGCAAATCATGTGCGACTG-31
TAATGARAT Oligonucleotide. The TAATGARAT motif 
(underlined) was taken from the control sequences of the 
HSV-1 IE3 gene and inserted into an identical background as 
the octamer motif (above). A gift of Dr. C. M. Preston.
5 1-AGCTTGCCTCATGAGTGCGGTAATGAGATGCGACTG-31
HSV TK CCAAT Box Oligonucleotide, Preston et a l ., 
(1988). Double stranded oligonucleotide representing 
sequences -66 to -100 in the HSV-1 TK gene. A kind gift of 
Dr. C.M. Preston.
5'-AGCTTGCGTCTTGTCATTGGCGAATTCGAACACG-31
Adenovirus 5 Major Late Promoter oligonucleotide 
Preston et al., (1988). Double stranded oligonucleotide
representing sequences -44 to -88 in the adenovirus 2 major 
late promoter. A kind gift of Dr. C.M. Preston
5'-AGCTTGGTTTATAGGTGTAGGCCACGTGACCGGGTG-3'
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A herpes simplex virus mutant, i'«1814, possessing a 12-base-pair insertion in the gene encoding the 
transinducing factor Vm w65 has been constructed. The insertion abolished the ability of Vimv65 to transinduce 
immediate-early (IE ) gene expression and to form  a protein-DNA complex with cell proteins and the IE-specific 
regulatory element T A A T G A G A T . Accumulation of IE  R N A  1 and 2 was reduced four- to fivefold in 
///1814-infected cells, but the level o f IE  R N A  4 was reduced only by twofold, and IE  RNA 3 was unaffected.
M utant //il814  had a high particIe/PFU ratio, but many of the particles, although unable to form plaques, were 
capable of normal participation in the early stages of infection at high m ultiplicity of infection. The defect of 
i»1814 was overcome partially by transfection of a plasmid encoding the IE  protein V m w l 10 into cells prior to 
titration and by prior infection with ultraviolet light-inactivated herpes simplex virus. Mutant in 1814 was 
essentially avirulent when injected into mice. The results demonstrate that transinduction of IE  transcription  
by Vmw65 is important at low multiplicity o f infection and in vivo but that at high multiplicity of infection the 
function is redundant.
Herpes simplex virus type 1 (HSV-1) encodes 70 predicted 
genes which are expressed as three tem porally regulated 
classes (35. 70). The five immediate-early ( IE  o r a) genes 
are the first to be transcribed after in fection , and the ir 
expression does not require de novo prote in "synthe­
sis. whereas early ((3) and late (y) gene expression is depen­
dent on the prio r synthesis o f  IE  polypeptides (8, 23). 
The products o f IE  gene 1 (polypeptide V m w llO  o r ICP0) 
and IE  gene 3 (V m w l75 or ICP4) are potent transactivators 
o f early- and late-gene promoters in transient expression 
assays (12. 18. 40, 53). The IE  gene 2 product (Vmw63 
or ICP27) has also been implicated in the regulation o f 
viral promoters (13. 54. 60). Analysis o f temperature-sensi­
tive mutants indicates that both V m w l75 and Vmw63 are 
essential fo r productive in fection ; V m w l75  is required 
fo r early- and lale-gcne expression (11, 47, 71), whereas 
Vmw63 appears to be required after the onset o f  early-gene 
expression and D N A  replication (56). Viable mutants 
w ith deletions in V m w llO  exhib it restricted growth in cer­
tain cell types at low m u ltip lic ity  o f in fection (M O D  but 
arc apparently normal at high M O I (57, 65). Deletion muta­
tions in IE  gene 4 (which specifies Vmw68 o r ICP22) 
also confer a host range phenotype to the v irus (45. 59). The 
IE  gene 5 product (V m w l2  or ICP47) appears to be un im ­
portant lo r virus replication in tissue culture cells since 
deletions w ith in the gene have litt le  effect on growth o f  HSV 
(4. 29. 69).
A distinguishing feature o f IE  genes is the presence o f  the 
c/.v-acling element T A A T G A R A T  (where R is a purine 
residue) in the ir 5' regulatory regions. This element responds 
to the HSV-1 virion polypeptide Vmw65 (otherwise desig­
nated VP16 or aT IF ). resulting in a stim ulation o f transcrip ­
tion from  IE promoters (2. 5, 7, 9. 17. 25. 31-33. 41, 43. 44, 
48). A lthough Vmw65 does not itse lf bind to D N A  (34), the 
evidence currently available suggests that the polypeptide 
mediates transinduction o f IE  genes by associating w ith  
cellu lar proteins, including nuclear factor I I I ,  to form  an IE
■ Corresponding author.
com plex (IE C ) w hich is able to bind specifica lly to D N A  
sequences that contain T A A T G A R A T  (1. 19. 38. 39, 49). 
M utation analysis o f  cloned D N A  fragments encoding 
Vmw65 suggests that the polypeptide contains at least two 
separable regions, both o f which arc necessary for transin­
duction o f  IE  transcrip tion. The am ino-term inal 411 amino 
acids are sufficient fo r binding to the cellu lar factor (1; T. A. 
M cKee, C. I. Ace, and C. M. Preston, manuscript in prep­
aration). and the acidic carboxy-lerm inal domain defined by 
am ino acids 411 to 490 (the “ acid ta il ."  a feature common to 
many other eucaryotic and procaryotic transaciivators (3. 
20, 30, 52, 58, 66. 67]) is required for stim ulating transcrip­
tion and may interact w ith  fundamental transcription com ­
ponents, fo r example, the T A T A  binding factor TEI1D or 
R N A  polymerase, o r both (24).
Because Vmw65 regulates the set o f genes expressed at 
the earliest stages o f  in fection, it is im portant to determine 
the role o f the polypeptide during HSV grow th. A ll in form a­
tion  to date regarding the properties o f Vmw65 has been 
obtained by transfection, using either stably transformed cell 
lines o r transient expression assays. Such systems arc 
c learly artific ia l, and the crucial biological question concerns 
the phenotype o f v irus mutants which lack the transinducing 
ac tiv ity  o f Vmw65. A d ifficu lty  inherent in attempts to 
construct such mutants is that, apart from its role in transin­
ducing IE  genes. Vmw65 is also a major structura l com po­
nent which is required fo r v irion  assembly (1). To address 
this problem , functional domains o f Vmw65 required fo r 
v irion  assembly and fo r transinduction were identified by 
insertion mutagenesis o f a cloned gene fragment (1). The 
construction and characterization o f a viable HSV-1 mutant 
that contains an insertion which affects on ly the transinduc­
ing ac tiv ity  o f Vmw65 are described here. The results 
indicate that IE  gene transinduction by Vmw65 is not 
essential fo r virus grow th at high M O I but plays a critica l 
role in determ ining whether infection is ly tic  o r nonproduc­
tive at low  M O I. Vrmv65 is also im portant fo r the virulence 
o f HSV-1 in mice.
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M A T E R IA LS  AND METHODS
Cells and viruses. B H K  cells (clone 13) were grown in 
Eagle medium w ith  10% newborn ca lf serum, 10% tryptose 
phosphate b ro th , and 100 U o f  penic illin  and 100 pg o f 
streptom ycin per m l. Human fetal lung (H F L ) cells (F low  
Laboratories) were grown in Eagle medium w ith  10% fetal 
ca lf serum and 100 U o f pen ic illin  and 100 pg o f streptom ycin 
per ml. The w ild -type (w t) HSV-1 virus used in these studies 
was G lasgow strain 17 syn + . V irus  particle concentrations 
were determ ined by com parison o f  v irus stocks w ith  bead 
preparations o f  known concentration.
Plasmids. Plasmid p M C l, w h ich  contains the coding se­
quences fo r Vm w65, has been described previously (7). The 
construction o f  p M C l. in l4 ,  w h ich contains a 12-base-pair 
(bp) f in m H l o ligonucleotide lin ke r inserted in the Vmw65 
gene, has also been described (1). Plasmid p lE 3C A T  con­
tains the HSV-1 IE  gene 3 prom oter and regulatory se­
quences linked to the chloram phenicol acetyltransferase 
coding region (64), and p i l l  expresses w t HSV-1 V m w llO  
(14).
Isolation o f (7*1814 and Southern blot analysis. A  B H K  cell 
monolayer in a 35-mm-diameter petri dish was cotransfected 
w ith 0.5 pg o f in tact HSV-1 D N A , 0.5 pg o f an EcoRI- 
cleavcd plasmid w ith  the m utation o f  p M C l. in l4  in the larger 
plasmid pGX158 (which contains B a m H l f [ l ] ) ,  and 2.0 pg o f 
ca lf thym us ca rrie r D N A  by the calcium  phosphate precip i­
tation method (51). A fte r incubation fo r 3 days at 31°C, the 
progeny viruses were harvested and titra ted on B H K  cells. 
Single plaques were picked and used to  infect B H K  cells in 
m ultiw ell plates contain ing 15-mm-diameter wells. A fte r 2 
days at 37°C, to ta l D N A  was prepared from  infected cells 
(65) and the medium was retained as a v ira l stock. D N A  
samples were screened fo r the presence o f  v ira l genomes 
containing a B a m H l  linke r insertion w ith in  the Vmw65 gene. 
D N A was cleaved w ith  B a m H l,  and v ira l D N A  analyzed by 
agarose gel electrophoresis and Southern b lo tting (61). Plas­
mid pMC17, w hich contains the Vm w65 coding sequences 
cloned in pUC9 (1), was radiolabeled w ith  32P by nick 
translation (55) and used as a probe. H yb rid iza tion , mem­
brane washing, and autoradiography conditions were as 
described previously (42). Progeny from  a sample which 
contained v ira l D N A  w ith  a lin ke r insertion was plaque 
purified and screened by hyb rid iza tion  tw ice more, and a 
working stock o f  v irus was prepared from  B H K  cells. The 
virus was named /"//1814.
M arke r rescue o f *7(1814. A  B H K  cell m onolayer was 
cotransfected w ith  0.1 pg o f  in tact (7(1814 D N A , 0.5 pg o f 
pM C l cleaved w ith  F coR I, and 2.0 pg o f  ca lf thym us D N A , 
as described above. A fte r 5 days at 31°C, progeny were 
harvested and used to in fect a B H K  cell m onolayer on a 
90-mm-diamcter petri dish at 0.0001 PFU per cell. A fte r 3 
days, the progeny were harvested and titrated on B H K  cells. 
Single plaques were picked and used to  in fect B H K  cells on 
m ultiw ell plates. V irus  stocks were prepared from  wells, and 
the ir genomes were analyzed as described above. Progeny 
from a sample that exhib ited a w t HSV-1 D N A  structure was 
plaque purified, and a w ork ing stock o f  v irus was prepared in 
B H K  cells. The virus was named 1814R.
Quantitation o f v ira l DNA in nuclei. B H K  cell monolayers 
in 90-mm-diameter petri dishes were infected in the presence 
o f 200 pg o f cyclohexim ide (C H ) per ml. A fte r incubation fo r 
3 h at 38.5°C, cell nuclei were isolated (46) and D N A  was 
extracted. V irus D N A  was quantitated by Southern b lotting 
as described above but by using 32P-labeled p T K l,  which
contains the cloned HSV-1 Ham  H I p fragment, in t he  
hybrid ization procedure.
Radiolabeling of v ira l polypeptides. For IE  polvpepiidcs. 
B H K  cell monola vers were infected in the presence o f 200 
pg o f CH per ml. A fte r 4 h at 38.5CC. CH was washed from 
the plates and proteins were radiolabeled fo r 1 It w ith 
p 5S]methionine in the presence o f 1 pg o f actinom ycin D p er  
ml and analyzed by sodium dodecyl sulfate-polyacryianude 
gel electrophoresis (SDS-PAG F) (46). For early and late 
polypeptides, B H K  cell monolayers were infected and incu­
bated at 37°C fo r 8 h. and proteins were radiolabeled fo r 1 h 
w ith  (3<1S]m ethionine and analyzed by SDS-PAGE.
Gel retardation analysis. V ir ion  extracts were prepared 
(49), and proteins were analyzed by SDS-PAGE. The gel 
was stained w ith  Coomassie brillian t blue. V irion  extract 
was added to  a m ixture contain ing HeLa cell nuclear extract 
and a 32P-labeled 74-bp D N A  fragment contain ing HSV-1 IF 
gene 4/5 regulatory sequences (49). Reaction conditions for 
complex form ation and analysis o f p ro te in -D N A  c o m p l e x e s  
were as described previously (49).
Transinduction assay. B H K  cell monolayers in 35-mm- 
diameter pe tri dishes were transfected w ith 3 pg o f pi F3CAT 
by the calcium  phosphate precip itation method (7). except 
that the d im ethyl sulfoxide boost was pet formed 1 h after the 
medium overlay. The cells were incubated tit 38.5°C for 1 h 
and then supcrinfectcd. A fte r incubation fo r a further 3 h at 
38.5°C. extracts were made from  the cells and chloram phen­
icol acetyltransferase assays were performed (21).
Q uantitation o f IE  RNA. B H K  cells were infected in the 
presence o f 200 pg o f CH per m l. A fte r incubation fo r 4 h at 
38.5°C, cytoplasm ic R N A was extracted and quantitated by 
dot blot analysis (72) by using D N A  probes radiolabeled w ith 
32P by p rim er extension (15). Gene-specific probes were 
prepared from  D N A  fragments that correspond to IF  genes 
1 (a 1,367-bp S a l l-N ra l  fragment from  pJR3 f 12j ). 2 (a 2 .760- 
bp M lu l-B a m H l  fragment from B am H l h [351). 3 (a 3,210-bp 
H i n d i  fragment from  Xho l c [36]), and 4 (a 2.200-bp 
N ru l-M lu l  fragment from  B am H l  // hybrid iz ing predom i­
nantly to IE  R N A  4 [37]).
T K  assay. B H K  cells were infected in the presence o f 200 
p g o f  phosphonoacclic acid per m i. A fte r incubation fo r 15 h 
at 38.5°C, cytoplasm ic extracts were made and thym idine 
kinase (T K ) assays were performed (9).
Complementation assay. B H K  cell monolayers in 35-mm- 
diameter petri dishes were transfected w ith 3 pg o f p i 11 or 
pUC9 by the calcium phosphate precip itation method (7) and 
treated w ith  dim ethyl sulfoxide 1 h Utter. A fte r a further 1 h 
at 37°C, v irus was titra ted on the monolayers. A lte rnative ly , 
monolayers were treated w ith the HSV-1 mutant t.vK. which 
had been U V  irradiated to reduce its tite r by 5 x 10s (48). 
The M O I o f U V -irradiated t.vK corresponded to 0.1 PFU of 
unirradiatcd virus per cell. W t HSV-1 or (711814 was titrated 
on the UV-irradiated-t.vK-pretreated ceils. A lte r 2 days at 
37°C, plates were stained and plaques were counted.
Virulence assay. Female Charles R iver mice, each weigh­
ing approxim ately 15 g, were inoculated either in lracrania lly  
(ic) w ith  20 p i o r in lrap c rilo nca lly  (ip) w ith 200 pi o f 10-fold 
d ilutions o f  virus stocks, as described previously (6). fen 
mice were inoculated fo r each v irus d ilu tion , and the number 
o f survivors after 21 days was recorded. The mean 50G 
lethal dose values from  two experiments were calculated.
RESULTS
Isolation o f a mutant containing an insertion w ith in  the 
Vmw65 gene. The gene encoding Vmw65 lies between map
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FIG. 1. (a) Structure of the HSV-1 genome showing the positions of the five IE genes (without introns) and Vmw65. The open boxes 
represent repealed sequences, (b) Structures of the insertion mutation in Vmw65 encoded on a S«/l(S)-A7/oI(X) fragment in plasmid 
pMCl.inl4.
coordinates 0.669 and 0.685 in the U,_ region o f the prototype 
HSV-1 genome and is contained w ith in  plasmid p M C l (Fig. 
1A; 7. 10). The isolation o f a number o f plasmids w ith 
in-frame Bam  H I linker insertion mutations w ith in .the  gene 
encoding Vrmv65 has been described previously ’ (1). In 
particular, a four-amino-acid insertion at codon 397, speci­
fied on plasmid p M C l. in l4  (Fig. IB ), abolished the transin­
ducing a c tiv ity  o f the polypeptide in transfection assays. The 
mutation disabled the binding o f Vmw65 to the host-cell 
factors and thus defined a region o f the polypeptide involved 
in this interaction. The essential role o f  the polypeptide 
during v irion  assembly was not affected by the m utation, as 
inferred from  its ab ility  to rescue an HSV-2 mutant w ith  a 
temperature-sensitive mutation in Vmw65 (1). suggesting 
that a viable virus could be constructed that contained the 
transinducing mutation specified by p M C l. in l4 . T o  con­
struct such a mutant virus, a plasmid consisting o f  B a m H l J' 
containing the p M C l. in l4  mutation was cotransfected w ith  
intact w t HSV-1 D N A  into B H K  cells, and the structure o f 
progeny virus D N A  was examined by restriction enzyme 
analysis. One plaque from a total o f 84 screened was 
identified as a recombinant that contained the Bam  H I linker 
insertion. This mutant isolate. ///1814. was plaque purified 
twice more, and a large-scale stock o f virus w'as prepared. 
To rule out the possib ility o f a second site mutation in ///1814 
that might affect the phenotype o f the mutant v irus, a 
rescued virus w'as constructed by recombining ///1814 D N A  
w ith p M C l. If. as desired, the phenotype o f  m l814 depended 
on the insertion m utation, then a rescued virus should 
behave as wt HSV-1. In itia l observation o f  the properties o f 
//? 1814 suggested that it grew' poorly in comparison w ith  wt 
HSV-1; thus, it was expected that rescued recombinants 
would outgrow' /7/1814 during successive passages o f a mixed 
population. This turned out to be the case, since after a 
single passage o f the progeny virus from the in itia l cotrans­
fection o f ///1814 D N A  and p M C l. 75% o f the plaques 
screened had the w't D N A  structure. These viruses were 
un like ly to result from  spontaneous reversion o f //?1814. 
since no reversion w'as delected at any stage during the
passaging and propagation o f mutant virus. A stock of 
rescued v irus , 1814R, was prepared after plaque purification. 
Figure 2 shows a Southern b lot o f w t HSV-1. //; 1814. and 
1814R D N A  which was digested w ith  B am H l  and probed 
w ith  pMC17, a plasmid contain ing the Vmw65 coding se­
quences. The B am H l f  fragment o f 8 kilobase pairs was seen 
in both w t HSV-1 (lane 1) and 1814R (lane 3). whereas in 
/7/1814 (lane 2), th is fragment was replaced by two fragments 
o f  the sizes (5 and 3 kilobase pairs) expected from  the 
presence o f  the B a m H l  linker insertion. Overexposure o f the 
autoradiograph revealed no detectable Bam H l  / fra g m e n t in
1 2 3
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FIG. 2. Structure of the /7il814 genome. Wt HSV-1 (lane 1). 
///1814 (lane 2). or 1814R (lane 3) DNA was cleaved with BamHl, 
and the fragments were separated on a 1.5% agarose gel. transferred 
to nitrocellulose, and hybridized to -^P-labelcd pMC17. The position 
of HSV-1 BamHl f is indicated.
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TABLE 1. Titration of wt HSV-1, //H814, and 1814R 
on BHK and HFL cells
Virus Panicles/ml B H K  titer 
(P F U /m l)
H F L  titer 
(PFU /m l)
w t HSV-1 1.9 x 10n 5.0 x 109 1.7 x 1010
/T1814 1.2 x 10n 1.3 x 107 7.0 x 10?
1814R 4.6 x IQ10 4.0 x 109 ND"
N D . N ot determined.
//?1814 and therefore that the stock o f  mutant virus was 
essentially pure.
The efficiency o f plaque form ation by m !814 is markedly 
reduced and dependent on cell type. The successful isolation 
and propagation o f  ///1814 confirm s that the insertion muta­
tion is com patible w ith  virus grow th in B H K  cells. When 
m l814 was titrated on B H K  cells, however, a low  tite r was 
obtained, and therefore v irus particle concentrations were 
determined (Table 1). It was found that the particle concen­
trations o f w t HSV-1, //;1814, and 1814R stocks were com­
parable but that the partic le /PFU ratio  was approxim ately 
100 times greater fo r //r 1814 than fo r w t HSV-1 and 1814R. 
The apparent lite r  o f  a given preparation o f //r 1814 on B H K  
cells varied by as much as 10-fold on different batches o f 
cells, whereas the lite rs o f w t HSV-1 and 1814R were much 
more consistent, suggesting that the ce llu lar metabolic state 
affects the efficiency o f plaque form ation by //r 1814. When 
titra tions were performed on H F L  cells, an even higher 
parlicle/PFU ratio . 1.7 x 105, was observed fo r /7/1814. In 
view o f the varia tion in t ite r o f  /7il814 when expressed in 
terms o f  PFU, cell monolayers were infected w ith  equal 
numbers o f particles o f w t HSV-1, /7/1814, o r 1814R in 
subsequent experiments.
DNA m igration to the nucleus. The early stages o f  infection 
by //i 1814 were examined, since it was possible that the 
insertion mutation affected virus adsorption, penetration, or 
uncoating. In in itia l experiments, the rate o f  adsorption o f w t 
HSV-1 o r //tl814 preparations, radiolabeled by incubation 
w ith pH Jthym id ine during v irus propagation, to B H K  cell 
monolayers was investigated. The adsorption rates o f w t 
HSV-1 and //i 1814 particles were indistinguishable (results 
not shown). The efficiency o f  D N A  m igration to the cell 
nucleus was also determ ined. B H K  cell monolayers were 
infected in the presence o f  CH  w ith  1.000, 100, or 10 
particles o f w t HSV-1, m l814, o r 1814R per cell, nuclei were 
prepared at 3 h postinfection, and nuclear D N A  was ana­
lyzed by Southern b lo t hybrid ization (F ig. 3). No significant 
differences were detected in the levels o f  H SV D N A , show­
ing that the nuclear m igration o f  m l814 D N A  is not impaired 
at either high or low  M O I.
This result underlines the requirem ent to use particles 
rather than PFU as a basis fo r  the design o f  experiments w ith 
/7tl814; 1,000 particles o f w t HSV-1 and //il814  represent 26 
and 0.1 PFU, respectively.
<7tl814 docs not exh ib it virion-mediated transinduction o f IE 
genes. The ab ility  o f  Vm w65, encoded by m l814, to fo rm  the 
pro te in -D N A com plex IE C  and to transinduce expression 
from transfected IE  promoters was investigated, since both 
o f these properties were disrupted in p M C l. in l4  (1).
Extracts o f w t HSV-1, m l814 , and 1814R virions were 
prepared and analyzed by SDS-PAGE (Fig. 4). The levels o f 
Vmw65 in these extracts were very sim ilar, and the slightly 
increased m olecular weight o f the mutant polypeptide due to 
the four-am ino-acid insertion was apparent (lane 2). The 
virion extracts were incubated w ith  H eLa cell nuclear ex-
Parlicles 
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FIG. 3. DNA migration to the nucleus. DNA isolated from nuc le i  
of cells infected with wt HSV-1 (W), uil814 (14), or 1814R (R) or 
mock infected (M), in the presence of CH, was cleaved with BamW 1. 
and the fragments were separated on an agarose gel, transferred to 
GeneScreen Plus membrane, and probed with radiolabeled pTKL 
The portion of the blot representing BamHl p is presented. E x p o  
sure times were 0.4 h (1,000 particles per cell), 4 h (100 particles per 
cell), or 40 h (10 particles per cell).
tract and a 74-bp D N A  fragment contain ing the T A A T  
G A G A T sequence m o tif o f IE  gene 4/5. As shown in Fig. 5. 
the IEC  was readily detected w ith  extracts o f w t HSV-1 
(lane 2) and 1814R (lane 4) v irions but not w ith  extracts of 
m l814 (lane 3) o r when no v ir ion  extract was present (lane 
1). This result demonstrates that Vmw65 specified by /7/1814 
is not capable o f binding the ce llu la r proteins required for 
IEC form ation because o f the m utation in the v ira l po lypep­
tide.
The ab ility  o f  /7il814 to transinduce IE  gene expression 
was investigated by comparing the level o f  activa tion  from  a 
transfected IE  prom oter in the presence o r absence o f 
superinfecting virus (F ig. 6). B H K  cells were transfected 
w ith p IE 3C A T  and infected w ith  1,000 particles o f wt 
HSV-1, m l814, o r 1814R per ce ll. An increase o f  approx i­
mately s ixfo ld  in chloram phenicol acetyltransferase ac tiv ity  
was observed when cells were superinfected w ith  w t HSV-1 
(lane 2) o r 1814R (lane 4), but in fection w ith  m l814 (lane 3)
1 2 3
Vmw65*
FIG. 4. Proteins extracted from virions of wt HSV-1 (lane 1), 
/7/1814 (lane 2), and 1814R (lane 3) and used as a source of Vmw65 
for gel retardation analysis. The gel was stained with Coomassie 
brilliant blue.
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FIG. 5. IEC formation by Vmw65. A 74-bp DNA fragment 
containing the IE gene 4/5 TAATGAGAT sequence was incubated 
with HeLa cell nuclear extract alone (lane 1) or with virion extract 
(EXT) from wt HSV-1 (lane 2). i/;1814 (lane 3), or 1814R (lane 4), 
and was analyzed by gel electrophoresis. The positions of IEC and 
the cell-specific complexes HC1 and HC3 (49) are indicated.-'
gave no stim ulation over the level in mock-infected cells 
(lane 1).
Taken together, these results confirm  that the properties 
o f the mutant Vmw65 polypeptide in the v ira l context reflect 
the observations and expectations im p lic it in the in itia l 
characterization o f the mutation in cloned copies o f the gene; 
that is, the mutation in /7/1814 disables the ab ility  o f the virus 
to d irect the form ation o f IEC and consequently abolishes its 
transducing activ ity .
Gene expression in m l814-infected cells. I t  would be ex­
pected that the abolition o f transinduction by Vmw65 would 
affect the expression o f  viral genes, especially IE  genes. The 
accum ulation o f IE  R N A  was quantitated by hybrid ization 
by using IE  gene-specific probes. B H K  cells were infected in 
the presence o f CH w ith  1,000 particles o f w t HSV-1, /7tl814, 
or 1814R per cell fo r 4 h, and cytoplasm ic R N A  was applied
1 2 . ' 
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FIG. 6. Transinduction of IE transcription. Cells were trans­
fected with plE3CAT and mock infected (lane 1) or infected with wt 
HSV-1 (lane 2). /7T814 (lane 3). or 1814R (lane 4). Chloramphenicol 
acetyltransferase assays were carried out on cytoplasmic cell ex­
tracts. The positions of chloramphenicol (CAM) and 3-acetyl chlor­
amphenicol (3-AC. CAM) are shown.
18 MR
FIG. 7. Production of IE RNA. Cells were mock infected (MI: 
row 1) or infected with wt HSV-1 (row 2), /«1814 (row 3). or 1814R 
(row 4) in the presence of CH. RNA was prepared after 4 h and 
applied to nitrocellulose filters in four sequential dilutions (3 p.g. 1 
p.g, 0.3 pLg, and 0.1 p.g). Filters were separately hybridized with 
32P-labeled DNA probes corresponding to IE genes 1, 2. 3. and 4/5 
(panels a, b, c, and d, respectively).
to nitrocellulose and separately hybrid ized w ith  radiolabeled 
D N A  fragments corresponding to the IE-1, IE-2. IE-3, or 
IE -4 genes. The levels o f  IE-1- and IE-2-specific R N A , as 
determined by densitom etric analysis, were reduced four- to 
fivefo ld in m l814-infected cells compared w ith  wt HSV-1- 
and 1814R-infected cells (Fig. 7, a and b), whereas the 
reduction in IE-4/5-specific R N A  was on ly tw ofo ld  (Fig. 7d), 
and no significant effect on IE-3-specific R N A  was delected 
(F ig. 7c).
The expression o f  IE  polypeptides was also investigated. 
B H K  cells were infected as described above, but after 4 h 
CH  was washed from  the cells and polypeptides were 
radiolabeled in the presence o f actinom ycin D and separated 
by SDS-PAGE (Fig. 8). Densitom etric analysis was used to
1 2' 3 4
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FIG. 8. IE polypeptide synthesis. Cells were mock infected (MI; 
lane 1) or infected with wt HSV-1 (lane 2). 1814 (lane 3). or 1814R
(lane 4) in the presence of CH. Proteins were labeled with 
[,5S]methionine after removal of CH by washing at 4 h postinfection. 
The positions of viral IE polypeptides and cellular actin are indi­
cated.
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FIG. 9. Lale polypeptide synthesis. Cells were mock infected 
(Ml; lane 1) or infected with wt HSV-1 (lane 2), /7il814 (lane 3), or 
1814R (lane 4), and proteins were labeled with [,5S]melhionine at 8 
h poslinfcction. The position of Vmw65 is indicated.
determine the relative rates o f  synthesis o f  ind iv idual IE  
polypeptides, and the values were normalized to that o f 
actin. The rates o f synthesis o f  V m w llO  and Vm w63, the 
products o f IE  genes 1 and 2, respectively, were reduced 
four- to fivefo ld in m l814-infected cells, whereas the rates o f 
synthesis o f V m w l75 , the product o f IE  gene 3, were 
equivalent fo r the three viruses. It was not possible to 
measure accurately the rate o f  synthesis o f V m w 6 8 , the 
product o f  IE  gene 4, since th is polypeptide ran as a diffuse 
band. It is clear, however, that the data on IE  R N A  levels 
and IE  prote in synthesis rates are in good agreement and 
show that the expression o f IE  genes 1 and 2 is s ignificantly 
reduced in ;7/1814-infected cells but that the expression o f  IE  
gene 3 is essentially unaffected.
Protein synthesis at 8  h postinfection, a tim e when early 
and, especially, late polypeptides are synthesized, was also 
examined (Fig. 9). The profiles o f  w t HSV-1, i/il814 -, and 
1814R-infccled cells were very sim ilar, the increased molec­
ular weight o f Vmw65 specified by m l814 being the on ly 
major difference.
Thus, upon infection o f B H K  cells w ith 1,000 particles o f 
///1814 per cell in the presence o f  C H , the level o f  expression 
o f IE  genes 1, 2, 4, and presumably 5 is reduced, but under 
normal conditions in fection procedes to  the late stage, 
suggesting that there is no overall consequence o f reduced 
IE  gene expression. From the high partic le /PFU  ratio , 
however, it appears that the grow th o f /'/? 1814 is inefficient 
when cells are infected w ith  1 virus particle per cell. To 
investigate whether the incapacity o f //tl814 at low M O I is 
reflected in reduced gene expression, the synthesis o f T K , an 
early enzyme that can be detected w ith high sensitiv ity , was 
examined. B H K  cells were infected w ith 1,000, 100, 10, o r 1 
particle o f w t HSV-1, //? 1814, o r 1814R per cell, and incuba­
tion was continued fo r 15 h in the presence o f phosphono-
TABLE 2. TK production by wt HSV-]. //;1814. and 1814R 
at high and low MOI"
Viral T K  activity (cpm /m in of assay 
M O I per pg of protein) Ratio o f wt
(particles/cell) ------------------------------------------------------------------- H S V -l/// i l8 1 4
wt H S V -1  i / i 1814 1814R
1,000 2,693 2,285 2,789 1.2
100 1.988 2.549 2,478 0.8
10 935 161 792 6.0
1 100 3 63 33.3
"  B H K  cells were infected at the multiplicities indicated. Cytoplasmic  
extracts were diluted as necessary to ensure that T K  determinations were 
w ithin the linear response range o f  the assay. A  background o f 3 cpm per min 
o f assay per p.g o f protein has been subtracted from all values.
acetic acid to prevent the secondary spread o f  virus. Table 2 
shows the results o f T K  assays performed on the cell 
extracts. The level o f T K  after in fection w ith  1,000 o r 100 
particles per cell was indistinguishable fo r wt HSV-1, /7/1814, 
and 1814R, reemphasizing that in 1814 is not delectably 
impaired at high M O I. A t 10 particles per cell, the T K  level 
in m l814-infected cells relative to that in w t H S V -l-in fec te d  
cells was reduced by 6 -fo ld , and at 1 particle per cell the 
decrease was 33-fold. Therefore, the expression o f T K  (and 
presumably o f  other early and lale genes) is more s tric tly  
dependent on M O I fo r  1814 than fo r w t H S V -1  or 1814R, 
and it is like ly  that the observed reduction in expression is 
large enough to  account fo r the inefficiency o f  plaque form a­
tion by the mutant.
Complementation o f //iI814 by V m w llO  and Vmw65. I f  
/«1814 fails to form  plaques at low  M O I because o f  the 
reduction in IE  gene expression, then com plem entation o f 
this state should increase the efficiency o f plaque form ation 
and consequently the apparent t ite r  o f the m utant virus. In 
contrast, a compensating increase in IE  gene expression 
would not complement m l814 grow th i f  the mutant pheno­
type resulted from  a defect at a stage before the onset o f IE  
transcription. Tw o experiments were carried out to test 
these possibilities.
B H K  cells were transfected w ith  p i l l  (a plasmid encoding 
the HSV-1 transactivator V m w llO ) or pUC9 and then used 
separately fo r titra tion  o f  w t HSV-1, /7/1814. o r 1814R (Table 
3). A lthough the titers o f  w t HSV-1 and 1814R were constant 
in both cell samples, the apparent t ite r o f  in 1814 increased 
approxim ately 10-fold on cells transfected w ith  p i l l .  Since 
on ly a proportion o f cells (norm ally between 5 and 50%) in a 
B H K  monolayer express V m w llO  after transfection o f p i l l ,  
it is like ly  that a higher level o f com plementation could 
potentia lly be obtained. Therefore, raising the level o f 
V m w llO  can, at least pa rtia lly , rec tify  the defect o f m l814 in 
B H K  cells.
Complementation o f /7/1814 in H F L  cells was achieved by 
infecting monolayers w ith  UV-irrad ia ted /.vK, which sup­
plied functional Vmw65 in trans  (48), p rio r to titra tion  o f wt 
HSV-1 or m l814. The apparent t ite r o f  /7/1814 increased from
5.7 x  106 to 1.5 x  10v PFU /m l, whereas the tite r  o f  w t H S V -1
TABLE 3. Titration of wt HSV-1. //tl814. and 1814R on BHK 
cells transfected with pUC9 or pill (encoding VmwllO)
Plasmid
P FU /m l
wt HSV-1 ///1814 1814R
+ pUC9 
+ plll
1.2 x 10'° 
9.5 x 109
4.0 x 10'1 
4.2 x 107
1.7 X 109 
2.2 x 109
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TABLE 4. Virulence of wt HSV-1, /«1814, and 1814R in mice
Virus
50% Lethal dose (PFU)"
ip  injection ic injection
w t  HSV-1 9.7 x 102 (4.0 x 104) 3.1 (1.3 X 102)
i/71814 >7.4 x 104 (>2.4 x 108) >7.4 x 103 (>2.4 x 107)
1814R 3.0 x 103 (9.2 x 104) 19.1 (5.8 x 10:)
a 50% Lethal dose in terms o f particles per mouse is shown in parentheses.
was 6.0 x  lO10 on both cell monolayers. N o plaques were 
observed on monolayers treated on ly w ith  UV-irradiated 
rsK. The tite r o f /n l814 on UV-irradiated-rsK -treated cells 
represented a partic le /PFU ra tio  o f 74, and after account is 
taken o f  the fact that the M O I fo r U V -irrad ia ted rsK  was 
only 0.1 PFU per cell, it  is clear that the efficiency o f  plaque 
fo rm ation  was sim ilar to that o f  w t HSV-1. Thus, the 
observed phenotype o f /«1814 on H F L  cells was reversed by 
provis ion o f Vmw65 in trans , arguing against a c/.v-acting 
defect, fo r  example, inh ib ition  o f uncoating by the mutant 
protein.
i7il814 has reduced virulence in mice. An assessment o f the 
in v ivo  properties o f  m l814 was made by studying virulence 
after inoculation o f  mice either ic o r ip. The results (Table 4) 
show that m l814 was much less viru len t than wt HSV-1 or 
1814R, regardless o f  the method o f inoculation. In fact, all 
mice challenged w ith  m l814 survived, w ith  the exception o f 
three m ice injected ic w ith  undiluted virus. In these cases, 
death was atyp ica lly rapid, occurring w ith in  1 2  h as opposed 
to the usual 3 to 5 days, and it is suspected that the effect was 
due to  the large number o f v irus particles injected.-The 50% 
lethal dose values in terms o f  particles per mouse, the more 
relevant value, show that virulence o f m l814 was reduced by 
a factor o f  at least 3 x  103 fo r ip o r 2.5 x  1 0 4 fo r  ic 
inoculation, compared w ith  w t HSV-1 o r 1814R.
DISC U SSIO N
The isolation o f  a mutant defective in transinduction o f IE 
transcrip tion is a crucial step in determ ining the biological 
role o f  Vmw65. The 12-bp insertion mutation in 7/71814 
appears to  be stable, since no revertants have been detected 
during passage and growth o f  virus stocks; reversion to  the 
phenotype o f w t HSV-1 would readily be detected, as shown 
by the ease w ith  which 1814R was isolated. Tw o features o f 
m l814 are particularly noteworthy. A t M O I o f 100 o r more 
particles per cell, no significant effect was observed on the 
overall pattern o f  virus gene expression, whereas at low 
M O I, the efficiency o f  plaque form ation was severely re­
duced in a cell-dependent manner. The phenotype is s im ilar 
to that exhibited by deletion mutants w hich do not express 
V m w llO  (57, 65).
A lthough the results presented here suggest that transin­
duction by Vmw65 is not essential fo r H SV gene expression 
at high M O I, this in terpretation must be taken cautiously, as 
the assays available are o f lim ited sensitiv ity. The degree o f 
im pairm ent o f transinduction is d ifficu lt to assess because 
the stim ulation o f expression from  a transfected IE  prom oter 
is on ly 5- to 10-fold, and thus, as argued previously (1). it is 
possible to  state on ly that ///1814 is reduced by at least 90% 
in its ab ility  to stimulate IE  transcription. Analysis o f  the 
ab ility  to  form  IE C , as shown in Fig. 5, is more sensitive, 
and by this criterion //?1814 is disabled by 99% or more. 
Nevertheless, each HSV particle contains approxim ately
1,000 molecules o f Vmw65 (22), and therefore a cum ulative 
effect o f  a low residual ac tiv ity  might be sufficient to endow
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7/71814 w ith  the ab ility  to form plaques at the observed low 
efficiency.
In the absence o f transinduction by Vm w65, the IE  genes 
would be expected to be transcribed according to the inher­
ent strengths o f the ir promoters, a feature that is presumably 
determined by in teraction w ith  cellu lar proteins. F or IE  
genes 1 and 2, the 4- to 5-fold reduction in R N A  accumula­
tion and prote in synthesis correlates well w ith  the 5- to 
10-fold stim ulation o f transcription in B H K  cells from trans­
fected IE  gene 1 and 2 promoters by Vmw65 (C. M . Preston, 
unpublished results). The expression o f IE  genes 3 and 4, 
however, is greater than would be anticipated from  transfec­
tion studies, since these promoters are also activated by 
more than fivefo ld (5, 48), and it is d ifficu lt to o ffe r an 
obvious explanation fo r this apparent discrepancy. One 
possib ility is that the enhancer-like sequence which lies 
between the promoters o f IE  genes 3 and 4 (28, 50), rather 
than the T A A T G A R A T  elements, is the m ajor requirement 
fo r transcription o f IE  gene 3 in the context o f the v ira l 
genome and that the strong proxim al prom oter suffices fo r  IE  
genes 4 and 5 (48). It is also noteworthy that the four 
upstream nucleotides o f the T A A T G A R A T  elements which 
contro l IE  genes 1 and 2 confer a strong homology to the 
nuclear factor I I I  binding site, the octamer element ATG C  
A A A T , whereas this is not the case fo r the T A A T G A R A T  
elements located between IE  genes 3 and 4/5. A  fu rther 
consideration is that the topology o f the D N A  template and 
the stoich iom etric relationships between D N A  and protein 
factors may vary considerably between transfected and 
infected cells. C learly, the findings w ith  virus-infected cells 
are the more relevant.
Even though 7/71814 lacks transinducing a c tiv ity , the m ajor 
polypeptides synthesized under IE  conditions are the IE  
proteins. A ctiva tion  by Vmw65 is therefore not a de fin itive 
characteristic o f IE  genes, and other features must d is tin ­
guish them from early and late genes. It may be that the 
presence o f strong promoters and enhancer-like sequences 
determines the re la tive ly  high efficiency o f IE  gene transcrip­
tion in the absence o f  IE  proteins, but equally, the T A A T G  
A R A T  or other IE-specific elements might be responsible. It 
is known that cellu lar proteins bind to various sequences in 
IE  gene upstream regions (26, 27, 39, 49, 6 8 ), and these 
factors might increase the ava ilab ility  o f IE  promoters to 
transcription components in the absence o f  Vmw65. Thus, 
IE-specific D N A  sequences, rather than Vm w65, may be the 
prim ary determ inants o f an IE  gene.
Transinduction by Vmw65 is im portant fo r infection on ly 
at low M O I. A t a superficial level, it is straightforward to 
view this properly as a reasonable adaptation, since the 
in itia l interaction o f H SV w ith an organism is like ly  to 
involve a small number o f virus particles. The inab ility  to 
replicate at low M O I appears to result from  the failure to 
produce IE  proteins at levels sufficient to in itia te in fection, 
and it is probable that the reductions in V m w llO  and Vmw63 
are crucia l, since these polypeptides are required fo r gene 
expression (56, 57, 65). Thus, it seems that threshold levels 
o f IE  polypeptides must be attained, and the role o f Vmw65 
is to ensure that such levels are reached, especially at low 
M O I. It is not clear whether the few cells in which infection 
w ith 7/71814 results in the form ation o f a plaque represent a 
subpopulation in a particular metabolic state or sim ply 
random variation in response to infection. Furtherm ore, the 
basis for the difference in behavior o f 7//1814 in B H K  and 
H F L  cells remains undefined. It may be that IE  transcription 
in the absence o f Vmw65 is less efficient in H F L  cells at low 
M O I or that H F L  cells are less able to compensate fo r low
V o l .  63, 19X9 V m u ( o  M U T A N ' l
levels o f IE  proteins. The fact that deletion mutants in 
V m w llO  are also impaired fo r growth at low  M O I and show 
a re la tive ly greater reduction in H F L  cells than B H K  cells 
(65; R. D. Everett. J. Gen. V iro l. ,  in press) supports the 
la tter proposal, but fu rthe r w o rk  is needed to c la rify  this 
im portant point.
Recently. Friedman et al. have shown that a transformed 
cell line w hich expresses the prote in-binding portion o f 
Vmw65 supports v irus grow th poorly, presumably because 
the expressed protein sequesters the cell factors required to 
mediate transinduction (16). In  essence, transinduction by 
Vmw65 is thought to be abrogated in the transformed cell 
line. The experiments dealt on ly  w ith in fection at low  M O I 
(0.1 o r 0.3 PFU per cell), but the results are s im ilar to those 
found w ith  <7tl814, namely, a significant reduction in the 
efficiency o f plaque form ation, inefficient virus grow th, and a 
decrease (by 12-fold) in accumulation o f IE  RN A 1. From 
the results reported here, it is predicted that virus replication 
in the transformed cells should not be as severely affected at 
high M O I.
The avirulence o f 7/71814 in mice, even after in jection of 
high doses, demonstrates that transinduclion is im portant for 
infection in v ivo and emphasizes the importance o f host-cell 
factors in the replication o f 7/71814. Furtherm ore, Vmw65 
may be a good target fo r the design o f new antiv ira l agents.
It is interesting to speculate on the role o f  Vmw65 in HSV 
latency in the light o f  the phenotype o f  7/71814. since the 
m ajority o f genes, includ ing IE  genes, are silent during 
latency (62, 63), suggesting that an early transcriptional 
block may operate. One hypothesis is that Vmw65 may be 
lost o r rendered inactive during transport o f  the HSV^nucle- 
ocapsid from  the neuronal cell surface to the nucleus (27). 
From the analysis o f 7/71814 presented here it is possible to 
predict that under such circumstances, at low  M O I, virus 
rep lication would not ensue, and thus latency m ight be 
established. Support fo r this v iew  comes from  our recent 
observation that noninfectious particles o f  7//1814 can be 
retained by tissue culture cells a fte r in fection al low  M O I 
and can subsequently be reactivated to form  plaques (C. Ace 
and C. M . Preston, unpublished results), as found in studies 
w ith  a mutant lacking V m w llO  (N . D. S low  and E. C. Stow. 
J. Gen. V iro l. ,  in press). Therefore, the fa ilure to transin­
duce IE  transcription by interference w ith Vmw65 function 
is w orthy o f  serious consideration as a basic precondition fo r 
latency.
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A herpes simplex virus mutant, r/i 1814, possessing a 12-base-pair insertion in the gene encoding the 
transinducing factor Vm w65 has been constructed. The insertion abolished the ability of Vm\v65 to transinduce 
immediate-early (IE ) gene expression and to form  a protein-DNA complex with cell proteins and the IE-spccific 
regulatory element T A A T G A G A T . Accumulation of IE  R N A  1 and 2 was reduced four- to fivefold in 
i/il814-infected cells, but the level of IE  R N A  4 was reduced only by twofold, and IE  RNA 3 was unaffected.
M utant m l814 had a high particle/PFU ratio, but many of the particles, although unable to form plaques, were 
capable of normal participation in the early stages of infection at high m ultiplicity of infection. The defect of 
///1814 was overcome partially by transfection of a plasmid encoding the IE  protein V m w l 10 into cells prior to 
titration and by prior infection with ultraviolet light-inactivated herpes simplex virus. Mutant Z//I814 was 
essentially avirulent when injected into mice. The results demonstrate that transinduction of IE  transcription 
by Vmw65 is important at low multiplicity o f infection and in vivo but that at high multiplicity of infection the 
function is redundant.
Herpes simplex virus type 1 (HSV-1) encodes 70 predicted 
genes which are expressed as three tem porally regulated 
classes (35. 70). The five immediate-early (IE  o r a) genes 
are the first to be transcribed after in fection , and the ir 
expression does not require de novo protein 'synthe­
sis. whereas early ((3) and late (7 ) gene expression is depen­
dent on the prior synthesis o f  IE  polypeptides (8 , 23). 
The products o f IE  gene 1 (polypeptide V m w llO  o r ICP0) 
and IE  gene 3 (V m w l75 or ICP4) are potent transactivators 
o f early- and lale-gene promoters in transient expression 
assays (12. 18. 40, 53). The IE  gene 2 product (Vmw63 
or ICP27) has also been implicated in the regulation o f 
v ira l promoters (13. 54. 60). Analysis o f temperature-sensi­
tive mutants indicates that both Vm w l75  and Vmw63 are 
essential fo r productive in fection ; V m w l75  is required 
fo r early- and late-gene expression (11, 47, 71), whereas 
Vmw63 appears to be required after the onset o f  early-gene 
expression and D N A  replication (56). Viable mutants 
w ith deletions in V m w llO  exh ib it restricted growth in cer­
tain cell types at low  m u ltip lic ity  o f in fection (M O I) but 
are apparently normal at high M O I (57, 65). Deletion muta­
tions in IE  gene 4 (which specifies V m w 6 8  o r 1CP22) 
also confer a host range phenotype to the v irus (45. 59). The 
IE gene 5 product (V m w l2  or ICP47) appears to be un im ­
portant fo r virus replication in tissue culture cells since 
deletions w ith in the gene have little  effect on grow th o f  HSV 
(4. 29. 69).
A  distinguishing feature o f IE  genes is the presence o f  the 
c/.Y-acting element T A A T G A R A T  (where R is a purine 
residue) in their 5' regulatory regions. This element responds 
to the HSV-1 virion polypeptide Vmw65 (otherwise desig­
nated VP16 or uT IF ). resulting in a stim ulation o f transcrip ­
tion from  IE  promoters (2. 5. 7, 9. 17. 25, 31-33. 41. 43. 44. 
48). A lthough Vmw65 does not itse lf bind to D N A  (34), the 
evidence currently available suggests that the polypeptide 
mediates transinduction o f IE  genes by associating w ith 
cellu lar proteins, including nuclear factor I I I .  to form  an IE
Corresponding author.
com plex (IE C ) which is able to bind specifica lly to DNA 
sequences that contain T A A T G A R A T  (1. 19. 38. 39, 49). 
M utation analysis o f  cloned D N A  fragments encoding 
Vmw65 suggests that the polypeptide contains at least two 
separable regions, both o f  which arc necessary fo r transin- 
duction o f  IE  transcription. The am ino-term inal 411 amino 
acids are sufficient fo r binding to the cellu lar factor (1; T. A. 
M cKee, C. I. Ace, and C. M. Preston, manuscript in prep­
aration). and the acidic carboxy-tcrm inal domain defined by 
amino acids 411 to 490 (the "a c id  ta il.”  a feature common to 
many other eucaryo lic and procaryotic transactivators (3, 
20, 30, 52. 58, 6 6 . 67]) is required fo r stim ulating transcrip­
tion and may interact w ith  fundamental transcrip tion com ­
ponents, fo r example, the T A T A  binding factor TFI1D  or 
R N A  polymerase, o r both (24).
Because Vmw65 regulates the set o f genes expressed at 
the earliest stages o f in fection, it is im portant to determine 
the role o f the polypeptide during HSV grow th. A ll in form a­
tion to date regarding the properties o f Vmw65 has been 
obtained by transfection, using either stably transformed cell 
lines or transient expression assays. Such systems arc 
c learly artific ia l, and the crucial biological question concerns 
the phenotype o f virus mutants which lack the transinducing 
ac tiv ity  o f Vmw65. A  difficu lty  inherent in attempts to 
construct such mutants is that, apart from its role in transin- 
ducing IE  genes. Vmw65 is also a major structura l com po­
nent which is required fo r v irion assembly ( 1 ). To address 
this problem , functional domains o f Vmw65 required fo r 
v irion  assembly and fo r transinduction were identified by 
insertion mutagenesis o f  a cloned gene fragment (1). The 
construction and characterization o f a viable HSV-1 mutant 
that contains an insertion which affects on ly the transinduc­
ing activ ity  o f Vmw65 are described here. The results 
indicate that IE  gene transinduction by Vmw65 is not 
essential fo r virus grow th at high M O I but plays a critica l 
role in determ ining whether infection is ly tic  o r nonproduc­
tive at low  M O I. Vmw65 is also important fo r the virulence 
o f HSV-1 in mice.
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Cells and viruses. B H K  cells (clone 13) were grown in 
Eagle medium w ith  10% newborn ca lf serum, 10% tryptose 
phosphate b ro th , and 1 0 0  U o f  penic illin  and 1 0 0  jxg o f 
streptom ycin per m l. Human fetal lung (H F L ) cells (F low  
Laboratories) were grown in Eagle medium w ith  10% fetal 
ca lf serum and 1 0 0  U o f pen ic illin  and 1 0 0  (xg o f streptom ycin 
per ml. The w ild -type  (w t) H S V - 1  virus used in these studies 
was G lasgow strain 17 svn + . V irus particle concentrations 
were determ ined by comparison o f virus stocks w ith  bead 
preparations o f  known concentration.
Plasmids. Plasmid p M C l, w hich contains the coding se­
quences fo r Vm w65, has been described previously (7). The 
construction o f  p M C l. in l4 ,  w hich contains a 1 2 -base-pair 
(bp) Bam  H I o ligonucleotide lin ke r inserted in the Vmw65 
gene, has also been described (1). Plasmid p IE 3C A T  con­
tains the H S V - 1  IE  gene 3 prom oter and regulatory se­
quences linked to  the chloram phenicol acetyltransferase 
coding region (64), and p i l l  expresses w t HSV-1 V m w llO  
(14).
Isolation o f i«1814 and Southern blot analysis. A B H K  cell 
m onolayer in a 35-mm-diameter petri dish was cotransfected 
w ith 0.5 [xg o f  in tact H S V - 1  D N A , 0.5 p.g o f an EcoRI- 
cleaved plasmid w ith  the m utation o f p M C l. in l4  in the larger 
plasmid pGX158 (which contains B a m H l f  f7]), and 2.0 (xg o f 
ca lf thym us carrie r D N A  by the calcium  phosphate precip i­
tation method (51). A fte r incubation fo r 3 days at 31°C, the 
progeny viruses were harvested and titrated on B H K  cells. 
Single plaques were picked and used to infect B H K  cells in 
m ultiw ell plates contain ing 15-mm-diameter wells. A fte r 2 
days at 37°C, to ta l D N A  was prepared from  infected cells 
(65) and the medium was retained as a v ira l stock. D N A  
samples were screened fo r the presence o f  v ira l genomes 
containing a B a m H l  linker insertion w ith in  the Vmw65 gene. 
D N A  was cleaved w ith  B am H l,  and v ira l D N A  analyzed by 
agarose gel electrophoresis and Southern b lo tting (61). Plas­
mid pMC17, wh ich contains the Vmw65 coding sequences 
cloned in pUC9 (1), was radiolabeled w ith  by nick 
translation (55) and used as a probe. H yb rid iza tion , mem­
brane washing, and autoradiography conditions were as 
described previously (42). Progeny from  a sample which 
contained v ira l D N A  w ith  a linke r insertion was plaque 
purified and screened by hybrid ization tw ice more, and a 
working stock o f  virus was prepared from  B H K  cells. The 
virus was named /7;1814.
M arker rescue o f i/i 1814. A  B H K  cell m onolayer was 
cotransfected w ith  0.1 p.g o f  in tact m l814 D N A , 0.5 p.g o f 
pM C l cleaved w ith  EcoR I, and 2.0 p.g o f  ca lf thym us D N A , 
as described above. A fte r 5 days at 31°C, progeny were 
harvested and used to infect a B H K  cell m onolayer on a 
90-mm-diameter petri dish at 0.0001 PFU per cell. A fte r 3 
days, the progeny were harvested and titrated on B H K  cells. 
Single plaques were picked and used to infect B H K  cells on 
m ultiwell plates. V irus stocks were prepared from  w ells, and 
the ir genomes were analyzed as described above. Progeny 
from a sample that exhib ited a w t H SV - 1  D N A  structure was 
plaque purified, and a w ork ing  stock o f virus was prepared in 
B H K  cells. The virus was named 1814R.
Q uantitation o f v ira l DNA in  nuclei. B H K  cell monolayers 
in 90-mm-diameter petri dishes were infected in the presence 
o f 200 p.g o f  cyclohexim ide (C H ) per ml. A fte r incubation for 
3 h at 38.5°C, cell nuclei were isolated (46) and D N A  was 
extracted. V irus D N A  was quantitated by Southern b lotting 
as described above but by using 3 2P-labeled p T K l,  which
contains the cloned H S V -1  B am H l [) fracment, in the 
hybrid ization procedure.
Radiolabeling o f v ira l polypeptides. For IE  polypeptides. 
B H K  cell monolayers were infected in the presence o f 2 0 0  
p.g o f CH per ml. A fte r 4 h al 38.5CC. CH was washed from 
the plates and proteins were radiolabeled fo r 1 h with 
[?5S]methionine in the presence o f 1 p.g o f actinom ycin D per 
ml and analyzed by sodium dodecyl sulfate-polyacrylam ide 
gel electrophoresis (SDS-PAGE) (46). For early and late 
polypeptides, B H K  cell monolayers were infected and incu­
bated at 37°C fo r 8  h. and proteins were radiolabeled fo r 1 h 
w ith [25S]methionine and analyzed by SDS-PAGE.
Gel retardation analysis. V ir ion  extracts were prepared 
(49), and proteins were analyzed by SDS-PAGE. The gel 
was stained w ith  Coomassie b rillian t blue. V irion  extract 
was added to a m ixture contain ing HeLa cell nuclear extract 
and a '^P-labeled 74-bp D N A  fragment containing H S V -1  IE 
gene 4/5 regulatory sequences (49). Reaction conditions for 
complex form ation and analysis o f p ro lc in -D N  A complexes 
were as described previously (49).
Transinduction assay. B H K  cell monolayers in 35-mm- 
diameter petri dishes were transfected w ith 3 p.g o f p IE3C A T 
by the calcium phosphate precip itation method (7). except 
that the d im ethyl sulfoxide boost was pet formed 1 h after the 
medium overlay. The cells were incubated al 38.5°C for 1 h 
and then superinfected. A lte r incubation fo r a further 3 h at 
38.5°C, extracts were made from  the cells and chloramphen­
icol acetyltransferase assays were performed (2 1 ).
Quantitation of IE  RNA. B H K  cells were infected in the 
presence o f  200 p.g o f C H per m l. A fte r incubation fo r 4 h at 
38.5°C, cytoplasm ic R N A was extracted and quantitated by 
dot blot analysis (72) by using D N A  probes radiolabeled with 
,2P by prim er extension (15). Gene-specific probes were 
prepared from  D N A  fragments that correspond to IE  genes 
1 (a 1,367-bp S a l l-N n d  fragment from  pJR3 [12]), 2 (a 2.760- 
bp M lu l-B am H \  fragment from  B am H l h [35]). 3 (a 3,210-bp 
H i n d i  fragment from  Xho l c [36]), and 4 (a 2.200-bp 
N r id -M l id  fragment from  Bam  H I n hybrid iz ing predom i­
nantly to  IE  R N A  4 [37]).
TK  assay. B H K  cells were infected in the presence o f 200 
(xg o f phosphonoacctic acid per m l. A fte r incubation fo r 15 h 
at 38.5°C, cytoplasm ic extracts were made and thym idine 
kinase (T K ) assays were performed (9).
Complementation assay. B H K  cell monolayers in 35-mm- 
diameter petri dishes were transfected w ith  3 (xg o f p i l l  or 
pUC9 by the calcium phosphate precip itation method (7) and 
treated w ith  dim ethyl sulfoxide 1 h later. A fte r a further 1 h 
at 37°C, v irus was titra ted on the monolayers. A lte rnative ly , 
monolayers were treated w ith  the HSV-1 mutant / \K .  which 
had been UV irradiated to reduce its tile r  by 5 x 1 0 s (48). 
The M O I o f  UV-irradiated t.vK corresponded to 0.1 PFU o f 
unirradiatcd virus per cell. W t HSV-1 or ///1814 was titrated 
on the UV-irradiated-LYK-prelreated cells. A fte r 2 days at 
37°C, plates were stained and plaques were counted.
Virulence assay. Female Charles R iver mice, each weigh­
ing approxim ately 15 g, were inoculated either in lracran ia lly 
(ic) w ith 2 0  (x! or in trapcritonca lly  (ip) w ith 2 0 0  |xl o f 1 0 -fold 
d ilutions o f virus stocks, as described previously (6 ). Ten 
mice were inoculated fo r each virus d ilu tion , and the number 
o f survivors after 21 days was recorded. The mean 50% 
lethal dose values from  two experiments were calculated.
RESULTS
Isolation o f a mutant containing an insertion w ith in the 
Vmw65 gene. 'The gene encoding Vmw65 lies between map
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FIG. 1. (a) Structure of the HSV-I genome showing the positions of the five IE genes (without introns) and Vmw65. The open boxes 
represent repeated sequences, (b) Structures of the insertion mutation in Vmw65 encoded on a S(tlHS)-XlioHX) fragment in plasmid 
pMCl.in!4.
coordinates 0.669 and 0.685 in the U, region o f the prototype 
HSV-1 genome and is contained w ith in plasmid p M C l (Fig. 
1A; 7. 10). The isolation o f  a number o f plasmids w ith  
in-frame Bam  H I linker insertion mutations w ith in .the  gene 
encoding Vmw65 has been described previously ( 1 ). In 
particular, a four-am ino-acid insertion at codon 397, speci­
fied on plasmid p M C l. in l4  (Fig. IB ), abolished the transin­
ducing ac tiv ity  o f the polypeptide in transfection assays. The 
mutation disabled the binding o f Vmw65 to the host-cell 
factors and thus defined a region o f the polypeptide involved 
in this interaction. The essential role o f the polypeptide 
during v irion  assembly was not affected by the m utation, as 
inferred from  its ab ility  to rescue an HSV-2 mutant w ith  a 
temperature-sensitive mutation in Vmw65 (1). suggesting 
that a viable virus could be constructed that contained the 
transinducing mutation specified by p M C l.in l4 . To con­
struct such a mutant virus, a plasmid consisting o f B am H l f  
containing the p M C l. in l4  mutation was cotransfected w ith  
intact w t HSV-1 D N A  into B H K  cells, and the structure o f 
progeny virus D N A  was examined by restriction enzyme 
analysis. One plaque from a total o f 84 screened was 
identified as a recombinant that contained the B am H l  linker 
insertion. This mutant isolate. m l814. was plaque purified 
tw ice more, and a large-scale stock o f virus was prepared. 
To rule out the possib ility o f a second site mutation in /'//1814 
that might affect the phenotype o f the mutant v irus, a 
rescued virus was constructed by recombining hi 1814 D N A  
w ith  p M C l. If. as desired, the phenotype o f ///1814 depended 
on the insertion mutation, then a rescued virus should 
behave as wt HSV-1. In itia l observation o f the properties o f 
m l814 suggested that it grew poorly in comparison w ith  wt 
HSV-1; thus, it was expected that rescued recombinants 
would outgrow m l814 during successive passages o f a mixed 
population. This turned out to be the case, since after a 
single passage o f the progeny virus from the in itia l cotrans- 
fection o f iu l814 D N A  and p M C l. 75% o f the plaques 
screened had the wt D N A structure. These viruses were 
un like ly to result from spontaneous reversion o f /7/1814. 
since no reversion was detected at any stage during the
passaging and propagation o f  mutant virus. A stock o f 
rescued virus, 1814R. was prepared after plaque purifica tion. 
Figure 2 shows a Southern b lot o f  w t HSV-1. iu l814, and 
1814R D N A  which was digested w ith  Bam  H I and probed 
w ith  pMC17, a plasmid contain ing the Vmw65 coding se­
quences. The BamH  I / fra g m e n t o f  8  kilobase pairs was seen 
in both w t HSV-1 (lane 1) and 1814R (lane 3), whereas in 
f/r 1814 (lane 2), th is fragment was replaced by tw o fragments 
o f the sizes (5 and 3 kilobase pairs) expected from  the 
presence o f the B a m H l  linker insertion. Overexposure o f  the 
autoradiograph revealed no detectable B a m H l f  fragment in
1 2 3
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FIG. 2. Structure of the ///1814 genome. Wt FISV-1 (lane 1). 
/7/1814 (lane 2). or 1814R (lane 3) DNA was cleaved with BamHl. 
and the fragments were separated on a 1.5% agarose gel. transferred 
to nitrocellulose, and hybridized to ^P-labeled pMC17. The position 
of HSV-1 BamHl f is indicated.
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T A B L E  1. T itra tio n  o f  w t H S V-1, /h 1814. and 1814R 
on B H K  and H F L  cells W 1 4  R M
Virus Paniclcs/ml B H K  titer 
(P F U /m l)
H F L  titer 
(P FU /m l)
w t  HSV-1 1.9 X 10“ 5.0 X  109 1.7 X 10’ °
//11814 1.2  x 10u 1.3 x  107 7.0 x  10s
1814R 4.6 x  IQ10 4.0 x  109 N D "
ND. Not determined.
/»1814 and therefore that the stock o f  mutant virus was 
essentially pure.
The efficiency o f plaque form ation by /«1814 is m arkedly 
reduced and dependent on cell type. The successful isolation 
and propagation o f  //r 1814 confirm s that the insertion muta­
tion is com patible w ith  v irus grow th in B H K  cells. When 
/A71814 was titra ted on B H K  cells, however, a low  tite r was 
obtained, and therefore virus particle concentrations were 
determined (Table 1). It was found that the particle concen­
trations o f wt HSV-1, /7/1814, and 1814R stocks were com ­
parable but that the partic le /PFU  ratio  was approxim ately 
100 times greater fo r /«1814 than fo r w t HSV-1 and 1814R. 
The apparent t ite r o f  a given preparation o f m l814 on B H K  
cells varied by as much as 1 0 -fold on different batches o f 
cells, whereas the titers o f w t HSV-1 and 1814R were much 
more consistent, suggesting that the ce llu la r metabolic state 
affects the efficiency o f plaque form ation by m l814. When 
titra tions were performed on H F L  cells, an even higher 
particle/PFU ra tio . 1.7 x  10s, was observed fo r m l814. In 
view o f the variation in t ite r o f  ///1814 when expressed in 
terms o f PFU, ce ll monolayers were infected w ith  equal 
numbers o f particles o f  w t HSV-1, m l814 , or 1814R in 
subsequent experiments.
DNA m igration to the nucleus. The early stages o f  infection 
by //i 1814 were examined, since it was possible that the 
insertion mutation affected v irus adsorption, penetration, or 
uncoating. In in itia l experiments, the rate o f  adsorption o f  w t 
HSV-1 o r u il814 preparations, radiolabeled by incubation 
w ith [sH ]thym id ine  during v irus propagation, to B H K  cell 
monolayers was investigated. The adsorption rates o f  w t 
H S V -1  and //? 1814 particles were indistinguishable (results 
not shown). The efficiency o f  D N A  m igration to the cell 
nucleus was also determ ined. B H K  cell monolayers were 
infected in the presence o f  C H  w ith  1,000, 100, o r 10 
particles o f w t HSV-1, m l814, o r 1814R per cell, nuclei were 
prepared at 3 h postin fection, and nuclear D N A  was ana­
lyzed by Southern b lo t hybrid ization (F ig. 3). No significant 
differences were detected in the levels o f  H S V  D N A , show­
ing that the nuclear m igration o f  m l814 D N A  is not impaired 
at either high or low  M O I.
This result underlines the requirem ent to use particles 
rather than PFU as a basis fo r  the design o f  experiments w ith 
//r 1814; 1,000 particles o f  w t HSV-1 and /»1814 represent 26 
and 0.1 PFU, respectively.
7nl814 does not exh ib it virion-mediated transinduction o f IE  
genes. The ab ility  o f  Vm w65, encoded by m l814, to fo rm  the 
pro te in-D N A com plex IEC  and to transinduce expression 
from transfected IE  prom oters was investigated, since both 
o f these properties were disrupted in p M C l. in l4  ( 1 ).
Extracts o f w t HSV-1, m l814 , and 1814R v irions were 
prepared and analyzed by SDS-PAGE (F ig. 4). The levels o f 
Vmw65 in these extracts were very sim ilar, and the s lightly 
increased m olecular weight o f  the mutant polypeptide due to 
the four-am ino-acid insertion was apparent (lane 2). The 
virion extracts were incubated w ith  H eLa cell nuclear ex­
, Particles 
per c e ll
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FIG . 3. D N A  m igration to  the nucleus. D N A  isolated from  nuclei 
o f  cells in fected w ith  w t HSV-1 (W ), /«1814 (14), o r 1814R (R) or 
mock infected (M ), in the presence o fC H , was cleaved w ith  B a m  H I, 
and the fragments were separated on an agarose gel, transferred to 
GeneScreen Plus membrane, and probed w ith  radiolabeled p T K l.  
The po rtion  o f  the b lo t representing ZLrmHI p  is presented. E xpo ­
sure times were 0.4 h (1,000 partic les per ce ll), 4 h (100 partic les per 
cell), o r 40 h (10 particles per cell).
tract and a 74-bp D N A  fragment contain ing the T A A T  
G A G A T  sequence m o tif o f IE  gene 4/5. As shown in Fig. 5. 
the IEC  was readily detected w ith  extracts o f w t H S V -1  
(lane 2) and 1814R (lane 4) v irions but not w ith  extracts o f 
7/i 1814 (lane 3) or when no v ir io n  extract was present (lane 
1). This result demonstrates that Vmw65 specified by /7il814 
is not capable o f binding the ce llu la r proteins required for 
IEC  form ation because o f the m utation in the vira l po lypep­
tide.
The ab ility  o f  /'//1814 to transinduce IE  gene expression 
was investigated by comparing the level o f  activa tion from  a 
transfected IE  prom oter in the presence or absence o f 
superinfecting virus (Fig. 6 ). B H K  cells were transfected 
w ith  p IE 3C A T  and infected w ith  1,000 particles o f  wt 
HSV-1, //il814 , o r 1814R per cell. An increase o f app rox i­
mately s ixfo ld in chloramphenicol acetyltransferase a c tiv ity  
was observed when cells were superinfected w ith  w t HSV-1 
(lane 2) o r 1814R (lane 4), but in fection  w ith  /'nl814 (lane 3)
1 2 3
Vmw65*
FIG . 4. P roteins extracted from  v irion s  o f w t HSV-1 (lane 1), 
/«1814 (lane 2), and 1814R (lane 3) and used as a source o f  Vm w65 
fo r gel re tardation analysis. The gel was stained w ith  Coomassie 
brillian t blue.
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FIG . 5. IE C  form ation by Vm w65. A  74-bp D N A  fragment 
con ta in ing  the IE  gene 4/5 T A A T G A G A T  sequence was incubated 
w ith  H eLa  cell nuclear extract alone (lane 1) o r  w ith  v irion  extract 
(E X T ) from  w t HSV-1 (lane 2). /7/1814 (lane 3), o r  1814R (lane 4). 
and was analyzed by gel electrophoresis. The positions o f  IE C  and 
the cell-specific  complexes HC1 and HC3 (49) are indicated.
gave no stim ulation over the level in m ock-infected cells 
(lane 1 ).
Taken together, these results confirm  that the properties 
o f  the mutant Vmw65 polypeptide in the v ira l context reflect 
the observations and expectations im p lic it in the in itia l 
characterization o f the mutation in cloned copies o f the gene; 
that is, the mutation in ///1814 disables the ab ility  o f the virus 
to d irect the form ation o f I EC and consequently abolishes its 
transducing activ ity .
Gene expression in in l8 l4 -in fcc tcd  cells. I t  would be ex­
pected that the abolition o f transinduction by Vmw65 would 
affect the expression o f vira l genes, especially IE  genes. The 
accumulation o f IE  R N A  was quantitated by hybrid ization 
by using IE  gene-specific probes. B H K  cells were infected in 
the presence o f CH w ith  1.000 particles o f w t H S V -1 , m l814, 
o r 1814R per cell fo r 4 h, and cytoplasm ic R N A  was applied
1 2 3 *: 4
Ml HSV-1 1814 ; 1814R
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F IG . 6. T ransinduction o f IE  transcrip tion. Cells were trans­
fected w ith  p IE 3 C A T a n d  mock infected (lane 1) o r infected w ith  w t 
HSV-1 (lane 2). /'//1814 (lane 3). o r 1814R (lane 4). C hloram phenico l 
acetyltransferase assays were carried out on cytop lasm ic cell ex­
tracts . The positions o f ch loram phenico l (C A M ) and 3-acetyl ch lo r­
am phenicol (3-AC. C A M ) are shown.
18 UR
F IG . 7. P roduction o f  IE  R N A . Cells were m ock infected (M l;  
row  1) o r infected w ith  w t HSV-1 (row  2), m l814 (row  3). o r 1814R 
(ro w  4) in the presence o f  C H . R N A  was prepared a fte r 4 h and 
applied to n itroce llu lose  filte rs  in fo u r sequential d ilu tions  (3 pg. 1 
pg, 0.3 pg, and 0.1 pg). F ille rs  were separately hybrid ized w ith  
■''P-labeled D N A  probes corresponding to  IE  genes 1, 2. 3. and 4/5 
(panels a, b, c , and d, respective ly).
to nitrocellu lose and separately hybrid ized w ith  radiolabeled 
D N A  fragments corresponding to the IE -1, IE -2, IE-3, o r 
IE-4 genes. The levels o f  IE-1- and IE-2-specific R N A , as 
determined by densitom etric analysis, were reduced four- to 
fivefo ld in m l814-infected cells compared w ith  w t HSV-1- 
and 1814R-infected cells (Fig. 7, a and b), whereas the 
reduction in IE-4/5-specific R N A was only tw ofo ld  (Fig. 7d), 
and no significant effect on IE-3-specific R N A  was detected 
(F ig. 7c).
The expression o f  IE  polypeptides was also investigated. 
B H K  cells were infected as described above, but after 4 h 
CH was washed from  the cells and polypeptides were 
radiolabeled in the presence o f actinom ycin D and separated 
by SDS-PAGE (Fig. 8 ). Densitom etric analysis was used to
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F IG . 8. IE  po lypeptide synthesis. Cells were m ock infected (M l;  
lane 1) o r infected w ith  w t H SV-1 (lane 2). /7il814 (lane 3). o r 1814R 
(lane 4) in the presence o f  C H . Prote ins were labeled w ith  
F 'S jm e th ion ine  a fte r rem oval o f  CH by washing at 4 h postin fection. 
The positions o f  v ira l IE  po lypeptides and ce llu la r ac lin  are in d i­
cated.
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FIG. 9. Lale polypeptide synthesis. Cells were mock infected 
(Ml; lane 1) or infected with wt HSV-1 (lane 2), /7j1814 (lane 3), or 
1814R (lane 4), and proteins were labeled with [?5S]methionine at 8 
h posiinfection. The position of Vmw65 is indicated.
determine the relative rates o f  synthesis o f  ind iv idua l IE  
polypeptides, and the values were normalized to that o f 
aclin. The rates o f synthesis o f  V m w llO  and Vm w63, the 
products o f IE  genes 1 and 2, respectively, were reduced 
four- to fivefo ld in m l814-infected cells, whereas the rates o f 
synthesis o f V m w l75 , the product o f IE  gene 3, were 
equivalent fo r the three viruses. I t  was not possible to 
measure accurately the rate o f  synthesis o f V m w 6 8 , the 
product o f  IE  gene 4, since th is polypeptide ran as a diffuse 
band. It is clear, however, that the data on IE  R N A  levels 
and IE  protein synthesis rates are in good agreement and 
show that the expression o f IE  genes 1 and 2 is s ignificantly 
reduced in //tl814-infected cells but that the expression o f  IE  
gene 3 is essentially unaffected.
Protein synthesis at 8  h postin fection, a tim e when early 
and, especially, late polypeptides are synthesized, was also 
examined (Fig. 9). The profiles o f  w t HSV-1, m l814-, and 
1814R-infectcd cells were very s im ilar, the increased m olec­
ular weight o f Vmw65 specified by i/il814  being the only 
major difference.
Thus, upon infection o f  B H K  cells w ith  1,000 particles o f 
f/r 1814 per cell in the presence o f  C H , the level o f  expression 
o f IE genes 1, 2 , 4, and presumably 5 is reduced, but under 
normal conditions in fection procedes to  the late stage, 
suggesting that there is no overall consequence o f  reduced 
IE  gene expression. From  the high partic le /PFU  ratio , 
however, it appears that the grow th o f ///1814 is inefficient 
when cells are infected w ith  1 virus particle per ce ll. To 
investigate whether the incapacity o f /7j1814 at low  M O I is 
reflected in reduced gene expression, the synthesis o f  T K , an 
early enzyme that can be detected w ith  high sens itiv ity , was 
examined. B H K  cells were infected w ith  1,000, 100, 10, o r 1 
particle o f w t HSV-1, m l814, o r 1814R per ce ll, and incuba­
tion was continued fo r 15 h in the presence o f  phosphono-
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TABLE 2. TK production by wt HSV-], ;/,1814. and 1814R 
at high and low MOI"
MOI
(particles/ccll)
Viral TK activity (cpm/min 
per pg of protein)
o f assay
Ratio o f wt 
H S V -1//, ,1814
wt HSV-1 //j 1814 1814R
1,000 2.693 2,285 2.789 1.2
100 1.988 2.549 2.478 0 .8
10 935 161 792 6 .0
1 100 3 63 33.3
" BHK cells were infected at the multiplicities indicated. Cytoplasmic 
extracts were diluted as necessary to ensure that TK determinations were 
within the linear response range of the assay. A background of 3 cpm per min 
of assay per pg of protein has been subtracted from all values.
acetic acid to prevent the secondary spread o f virus. Table 2 
shows the results o f T K  assays performed on the cell 
extracts. The level o f T K  after in fection w ith  1,(KK) or 100 
particles per cell was indistinguishable fo r wt HSV-1, //;1814, 
and 1814R, reemphasizing that m l814 is not delectably 
impaired at high M O I. A t 10 particles per cell, the T K  level 
in m l814-infected cells relative to that in w t H S V -l-in fec ted  
cells was reduced by 6 -fold , and at 1 particle per cell the 
decrease was 33-fold. Therefore, the expression o f T K  (and 
presumably o f other early and late genes) is more s tric tly  
dependent on M O I fo r u/1814 than fo r w t H S V - 1  or 1814R, 
and it is like ly  that the observed reduction in expression is 
large enough to account fo r the inefficiency o f plaque form a­
tion by the mutant.
Complementation of /«1814 by V m w llO  and Vmw65. I f  
//i 1814 fails to form  plaques at low  M O I because o f the 
reduction in IE  gene expression, then com plementation o f 
this state should increase the efficiency o f plaque form ation 
and consequently the apparent t ite r o f the m utant virus. In 
contrast, a compensating increase in IE  gene expression 
would not complement /7;1814 growth i f  the m utant pheno­
type resulted from  a defect at a stage before the onset o f IE  
transcription. Tw o experiments were carried out to test 
these possibilities.
B H K  cells were transfected w ith  p i l l  (a plasm id encoding 
the HSV-1 transactivator V m w llO ) or pUC9 and then used 
separately fo r titra tion  o f w t HSV-1, /7/1814, o r 1814R (Table 
3). A lthough the titers o f  w t HSV-1 and 1814R were constant 
in both cell samples, the apparent t ile r  o f /'/;1814 increased 
approxim ately 10-fold on cells transfected w ith  p i l l .  Since 
on ly a proportion o f cells (norm ally between 5 and 50%) in a 
B H K  monolayer express V m w llO  after transfection o f p l l  1, 
it is like ly  that a higher level o f  com plem entation could 
potentia lly be obtained. Therefore, raising the level o f 
V m w llO  can, at least partia lly , rec tify  the defect o f f/r 1814 in 
B H K  cells.
Complementation o f ///1814 in H F L  cells was achieved by 
infecting monolayers w ith  UV-irrad iated r.vK, which sup­
plied functional Vmw65 in trans (48), p rio r to titra tion  o f wt 
HSV-1 or </il814. The apparent t ite r o f  //i 1814 increased from
5.7 x  106 to 1.5 x  10v P FU/m l, whereas the t ile r  o f  w t HSV-1
TABLE 3. Titration of wt HSV-1. //11814, and 1814R on BHK 
cells transfected with pUC9 or pill (encoding VmwllO)
Plasmid
PFU/ml
wt HSV-1 ,,,1X14 1814R
+ pUC9 
+ plll
1.2 x 10'" 
9.5 x 10v
4.0 x 10'' 
4.2 x 107
1.7 X 10v 
2.2 x 1()9
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TABLE 4. Virulence of wt HSV-1, Z/j1814, and 1814R in mice
Virus
50% Lethal dose (PFU)"
ip injection ic injection
wt HSV-1 9.7 X 102 (4.0 X 104) 3.1 (1.3 x 10=)
/nl814 >7.4 x  10“ (>2.4 X 108) >7.4 x 103 (>2.4 x 107)
1814R 3.0 x  103 (9.2 x  104) 19.1 (5.8 x 10-)
a 50% Lethal dose in terms of particles per mouse is shown in parentheses.
was 6.0 x  lO 10 on both cell monolayers. No plaques were 
observed on monolayers treated only w ith  UV-irradiated 
rsK . The tite r o f m l814 on U V-irrad iated-/sK -treated cells 
represented a partic le /PFU  ra tio  o f 74, and after account is 
taken o f  the fact that the M O I fo r U V -irrad iated r.vK was 
on ly 0.1 PFU per ce ll, it  is clear that the efficiency o f plaque 
form ation was sim ila r to that o f w t H S V -1 . Thus, the 
observed phenotype o f  m l814 on H F L  cells was reversed by 
prov is ion o f Vmw65 in t rans , arguing against a o.v-acting 
defect, fo r  example, inh ib ition  o f uncoating by the mutant 
prote in .
in l814  has reduced virulence in  mice. An assessment o f the 
in  v ivo  properties o f m l814 was made by studying virulence 
after inoculation o f  mice either ic or ip. The results (Table 4) 
show that m l814 was much less v iru len t than wt HSV-1 or 
1814R, regardless o f  the method o f inoculation. In fact, all 
m ice challenged w ith  in l814  survived, w ith  the exception of 
three m ice injected ic  w ith  undiluted virus. In these cases, 
death was a typ ica lly  rapid, occurring w ith in  1 2  h as opposed 
to the usual 3 to 5 days, and it  is suspected that the effect was 
due to  the large number o f  v irus particles injected. The 50% 
lethal dose values in  terms o f  particles per mouse, the more 
relevant value, show that virulence o f  m l814 was reduced by 
a fac to r o f  at least 3 x  103 fo r ip o r 2.5 x  1 0 4 fo r ic 
inoculation, compared w ith  w t HSV-1 o r 1814R.
D ISC U SSIO N
The isolation o f a mutant defective in transinduction o f IE 
transcrip tion is a crucial step in determ ining the biological 
role o f  Vmw65. The 12-bp insertion mutation in ml814 
appears to  be stable, since no revertants have been detected 
during passage and grow th o f virus stocks; reversion to the 
phenotype o f w t HSV-1 would readily be detected, as shown 
by the ease w ith  w hich 1814R was isolated. Tw o features o f 
/«1814 are particu larly noteworthy. A t M O I o f 100 or more 
particles per cell, no significant effect was observed on the 
overall pattern o f v irus gene expression, whereas at low 
M O I, the efficiency o f  plaque form ation was severely re­
duced in a cell-dependent manner. The phenotype is sim ilar 
to that exhib ited by deletion mutants w h ich do not express 
V m w llO  (57, 65).
A lthough the results presented here suggest that transin­
duction by Vmw65 is not essential fo r HSV gene expression 
at high M O I, this in terpretation must be taken cautiously, as 
the assays available are o f  lim ited sensitiv ity. The degree o f 
im pairm ent o f  transinduction is d ifficu lt to assess because 
the stim ulation o f  expression from  a transfected IE  prom oter 
is on ly 5- to 10-fold, and thus, as argued previously (1). it is 
possible to state on ly that /7/1814 is reduced by at least 90% 
in its ab ility  to stimulate IE  transcription. Analysis o f  the 
ab ility  to  form  IE C , as shown in Fig. 5, is more sensitive, 
and by this crite rion  m l814 is disabled by 99% or more. 
Nevertheless, each HSV particle contains approxim ately
1,000 molecules o f  Vmw65 (2 2 ), and therefore a cumulative 
effect o f  a low  residual ac tiv ity  might be sufficient to endow
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m l814 w ith the ab ility  to form  plaques at the observed low 
efficiency.
In the absence o f transinduction by Vm w65, the IE  genes 
would be expected to be transcribed according to the inher­
ent strengths o f the ir promoters, a feature that is presumably 
determined by in teraction w ith  ce llu lar proteins. For IE  
genes 1 and 2, the 4- to 5-fold reduction in R N A  accumula­
tion and protein synthesis correlates we ll w ith  the 5 - to 
1 0 -fold stim ulation o f transcription in B H K  cells from trans­
fected IE  gene 1 and 2 promoters by Vmw65 (C. M . Preston, 
unpublished results). The expression o f IE  genes 3 and 4, 
however, is greater than would be anticipated from  transfec­
tion studies, since these promoters are also activated by 
more than fivefo ld (5, 48), and it is d ifficu lt to o ffe r an 
obvious explanation fo r this apparent discrepancy. One 
possib ility is that the enhancer-like sequence which lies 
between the promoters o f IE  genes 3 and 4 (28, 50), rather 
than the T A A T G A R A T  elements, is the m ajor requirement 
fo r transcription o f IE  gene 3 in the context o f the v ira l 
genome and that the strong proxim al prom oter suffices fo r  IE  
genes 4 and 5 (48). It is also no tew orthy that the four 
upstream nucleotides o f the T A A T G A R A T  elements which 
contro l IE  genes 1 and 2 confer a strong homology to the 
nuclear factor I I I  b ind ing site, the octam er element ATG C  
A A A T . whereas this is not the case fo r the T A A T G A R A T  
elements located between IE  genes 3 and 4/5. A  fu rther 
consideration is that the topology o f  the D N A  template and 
the stoichiom etric relationships between D N A  and protein 
(actors may vary considerably between transfected and 
infected cells. C learly, (he findings w ith  virus-infected cells 
arc the more relevant.
Even though Z//1814 lacks transinducing ac tiv ity , the m ajor 
polypeptides synthesized under IE  conditions are the IE  
proteins. A ctiva tion  by Vmw65 is therefore not a defin itive 
characteristic o f IE  genes, and other features must d is tin ­
guish them from  early and late genes. I t  may be that the 
presence o f strong promoters and enhancer-like sequences 
determines the re la tive ly  high efficiency o f  IE  gene transcrip­
tion in the absence o f  IE  proteins, but equally, the T A A T G  
A R A T  or other IE-specific elements m ight be responsible. It 
is known that ce llu lar proteins bind to various sequences in 
IE  gene upstream regions (26, 27, 39, 49, 6 8 ), and these 
factors might increase the ava ilab ility  o f  IE  promoters to 
transcription components in the absence o f  Vmw65. Thus, 
IE-specific D N A  sequences, rather than Vm w65, may be the 
prim ary determ inants o f  an IE gene.
Transinduction by Vmw65 is im portant fo r  infection only 
at low M O I. A l a superficial level, it is stra ightforward to 
view this property as a reasonable adaptation, since the 
in itia l interaction o f HSV w ith an organism is like ly  to 
involve a small number o f virus particles. The inab ility  to 
replicate at low  M O I appears to result from  the failure to 
produce IE  proteins at levels sufficient to in itia te  in fection, 
and it is probable that the reductions in V m w llO  and Vmw63 
are crucial, since these polypeptides are required fo r gene 
expression (56, 57, 65). Thus, it seems that threshold levels 
o f IE polypeptides must be attained, and the role o f Vmw65 
is to ensure that such levels are reached, especially at low  
M O I. It is not clear whether the few  cells in which infection 
w ith r/i 1814 results in the form ation o f a plaque represent a 
subpopulalion in a particular m etabolic state or sim ply 
random variation in response to in fection. Furtherm ore, the 
basis for the difference in behavior o f //i 1814 in B H K  and 
H F L  cells remains undefined. It may be that IE  transcription 
in the absence o f Vmw65 is less efficient in H F L  cells at low 
M O I or that H F L  cells are less able to compensate fo r low
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levels o f  IE  proteins. The fact that deletion mutants in 
V m w llO  are also im paired fo r grow th at low  M O I and show 
a re la tive ly  greater reduction in H F L  cells than B H K  cells 
(65; R. D . E vere tt, J. Gen. V iro l. ,  in press) supports the 
la tter proposal, but fu rthe r w ork  is needed to c la rify  this 
im portant po int.
Recently. Friedman et al. have shown that a transformed 
cell line w h ich expresses the prote in-binding portion of 
Vmw65 supports v irus grow th poorly, presumably because 
the expressed protein sequesters the cell factors required to 
mediate transinduction (16). In essence, transinduction by 
Vmw65 is thought to be abrogated in the transformed cell 
line. The experiments dealt on ly  w ith  in fection at low  M O I 
(0.1 o r 0.3 PFU per cell), but the results are sim ilar to those 
found w ith  //il814, namely, a significant reduction in the 
efficiency o f  plaque form ation, inefficient virus grow th, and a 
decrease (by 12-fold) in accumulation o f IE  RNA 1. From 
the results reported here, it is predicted that virus replication 
in the transformed cells should not be as severely affected at 
high M O I.
The avirulence o f  m l814 in m ice, even after in jection o f 
high doses, demonstrates that transinduction is im portant for 
in fection in  v ivo  and emphasizes the importance o f host-cell 
factors in the rep lication o f ///1814. Furtherm ore. Vmw65 
may be a good target fo r the design o f new antiv ira l agents.
It is interesting to speculate on the role o f  Vmw65 in HSV 
latency in  the light o f  the phenotype o f m l814. since the 
m ajority o f  genes, includ ing IE  genes, are silent during 
latency (62, 63), suggesting that an early transcriptional 
block may operate. One hypothesis is that Vmw65 may be 
lost o r rendered inactive during transport o f  the HSV^nucIe- 
ocapsid from  the neuronal cell surface to the nucleus (27). 
From the analysis o f  m l814 presented here it is possible to 
predict tha t under such circumstances, at low  M O I, virus 
replication would not ensue, and thus latency m ight be 
established. Support fo r  this v iew  comes from  our recent 
observation that noninfectious particles o f  ///1814 can be 
retained by tissue cu ltu re cells a fter in fection at low  M O I 
and can subsequently be reactivated to form  plaques (C. Ace 
and C. M . Preston, unpublished results), as found in studies 
w ith  a m utant lacking V m w llO  (N . D. Stow and E. C. S low . 
J. Gen. V iro l. ,  in press). Therefore, the fa ilure to transin­
duce IE  transcrip tion by interference w ith Vmw65 function 
is w orthy o f  serious consideration as a basic precondition for 
latency.
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Control of expression of the varicella-zoster virus major immediate early 
gene
Tom A. McKee, Graham H. Disney, Roger D. Everett and Chris M. Preston*
Medical Research Council Virology Unit, Church Street, Glasgow, G i l  5JR, U.K.
The cis-acting D N A  sequences and trans-acting pro­
teins that control the expression o f  the m ajor im m edi­
ate early (IE) gene o f varicella-zoster virus (V Z V ) were 
investigated. The location o f the IE  m R N A  5' terminus 
was determined by prim er extension and S I nuclease 
analyses and the functional activities o f D N A  se­
quences upstream o f this site were analysed by a 
transfection assay. The V Z V  IE  prom oter exhibited 
low activ ity in B H K  and HeLa cells, but was trans­
activated by the herpes simplex virus type 1 (HSV-1) 
v irion  protein Vmw65. D N A  sequences between 
positions -131 and +57 were responsible for promoter 
activity, whereas sequences between -4 1 0  and -131 
mediated the response to Vmw65. Tw o short elements
Introduction
Varicella-zoster virus (VZV), an alphaherpesvirus, is the 
causative agent o f two human diseases, chicken pox and 
shingles. Primary exposure to V Z V  results in chicken 
pox and, after an in itia l infection, the virus becomes 
latent in  the dorsal root ganglia. Reactivation o f latent 
virus results in shingles, a painful vesicular rash which is 
usually confined to the distribution o f a single sensory 
nerve root. Understanding o f the biology o f V Z V  has 
been hindered by difficulties in propagating viable cell- 
free virus at high titre in tissue culture. The determina­
tion o f the complete V ZV  D N A  sequence (Davison &  
Scott, 1986) has enabled the structure and function o f the 
products o f the 71 major open reading frames (ORFs) to 
be investigated, thus bypassing, to some extent, the 
problem o f virus isolation.
Regulation o f herpesvirus gene expression has been 
most intensively studied in the case o f herpes simplex 
virus type 1 (HSV-1), in which the genes can be classified 
as immediate early (IE), early or late, depending on their 
kinetics o f expression and response to inhibitors o f 
macromolecular synthesis (Honess &  Roizman, 1974;
; Clements et al., 1977). The five IE  genes of HSV-1 are 
transcribed when infection occurs in the absence o f de 
\ novo protein synthesis and at least three o f the IE  proteins
in the -4 1 0  to -131  region formed p ro te in -D N A  
complexes w ith  H eLa cell nuclear proteins and formed 
a ternary complex when Vm w65 was added. One o f the 
elements, A T G T A A A T G A A A T , possessed a strong 
s im ila rity  to the HSV-1 T A A T G A R A T  element. The 
V Z V  homologue o f Vm w65, encoded by open reading 
frame (O RF) 10, failed to trans-activalc expression 
from  HSV-1 or V Z V  IE  promoters and did not form  a 
ternary complex w ith  functional T A A T G A R A T  ele­
ments and H eLa cell proteins. Therefore, stim ulation 
o f V Z V  IE  transciption by Vmw65 can occur by a 
mechanism sim ila r to that employed by HSV-1, but 
V Z V  O R F  10 does not function as a trans-activator o f 
IE  gene expression.
I are im portant trans-activators that are required for 
[ maximal expression o f early and late genes (Honess &
; Roizman, 1974; Clements et al., 1977; Preston, 1979; 
j Everett, 1984; O ’Hare &  Hayward, 1985a; Sacks et al.,
I 1985). The HSV-1 IE  genes possess one or more copies o f 
| the element T A A T G A R A T  (where R is a purine), a cis- 
j -acting m o tif that mediates stimulation o f IE  transcrip- 
i tion by the v irion  protein Vmw65 (otherwise named 
j VP16 or oc-TIF), between 100 and 600 base pairs (bp)
| upstream o f the m R N A  in itia tion  sites (Post et al., 1981;
Mackem &  Roizman, 1982; Campbell et al., 1984;
; Preston et al., 1984). Vmw65 does not bind directly to 
! D N A  (Marsden et al., 1987), but interacts with one or 
; more cellular factors to form a ternary complex, IEC, 
i that binds to T A A T G A R A T  (M cK nigh t et al., 1987; 
j Preston el al., 1988; O ’Hare et al., 1988). One o f the 
| cellular components o f IEC  appears to be a ubiquitous 
| protein w ith  various names, including N F II I  (Pruijn el 
j al., 1986), OBP100 (Baumruker et al., 1988; Strum el al.,
! 1987), OTF-1 (G erster&  Roeder, 1988), TR F (OTlarc &  
| Coding, 1988) and a -H l (K ristie  &  Roizman, 1987), that 
! recognizes an octamer element o f consensus A TG C A  AT 
j as well as T A A T G A R A T . Although N F II I  binds to a 
| range o f target sequences, complex IEC  is formed 
! efficiently only when a match to T A A T G A R A T  is 
! present (Gerster &  Roeder, 1988; O ’Hare et al., 1988;
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ApRhys et al., 1989). The formation o f IEC upstream o f 
IE  m R N A  in itia tion sites enables a strongly acidic 
activating domain, located w ith in the C-terminal 80 
amino acids o f Vmw65, to interact w ith a transcription 
complex and thereby augment transcription (Dalrymple 
et al., 1985; Triezenberg et al., 1988; Sadowski et a!., 
1988; Cousens et al., 1989). A t the biological level the 
stimulation o f IE  transcription by Vmw65 is important 
for virus replication after infection at low m.o.i. or in vivo 
(Ace et al., 1989).
Four V Z V  IE  gene products have been detected in 
infected cells (Shiraki &  Hyman, 1987), but little  is 
known about the regulation o f their expression. The 
product o f V Z V  ORF 62 (and ORF 71, since this gene is 
d iploid), a polypeptide o f calculated M r 139989, is 
thought to be equivalent to HSV-1 Vm w l75, which is a 
major trans-activator o f HSV-1 early and late gene 
transcription. This conclusion is based on comparable 
their locations in the short repeat region o f the genome 
(Davison &  Scott, 1985, 1986), sequence homology 
(Davison &  Scott, 1986) and the ab ility  to stimulate gene 
expression in transfection assays (Everett &  Dunlop, 
1984; Everett, 1984). Furthermore, Vero cells that 
contain integrated copies o f ORF 62 (F I 14 cells) 
complement the growth o f HSV-1 temperature-sensitive 
mutants w ith  mutations in the coding sequences o f 
V m w l75 (Felser etal., 1988). Interestingly, the transcrip­
tion o f ORF 62 in  F I 14 cells is stimulated by HSV-1 
infection and this effect occurs even in the absence o f 
protein synthesis, suggesting that a component o f the 
KSV-1 inoculum, possibly Vmw65, is responsible (Felser 
et al., 1988). A homologue o f Vmw65, ORF 10, has been 
identified in the V Z V  genome (Dalrymple et al., 1985). 
The two proteins share homology over the N-term inal 
410 amino acids, but strik ingly ORF 10 is 81 amino acids 
shorter, lacking the acidic C-terminal activating region 
o f Vmw65 (Dalrymple et al., 1985).
Studies w ith HSV-1 indicate that the efficiency o f IE  
gene expression has important implications for the 
biological properties o f the virus (Ace et al., 1989). We 
have therefore investigated the cis-acting sequences that 
control the expression o f V Z V  ORF 62 and have clarified 
the functional relationship between Vmw65 and VZV  
ORF 10.
Methods
Plasmids. Plasmid pl40CATcontains the region from — 1146 to +57 
of the VZV ORF 62 gene inserted into the chloramphenicol 
acetyltransferase (CAT) vector pCAT, which was derived from 
pBLW2 (Gaffney et al., 1985) and contains restriction sites for 7////d III, 
Pjrl, Smal and Bam HI upstream of the CAT coding region. The ORF 
62 promoter region in pNOCAT was derived from pVZVSstf (kindly 
provided by Dr A. Davison), which contains the terminal S'.r/I fragment 
from the short repeat region of VZV cloned into the Pstl site of pATl 53
by GC tailing, thus effectively creating a Pstl site at the genome 
terminus. Plasmid pl40 contains the VZV ORF 62 gene from the ClaI 
site at — 1146 to the genome terminus Pstl site of pVZVSstf inserted 
between the Acc 1 and Pstl sites of a pUC9 plasmid from which the 
£caRI site had been removed bycuttingand filling in. Plasmid pl40FT 
is a derivative of pl40, in which an £coRI site had been created at 
position +57 by oligonucleotide mutagenesis of nucleotide +57, 
changing the sequence AAATTC to GAATTC (Fig. 1). The new 
£cy»RI site in p!40FT was converted to a Bgfll site (p140BT) by 
cleaving with £coRI, filling in and insertion of an oligonucleotide 
linker (GAGATCTC). Using this novel Bgfll site and the Smal site in 
vector sequences immediately 5' of the VZV insert, the ORF 62 region 
from —1146 to +57 of pl40BT was cloned between the Smal and 
.SomHI sites of pCAT to give pMOCAT. Sequential 5' deletions of 
pl40CAT were produced by cleaving pMOCAT at the unique //mdlll 
and Safi ( — 410) or Xliol (—131) sites, filling in the 5' overhangs^with 
T4 DNA polymerase and all four deoxynucleoside triphosphates and 
religating, to yield pl40A410CAT and pI40A131CAT.
The ORF 10 of VZV was cloned by introducing an 8 bp £coRI linker 
(GGAATTCC) into a Dral site 25 bp upstream of the ORF 10 
initiating ATG, then subcloning a 1290 bp EcoKl/Sphl fragment 
containing the entire ORF into pTZ18R (Pharmacia), to yield two 
apparently identical isolates, pTZORFlOA and pTZORFlOB. The 
1290 bp EcoRl/Sphl fragment from pTZORFlOA was recloned 
between the £coRV and Sphl sites of pMCl.inl7 (Ace et al., 1988). 
Plasmid pMCl contains the HSV-1 gene encoding Vmw65 (Campbell 
etal., 1984) and pMCl .in 17 contains a 12 bp insertion, very near to the 
C terminus of the coding sequences, that does not affect the activity of 
Vmw65 {Ace etal., 1988). The use of pMCl .in 17, as opposed to pMCl, 
is irrelevant to the work described here. The resultant plasmid, 
pMCORFlO, contains the VZV ORF 10 coding sequences in place of 
the Vmw65 coding sequences.
Plasmids pGEMTIF and the insertion mutant pGEMTIF.ini5, 
described previously (Ace et al., 1988), were used for in vitro 
transcription and translation. Plasmid pFJ3, containing the /?- 
galaclosidase gene controlled by simian virus 40 promoter and 
enhancer sequences was kindly provided by Dr F. J. Rixon. Plasmid 
pRR55, containing the CAT gene under the control of human 
cytomegalovirus (HCMV) strain AD169 IE gene promoter and 
enhancer sequences (Fickenscher et al., 1989), was kindly provided by 
Dr R. Riiger. Plasmid plE3CAT, containing the CAT gene under 
HSV-1 IE gene 3 control (Stow et al., 1986), was kindly supplied by Dr 
T. Paterson.
Cells. Baby hamster kidney (BHK) cells were grown in Eagle’s 
medium containing 10% tryplose phosphate and 10% newborn calf 
serum. Human foetal lung (HFL) cells were grown in Eagle’s medium 
containing 10% foetal calf serum and HeLa cells were grown in 
Dulbecco’s medium containing 2-5% newborn and 2-5% foetal calf 
serum. Penicillin (100 units/ml) and streptomycin (100 pg/ml) were 
added to all media.
Preparation of VZ V-infecled cell RNA. HFL cells were infected by the 
addition of a one-sixth quantity of VZV-infected HFL cells showing 70 
to 80% c.p.e. When the culture reached 70 to 80% c.p.e. cytoplasmic 
RNA was extracted as described by Preston (1977).
Primer extension. A 29 base oligonucleotide (5'GGGGTGTA- 
GAGCGCTGCATCGGCGGCGTA3', complementary to a region 
close to the N terminus of VZV ORF 62 (Fig. 1), was 5' end-labelled 
with 3JP using T4 polynucleotide kinase. Ten pg of cytoplasmic RNA 
was mixed with radiolabelled oligonucleotide in hybridization buffer 
(40 mM-KCl and 50 mM-Tris-HCl pH 8-3) and heated to 90 °C. The 
temperature was decreased to 45 °C over 1 h, MgCl2 was added to a 
final concentration of 5 mM and the four deoxynucleoside triphos­
phates were added at a concentration of 0-5 mM. Reverse transcriptase
VZ V IE  gene expression 003
"  Sail
CACACCGTCGACGTGCATTTGATTAACTAGATGCCGGATGGGTGGAAACAACCCGTGTTA - 356
Octamer
TATAAGATGTTTTGCATGTGAGACAACCCCAATTGTGTTTATGTATATTATATATCGTCT — 296
Accl Oct/TG AJtlll
GTAGACACACGATGATTGGTTGTTATTTAAACATATGTAAATGAAATTCACATGTCTGGT -236 
ATCCCTTGTTATGATGTTGTAAGGTATGCGG AAATAGACACCGGGCGTACATCGCCAACC - I 76
Xho\
AGCGGTCTCTCCTTAAACGCATACTATGGTCCATGAACTTCCCOCCTCGAGTCTCGTCCA - 1 1 6 
ATCACTACATCGTCTTATCATTAAGAATATTTACACGGTGACGACACGGGGAGGAAATAT -56
'TATA' mRNA|-►
GCGGTCGACGGGGGCOCACAACACGTTTTAAGTACTGTTGGAACTCCCTCACCAACCGCA +5
£coRI
ATCGCAATCCTTTGAAGGCTGCGAG AGCGTTTGG AAAACTCGGGT ACGTCT AAATTC ACC +65
Met (G)
CCAGTGCGATGGATAeCCCGeCCATGCACCGCTCTACACCCCAACGC +112
Fig. 1. DNA sequences in the upstream regulatory region of VZV 
ORF 62. Restriction endonuclease cleavage sites relevant to the results 
are underlined. The mRNA start site is designated + 1 by convention 
and a TATA box homology TTTTAA is found at positions — 25 to 
—  30. A 13 bp sequence centred at — 255 contains both octamer and 
TAATGARAT motifs and a simple octamer motif in inverse 
orientation is present al nucleotides — 346 to —339. Sequences from 
which oligonucleotides for use in primer extension and SI nuclease 
analysis were constructed are underlined. The A residue at position 
+ 57 was changed to a G residue during the construction of pMOCAT.
j (10 units) was added and the reaction continued at 45 °C for 30 min. 
j Reaction mixtures were extracted with phenol-chloroform and 
precipitated with ethanol. Precipitates were dissolved in 90% 
formamide in 90 mM-Tris-borate pH 8-3 and 2-5 mM-EDTA, and 
heated at 90 °C for 1 min. Samples were electrophoresed on a 12% 
sequencing polyacrylamide gel and radiolabelled bands detected by 
autoradiography.
, Nuclease SI mapping. A 77 base oligonucleotide (5'GAGTTTTCC- 
, AAACGCTCTCGCACCTTCAAAGGATTGCGATTGCGTTG- 
! GTGAGGGAGTTCCAACAGTACTTAAAACGT3') was synthe­
sized and 5' end-labelled with 32P using T4 polynucleotide kinase. The 
oligonucleotide was designed to overlap the VZV major IE RNA 5' 
terminus predicted by primer extension analysis (Fig. 1). Radiolabelled 
oligonucleotide was hybridized with 10 pg of VZV-infected cell RNA 
| at 42 °C for 16 h, the reaction mixture treated with nuclease S1 and the 
! products were electrophoresed on denaturing 12% polyacrylamide 
sequencing gels, as described previously (Rixon & Clements, 1982; 
j Preston et al., 1984).
■ Transfections. Monolayers of 3 x 106 BHK cells in 50 mm diameter
■ Petri dishes were transfected with calcium phosphate-precipitated 
DNA, as described by Cordingley et al. (1983). Precipitates contained 
5 pgof CAT-containing plasmid and 0-5 pgof pFJ3. Three pg of pMCl 
was added, where appropriate, and the total amount of DNA was 
adjusted to 9 pg by the addition of pUC18 DNA. Cells were harvested 
after 18 h at 37 °C.
Monolayers of 106 HeLa cells in 50 mm diameter Petri dishes were 
transfected with calcium phosphate-precipitated DNA, as described 
by Corsalo & Pearson (1981). Precipitates contained 8 pg of CAT- 
containing plasmid, 1 pg of pFJ3, 5 pg of pMCl, where appropriate, 
and pUC18 DNA to give a total of 16 pg. HeLa cells were harvested 
after incubation at 37 °C for 40 h.
| CAT and fi-galactosidase assays. Cell extracts were prepared and 
! assayed for CAT activity as described by Gorman et al. (1982). /?- 
Galactosidase was assayed as described by Spaete & Mocarski (1985).
■ Before conducting CAT assays, extracts were adjusted to contain equal
| /?-galatosidase activities, to correct for variations in transfection 
i efficiencies. In practice this resulted in dilutions never greater than 
threefold for BHK cell extracts and fivefold for HeLa cell extracts. To 
quantify CAT assays radioactive spots were cut out and the percentage 
of substrate acetylated was calculated after scintillation counting. The 
amount of extract was varied to ensure that the linear response range of 
the assay was used.
In vitro transcription and translation. Plasmids were cleaved with 
appropriate restriction enzymes and in vitro transcription and 
translation was carried out as described by Ace et al. (1988). Duplicate 
translations were performed in either the presence or absence of 
(J5S]melhionine. Radiolabelled samples were analysed by SDS-PAGE 
(Preston, 1979) and non-radioactive samples were used in gel 
retardation assays.
Gel retardation assays. HeLa cell nuclear extracts and extracts of 
HSV-1 particles were prepared as described previously (Preston et a!., 
1988). DNA fragments were radiolabellcd by incubation with T4 DNA 
polymerase and two non-radioactive and two 32P-labelIed dcoxynu- 
cleoside triphosphates and purified from polyacrylamide gels. Binding 
reactions contained 10 mM-HEPES pH 7-9, 0-6 inM-dithiothrcilol, 2 3 
mM MgCI2, 0-1 mg/ml bovine scrum albumin, 4 pg poly(dl). poly(dC), 
approximately 0-2 ng radiolabellcd DNA fragment, 5 pg HeLa cell 
nuclear extract and, where appropriate, HSV-1 extract (0-5 pg) or a 
sample containing Vmw65 or VZV ORF 10 synthesized in vitro. After 
incubation at 25 °C for 30 min reaction mixtures were loaded onto a 
3-5% polyacrylamide gel, electrophoresis was carried out for 3-5 h at 
160 V and the gel was dried and exposed for autoradiography. If assays 
involved the use of competitor oligonucleotides then a 100-fold molar 
excess was incubated with the reaction components for 15 inin prior to 
the addition of a radiolabelled DNA fragment. Competitors used were 
all 36 bp, one containing a CCAAT sequence (Preston et al., 1988), one 
the adenovirus major late promoter (MLP) recognition sequence 
(Preston et al., 1988) and the other two containing ATGCAAAT- 
CATGT (octamer) or GCGGTAATGAGAT (TAATGARAT) in an 
otherwise identical sequence context.
DNase I protection assays. DNA fragments were uniquely 3' end- 
labelled and used for gel retardation analysis. Prolein-DNA complexes 
were eluted from polyacrylamide gels, and DNase I protected regions 
were identified as described by Preston et al. (1988).
Results
Mapping the 5' terminus o f the V Z V  major IE  RNA
To analyse the regulation o f V Z V  IE  transcription it  was 
first necessary to determine the location o f the m R N A  5' 
terminus. Two techniques were used for this analysis. 
First, the length o f the 5' untranslated region was 
determined by prim er extension analysis using an 5' 32P- 
labelled synthetic oligonucleotide complementary to 29 
bases o f the N-term inal coding sequence o f ORF 62. Fig. 
2 shows that an extension product o f 105 bases was 
produced from VZV-infected cell R N A , but not mock- 
infected cell R N A , indicating that the length o f the 5' 
non-coding region is 71 bases. No extension products 
| longer than 105 bases were detected (results not shown). 
| To confirm the primer extension result and to exclude the 
1 existence o f an intron w ith in  the 5' non-coding region,
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Fig. 2. Mapping the 5' end of the mRNA. (a) Primer extension analysis 
was performed on three RNA samples prepared from different batches 
of VZV-infected HFL cells (lanes 1, 2 and 3) and from mock-infected 
HFL cells (lane 4). Markers of the indicated sizes (bp) were run in 
parallel and the extended product is labelled (# ). (b) Nuclease SI 
analysis was performed on RNA prepared from VZV-infected HFL 
cells (lane 5) or mock-infected cells (lane 6 ). G and G +  A lanes of the 
oligonucleotide used in the assay were included as size markers and 
appropriate exposures are shown (lanes 7 and 8 ). Undigested 
oligonucleotide (□ ) and digested product (■ )  are labelled.
nuclease SI analysis was carried out using a radiolabelled 
probe that spanned the 5' terminus predicted by primer 
extension. As shown in Fig. 2(b) a cluster o f protected 
D N A  bands o f 45, 46 and 47 bases was observed when 
VZV-infected cell R N A , but not mock-infected cell 
R N A , was used, in agreement w ith  the result o f the 
primer extension analysis and excluding the possibility 
o f splicing in the 5' untranslated region.
Inspection o f the sequence (Fig. 1) reveals the element 
T T T T A A  to be 25 to 30 bp upstream o f the m R N A  start 
site. This probably represents the T A T A  box, a cis- 
acting element known to be an important signal for the 
correct in itia tion  o f transcription by R N A  polymerase 
II.
| Functional activity o f V Z V  IE  gene control sequences
; Having ascertained the location o f the m R N A  5' 
terminus a plasmid, pMOCAT, was constructed in which 
sequences from +57 to —1146 were inserted 5' to the 
C A T  gene. A comparison o f the activ ity o f this plasmid 
w ith p IE3C AT and pRR55, in which the HSV IE3 and 
the H C M V  IE  control sequences, respectively, direct 
i expression o f C AT, is shown in Fig. 3. The activities o f
p!40CAT pRR55 plE3CAT
pMCl - + - - + - +
Dilution 1 i i 250 250 250 250
Lane 1 2 3 4 5 6 7
m O &
m m 0 0 o 0 0
Fig. 3. Comparison of the activities of IE control sequences of VZV 
(lanes 1 and 2), HCMV (Ianes4and 5) and HSV-1 (lanes 6 and 7) linked 
to the CAT gene. Lane 3 represents mock-transfection. In lanes 
marked +  (lanes 2, 5 and 7) reporter plasmids were cotransfected with 
pM Cl, whereas in lanes marked — (lanes 1,4 and 6 ) pUC18 was added 
in order to equalize plasmid quantities.
pMOCAT
p M C l -  
Lane 1
pA410CAT p A I3 IC A T
-------- :— i i-----------1
pC A T M I
O  o  O  O
o
o
pMOCAT pA410CAT 
p M C l ^  + 1 r“ ^  + -1
Lane 10 11 12 13
PA131CAT M T
14 16
- . • m m  i: ■ ■
Fig. 4. Activity of pMOCAT and deletion mutants in BHK cells (lanes 
1 to 9) and HeLa cells (lanes 10 to 16). To demonstrate the 
reponsiveness of these sequences to Vmw65, cells for lanes marked + 
were cotransfected with pMCl and those for lanes marked — with 
pU C l8 . Samples 10 to 16 were excised from the same autoradiograph 
and represent equal exposures.
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Formation o f protein-DNA complexes responsible for 
stimulation by Vmw65
Previous studies have shown that stimulation o f tran­
scription by Vmw65 depends on the presence o f 
T A A T G A R A T  in the control sequences o f the gene in 
question. Vmw65 does not bind directly to T A A T ­
G A R A T, but interacts w ith  proteins that themselves 
recognize the octamer element A T G C A A A T  as well as 
T A A T G A R A T . Analysis o f the region upstream o f the 
T A T A  box reveals two sites that match the octamer 
element closely. Site I (TT T T G C A T ) is centred at —345 
and matches the octamer element at seven out o f eight 
positions in the opposite orientation. Site I I  (ATG - 
T A A A T G A A A T ) is centred at —256 and is a more 
complicated m otif representing a combination o f the 
octamer sequence (seven out o f eight matches) and the 
T A A T G A R A T  m otif (eight out o f nine matches). Both 
o f these sites are w ith in  nucleotides —410 to —131, 
defined above as the region that determines the response 
to Vmw65.
Binding o f cell proteins and Vmw65 to these sites was 
investigated by gel retardation assays (Fig. 5). Three 
radiolabelled fragments from the region —410 to — 131 
in the VZV  IE  promoter were tested in the assay. A 114 
bp SalljAccl fragment, containing T T T T G C A T , gave a 
complex (lane 2) and, upon addition o f v irion extract, 
slightly more material that migrated slowly into the gel 
was observed (lane 1). Additional experiments con­
firmed that the major complexes comigrated w ith  the 
previously described HC3 (Preston et al., 1988) (results 
not shown). Production o f the radiolabelled complexes ■ 
was competed for by the addition o f oligonucleotide 
containing A T G C A A A T  (lanes 3 and 4), but not by an 
oligonucleotide containing C C A A T  (lanes 5 and 6). A  49 
bp AccljAflWl fragment containing A T G T A A A T - ; 
G A A A T  readily formed the HC3 complex (lane 8) and : 
upon addition o f virion extract a major band represent­
ing IEC was formed (lane 7). Oligonucleotides contain­
ing T A A T G A G A T  or A T G C A A A T  competed effi­
ciently (lanes 9 to 12), but oligonucleotides containing !
C C A A T or M LP recognition sites did not (lanes 13 to ^
16). An A /llll/X h o l fragment making up the remainder 
o f the —410 to — 131 region failed to form any pro te in - . 1 
D N A  complexes (results not shown). Thus two subfrag- j
ments of the —410 to — 131 region bind proteins to form j
an HC3-like complex, the IEC  forms efficiently on the 
A cc llA filll fragment that contains an eight out o f nine !
match to T A A T G A R A T . j
The protein binding site on an AccljXhol fragment j
(Fig. 1) was determined by DNase I protection analysis j
(Fig. 6). The only footprin t detected in the HC3 complex j
was a disturbance to the digestion pattern at A T G - ; j 
T A A A T G A A A T  (lane 2) and a slight extension o f the i
A
Fig. 6 . DNase I footprinting analysis of a 165 bp Accl/Xhol ( —296 to 
— 131) fragment. Lanes 4 and 5 are G and G +  A sequencing tracks. 
Prior to DNase I treatment, the fragment in lane 1 was incubated with 
HeLa cell extract and virion extract, the fragment in lane 2 with HeLa 
extract, whereas lane track 3 represents free fragment alone. Dark bars 
represent the sequences protected and hypersensitive sites are labelled 
HS.
region o f protection occurred in the presence o f Vmw65 
(lane 1).
By analogy w ith  the well characterized HSV-1 system 
it is likely that the element A T G T A A A T G A A A T  is o f 
major importance for the observed stimulation of 
expression from the V Z V  major IE  promoter by Vmw65.
Activity o f V Z V  O R F  10
It was o f interest to determine whether the VZV  
homologue o f Vmw65, the ORF 10 product, could also
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stimulate transcription from  the V Z V  major IE  gene. 
The coding sequences o f Vmw65 in the plasmid p M C l 
were replaced by those o f ORF 10 to form the plasmid 
pMCORFlO. When pM CO RFlO  was used in  short term 
transfection assays it failed to stimulate expression from 
either pMOCAT or p IE3C A T (results not shown). To 
determine whether the protein encoded by O RF 10 was 
able to form a complex analogous to IEC, the coding 
sequences were inserted into the polylinker o f the 
plasmid pTZ18R, which allows the transcription o f 
ORFs in vitro. Two separate clones o f this construction, 
pTZO RFlO A and pTZORFlOB, were isolated and 
transcribed, together w ith  the plasmid p G E M T IF  (Ace 
et al., 1988), which encodes Vmw65, using T7 R N A  
polymerase. In  addition, p G E M T IF .in i5  cleaved w ith  
BamYLl was transcribed to provide a transcript lacking 
the sequences encoding the acidic C-terminal tail, but 
retaining the N-term inal 410 amino acids o f Vmw65 that 
are homologous to ORF 10. The transcripts were then 
translated using rabbit reticulocyte lysate in  the presence 
or absence o f [35S]methionine. Samples o f reactions in 
which [35S]methionine was incorporated revealed the 
presence o f translation products o f the expected sizes 
upon SDS-PAGE (Fig. 7); differences in the intensities 
o f the bands produced by the V Z V  and HSV polypep­
tides, are largely due to the occurrence o f threefold more 
methionine residues in HSV-1 Vmw65 than in  V Z V
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Fig. 8. Gel retardation assay using in vitro synthesized Vmw65 and 
ORF 10 products. Radiolabellcd probes used on binding reactions were 
a 49 bp Accl/Afllll fragment from the VZV major IE gene control 
sequences (lanes I to 7) and a 74 bp fragment from HSV 1 IE control 
sequences (lanes 8 to 12). Fragments were incubated with HeLa cell 
nuclear extract alone (lanes 1 and 8) and with addition of virion extract 
(lanes 2 and 9), or translated products of ORF 10 (lanes 3, 4 and 10), 
pGEMTIF (lanes 5), pGEMTIF. inl5 (lanes 6 and 11), or pGEMTIF 
(lanes 7 and 12). The positions of complexes IEC and HC3 are 
indicated.
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ORF 10 protein. Samples o f reactions lacking [ 35S]meth- 
ionine were used for gel retardation assays with 
radiolabelled D N A  fragments containing the T A A T ­
G A R A T  elements o f V Z V  or HSV-1 (Figl 8). As 
expected, Vmw65 produced in vitro from pG E M T IF  
directed the formation o f IEC  when tested w ith the 49 bp 
A ccl/A /nU  from the V Z V  IE gene or the 74 bp 
oligonucleotide derived from HSV-1 IE  gene 4/5 (lanes 7 
and 12). Truncated Vmw65 also formed IEC w ith  each 
fragment (lanes 6 and 11), showing that the acidic C 
terminus does not participate in the interaction of 
Vmw65 w ith cellular proteins to form IEC. However, 
VC V ORF 10 did not direct the formation o f a complex 
analogous to IEC  with either VZV  or HSV-1 fragments 
(lanes 3, 4 and 10). Therefore, although ORF 10 protein 
is a homologue o f Vmw65, it does not active IE 
transcription or form IEC.
Fig. 7. In vitro translation of Vmw65 and ORF 65 polypeptides. RNA 
transcribed from pGEMTIF.in 15 (lane 1), pGEMTIF (lane 2), 
pGEM2 (lane 3) and pGEMORFlOA and -B (lanes 4 and 5) were 
translated in vitro in the presence of {35Sjmethionine. M r values of the 
proteins predicted from the DNA sequence are given. Comparison 
with M r standards gives apparent M t of 63000 (Vmw65) and 54000 
(ORF 10).
Discussion
The V Z V  major IE  gene possesses two classes o f control 
sequences, as measured in the transfection assays. A 
promoter responsible for basal gene expression lies
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w ith in  the region —131 to +55, whereas sequences that 
mediate stimulation o f expression by Vmw65 are located 
further upstream, between —410 and — 131. The identity 
o f the promoter is unknown, but the elements 
T T T TG C A T  and, particularly, A T G T A A A T G A A A T  
are strongly implicated in the response to Vmw65. The 
observation that expression o f ORF 62 is stimulated by 
Vmw65 confirms and extends the work o f Felser et al. 
(1988), in which the response o f ORF 62 to infection by 
HSV-1 was first described. However, our candidate 
responding sequences d iffer from the predicted regula­
tory elements o f the earlier study. Felser et al. (1988) 
assumed that the T A T A  box is located 374 bp from the 
first A U G  o f ORF 62 and consequently identified a 
number o f potential signals upstream o f this site. The 
primer extension and nuclease SI analyses presented 
here result in an assignment o f the element T T T T A A , 97 
bp from the first A U G  o f O RF 62, as the T A T A  box and 
hence a different set o f regulatory sequences.
The V ZV  IE  gene upstream region was considerably 
less effective at directing C A T  production than were 
equivalent control sequences o f HSV-1 or H C M V . Thus, 
VZV  does not possess an efficient promoter or enhancer 
that operates in the systems tested here, in contrast to 
HSV-1 (Lang et al., 1984; Preston &  Tannahill, 1984), 
H C M V  (Boshart et al., 1985) and, presumably, pseudo­
rabies virus (PRV) (Campbell &  Preston, 1987). This 
finding can be viewed in two ways. The alphaherpesvir- 
uses HSV-1 and PRV produce only lim ited amounts o f 
Vm wl75 and 180K, the respective IE  proteins homolo­
gous to the product o f V Z V  ORF 62, during normal 
infection because autoregulation by the HSV-1 and PRV 
IE  proteins results in a rapid reduction in transcription o f 
their genes (Watson, &  Clements, 1980; lhara et al., 
1983; O ’Hare &  Hayward, 19856; M uller, 1987). This 
homeostatic mechanism stabilizes the levels o f Vm w l75 
and 180 K  and thus the potential fo r high level synthesis, 
which occurs when autoregulation is prevented, is not 
realized. In the case o f V Z V , ORF 62 product may 
accumulate more slowly, but reaches intracellular levels 
comparable to those o f Vm w 175 or 180 K . Alternatively, 
the low observed activ ity o f p l40C T  may be related to 
the cell types used in this study. Even the most 
permissive tissue culture cells, such as H F L  cells, human 
foreskin fibroblasts or Vero cells, give low virus yields 
and could be viewed as only semi-permissive. Although 
the activity o f pMOCAT is low in  Vero as well as B H K  
and HeLa cells (T. A . McKee, unpublished results), the 
possibility remains that the V Z V  major IE  promoter 
would be stronger in a natural host cell type. U nfortu ­
nately, the tissue culture systems currently available do 
not accurately reproduce the efficient growth o f V ZV  
that occurs during infection in vivo.
The failure o f VZV  O RF 10 protein to stimulate
j expression from HSV-1 or V Z V  IE  gene promoters was 
' expected, since it lacks the C-terminal acidic region that 
: is crucial for the activ ity o f Vmw65 (Sadowski et al., 
1988; Triezenberg et al.,  1988). It was more suprising to 
find that ORF 10 did not form a ternary complex w ith 
cellular factors and either homologous or heterologous 
T A A T G A R A T  elements. The possibility that the acidic 
C terminus is required for formation o f IEC  was 
eliminated by the demonstration that the N-term inal 411 
amino acids o f Vmw65 are fully active in the gel 
retardation assay, in agreement w ith the recent report o f 
Greaves &  O ’Hare (1989). Thus, the observed homology 
between Vmw65 and V Z V  ORF 10 protein reflects 
conservation o f features required for assembly o f virus 
particles rather than for structures involved in interac­
tion w ith cellular factors that bind T A A T G A R A T . The 
HSV-1 protein Vmw65 therefore possesses two distinct 
functional characteristics that are absent from the latter, 
i namely a binding site, as yet undefined, for cellular 
: proteins and an acidic C-terminal activating region.
' Functional analyses have now been performed on IE 
; control regions from the alphaherpcsviruses HSV-1 
i (Mackein &  Roizman, 1982; Preston et al., 1984; O ’Hare 
; &  Hayward, 1987), herpes simplex virus type 2 (HSV-2) 
(Gaffney et al., 1985), PRV (Campbell &  Preston, 1987)
; and VZV . The HSV-1 protein Vmw65 and its HSV-2 
• homologue stimulate IE  transcription from all these 
■ viruses, but PRV particles do not contain an active 
I counterpart and V ZV  ORF 10 is inactive. W ith  the 
: reservation that stimulation o f VZV  IE  transcription 
! may be carried out by another virion protein, it appears 
; that HSV-1 and HSV-2 differ fundamentally from PRV 
J and V Z V  in this respect. A ll four viruses possess 
| elements that respond to Vmw65 in their IE  control 
j regions, but the reason that the sequences are retained in 
j the absence o f the effector protein is unclear at present, 
j One possibility is that binding o f cellular proteins to 
| T A A T G A R A T  per se is sufficient to confer IE  speci- 
| ficity to a gene, perhaps by displacing repressors and 
| rendering the promoter accessible to transcription 
j factors. This hypothesis is compatible w ith  the obscrva- 
| tion that the HSV-1 mutant m l814, which specifies a 
j form o f Vmw65 inactive for trans-induction, ncverthe- 
| less transcribes IE  genes during infection in the absence 
! o f protein synthesis (Ace et al., 1989). As previously 
j suggested (Ace et al., 1989) T A A T G A R A T , rather than 
! an active effector protein, may be the primary detcrmi- 
; nant o f an IE  gene. It  is also possible that functional
i T A A T G A R A T  elements are retained by V ZV  and PRV! J
j because certain cell types contain homologues o f Vmw65 
! that replace its function. This explanation could account 
; for the low activ ity o f the V Z V  major IE  gene promoter 
I in tissue culture cells and suggests that higher activity 
j could be attained in the appropriate host cells. It is a
V ZV  IE  gene expression 00‘
challenging future prospect to determine whether the 
intriguing variations in strategies used for the expression 
o f IE  genes is related to the biological properties o f 
different herpesviruses.
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  Origin of DNA Repilcation
C G C G C G A A C A A G A A A C T C T C T C T C T T T C T C T A T A T A T A T A T A T A T A T A T A T A T A T A T A T A
TAG AAAG AA AG TG C G A AC G G TG G TTG G AC AC A TG C C AA AA C A TG AA AAC C C ATAC A G TG A
AA AA AC G G G A AG TG C G A ATG C AG ATC AAAAG AG TG TATC C G ATTG G CG TAC AC C AC AG AC
AT G C G G A C G C C C A ATTTAAC C C C C C C C C TTTTTC A C C C C C C C A C C C C AC C C C ATTC C AC C
Ddel
C C A G G A A G T G C G A A C G G G T TT A C A T G C C T C A G A T A T G A A G T T C T TC G A C TT G TT T T T G A A
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Kpnl......................................................
G TAC C GCGCCCCCTCCCCATCGGCGGGGTACCGCGCCCCCTCCCCATCGGCGGGGTACCG
Reiteration R4 ............................ Kpnl.......
CGCCCCCTCCCCATCGGCGGGGTACCGCGCCCCCTCCCCATCGGCGGGGTACCGCGCCCC
C TCC C C ATC G G C G G G G G G TTAC G TG A AC AC C AC AA C CC C G TG TG TA TTTTATG G G TTATC
ACC I
GCGGG CTTCGTGCCGCCTG ACATAATCG TTG GGAG GGGTGG TG GTG T A T A C G C TTG TTG A
Sail
TTGCGCGAACG TAATG ACG ACG G AG AG GG ACCCAAACACACCGTCGACG T G C A T T T G A T T
Octamer
AAC  TAG A T  GCCGGATGGGTG G A A A C  AA C  C C G T G T T A  T A T  AAG A T  G TTTTGCATG T GAG AC
ACC I
A A C C C C A A T T G T G T T T A T G T A T A T T A T A T A T C G T C T G T A G A C A C A C G A T G A T T G G T T G T T
Octamer/TG AflIII
A T T T A A A C A T A T G T A A A T G A A A T TCA C A T G T C T G G T A T C C C T T G T T A T G A T G T T G T A A G G
TATG C G G AAATAG ACACC G G G C G TAC ATC G C C AAC C AG CG G TCTC TC CTTAAAC G C ATAC
Xhol CCAAT
T A T G G TC C A T G A A C T T C C C G C CTCG AGT C T C G T C C AATC A C T A C A T C G T C T T A T C A T T A A
SspI ATF/CRE PEA-2 Af\ZIII
GA A T A T T TA C A C G G TGACGACACG GGG AGG AAATATGCGGTCGAGGGGGGGGCACAACAC
'TATA' Seal mRNA|
G T T T T A A G T A C T G TTG G A AC TC C C TC AC C AAC C G C AATCG CAATC CTTTG AAG G C TG C G A
  SI Nuclease Oligo . ■■.. .. —
EcoRI Met
G A G C G TTTG G AAAAC TC G G G TACG TCTA A A T T C A CCCCAGTGCGATGGATACGCCGCCGA 
----------------- (G) «
TG C AG C G C TC TAC AC C C CAACG CG CG G G G TCG CCTG ATACTTTG G AG TTAATG GACCTG T 
P.E. Oligo. — ..
- 1 0 5 2  
- 9 9 2  
- 9 3 2  
- 8 7 2  
- 8 1 2  
- 7 5 2  
- 6 9 2  
- 6 3 2  
- 5 7 2  
- 5 1 2  
- 4 5 2  
- 3 9 2  
- 3 3 2  
- 2 7 2  
-212 
- 1 5 2  
- 9 2  
- 3 2  
+ 2 9  
+ 89  
+ 1 4 9
